Psyllid ID: psy7902
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 342 | 2.2.26 [Sep-21-2011] | |||||||
| O73790 | 410 | Heterochromatin-associate | yes | N/A | 0.970 | 0.809 | 0.271 | 3e-28 | |
| P50453 | 376 | Serpin B9 OS=Homo sapiens | yes | N/A | 0.932 | 0.848 | 0.276 | 4e-28 | |
| P05154 | 406 | Plasma serine protease in | no | N/A | 0.938 | 0.790 | 0.292 | 1e-27 | |
| Q5BIR5 | 374 | Serpin B8 OS=Bos taurus G | no | N/A | 0.944 | 0.863 | 0.275 | 1e-27 | |
| P29524 | 416 | Plasminogen activator inh | yes | N/A | 0.970 | 0.798 | 0.280 | 1e-27 | |
| P12388 | 415 | Plasminogen activator inh | no | N/A | 0.973 | 0.802 | 0.289 | 3e-27 | |
| P05120 | 415 | Plasminogen activator inh | no | N/A | 0.961 | 0.792 | 0.274 | 6e-27 | |
| Q5I0S8 | 377 | Leukocyte elastase inhibi | no | N/A | 0.959 | 0.870 | 0.294 | 7e-27 | |
| P29508 | 390 | Serpin B3 OS=Homo sapiens | no | N/A | 0.961 | 0.843 | 0.311 | 3e-26 | |
| Q5JJ64 | 426 | Uncharacterized serpin-li | yes | N/A | 0.944 | 0.758 | 0.315 | 4e-26 |
| >sp|O73790|SPB10_CHICK Heterochromatin-associated protein MENT OS=Gallus gallus GN=SERPINB10 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 125 bits (315), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 109/402 (27%), Positives = 189/402 (47%), Gaps = 70/402 (17%)
Query: 2 FTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTM 61
FT DL LN N+ KN+F SP+SI AL Y + +T + +VL E + + ++
Sbjct: 11 FTVDLFNKLNETNRDKNIFFSPWSISSALALTYLAAKGSTAREMAEVLHFTEAV-RAESS 69
Query: 62 NVYKMEKLIQGLR---------ANADSGL--------------TFTSTNKIFVNDK---I 95
+V + + R N SG + S N+I+V +
Sbjct: 70 SVARPSRGRPKRRRMDPEHEQAENIHSGFKELLTAFNKPRNNYSLRSANRIYVEKTYALL 129
Query: 96 PVK-ECMTAIFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL 153
P + + +E Q ++F E +R IN+WV ++T++ IK+L+++ V + T L+L
Sbjct: 130 PTYLQLSKKYYKAEPQKVNFKTAPEQSRKEINTWVEKQTESKIKNLLSSDDVKATTRLIL 189
Query: 154 ---------WLPSTQESIIII-----------------------TVLSSELNAHILEVPY 181
W Q I ++ ++N ++E+PY
Sbjct: 190 VNAIYFKAEWEVKFQAEKTSIQPFRLSKNKSKPVKMMYMRDTFPVLIMEKMNFKMIELPY 249
Query: 182 KGGNMSMFFLLPPFASQDGVGDILAALKKDPTSFKRFTE--DSQNLKP--VEIAIPKFSL 237
+SMF LLP G L L+++ T ++R +E DS+ + V++ +PKFSL
Sbjct: 250 VKRELSMFILLPDDIKDGTTG--LEQLERELT-YERLSEWADSKMMTETLVDLHLPKFSL 306
Query: 238 TQEMNLIPTLSDLGVKDLFSPGADLSRLTDSH-IAFGDAVHKARLDLDEQGTTAAAATAV 296
++L TL ++G+ F+ AD +TD +A +H++ + +DE+GT AAAATAV
Sbjct: 307 EDRIDLRDTLRNMGMTTAFTTNADFRGMTDKKDLAISKVIHQSFVAVDEKGTEAAAATAV 366
Query: 297 -FAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337
+F +S ++++ +HPF +F+ + ++ILF G F P
Sbjct: 367 IISFTTSVINHVLKFKVDHPFHFFIRHNKSKTILFFGRFCCP 408
|
DNA-binding protein that promotes DNA condensation into transcriptionally inactive heterochromatin in terminally differentiated avian blood cells. Promotes tight packing of nucleosomes into spherical clusters by binding to linker DNA and subsequent oligomerization. Act as a cysteine protease inhibitor towards CTSL1 (cathepsin L1) and CTSL2 (cathepsin L2), but does not inhibit serine proteases. Gallus gallus (taxid: 9031) |
| >sp|P50453|SPB9_HUMAN Serpin B9 OS=Homo sapiens GN=SERPINB9 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 125 bits (314), Expect = 4e-28, Method: Compositional matrix adjust.
Identities = 106/383 (27%), Positives = 170/383 (44%), Gaps = 64/383 (16%)
Query: 2 FTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTM 61
F LL +L N NVF SP SI AL + NT + Q L L D
Sbjct: 11 FAIRLLKILCQDNPSHNVFCSPVSISSALAMVLLGAKGNTATQMAQALSLNTEED----- 65
Query: 62 NVYKMEKLIQGLRANADSGLT---FTSTNKIFVNDKIPV----KECMTAIFPSEIQSMDF 114
+ + Q L + T + N++F KE + +E++ + F
Sbjct: 66 ----IHRAFQSLLTEVNKAGTQYLLRTANRLFGEKTCQFLSTFKESCLQFYHAELKELSF 121
Query: 115 GNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL---------W---------- 154
E +R IN+WV+++T+ I++L+ +++ T LVL W
Sbjct: 122 IRAAEESRKHINTWVSKKTEGKIEELLPGSSIDAETRLVLVNAIYFKGKWNEPFDETYTR 181
Query: 155 -LP-------------STQESIIIITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDG 200
+P QE+ + + E+ A +LE+PY +S+ LLP DG
Sbjct: 182 EMPFKINQEEQRPVQMMYQEATFKLAHVG-EVRAQLLELPYARKELSLLVLLP----DDG 236
Query: 201 VGDILAALKKDPTSFKRFTE----DSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLF 256
V L+ ++K T F++ T D VE+ +PKF L ++ ++ L LG+ D F
Sbjct: 237 VE--LSTVEKSLT-FEKLTAWTKPDCMKSTEVEVLLPKFKLQEDYDMESVLRHLGIVDAF 293
Query: 257 SPG-ADLSRLT-DSHIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANH 314
G ADLS ++ + + VHK+ ++++E+GT AAAA++ F R+ A+H
Sbjct: 294 QQGKADLSAMSAERDLCLSKFVHKSFVEVNEEGTEAAAASSCFVVAECCMESGPRFCADH 353
Query: 315 PFLYFLVDKEIQSILFAGVFNEP 337
PFL+F+ SILF G F+ P
Sbjct: 354 PFLFFIRHNRANSILFCGRFSSP 376
|
Granzyme B inhibitor. Homo sapiens (taxid: 9606) |
| >sp|P05154|IPSP_HUMAN Plasma serine protease inhibitor OS=Homo sapiens GN=SERPINA5 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 124 bits (311), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 110/376 (29%), Positives = 184/376 (48%), Gaps = 55/376 (14%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
+FTFDL L +A +++F SP SI +L + +T+ + + L L NL K
Sbjct: 47 DFTFDLYRALASAAPSQSIFFSPVSISMSLAMLSLGAGSSTKMQILEGLGL--NLQKSSE 104
Query: 61 MNVYK-MEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKE----CMTAIFPSEIQSMDFG 115
+++ ++L+Q L D G + N +F + + +++ M ++ ++ +F
Sbjct: 105 KELHRGFQQLLQELNQPRD-GFQLSLGNALFTDLVVDLQDTFVSAMKTLYLADTFPTNFR 163
Query: 116 NEVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLV-------LWLPS----------- 157
+ A + IN +VA++TK I DL+ N+ +V W S
Sbjct: 164 DSAGAMKQINDYVAKQTKGKIVDLLKNLDSNAVVIMVNYIFFKAKWETSFNHKGTQEQDF 223
Query: 158 --TQESIIIITVLSSE----------LNAHILEVPYKGGNMSMFFLLPPFASQDGVGDIL 205
T E+++ + ++S E L+ ++ VPY+G N + F+LP V + L
Sbjct: 224 YVTSETVVRVPMMSREDQYHYLLDRNLSCRVVGVPYQG-NATALFILPSEGKMQQVENGL 282
Query: 206 A--ALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLS 263
+ L+K FK+ + +E+ +PKFS+ L L LG+ ++F+ ADLS
Sbjct: 283 SEKTLRKWLKMFKK--------RQLELYLPKFSIEGSYQLEKVLPSLGISNVFTSHADLS 334
Query: 264 RLTD-SHIAFGDAVHKARLDLDEQGTTAAAATA-VFAFRSSRPLEPVRYEANHPFLYFLV 321
+++ S+I + VHKA +++DE GT AAAAT +F FRS+R L R N PFL F+V
Sbjct: 335 GISNHSNIQVSEMVHKAVVEVDESGTRAAAATGTIFTFRSAR-LNSQRLVFNRPFLMFIV 393
Query: 322 DKEIQSILFAGVFNEP 337
D +ILF G N P
Sbjct: 394 DN---NILFLGKVNRP 406
|
Heparin-dependent serine protease inhibitor acting in body fluids and secretions. Inactivates serine proteases by binding irreversibly to their serine activation site. Involved in the regulation of intravascular and extravascular proteolytic activities. Plays hemostatic roles in the blood plasma. Acts as a procoagulant and proinflammatory factor by inhibiting the anticoagulant activated protein C factor as well as the generation of activated protein C factor by the thrombin/thrombomodulin complex. Acts as an anticoagulant factor by inhibiting blood coagulation factors like prothrombin, factor XI, factor Xa, plasma kallikrein and fibrinolytic enzymes such as tissue- and urinary-type plasminogen activators. In seminal plasma, inactivates several serine proteases implicated in the reproductive system. Inhibits the serpin acrosin; indirectly protects component of the male genital tract from being degraded by excessive released acrosin. Inhibits tissue-and urinary-type plasminogen activator, prostate-specific antigen and kallikrein activities; has a control on the sperm motility and fertilization. Inhibits the activated protein C-catalyzed degradation of SEMG1 and SEMG2; regulates the degradation of semenogelin during the process of transfer of spermatozoa from the male reproductive tract into the female tract. In urine, inhibits urinary-type plasminogen activator and kallikrein activities. Inactivates membrane-anchored serine proteases activities such as MPRSS7 and TMPRSS11E. Inhibits urinary-type plasminogen activator-dependent tumor cell invasion and metastasis. May also play a non-inhibitory role in seminal plasma and urine as an hydrophobic hormone carrier by its binding to retinoic acid. Homo sapiens (taxid: 9606) |
| >sp|Q5BIR5|SPB8_BOVIN Serpin B8 OS=Bos taurus GN=SERPINB8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 124 bits (310), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 104/377 (27%), Positives = 172/377 (45%), Gaps = 54/377 (14%)
Query: 2 FTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTM 61
F +LL +L + +NVF SP S+ L + NT A + Q L L E+ D
Sbjct: 11 FAINLLKMLGEEDHLRNVFFSPLSLSSVLTMVLMGAKGNTAAQMSQALCLNESGD----- 65
Query: 62 NVYK-MEKLIQGLRANADSGLTFTSTNKIF---VNDKIPV-KECMTAIFPSEIQSMDFGN 116
V++ + L++ + + L T+ N++F D +P KE + ++++ + F
Sbjct: 66 -VHRGFQSLLREVSTSGPKCLLRTA-NRLFGEKTCDFLPAFKESCQKFYQADLEELSFAE 123
Query: 117 EVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL---------W------------ 154
+ E R IN WV ++T I +++ G V+ T LVL W
Sbjct: 124 DTEECRKHINDWVMEKTDGKISEILGAGTVSPLTKLVLVNAIYFKGKWNEQFDRKHTRGM 183
Query: 155 -LPSTQESIIIITVLSS---------ELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDI 204
+ QE + + E+ A +LE+PY G +SM LLP + V +
Sbjct: 184 PFKTNQEKKTVQMMFKQAKFKMGHVEEVPAQVLELPYVGAELSMLILLPDENTDLAVVEK 243
Query: 205 LAALKK--DPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPG-AD 261
+K TS ++ TE+ V++ +P+ L +L L LG+ D F AD
Sbjct: 244 ALTYEKFRTWTSPEKLTEEK-----VQVFLPRLKLEASYDLEAFLRSLGMTDAFEEAKAD 298
Query: 262 LSRLT-DSHIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFL 320
S ++ ++ HK ++++E+GT AA ATAV +EP ++ A+HPFL+F+
Sbjct: 299 FSGMSAKKNVPMSKVAHKCFVEVNEEGTEAAGATAVVRNSRCCRMEP-KFCADHPFLFFI 357
Query: 321 VDKEIQSILFAGVFNEP 337
+E SILF G F+ P
Sbjct: 358 RHRETNSILFCGRFSSP 374
|
Bos taurus (taxid: 9913) |
| >sp|P29524|PAI2_RAT Plasminogen activator inhibitor 2 type A OS=Rattus norvegicus GN=Serpinb2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 124 bits (310), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 115/410 (28%), Positives = 188/410 (45%), Gaps = 78/410 (19%)
Query: 2 FTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRL---------- 51
F +LL + +N +N+F+SP+SI L + + NTE + +VL
Sbjct: 11 FALNLLKQIEQSNSTQNIFISPWSISSTLAIVFLGAQANTEEQMAKVLNFDKIGSYDLTP 70
Query: 52 --PENLDKLD-TMNVYKMEKLIQGLRANAD-------SGLTFT------------STNKI 89
PEN D ++ + + L+A A S L+ T S NK+
Sbjct: 71 GNPENFHGCDFAQHIQRDNYPVAILQAQARDKIHSAFSSLSSTINTPRLGDYLLESANKL 130
Query: 90 FVNDKIPVKE-----CMTAIFPSEIQSMDFGNEV-EAARAINSWVAQETKNNIKDLIATG 143
F KE C + +E +++DF EA + INSWV +TK I +L+ G
Sbjct: 131 FGEKSARFKEEYIQRC-KKYYSTEPEAVDFLECANEARKKINSWVKTQTKGEIPNLLPEG 189
Query: 144 QVNSRTNLVL---------WLPSTQESI---------------IIITVLSSELN------ 173
V+ T +VL W Q+ + + + L +LN
Sbjct: 190 SVDEDTKMVLVNTIYFKGRWKTPFQKRLNGLYPFRVNLNESKPVQMMYLREKLNIGYIKD 249
Query: 174 --AHILEVPYKGGNMSMFFLLPPFASQDGVGDILAALKKDPTSFKRF-TEDSQNLKPVEI 230
ILE+PY G N+SMF LLP G + + + +F ++ ++++ + V +
Sbjct: 250 LKTQILELPYIG-NISMFLLLPDEIEDSSTGLEMLEREINFDNFNKWISKETLDEDDVLV 308
Query: 231 AIPKFSLTQEMNLIPTLSDLGVKDLFSPG-ADLSRLTDSHIAF-GDAVHKARLDLDEQGT 288
IPKF L Q L P L +G++D F+ G AD S +++S+ F + H+A +D++E+GT
Sbjct: 309 YIPKFKLAQNYELKPILQRMGMEDAFNKGKADFSGMSESNDLFLSEVFHQATVDVNEEGT 368
Query: 289 TAAAAT-AVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337
AA T AV R+ ++ A+HPFL+F+++ ++ILF G F+ P
Sbjct: 369 VAAGGTGAVMTGRTGHG--GPQFVADHPFLFFIMNNITRTILFVGRFSSP 416
|
Inhibits urokinase-type plasminogen activator. Rattus norvegicus (taxid: 10116) |
| >sp|P12388|PAI2_MOUSE Plasminogen activator inhibitor 2, macrophage OS=Mus musculus GN=Serpinb2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 122 bits (307), Expect = 3e-27, Method: Compositional matrix adjust.
Identities = 118/408 (28%), Positives = 185/408 (45%), Gaps = 75/408 (18%)
Query: 2 FTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVL------------ 49
F +LL + +N +N+F+SP+SI L + NTE + +VL
Sbjct: 11 FALNLLKQIEKSNSTQNIFISPWSISSTLAIVLLGAGGNTEQQMAKVLQFNEIGSYGITT 70
Query: 50 RLPENLDKLDTMNVYKMEKLIQG-LRANAD-------SGLTFT-----------STNKIF 90
R PEN D + E L+A A S L+ T S NK+F
Sbjct: 71 RNPENFSGCDFAQQIQKENYPSAILQAQAGDKIHSAFSSLSSTINTPQGDYLLESANKLF 130
Query: 91 VNDKIPVKECMTAI----FPSEIQSMDFGNEVEAAR-AINSWVAQETKNNIKDLIATGQV 145
KE + + +E +++DF E AR INSWV +TK I +L+ G V
Sbjct: 131 GEKSARFKEEYIQLSKKYYSTEPEAVDFLECAEEAREKINSWVKTQTKGEIPNLLPEGSV 190
Query: 146 NSRTNLVL---------WLP--------------STQESI-IIITVLSSELN-------- 173
+ T +VL W ++ ESI + + L ++LN
Sbjct: 191 DEDTKMVLVNAVYFKGKWKTPFEKKLNGLYPFRVNSHESIPVQMMFLHAKLNIGYIKDLK 250
Query: 174 AHILEVPYKGGNMSMFFLLPPFASQDGVGDILAALKKDPTSFKRF-TEDSQNLKPVEIAI 232
ILE+P+ G N+SM LLP G L + + +F ++ ++D+ + V + I
Sbjct: 251 TQILELPHTG-NISMLLLLPDEIEDASTGLELLESEINFANFNKWISKDTLDEDDVVVYI 309
Query: 233 PKFSLTQEMNLIPTLSDLGVKDLFSPG-ADLSRLTDSHIAF-GDAVHKARLDLDEQGTTA 290
PKF L Q L L +G++D F+ G A+ S +++ + F + H+A +D+ E+GT A
Sbjct: 310 PKFKLAQSYELKSILQSMGMEDAFNKGKANFSGMSERNDLFLSEVFHQASVDVTEEGTVA 369
Query: 291 AAAT-AVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337
A T AV R+ ++ A+HPFL+F++DK +ILF G F+ P
Sbjct: 370 AGGTGAVMTGRTGHG--GPQFVADHPFLFFIMDKITHTILFVGRFSSP 415
|
Inhibits urokinase-type plasminogen activator. The monocyte derived PAI-2 is distinct from the endothelial cell-derived PAI-1. Not required for normal murine development or survival. Mus musculus (taxid: 10090) |
| >sp|P05120|PAI2_HUMAN Plasminogen activator inhibitor 2 OS=Homo sapiens GN=SERPINB2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 122 bits (305), Expect = 6e-27, Method: Compositional matrix adjust.
Identities = 113/412 (27%), Positives = 182/412 (44%), Gaps = 83/412 (20%)
Query: 2 FTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRL---------- 51
F +L L A+ +N+F+SP+SI + Y S +TE + +VL+
Sbjct: 11 FALNLFKHLAKASPTQNLFLSPWSISSTMAMVYMGSRGSTEDQMAKVLQFNEVGANAVTP 70
Query: 52 --PENLDKLDTMNVYK-------------MEKLIQGLRA-----NADSG-LTFTSTNKIF 90
PEN M + +K+ R+ NA +G S NK+F
Sbjct: 71 MTPENFTSCGFMQQIQKGSYPDAILQAQAADKIHSSFRSLSSAINASTGNYLLESVNKLF 130
Query: 91 VNDKIPVKE----CMTAIFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQV 145
+E + SE Q++DF E AR INSWV +TK I +L+ G V
Sbjct: 131 GEKSASFREEYIRLCQKYYSSEPQAVDFLECAEEARKKINSWVKTQTKGKIPNLLPEGSV 190
Query: 146 NSRTNLVL---------W---------------LPSTQESIIIITVLSSELN-------- 173
+ T +VL W + S Q + + + L +LN
Sbjct: 191 DGDTRMVLVNAVYFKGKWKTPFEKKLNGLYPFRVNSAQRTPVQMMYLREKLNIGYIEDLK 250
Query: 174 AHILEVPYKGGNMSMFFLLPPFASQDGVGDILAALK--KDPTSFKRF----TEDSQNLKP 227
A ILE+PY G++SMF LLP D + D+ L+ + ++ + ++D
Sbjct: 251 AQILELPY-AGDVSMFLLLP-----DEIADVSTGLELLESEITYDKLNKWTSKDKMAEDE 304
Query: 228 VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPG-ADLSRLTDSHIAF-GDAVHKARLDLDE 285
VE+ IP+F L + L L +G++D F+ G A+ S +++ + F + H+A +D++E
Sbjct: 305 VEVYIPQFKLEEHYELRSILRSMGMEDAFNKGRANFSGMSERNDLFLSEVFHQAMVDVNE 364
Query: 286 QGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337
+GT AAA T + P ++ A+HPFL+ ++ K ILF G F+ P
Sbjct: 365 EGTEAAAGTGGVMTGRTGHGGP-QFVADHPFLFLIMHKITNCILFFGRFSSP 415
|
Inhibits urokinase-type plasminogen activator. The monocyte derived PAI-2 is distinct from the endothelial cell-derived PAI-1. Homo sapiens (taxid: 9606) |
| >sp|Q5I0S8|ILEU_XENTR Leukocyte elastase inhibitor OS=Xenopus tropicalis GN=serpinb1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 121 bits (304), Expect = 7e-27, Method: Compositional matrix adjust.
Identities = 111/377 (29%), Positives = 183/377 (48%), Gaps = 49/377 (12%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLD---K 57
F+FDL +N N NVF SP SI AL + NT + ++L D
Sbjct: 10 HFSFDLFRKINENNATGNVFFSPISISTALAMVLLGARGNTAQQISRILHFDAVKDLHSN 69
Query: 58 LDTMNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKECMTAIFPSEIQSMDFGNE 117
T+N +K + N + L + K + VK+ A ++ ++DF +
Sbjct: 70 FQTLNAEINKKNVSSYALNLANRLFGEKSFKFLPDFLSSVKKQYNA----DLGTVDFISA 125
Query: 118 VEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL---------W-----------LP 156
E AR IN+WV+++TK I ++++ G VNS T LVL W +P
Sbjct: 126 AEDARKEINTWVSEQTKGKIPEVLSAGAVNSFTKLVLVNAIYFKGDWAKKFKAEHTKDMP 185
Query: 157 -----STQESIIIITVLSS-------ELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDI 204
Q+++ ++ + E+N +LE+PY +SM +LP + D G
Sbjct: 186 FQLNKKEQKTVKMMYQMEKLPFNYIPEINCRVLELPYVDYELSMVIVLPDNINDDTTG-- 243
Query: 205 LAALKKDPTSFKRFTEDSQNLKPVEIAI--PKFSLTQEMNLIPTLSDLGVKDLFSPG-AD 261
L L+K+ S ++ E ++N+ P+++ + PKF L L L+ +G+ DLF G AD
Sbjct: 244 LQQLEKE-LSLEKINEWTENMMPIDVHVHLPKFKLEDSYKLKSQLAGMGMADLFEAGSAD 302
Query: 262 LSRLTDSH-IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFL 320
LS ++ S+ + + +HK+ ++++E+GT AAAA+A A E + ANHPFL+F+
Sbjct: 303 LSGMSGSNDLYLSEVIHKSFVEVNEEGTEAAAASAGIAMMCLMREE--EFNANHPFLFFI 360
Query: 321 VDKEIQSILFAGVFNEP 337
+SILF G ++ P
Sbjct: 361 RHNATKSILFFGRYSSP 377
|
Regulates the activity of the neutrophil proteases. Xenopus tropicalis (taxid: 8364) |
| >sp|P29508|SPB3_HUMAN Serpin B3 OS=Homo sapiens GN=SERPINB3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 119 bits (298), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 121/389 (31%), Positives = 188/389 (48%), Gaps = 60/389 (15%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPE----NLD 56
+F FDL + K N+F SP SI AL + NT +K+VL +
Sbjct: 10 KFMFDLFQQFRKS-KENNIFYSPISITSALGMVLLGAKDNTAQQIKKVLHFDQVTENTTG 68
Query: 57 KLDTMNV-------YKMEKLIQGLRANADSGLTFTSTNKIFVNDK-IPVKECMTAI---F 105
K T +V ++ +KL+ + D+ NK+F + ++E + AI +
Sbjct: 69 KAATYHVDRSGNVHHQFQKLLTEFNKSTDA-YELKIANKLFGEKTYLFLQEYLDAIKKFY 127
Query: 106 PSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL---------WL 155
+ ++S+DF N E +R INSWV +T IK+LI G + S T LVL W
Sbjct: 128 QTSVESVDFANAPEESRKKINSWVESQTNEKIKNLIPEGNIGSNTTLVLVNAIYFKGQWE 187
Query: 156 P----------------STQESIIIITVLSS-------ELNAHILEVPYKGGNMSMFFLL 192
+T +SI ++ +S ++ A +LE+PYKG ++SM LL
Sbjct: 188 KKFNKEDTKEEKFWPNKNTYKSIQMMRQYTSFHFASLEDVQAKVLEIPYKGKDLSMIVLL 247
Query: 193 PPFASQDGVGDILAALKKDPTSFKRFTEDS-QNLKP--VEIAIPKFSLTQEMNLIPTLSD 249
P DG L L++ T+ K S QN++ V++ +P+F + + +L TL
Sbjct: 248 P--NEIDG----LQKLEEKLTAEKLMEWTSLQNMRETRVDLHLPRFKVEESYDLKDTLRT 301
Query: 250 LGVKDLFSPGADLSRLTDSH-IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPV 308
+G+ D+F+ ADLS +T S + +HKA +++ E+G AAAATAV F SS
Sbjct: 302 MGMVDIFNGDADLSGMTGSRGLVLSGVLHKAFVEVTEEGAEAAAATAVVGFGSSPTSTNE 361
Query: 309 RYEANHPFLYFLVDKEIQSILFAGVFNEP 337
+ NHPFL+F+ + SILF G F+ P
Sbjct: 362 EFHCNHPFLFFIRQNKTNSILFYGRFSSP 390
|
May act as a protease inhibitor to modulate the host immune response against tumor cells. Homo sapiens (taxid: 9606) |
| >sp|Q5JJ64|Y1782_PYRKO Uncharacterized serpin-like protein TK1782 OS=Pyrococcus kodakaraensis (strain ATCC BAA-918 / JCM 12380 / KOD1) GN=TK1782 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 119 bits (297), Expect = 4e-26, Method: Compositional matrix adjust.
Identities = 117/371 (31%), Positives = 176/371 (47%), Gaps = 48/371 (12%)
Query: 2 FTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTM 61
FTFDL L A NVF SPFSI AL AY + T +K+VL LPE+ D T
Sbjct: 66 FTFDLYKEL--AGNNNNVFFSPFSIETALAMAYEGARGKTAEEMKRVLHLPEDDDARWTG 123
Query: 62 NVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKECMTAI----FPSEIQSMDF-GN 116
Y L+ L++ S S N ++V ++E I + E + +DF GN
Sbjct: 124 FRY----LLLSLKSPEGSPFILRSVNALWVQRGYSLREEYLGIVKEFYLGEAKEVDFQGN 179
Query: 117 EVEAARAINSWVAQETKNNIKDLIATGQVNSR---TNLVL----WLPSTQES-------- 161
EAAR IN WV ++T IKD+++ +R TN V W + S
Sbjct: 180 PAEAAREINEWVEEQTNGRIKDIVSGLSPLTRLVITNAVYFKANWSSRFRASDTRNETFH 239
Query: 162 ------IIIITVLSSEL------NAHILEVPYKGGNMSMFFLLPPFASQDGVGDILAALK 209
I+ + + E + LE+PY+G + M +LP + V L+A
Sbjct: 240 APNGTVIVPMMHQTGEFPYFENDDLQALELPYEGERLGMLIILPKEGKFEKVEGNLSA-- 297
Query: 210 KDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLTDS- 268
S + ++ + K V++A+PKF L L D+G+K F D S +++
Sbjct: 298 ---GSIENILKNMREEK-VKVALPKFRFEASYKLRDVLMDMGMKRAFLV-PDFSGISNGE 352
Query: 269 HIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSS--RPLEPVRYEANHPFLYFLVDKEIQ 326
++A D VHK+ + + E GT AAAATAV ++ + EP ++A+HPF++F+ D+E
Sbjct: 353 NLAIEDVVHKSFISVAENGTEAAAATAVTLTMNAPMQEKEPKIFKADHPFIFFIYDRETG 412
Query: 327 SILFAGVFNEP 337
+ILF G P
Sbjct: 413 TILFMGRMMNP 423
|
Pyrococcus kodakaraensis (strain ATCC BAA-918 / JCM 12380 / KOD1) (taxid: 69014) |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 342 | ||||||
| 91083439 | 413 | PREDICTED: similar to serpin B6 [Triboli | 0.967 | 0.801 | 0.398 | 2e-71 | |
| 160333383 | 413 | serine protease inhibitor 6 precursor [B | 0.973 | 0.806 | 0.402 | 4e-70 | |
| 56418464 | 412 | serpin-6 [Manduca sexta] | 0.973 | 0.808 | 0.405 | 6e-69 | |
| 364023635 | 411 | serine protease inhibitor 003 [Chilo sup | 0.976 | 0.812 | 0.398 | 1e-68 | |
| 357615598 | 444 | serine protease inhibitor 6 [Danaus plex | 0.976 | 0.752 | 0.401 | 3e-68 | |
| 229577153 | 430 | serine protease inhibitor 5 precursor [A | 0.970 | 0.772 | 0.380 | 2e-67 | |
| 389611305 | 413 | serine protease inhibitor 5 [Papilio pol | 0.976 | 0.808 | 0.380 | 1e-65 | |
| 389608417 | 413 | serine protease inhibitor 5 [Papilio xut | 0.976 | 0.808 | 0.388 | 6e-65 | |
| 242005566 | 423 | serine protease inhibitor, putative [Ped | 0.982 | 0.794 | 0.387 | 8e-60 | |
| 307186650 | 481 | Antithrombin-III [Camponotus floridanus] | 0.941 | 0.669 | 0.373 | 1e-56 |
| >gi|91083439|ref|XP_969846.1| PREDICTED: similar to serpin B6 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 275 bits (703), Expect = 2e-71, Method: Compositional matrix adjust.
Identities = 149/374 (39%), Positives = 218/374 (58%), Gaps = 43/374 (11%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
EF+ LL +N +N+F SP+S Y ALL AYF++ TE+ LK++LRL + +K D
Sbjct: 45 EFSLALLQAINQLMPHENLFFSPYSTYHALLIAYFLAGGQTESYLKKILRLEPSQNKPDF 104
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKECMTAIFPSEIQSMDFGNEVEA 120
YK++KL Q L AN S FT+ NKI+V D+I V+ C+ ++F E++ + F N+ +A
Sbjct: 105 YQAYKLDKL-QTLTANRKSSHQFTNANKIYVADQIDVRSCIESLFKDELEKISFKNDPQA 163
Query: 121 AR-AINSWVAQETKNNIKDLIATGQVNSRTNLVL---------W---------------- 154
AR IN+WV + T+ IKDL+ G ++ + LVL W
Sbjct: 164 ARNLINTWVEEHTEKMIKDLLPPGSIDQSSTLVLVNAAYFNGTWENKFNPNETRPEIFYV 223
Query: 155 LPSTQESIIIITV-------LSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDILAA 207
PS Q + ++ V +S L AHILE+PY G N+SM+ LLPPF +D + + L
Sbjct: 224 SPSKQIMVDMMHVEGTFNHDVSESLEAHILEMPYTGNNISMYILLPPFTKEDAIDNTLKK 283
Query: 208 LKKDPTSFKRF----TEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLS 263
L + ++F S K V+++ PKFSL + L+P L +GV DLF GAD +
Sbjct: 284 L-----TLEKFQSIVNSGSLTSKTVQVSFPKFSLEHTVELVPVLEKMGVGDLFQNGADFT 338
Query: 264 RLTDSHIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDK 323
T S + G+A+HKAR++ +E+GT AAAAT +F+FRSSRP EP ++ NHPF+Y + DK
Sbjct: 339 TFTKSKVELGNALHKARIECNEEGTKAAAATVLFSFRSSRPAEPAQFHCNHPFIYVIYDK 398
Query: 324 EIQSILFAGVFNEP 337
+++LF GVF P
Sbjct: 399 VAKAVLFTGVFRRP 412
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|160333383|ref|NP_001103823.1| serine protease inhibitor 6 precursor [Bombyx mori] gi|157786102|gb|ABV74209.1| serpin-6 [Bombyx mori] | Back alignment and taxonomy information |
|---|
Score = 271 bits (693), Expect = 4e-70, Method: Compositional matrix adjust.
Identities = 149/370 (40%), Positives = 218/370 (58%), Gaps = 37/370 (10%)
Query: 2 FTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTM 61
FT +L +N+A N+F SPFS+Y +LL AY S TE L++ L + + LDK++ M
Sbjct: 44 FTLNLFNTINDAVPDDNIFFSPFSVYHSLLLAYLSSGGQTEEALRKSLEIEDGLDKINLM 103
Query: 62 NVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKECMTAIFPSEIQSMDFGNEVEAA 121
YK++K +G+ N+DS FTS NK+F D + V++CM +F ++++++F AA
Sbjct: 104 TAYKVDKRARGINNNSDS-YEFTSANKLFAADDLNVRQCMLDLFAEDLETLNFRENPGAA 162
Query: 122 R-AINSWVAQETKNNIKDLIATGQVNSRTNLVL---------W----------------- 154
R INSWV++ TKN+I DLI ++ T LVL W
Sbjct: 163 RDYINSWVSRVTKNHISDLIPASGISQTTRLVLANAAYFKGVWASKFLAERTRKEAFFVS 222
Query: 155 ------LPSTQESIIIITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDILAAL 208
+P ++ ++S EL A ILE+PYKG ++SM+ LLPP++ ++GV +I+ L
Sbjct: 223 ETRQTLVPFMKQKGTFHYMVSDELGAQILELPYKGSDISMYILLPPYSMKEGVSNIITNL 282
Query: 209 KKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLTDS 268
P E+S + V + IPKFS+ + + L L LGV DLF+ AD S LT+
Sbjct: 283 T--PERLAAVVEESYMGREVIVEIPKFSMERSLPLREILEKLGVGDLFNGTADFSTLTEQ 340
Query: 269 H-IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQS 327
H I F DA+HKA++D++E+GT AAAATA+F FRSSRP EP R+ AN PF+Y L ++ S
Sbjct: 341 HGILFDDAIHKAKIDVNEEGTVAAAATAIFGFRSSRPAEPTRFVANFPFVYVLYERPTSS 400
Query: 328 ILFAGVFNEP 337
ILF GV+ +P
Sbjct: 401 ILFMGVYRDP 410
|
Source: Bombyx mori Species: Bombyx mori Genus: Bombyx Family: Bombycidae Order: Lepidoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|56418464|gb|AAV91026.1| serpin-6 [Manduca sexta] | Back alignment and taxonomy information |
|---|
Score = 267 bits (682), Expect = 6e-69, Method: Compositional matrix adjust.
Identities = 150/370 (40%), Positives = 222/370 (60%), Gaps = 37/370 (10%)
Query: 2 FTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTM 61
FT +L +N+A N+F SPFS+YQ+LL AYF + TE +LK+ L + +N+DK++ M
Sbjct: 44 FTLNLFQTINSAVPDDNIFFSPFSVYQSLLLAYFSTGGRTEESLKKSLEIEDNMDKMNLM 103
Query: 62 NVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKECMTAIFPSEIQSMDFGNEVEAA 121
YK++K + N+DS FT+ NK+FV +++ V++CM +F EI++++F E +
Sbjct: 104 TAYKVDKRSRMTNNNSDS-YEFTTANKLFVANELQVRQCMFDLFGEEIEALNFRENPEVS 162
Query: 122 RA-INSWVAQETKNNIKDLIATGQVNSRTNLVL---------W----------------- 154
R IN+WV + TKN+IK L+ V+ T LVL W
Sbjct: 163 REYINNWVERITKNHIKKLLPADGVSEFTKLVLANAAYFKGVWASKFSPERTKKEPFFVS 222
Query: 155 ------LPSTQESIIIITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDILAAL 208
+P ++ +S EL A +LE+PYKG ++SMF LLPP++ ++GV +I+A L
Sbjct: 223 ETRQTLVPFMKQKGTFHYGVSEELGAQVLELPYKGNDISMFILLPPYSMKEGVTNIIANL 282
Query: 209 KKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-D 267
+ E+S + V + IPKF++ + ++L P L LGV DLF+ AD S LT D
Sbjct: 283 NTE--RLAAVMEESYMSREVIVEIPKFTIERTLSLRPILDRLGVGDLFNVSADFSTLTED 340
Query: 268 SHIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQS 327
S I F DAVHKA++ +DE+GT AAAATA+F FRSSRP EP R+ AN PF+Y + ++ S
Sbjct: 341 SGIRFDDAVHKAKIQIDEEGTVAAAATALFGFRSSRPAEPTRFIANFPFVYLIYERPTNS 400
Query: 328 ILFAGVFNEP 337
ILF GV+ +P
Sbjct: 401 ILFFGVYRDP 410
|
Source: Manduca sexta Species: Manduca sexta Genus: Manduca Family: Sphingidae Order: Lepidoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|364023635|gb|AEW46892.1| serine protease inhibitor 003 [Chilo suppressalis] | Back alignment and taxonomy information |
|---|
Score = 266 bits (680), Expect = 1e-68, Method: Compositional matrix adjust.
Identities = 148/371 (39%), Positives = 223/371 (60%), Gaps = 37/371 (9%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
EFT +L +N A N+F SPFS+Y +LL AYF + TE +LK L+L +NLDK++
Sbjct: 42 EFTLNLFNAINKAVPNDNIFFSPFSVYHSLLLAYFSAGGETEKSLKHSLQLSDNLDKINL 101
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKECMTAIFPSEIQSMDF-GNEVE 119
M YK++K + N+DS FT+ NK+FV++++ V+ECM +F E+++++F N E
Sbjct: 102 MTAYKVDKRSRAANNNSDS-YEFTNANKLFVDEQLRVRECMLQLFGEEMEALNFHDNPRE 160
Query: 120 AARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------W---------------L 155
+ IN WV++ TKNNIKDL+ V+ T LVL W +
Sbjct: 161 SKDYINEWVSRVTKNNIKDLLPDDGVSESTKLVLANAAYFKGVWASKFPVERTKKEAFFV 220
Query: 156 PSTQESIIIIT--------VLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDILAA 207
T+++++ ++S +L A ILE+PYKG ++SM+ LLPP++ ++GV +I+
Sbjct: 221 SETRQTLVHFMKQKGTFHYMVSDDLGAQILELPYKGNDISMYILLPPYSMKEGVTNIIQN 280
Query: 208 LKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLTD 267
L P E+S + V + IPKF++ + + L L +GV DLF+ AD S LT+
Sbjct: 281 LT--PERLAAVVEESYMGREVIVEIPKFTIERSLPLREILEVVGVGDLFNASADFSTLTE 338
Query: 268 -SHIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQ 326
+ F DAVHKA++ LD++GT AAAATA+F FRSSRP EP R+ AN PF+Y + ++
Sbjct: 339 QGGVLFDDAVHKAKIQLDDEGTVAAAATAIFGFRSSRPAEPSRFIANFPFVYVIYERPTS 398
Query: 327 SILFAGVFNEP 337
SILF GV+ +P
Sbjct: 399 SILFMGVYRDP 409
|
Source: Chilo suppressalis Species: Chilo suppressalis Genus: Chilo Family: Crambidae Order: Lepidoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|357615598|gb|EHJ69744.1| serine protease inhibitor 6 [Danaus plexippus] | Back alignment and taxonomy information |
|---|
Score = 265 bits (676), Expect = 3e-68, Method: Compositional matrix adjust.
Identities = 149/371 (40%), Positives = 213/371 (57%), Gaps = 37/371 (9%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
EFT +L V+N A NVF SPFS+Y ALL YF + TE LK+ LR+ + DK++
Sbjct: 75 EFTLNLFNVINEAVPNDNVFFSPFSVYHALLLGYFAAGGQTEKALKESLRIADTQDKVNL 134
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKECMTAIFPSEIQSMDFGNEVEA 120
+ YK++K ++ + N+DS FT+ NK+FV+ + V+EC F EI ++F +
Sbjct: 135 LMAYKVDKHLRAVNNNSDS-YEFTNVNKMFVDTALQVRECFKDAFGGEISGLNFHDHPGV 193
Query: 121 ARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL---------WLP-----STQESIIII 165
A IN WVA TKNNIKDLI V T LVL W ST++ + +
Sbjct: 194 AVGHINEWVAHVTKNNIKDLIPPSGVTQATKLVLANAAYFKGVWASKFQAQSTKKQVFFV 253
Query: 166 T------------------VLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDILAA 207
+ +++ EL A ILE+PYKG ++SM+ LLPP++ ++GV +I+A
Sbjct: 254 SETRQTLTHFMRQKGQFHFMVNDELGAQILELPYKGNDISMYILLPPYSMKEGVNNIIAN 313
Query: 208 LKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT- 266
L P E+ + V + IPKF++ + + L P L LGV DLF+ +D S +
Sbjct: 314 LT--PERLAAVVEEGYLGREVVVEIPKFTIERSLQLRPILERLGVGDLFNASSDFSTMME 371
Query: 267 DSHIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQ 326
D + F DAVHKA++ +DE+GT AAAATA+F FRSSRP EP + AN PF+Y + +K
Sbjct: 372 DRGVIFDDAVHKAKIQVDEEGTVAAAATAIFGFRSSRPAEPTVFIANFPFVYIIYEKPTN 431
Query: 327 SILFAGVFNEP 337
S+LF GVF +P
Sbjct: 432 SVLFMGVFRDP 442
|
Source: Danaus plexippus Species: Danaus plexippus Genus: Danaus Family: Nymphalidae Order: Lepidoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|229577153|ref|NP_001153315.1| serine protease inhibitor 5 precursor [Acyrthosiphon pisum] | Back alignment and taxonomy information |
|---|
Score = 262 bits (669), Expect = 2e-67, Method: Compositional matrix adjust.
Identities = 144/378 (38%), Positives = 211/378 (55%), Gaps = 46/378 (12%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
EF+ LL A+ +N+ SP SIY ALL YF+SN TE LK L LP KL
Sbjct: 55 EFSIKLLQTAVTASPKQNLIFSPHSIYTALLITYFLSNNETEETLKLFLNLPPEQSKLSV 114
Query: 61 MNVYKMEKLIQGLRA-NADSGLTFTSTNKIFVNDKIPVKECMTAIFPSEIQSMDFGNEVE 119
M Y+MEKL +RA N F+S +++FV+ ++P+++C+ +F E+ MDF + E
Sbjct: 115 MQAYRMEKLFHSMRALNTSGDYEFSSVDRLFVSQRLPIQKCIADVFKDEVHKMDFVVDPE 174
Query: 120 AARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL------------------------- 153
AR IN+WV +T IKDL+ G++ T LVL
Sbjct: 175 LARMYINNWVTNQTNQQIKDLLPEGKITYETRLVLANAAYFKGFWSSRFSSESTKDEVFY 234
Query: 154 -------WLPSTQESIIIITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDILA 206
++P +S + + S EL AH+LE+PYKGG++S+F +LPPF Q G+ +
Sbjct: 235 TSPTENAYVPMMWQSGVFNLLSSDELGAHVLELPYKGGDISLFVILPPFNKQRGISQLSK 294
Query: 207 ALK----KDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEM-NLIPTLSDLGVKDLFSPGAD 261
L ++ S +T +PVE+++PKF++ Q M NL+ L +G+ ++F D
Sbjct: 295 RLNTNILQNIVSSGEWTS-----RPVEVSLPKFNVEQSMDNLVSLLEQMGIGNVFKGKVD 349
Query: 262 LSRLTDS--HIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYF 319
LS LT + + DAVHKA++ +DE+GT AAAAT+ RSSRP+EP ++ NHPF+YF
Sbjct: 350 LSALTGNANDVTIDDAVHKAKISVDEEGTIAAAATSFLMSRSSRPVEPFKFRCNHPFIYF 409
Query: 320 LVDKEIQSILFAGVFNEP 337
+ DK S+LF GV+N P
Sbjct: 410 MFDKVTGSVLFMGVYNSP 427
|
Source: Acyrthosiphon pisum Species: Acyrthosiphon pisum Genus: Acyrthosiphon Family: Aphididae Order: Hemiptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|389611305|dbj|BAM19264.1| serine protease inhibitor 5 [Papilio polytes] | Back alignment and taxonomy information |
|---|
Score = 256 bits (653), Expect = 1e-65, Method: Compositional matrix adjust.
Identities = 141/371 (38%), Positives = 215/371 (57%), Gaps = 37/371 (9%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
EFT L +N N+F SPFS+Y ALL YF + TE +LK+ L++ + +DK++
Sbjct: 44 EFTLHLFNEINKKVPDDNIFFSPFSVYHALLLGYFGAGGQTEQSLKRSLKIADKMDKINL 103
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKECMTAIFPSEIQSMDF-GNEVE 119
M YK++K + + N+DS FTS NK+FV+ + V++CM + +EI++++F G E
Sbjct: 104 MTAYKVDKTSRAMNNNSDS-YEFTSVNKMFVDRGLHVRQCMLDVLGAEIEALNFQGQPGE 162
Query: 120 AARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------W----LPS--------- 157
+ IN WV+ TKNNIKD + + T LVL W LP
Sbjct: 163 SREYINDWVSSVTKNNIKDFLPPRAITEITRLVLTNAAYFKGLWASKFLPERTKKEPFFV 222
Query: 158 ----------TQESIIIITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDILAA 207
++ I +++ +L A ILE+PYKG ++SM+ LPP++ ++GV +I+A
Sbjct: 223 SESRQTLTHFMKQKGIFHYMVNDDLGAQILELPYKGNDISMYIFLPPYSMKEGVTNIIAN 282
Query: 208 LKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLTD 267
L P E+S + V + IPKF++ + +++ L LGV DLF+ AD S LT+
Sbjct: 283 LT--PERLAAVVEESFMGREVVVEIPKFTMERSLSIKSVLEGLGVGDLFNSSADFSTLTE 340
Query: 268 SH-IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQ 326
H I F DA+H+A++ +DE+GT AAAATA+F FRSSRP EP + AN PF+Y + ++
Sbjct: 341 DHGIRFDDAIHQAKIQVDEEGTVAAAATAIFGFRSSRPAEPSVFIANFPFVYIIYERPTN 400
Query: 327 SILFAGVFNEP 337
S+LF GV+ +P
Sbjct: 401 SVLFMGVYRDP 411
|
Source: Papilio polytes Species: Papilio polytes Genus: Papilio Family: Papilionidae Order: Lepidoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|389608417|dbj|BAM17818.1| serine protease inhibitor 5 [Papilio xuthus] | Back alignment and taxonomy information |
|---|
Score = 254 bits (648), Expect = 6e-65, Method: Compositional matrix adjust.
Identities = 144/371 (38%), Positives = 215/371 (57%), Gaps = 37/371 (9%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
EFT L +N N+F SPFS+Y ALL YF + TE +LK+ L++ E +DK++
Sbjct: 44 EFTLHLFNEINKMVPDDNIFFSPFSVYHALLLGYFGAGGQTEQSLKRSLKIAEKMDKINL 103
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKECMTAIFPSEIQSMDF-GNEVE 119
M YK++K + + N+DS FTS NK+FV+ I V++CM +EI++++F G E
Sbjct: 104 MTAYKVDKTSRAMNNNSDS-YEFTSVNKMFVDRSITVRQCMLDALSAEIEALNFQGQPGE 162
Query: 120 AARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------W----LPS--------T 158
+ IN WV++ TKNNIKD + ++ T +VL W LP
Sbjct: 163 SREYINDWVSRVTKNNIKDFLPPYAISQVTRMVLANAAYFKGLWASKFLPERTKKEPFFV 222
Query: 159 QESIIIIT-----------VLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDILAA 207
ES +T +++ +L A ILE+PYKG ++SM+ LPP++ ++GV +I+A
Sbjct: 223 SESRQTLTYFMKQKGTFHYMVNDDLGAQILELPYKGNDISMYIFLPPYSMKEGVTNIIAN 282
Query: 208 LKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLTD 267
L P E+S + V + IPKF++ + + + L LGV DLF+ AD + LTD
Sbjct: 283 LT--PERLAAVVEESFMGREVVVEIPKFTMERSLPIKGVLQALGVGDLFNSSADFTTLTD 340
Query: 268 SH-IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQ 326
I F DA+HKA++ +DE+GT AAAATA+F FRSSRP EP + AN PF+Y + ++
Sbjct: 341 DRGILFDDAIHKAKIQIDEEGTVAAAATAIFGFRSSRPAEPSVFIANFPFVYVIYERPTN 400
Query: 327 SILFAGVFNEP 337
S+LF GV+ +P
Sbjct: 401 SVLFMGVYRDP 411
|
Source: Papilio xuthus Species: Papilio xuthus Genus: Papilio Family: Papilionidae Order: Lepidoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242005566|ref|XP_002423635.1| serine protease inhibitor, putative [Pediculus humanus corporis] gi|212506795|gb|EEB10897.1| serine protease inhibitor, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 236 bits (603), Expect = 8e-60, Method: Compositional matrix adjust.
Identities = 147/379 (38%), Positives = 220/379 (58%), Gaps = 43/379 (11%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
+F+ LL N+ +K +N+F SP+SIYQ+L+ AY + TE LK+ L LPE +KL
Sbjct: 40 KFSVKLLKTFNDKHKEENIFFSPYSIYQSLILAYITAGNKTEEVLKEALYLPEKQNKLSV 99
Query: 61 MNVYKMEKLIQGLRA-NADSGLTFTSTNKIFVNDKIPVKECMTAIFPSEIQSMDFGNEVE 119
+ Y +EK + R N S NKIF++++I +EC++ I +++S++F N+
Sbjct: 100 IQTYDLEKYFETTRQLNGSLDYELNSFNKIFLSNEIEARECISNILKDDLESINFKNDPN 159
Query: 120 AAR-AINSWVAQETKNNIKDLIATGQVNSRTNLVL---------WLPS------------ 157
AAR IN V TKN+I +L+ T V+ T ++L W
Sbjct: 160 AARFYINDLVKNVTKNHISELLPTDGVHEETKIILANAAYFKGLWKSKFFEGNTKKNSLF 219
Query: 158 --TQESIIIITVL----------SSELNAHILEVPYKGGNMSMFFLLPPFASQ--DGVGD 203
+ E I I+ ++ S +L +HILE+PYKG ++SM +LP F S D + D
Sbjct: 220 YVSPEDIKIVDLMTQKGNFNHMTSEKLKSHILELPYKGDSVSMIIILPRFESNAIDKLID 279
Query: 204 ILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLS 263
ILA ++ S F D+ + VE+ IPKFS+ ++L P + LG+ ++FSP AD S
Sbjct: 280 ILA--EESIESLIDF--DALYPRQVEVEIPKFSVENSIDLRPVFTVLGLSEIFSPEADFS 335
Query: 264 RLTDS--HIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLV 321
L++ + F DA+HKA++++DE+GT AAAATA+F FRSSRPL+P R+ ANHPF+YF+
Sbjct: 336 TLSEKTKSVHFTDAIHKAKIEVDEEGTVAAAATAIFTFRSSRPLDPTRFIANHPFVYFIY 395
Query: 322 DKEIQSILFAGVFNEPPNK 340
DK Q+ILF GV+ P K
Sbjct: 396 DKISQNILFMGVYKVPEKK 414
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307186650|gb|EFN72133.1| Antithrombin-III [Camponotus floridanus] | Back alignment and taxonomy information |
|---|
Score = 226 bits (576), Expect = 1e-56, Method: Compositional matrix adjust.
Identities = 139/372 (37%), Positives = 203/372 (54%), Gaps = 50/372 (13%)
Query: 18 NVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRA-N 76
N+F SP SI+QAL AYF + TE++LKQ LR+PE L K+D Y EK + R+ N
Sbjct: 103 NIFFSPHSIHQALSLAYFGARGTTESSLKQALRIPEQLSKVDMQRFYAYEKFLNQPRSQN 162
Query: 77 ADSGLTFTSTNKIFVNDKIPVKECMTAIFPSEIQSMDF-GNEVEAARAINSWVAQETKNN 135
+ + NK ++ + +++CM F ++Q DF N E IN WV+ TK +
Sbjct: 163 ESTDYEYKVANKFWITNSRKLRDCMFDFFGDQMQVTDFRTNPAEVRTRINDWVSNMTKGH 222
Query: 136 IKDLIATGQVNSRTNLVL------------------------WLPSTQESIIIIT----- 166
I+DL+ ++ T+LVL ++ TQ S+I
Sbjct: 223 IRDLLPPNSISGDTDLVLANAAYFKGLWAQRFDPKNSKRDIFYVSGTQNSVITFMRQKGN 282
Query: 167 ---VLSSELNAHILEVPYKGGNMSMFFLLPPFAS----------QDGVGDILAAL--KKD 211
V+S EL +ILE+PYKG ++SMF LLPPF++ QDG+ ++ L +K
Sbjct: 283 FNHVVSEELGVYILELPYKGNDISMFVLLPPFSNARALSQDSEPQDGIRQLVERLATEKG 342
Query: 212 PTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGA-DLSRLT---D 267
++ +D + VE+ +P+F L +E+ L L LG +L SPGA DL +
Sbjct: 343 SRELRQLLDDGMPPREVEVNLPRFELERELQLNQLLYALGAGELLSPGAADLRGFVADGE 402
Query: 268 SHIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQS 327
S + GDA+H+AR+++ E+GTTAAAATA+F FRSSRP EP + ANHPF+Y + DK
Sbjct: 403 SSLHLGDAIHRARIEVTEEGTTAAAATAIFTFRSSRPTEPAIFNANHPFVYLIYDKRDHI 462
Query: 328 ILFAGVFNEPPN 339
+LFAG+F P N
Sbjct: 463 VLFAGIFRSPAN 474
|
Source: Camponotus floridanus Species: Camponotus floridanus Genus: Camponotus Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 342 | ||||||
| FB|FBgn0028984 | 427 | Spn88Ea "Serpin 88Ea" [Drosoph | 0.611 | 0.489 | 0.293 | 4.7e-47 | |
| UNIPROTKB|Q005M6 | 447 | SRPN9 "Serpin 9" [Anopheles ga | 0.438 | 0.335 | 0.311 | 7.5e-45 | |
| FB|FBgn0038299 | 426 | Spn88Eb "Serpin 88Eb" [Drosoph | 0.485 | 0.389 | 0.316 | 6.4e-39 | |
| UNIPROTKB|P29508 | 390 | SERPINB3 "Serpin B3" [Homo sap | 0.470 | 0.412 | 0.339 | 2.8e-32 | |
| UNIPROTKB|Q66KE4 | 379 | serpinb6 "Serpin peptidase inh | 0.479 | 0.432 | 0.308 | 3.2e-31 | |
| UNIPROTKB|Q5I0S8 | 377 | serpinb1 "Leukocyte elastase i | 0.473 | 0.429 | 0.315 | 1.2e-30 | |
| UNIPROTKB|P48594 | 390 | SERPINB4 "Serpin B4" [Homo sap | 0.479 | 0.420 | 0.333 | 5.1e-30 | |
| UNIPROTKB|P80229 | 378 | SERPINB1 "Leukocyte elastase i | 0.476 | 0.431 | 0.319 | 2e-29 | |
| UNIPROTKB|F1P1L7 | 401 | F1P1L7 "Uncharacterized protei | 0.461 | 0.394 | 0.311 | 2.3e-29 | |
| UNIPROTKB|F2Z5B1 | 378 | SERPINB1 "Leukocyte elastase i | 0.476 | 0.431 | 0.308 | 2.9e-29 |
| FB|FBgn0028984 Spn88Ea "Serpin 88Ea" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 277 (102.6 bits), Expect = 4.7e-47, Sum P(2) = 4.7e-47
Identities = 69/235 (29%), Positives = 121/235 (51%)
Query: 120 AARAINSWVAQ-ETKNNIKDLIATGQVNSRTNLVLWLPSTQESIIIITVLSSELNAHILE 178
AA W++Q +T+ + T N +LV + Q+ ++ V +L AH+L+
Sbjct: 197 AAYLKGQWLSQFKTEKTVPMPFYTSPSNY--SLVSMMQ--QKGTFLLNV-DEQLRAHVLQ 251
Query: 179 VPYK---------------GGNMSMFFLLPPFASQDGVGDILAALKKDPTSFKRFTEDSQ 223
+PY+ ++SM +LPPF S + + D+L+ L D S + +
Sbjct: 252 LPYRTVFESQEKEDSSPDENSDISMVLILPPFNS-NSLEDVLSRLNAD--SLDDSLKQAM 308
Query: 224 NLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPG-ADLSRLTDSHIAFGDAVHKARLD 282
+ +E+++PKF Q + L L+ +GV +F A LT I+ GD+ H ++
Sbjct: 309 P-REIEVSLPKFEFEQRLELNLILAKMGVSKMFDESVATFDDLTSETISIGDSKHVPKIK 367
Query: 283 LDEQGXXXXXXXXVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337
+DE+G +F +RS+RP+EP ++E NHPFL+ + D+ +SILF G++ +P
Sbjct: 368 VDEEGSTAAAATVLFTYRSARPVEPAKFECNHPFLFVIYDRTSRSILFTGIYRDP 422
|
|
| UNIPROTKB|Q005M6 SRPN9 "Serpin 9" [Anopheles gambiae (taxid:7165)] | Back alignment and assigned GO terms |
|---|
Score = 249 (92.7 bits), Expect = 7.5e-45, Sum P(3) = 7.5e-45
Identities = 48/154 (31%), Positives = 85/154 (55%)
Query: 186 MSMFFLLPPFASQDGVGDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIP 245
+SMF LPP A + + +L+ L + + + K V++ +PKFS+ + + + P
Sbjct: 295 VSMFVFLPP-AEPNALSKLLSRLAAETDILHEVVNEGISRK-VDVKLPKFSIEKTVGMKP 352
Query: 246 TLSDLGVKDLFSPGADLSRLTDSH--IAFGDAVHKARLDLDEQGXXXXXXXXVFAFRSSR 303
L +G+ LF GA+ TD I F + + K++++++E+G F+FRSSR
Sbjct: 353 VLERMGLGQLFDQGANFDAFTDGREPILFDEVLQKSKIEVNEEGSVAASATVAFSFRSSR 412
Query: 304 PLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337
P +P + NHPF++ + D +S+LF GV+ +P
Sbjct: 413 PADPAMFHCNHPFVFLIYDYGTRSVLFNGVYRQP 446
|
|
| FB|FBgn0038299 Spn88Eb "Serpin 88Eb" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 242 (90.2 bits), Expect = 6.4e-39, Sum P(2) = 6.4e-39
Identities = 55/174 (31%), Positives = 96/174 (55%)
Query: 166 TVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDILAALKKDPTSFKRFTEDSQNL 225
T+ S+ HI P ++SM +LP +++ + +++ L D S K++ E +
Sbjct: 254 TIYKSK-ETHI-STPESKSDISMIIILPN-SNKISLNRVISRLNAD--SVKKWFERALPQ 308
Query: 226 KPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLTDSHIAF--GDAVHKARLDL 283
K +E+++PKF Q + L P LS +GV +F+ A LT I+ DA H A++ +
Sbjct: 309 K-IELSLPKFQFEQRLELTPILSLMGVNTMFTRNATFGDLTADPISLVIDDAQHLAKIKV 367
Query: 284 DEQGXXXXXXXXVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337
DE G + RSSR +P ++ NHPF++ + D+++ +ILFAGV+++P
Sbjct: 368 DEVGSTAAAATILLVSRSSRQPDPTKFNCNHPFVFLIYDEKVDTILFAGVYSDP 421
|
|
| UNIPROTKB|P29508 SERPINB3 "Serpin B3" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 233 (87.1 bits), Expect = 2.8e-32, Sum P(2) = 2.8e-32
Identities = 58/171 (33%), Positives = 92/171 (53%)
Query: 171 ELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDILAALKKDPTSFKRFTEDS-QNLKP-- 227
++ A +LE+PYKG ++SM LLP DG L L++ T+ K S QN++
Sbjct: 226 DVQAKVLEIPYKGKDLSMIVLLPN--EIDG----LQKLEEKLTAEKLMEWTSLQNMRETR 279
Query: 228 VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLTDSH-IAFGDAVHKARLDLDEQ 286
V++ +P+F + + +L TL +G+ D+F+ ADLS +T S + +HKA +++ E+
Sbjct: 280 VDLHLPRFKVEESYDLKDTLRTMGMVDIFNGDADLSGMTGSRGLVLSGVLHKAFVEVTEE 339
Query: 287 GXXXXXXXXVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337
G V F SS + NHPFL+F+ + SILF G F+ P
Sbjct: 340 GAEAAAATAVVGFGSSPTSTNEEFHCNHPFLFFIRQNKTNSILFYGRFSSP 390
|
|
| UNIPROTKB|Q66KE4 serpinb6 "Serpin peptidase inhibitor, clade B (Ovalbumin), member 6" [Xenopus (Silurana) tropicalis (taxid:8364)] | Back alignment and assigned GO terms |
|---|
Score = 207 (77.9 bits), Expect = 3.2e-31, Sum P(2) = 3.2e-31
Identities = 53/172 (30%), Positives = 89/172 (51%)
Query: 171 ELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDILAALKKDPT--SFKRFTE-DSQNLKP 227
EL ++E+PY +SM LLP + G L AL+K+ T F ++T + ++
Sbjct: 211 ELFTKVVEIPYVDNELSMIILLPDDINDGTTG--LEALEKELTYEKFLKWTNPEMMDITE 268
Query: 228 VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPG-ADLSRLTDSHIAF-GDAVHKARLDLDE 285
+E+++PKF L + +L LS +G+ D F AD S ++ ++ F +HK+ +D++E
Sbjct: 269 MELSLPKFKLEDDYDLESFLSTMGMSDAFDQRRADFSGMSSANDLFLSKVLHKSFVDVNE 328
Query: 286 QGXXXXXXXXVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337
+G + P R +HPFL+F++ + QSILF G F P
Sbjct: 329 EGTEAAAATAAIMMLRCAMIIP-RIVCDHPFLFFILHRPSQSILFCGRFALP 379
|
|
| UNIPROTKB|Q5I0S8 serpinb1 "Leukocyte elastase inhibitor" [Xenopus (Silurana) tropicalis (taxid:8364)] | Back alignment and assigned GO terms |
|---|
Score = 227 (85.0 bits), Expect = 1.2e-30, Sum P(2) = 1.2e-30
Identities = 54/171 (31%), Positives = 92/171 (53%)
Query: 171 ELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDILAALKKDPTSFKRFTEDSQNLKPVEI 230
E+N +LE+PY +SM +LP + D G L L+K+ S ++ E ++N+ P+++
Sbjct: 212 EINCRVLELPYVDYELSMVIVLPDNINDDTTG--LQQLEKE-LSLEKINEWTENMMPIDV 268
Query: 231 AI--PKFSLTQEMNLIPTLSDLGVKDLFSPG-ADLSRLTDSH-IAFGDAVHKARLDLDEQ 286
+ PKF L L L+ +G+ DLF G ADLS ++ S+ + + +HK+ ++++E+
Sbjct: 269 HVHLPKFKLEDSYKLKSQLAGMGMADLFEAGSADLSGMSGSNDLYLSEVIHKSFVEVNEE 328
Query: 287 GXXXXXXXXVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337
G A E + ANHPFL+F+ +SILF G ++ P
Sbjct: 329 GTEAAAASAGIAMMCLMREE--EFNANHPFLFFIRHNATKSILFFGRYSSP 377
|
|
| UNIPROTKB|P48594 SERPINB4 "Serpin B4" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 229 (85.7 bits), Expect = 5.1e-30, Sum P(2) = 5.1e-30
Identities = 58/174 (33%), Positives = 94/174 (54%)
Query: 168 LSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDILAALKKDPTSFKRFTEDS-QNLK 226
L ++ A +LE+PYKG ++SM LLP DG L L++ T+ K S QN++
Sbjct: 223 LLEDVQAKVLEIPYKGKDLSMIVLLPN--EIDG----LQKLEEKLTAEKLMEWTSLQNMR 276
Query: 227 P--VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLTDSH-IAFGDAVHKARLDL 283
V++ +P+F + + +L TL +G+ ++F+ ADLS +T SH ++ +HKA +++
Sbjct: 277 ETCVDLHLPRFKMEESYDLKDTLRTMGMVNIFNGDADLSGMTWSHGLSVSKVLHKAFVEV 336
Query: 284 DEQGXXXXXXXXVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337
E+G V S P + NHPFL+F+ + SILF G F+ P
Sbjct: 337 TEEGVEAAAATAVVVVELSSPSTNEEFCCNHPFLFFIRQNKTNSILFYGRFSSP 390
|
|
| UNIPROTKB|P80229 SERPINB1 "Leukocyte elastase inhibitor" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 209 (78.6 bits), Expect = 2.0e-29, Sum P(2) = 2.0e-29
Identities = 55/172 (31%), Positives = 91/172 (52%)
Query: 171 ELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDILAALKKDPTSFK--RFTE-DSQNLKP 227
EL +LE+PY+G ++SM LLP + G L +++ T K +T+ D+ L
Sbjct: 211 ELKCRVLELPYQGKDLSMVILLPDSIEDESTG--LRKIEQHLTLEKLNEWTKPDNLELLE 268
Query: 228 VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLTDSHIAF-GDAVHKARLDLDEQ 286
V + +P+F L + +L L+ LGV+DLF ADL+ ++++ F VHKA ++++E+
Sbjct: 269 VNVHLPRFRLEESYDLNAPLARLGVQDLFGSRADLTGMSEARDLFISKVVHKAFVEVNEE 328
Query: 287 GXXXXXXXXVFA-FRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337
G A F P E + A+HPF++F+ +ILF G + P
Sbjct: 329 GTEAAAATAGIAVFAMLMPEED--FIADHPFIFFIRHNPSSNILFLGRLSSP 378
|
|
| UNIPROTKB|F1P1L7 F1P1L7 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 210 (79.0 bits), Expect = 2.3e-29, Sum P(2) = 2.3e-29
Identities = 52/167 (31%), Positives = 92/167 (55%)
Query: 176 ILEVPYKGGNMSMFFLLPPFASQDGVGDILAALKKDPTSFK--RFTEDSQNLK-PVEIAI 232
I+E+PY +SMF LLP S + G L ++++ T K ++ ++ +K VE+ +
Sbjct: 239 IIELPYVENELSMFVLLPDDISDNTTG--LELVERELTHEKLAEWSNSARMMKVEVELYL 296
Query: 233 PKFSLTQEMNLIPTLSDLGVKDLFSP-GADLSRLTDSHIAF-GDAVHKARLDLDEQGXXX 290
PK + + +L TLS++G+++ F P AD +R++ F +HKA ++++E+G
Sbjct: 297 PKLKIEENYDLTSTLSNMGIQNAFDPVQADFTRMSAKKDFFLSKVIHKAFVEVNEEGTEA 356
Query: 291 XXXXXVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337
V RS P V ++A+HPFL+F+ + ++ILF G P
Sbjct: 357 AAATGVLVLRSRTPR--VTFKADHPFLFFIRHNKSKTILFFGRLCSP 401
|
|
| UNIPROTKB|F2Z5B1 SERPINB1 "Leukocyte elastase inhibitor" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 208 (78.3 bits), Expect = 2.9e-29, Sum P(2) = 2.9e-29
Identities = 53/172 (30%), Positives = 91/172 (52%)
Query: 171 ELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDILAALKKDPT--SFKRFTE-DSQNLKP 227
EL +LE+PY+G ++SM LLP + G L +++ T + +T+ D+ L
Sbjct: 211 ELKCRVLELPYQGKDLSMVILLPDSIEDESTG--LRKIEQHLTLEKLREWTKPDNLELLE 268
Query: 228 VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLTDSHIAF-GDAVHKARLDLDEQ 286
V + +P+F L + +L L+ LGV+DLF ADL+ ++++ F VHK+ ++++E+
Sbjct: 269 VNVHLPRFRLEESYDLNAPLARLGVQDLFGSRADLTGMSEARDLFISKVVHKSFVEVNEE 328
Query: 287 GXXXXXXXXVFA-FRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337
G A F P E + A+HPF++F+ +ILF G + P
Sbjct: 329 GTEAAAATAGIAVFAMLMPEED--FIADHPFIFFIRHNPSSNILFLGRLSSP 378
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P50453 | SPB9_HUMAN | No assigned EC number | 0.2767 | 0.9327 | 0.8484 | yes | N/A |
| O73790 | SPB10_CHICK | No assigned EC number | 0.2711 | 0.9707 | 0.8097 | yes | N/A |
| Q5JJ64 | Y1782_PYRKO | No assigned EC number | 0.3153 | 0.9444 | 0.7582 | yes | N/A |
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 342 | |||
| cd00172 | 364 | cd00172, SERPIN, SERine Proteinase INhibitors (ser | 3e-85 | |
| pfam00079 | 369 | pfam00079, Serpin, Serpin (serine protease inhibit | 1e-82 | |
| smart00093 | 359 | smart00093, SERPIN, SERine Proteinase INhibitors | 3e-67 | |
| cd02058 | 380 | cd02058, PAI-2, Plasminogen Activator Inhibitor-2 | 2e-51 | |
| cd02056 | 361 | cd02056, alpha-1-antitrypsin_like, alpha-1-antitry | 2e-45 | |
| cd02059 | 389 | cd02059, ovalbumin_like, The ovalbumin_like group | 7e-45 | |
| COG4826 | 410 | COG4826, COG4826, Serine protease inhibitor [Postt | 1e-42 | |
| cd02044 | 370 | cd02044, ov-serpin, ovalbumin family of serpins (o | 2e-40 | |
| cd02049 | 364 | cd02049, bacterial_SERPIN, SERine Proteinase INhib | 5e-37 | |
| cd02048 | 388 | cd02048, neuroserpin, Neuroserpin is a inhibitory | 4e-31 | |
| cd02043 | 381 | cd02043, plant_SERPIN, SERine Proteinase INhibitor | 4e-30 | |
| cd02045 | 381 | cd02045, antithrombin-III_like, Antithrombin is a | 7e-29 | |
| cd02051 | 377 | cd02051, PAI-1_nexin-1, Plasminogen activator inhi | 8e-26 | |
| cd02057 | 372 | cd02057, maspin_like, Maspin (mammary serine prote | 6e-23 | |
| cd02055 | 365 | cd02055, PZI, Protein Z-dependent protease inhibit | 7e-23 | |
| cd02052 | 374 | cd02052, PEDF, Pigment epithelium-derived factor ( | 2e-22 | |
| cd02053 | 351 | cd02053, alpha2AP, Alpha2-antiplasmin (alpha2AP) i | 1e-21 | |
| cd02047 | 436 | cd02047, HCII, Heparin cofactor II (HCII) inhibits | 2e-20 | |
| cd02050 | 352 | cd02050, C1_inh, C1 inhibitor (C1-Inh) is a protea | 4e-16 | |
| cd02054 | 372 | cd02054, angiotensinogen, Angiotensinogen is part | 1e-15 | |
| PHA02948 | 373 | PHA02948, PHA02948, serine protease inhibitor-like | 4e-07 | |
| cd02046 | 366 | cd02046, hsp47, Heat shock protein 47 (Hsp47), als | 5e-06 | |
| PHA02660 | 364 | PHA02660, PHA02660, serpin-like protein; Provision | 2e-04 |
| >gnl|CDD|238101 cd00172, SERPIN, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms | Back alignment and domain information |
|---|
Score = 261 bits (669), Expect = 3e-85
Identities = 112/371 (30%), Positives = 178/371 (47%), Gaps = 47/371 (12%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
+F DL L + +NV SP SI AL Y + T L++VL LP LD D
Sbjct: 4 DFALDLYKQLAKSEPDENVVFSPLSIASALALLYLGAGGETREQLRKVLGLPS-LDDEDV 62
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKECMTAI----FPSEIQSMDFGN 116
+K L+ L+ +++ G+ N++FV + VKE + + +E++S+DF N
Sbjct: 63 HQAFK--SLLSSLK-DSEKGVELKLANRLFVQKGLTVKEDFLDLAKKYYDAEVESVDFAN 119
Query: 117 EVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------WL-----PSTQE-- 160
AA IN+WV ++T IKDL++ ++ T LVL W T++
Sbjct: 120 PEAAAAQINNWVEEKTNGKIKDLLSPDALDPDTRLVLVNAIYFKGKWKTPFDPELTRKRP 179
Query: 161 ----SIIIITV------------LSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDI 204
+ V EL+A +LE+PYKG ++SM +LP G+ ++
Sbjct: 180 FYVSEGESVQVPMMYQTGKFRYAEDEELDAQVLELPYKGSDLSMLIILPK--EVTGLAEL 237
Query: 205 LAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSR 264
L + + + + VE+ +PKF + ++L L LG+ DLFSP ADLS
Sbjct: 238 EEKLSAE--KLDDLLSNLKE-REVEVTLPKFKIESSLDLKEVLQALGITDLFSPSADLSS 294
Query: 265 LTDSH-IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDK 323
++ + +HKA ++++E+GT AAAATAV PV ++A+ PFL+ + D
Sbjct: 295 ISSDEPLYVSKVIHKAFIEVNEEGTEAAAATAVSIVPRRPS-PPVEFKADRPFLFLIRDD 353
Query: 324 EIQSILFAGVF 334
+ILF G
Sbjct: 354 TTGTILFLGRV 364
|
Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants have been associated with blood clotting disorders, emphysema, cirrhosis, and dementia. Length = 364 |
| >gnl|CDD|215699 pfam00079, Serpin, Serpin (serine protease inhibitor) | Back alignment and domain information |
|---|
Score = 254 bits (652), Expect = 1e-82
Identities = 114/375 (30%), Positives = 172/375 (45%), Gaps = 48/375 (12%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
+F FDL L+ + KN+F SP SI AL Y + T L VL PE LD +
Sbjct: 5 DFAFDLYKQLSKESPDKNIFFSPLSISTALAMLYLGARGETAEQLLSVLGFPE-LDDEEI 63
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKECMTAI----FPSEIQSMDFGN 116
++ L+ L D G T N++FV+ + +K + + +E++S+DF +
Sbjct: 64 HEGFQ--SLLSSLNKP-DKGYTLKIANRLFVDKGLKLKPDFLQLLKKYYGAEVESVDFSD 120
Query: 117 EVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------WL-----PSTQESI 162
EA + INSWV ++T IKDL+ G ++ T LVL W T+E
Sbjct: 121 PAEARKQINSWVEKKTNGKIKDLLPEGSLDPDTRLVLVNAIYFKGKWKTPFDPELTKEEP 180
Query: 163 ------IIITV------------LSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDI 204
+ V EL +LE+PYKG N+SM +LP G+ ++
Sbjct: 181 FHVDNGTTVKVPMMSQEGTFRYAEDEELGCKVLELPYKG-NLSMLIILP--DEGGGLEEL 237
Query: 205 LAALKKDPTSFKRFTEDSQNLKP-VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLS 263
+L + + + K E+ +PKF + +L L LG+ D FS AD S
Sbjct: 238 EKSL--TAELLEEWLSSLKPRKVREELYLPKFKIESSYDLKEVLKKLGITDAFSSKADFS 295
Query: 264 RLTDSHIAF-GDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVD 322
++ S + VHKA ++++E+GT AAAAT V + P P + A+ PFL+ + D
Sbjct: 296 GISSSEPLYVSKVVHKAFIEVNEEGTEAAAATGVVIVPRAPP-PPPEFVADRPFLFLIRD 354
Query: 323 KEIQSILFAGVFNEP 337
SILF G P
Sbjct: 355 NSTGSILFMGRVVNP 369
|
Structure is a multi-domain fold containing a bundle of helices and a beta sandwich. Length = 369 |
| >gnl|CDD|214513 smart00093, SERPIN, SERine Proteinase INhibitors | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 3e-67
Identities = 117/375 (31%), Positives = 183/375 (48%), Gaps = 57/375 (15%)
Query: 4 FDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNV 63
FDL L + KN+F SP SI AL + +T + +VL NL + ++
Sbjct: 1 FDLYKELAKESPDKNIFFSPVSISSALAMLSLGAKGSTATQILEVLGF--NLTETSEADI 58
Query: 64 YKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVK----ECMTAIFPSEIQSMDFGNEVE 119
++ + + L DS L + N +FV+ + +K E + ++ +E+QS+DF ++ E
Sbjct: 59 HQGFQHLLHLLNRPDSQLELKTANALFVDKSLKLKDSFLEDIKKLYGAEVQSVDFSDKAE 118
Query: 120 AAR-AINSWVAQETKNNIKDLIATGQVNSRTNLVL---------W----LPS-TQESI-- 162
A+ IN WV ++T+ IKDL++ ++S T LVL W P T+E
Sbjct: 119 EAKKQINDWVEKKTQGKIKDLLS--DLDSDTRLVLVNAIYFKGKWKTPFDPELTREEDFH 176
Query: 163 ----IIITV-------------LSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDIL 205
+ V ELN +LE+PYKG N SM +LP + G+ +
Sbjct: 177 VDETTTVKVPMMSQTGRTFNYGHDEELNCQVLELPYKG-NASMLIILP---DEGGLEKLE 232
Query: 206 AALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLS 263
AL + + + ++L VE+ +PKF + +L L LG+ DLFS ADLS
Sbjct: 233 KAL-----TPETLKKWMKSLTKRSVELYLPKFKIEGTYDLKDVLEKLGITDLFSNKADLS 287
Query: 264 RLTDSH-IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVD 322
+++ + +HKA L+++E+GT AAAAT V A S P E ++AN PFL+ + D
Sbjct: 288 GISEDKDLKVSKVLHKAVLEVNEEGTEAAAATGVIAVPRSLPPE---FKANRPFLFLIRD 344
Query: 323 KEIQSILFAGVFNEP 337
+ SILF G P
Sbjct: 345 NKTGSILFMGKVVNP 359
|
Length = 359 |
| >gnl|CDD|239013 cd02058, PAI-2, Plasminogen Activator Inhibitor-2 (PAI-2) | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 2e-51
Identities = 114/380 (30%), Positives = 179/380 (47%), Gaps = 51/380 (13%)
Query: 2 FTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTM 61
F +L L ++ KN+F SP+SI AL Y + NT A + +VL+ E + +
Sbjct: 8 FALNLFKKLAESSPTKNIFFSPWSISSALAMVYLGAKGNTAAQMAKVLQFNEVGGNSEDI 67
Query: 62 NVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKE----CMTAIFPSEIQSMDFGNE 117
+ + L+ + + L S N+++ P E + +E Q++DF
Sbjct: 68 HS-GFQSLLSEINKPGTNYL-LKSANRLYGEKTYPFLEKFLQLTQKYYQAEPQAVDFVEA 125
Query: 118 VEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL---------W------------- 154
E AR INSWV ++T+ I++L+ G V+S T LVL W
Sbjct: 126 AEQARKEINSWVERQTEGKIQNLLPPGSVDSLTRLVLVNAIYFKGNWEEKFLKENTRERP 185
Query: 155 --LPSTQESIIIITVLSSELN--------AHILEVPYKGGNMSMFFLLPPFASQDGVGDI 204
L + + L + A +LE+PY G +SMF LLP G
Sbjct: 186 FRLNKNTTKPVQMMFLKKKFPITYIEELKAQVLELPYVGKELSMFILLPDEIEDVTTG-- 243
Query: 205 LAALKKDPTSFKRFTE----DSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPG- 259
L L+K+ T +++ E + VE+ +PKF L + +L TLS +G++D F PG
Sbjct: 244 LEKLEKELT-YEKLNEWTSPEMMEEYEVEVYLPKFKLEESYDLKSTLSSMGMEDAFDPGK 302
Query: 260 ADLSRLTDSHIAF-GDAVHKARLDLDEQGTTAAAAT-AVFAFRSSRPLEPVRYEANHPFL 317
AD S ++ ++ F HKA ++++E+GT AAAAT A+ R P R+ A+HPFL
Sbjct: 303 ADFSGMSSANDLFLSKVFHKAFVEVNEEGTEAAAATAAIMMLRCLMP--SPRFNADHPFL 360
Query: 318 YFLVDKEIQSILFAGVFNEP 337
+F+ + +ILF G F P
Sbjct: 361 FFIRHNKTNTILFFGRFCSP 380
|
PAI-2 is a serine protease inhibitor that belongs to the ov-serpin branch of the serpin superfamily. It is is an effective inhibitor of urinary plasminogen activator (urokinase or uPA) and is involved in cell differentiation, tissue growth and regeneration. Length = 380 |
| >gnl|CDD|239011 cd02056, alpha-1-antitrypsin_like, alpha-1-antitrypsin_like | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 2e-45
Identities = 117/372 (31%), Positives = 185/372 (49%), Gaps = 56/372 (15%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
+F F L L + + KN+F SP SI AL + +T A + + L NL ++
Sbjct: 4 DFAFRLYRQLASESPSKNIFFSPVSISTALAMLSLGARSSTLAQILEGLGF--NLTEISE 61
Query: 61 MNVYK-MEKLIQGLRANADSGLTFTSTNKIFVNDKI-PVK---ECMTAIFPSEIQSMDFG 115
+++ + L+ L DSGL N +F++ ++ P+ E + ++ SE S DF
Sbjct: 62 EEIHQGFQHLLHLL-NQPDSGLQLNMGNALFLDKRLKPLDKFLEDVKHLYESEAFSTDFQ 120
Query: 116 NEVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------W-LP----STQES 161
+ EA + IN +V ++T I DL+ ++S T +VL W P TQE
Sbjct: 121 DSAEAKKQINDYVEKKTHGKIVDLVK--DLDSDTVMVLVNYIYFKGKWEKPFDPELTQEE 178
Query: 162 IIII----TV--------------LSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGD 203
+ TV SEL+ ++++PYKG N + FF+LP + +
Sbjct: 179 DFFVDEKTTVKVPMMHQTGRYDYLHDSELSCTVVQMPYKG-NATAFFVLP---DEGKMKQ 234
Query: 204 ILAALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGAD 261
+ AAL +D + K++ S+ L V++ +PKFS++ NL L +G+ D+FS AD
Sbjct: 235 VEAALSRD--TLKKW---SKLLSKRSVDLYLPKFSISGTYNLKDILPKMGITDVFSDKAD 289
Query: 262 LSRLT-DSHIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFL 320
LS +T ++ AVHKA LD+DE+GT AAAAT V S +++ N PFL +
Sbjct: 290 LSGITEQPNLKVSKAVHKAVLDVDEKGTEAAAATGVEITPMSALPPILKF--NRPFLLLI 347
Query: 321 VDKEIQSILFAG 332
D+ +SILF G
Sbjct: 348 FDRTTESILFLG 359
|
This family contains a variety of different members of clade A of the serpin superfamily. They include the classical serine proteinase inhibitors, alpha-1-antitrypsin and alpha-1-antichymotrypsin, protein C inhibitor, kallistatin, and noninhibitory serpins, like corticosteroid and thyroxin binding globulins. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants have been associated with blood clotting disorders, emphysema, cirrhosis, and dementia. Length = 361 |
| >gnl|CDD|239014 cd02059, ovalbumin_like, The ovalbumin_like group of serpins contains ovalbumin, the squamous cell carcinoma antigen 1 (SCCA1) and other closely related serpins of clade B of the serpin superfamily | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 7e-45
Identities = 110/392 (28%), Positives = 178/392 (45%), Gaps = 64/392 (16%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLR---LPENLDK 57
EF FDL L +K KN+F SP SI AL + +T A +++VL +
Sbjct: 7 EFCFDLFKELKKNHKNKNIFFSPLSISSALGMVLLGARDDTAAQIEKVLHFDHASGSGSS 66
Query: 58 L--------DTMNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVK----ECMTAIF 105
+ V+ K + + + N+++ P +C+ ++
Sbjct: 67 KPAASAQCNQSGGVHSQFKDLLSQINKPNDDYELSIANRLYGEKTYPFHQEYLDCVEKLY 126
Query: 106 PSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL----------- 153
++++ +DF N EA+R INSWV +T IK+L G ++S T LVL
Sbjct: 127 RAKLEPVDFQNAAEASRKKINSWVESQTNGKIKNLFGKGTIDSSTVLVLVNAIYFKGKWE 186
Query: 154 -------------WLPS---------TQESIIIITVLSSELNAHILEVPYKGGNMSMFFL 191
L Q + + E ILE+PY GG +SM L
Sbjct: 187 KKFEKENTVDAPFKLNENENKPVQMMYQIGKFKLASIE-EPKMKILELPYAGGGLSMIVL 245
Query: 192 LPPFASQDGVGDILAALKKDPTSFKRFTE--DSQNL--KPVEIAIPKFSLTQEMNLIPTL 247
LP D + L L+ T +++ E S+N+ + VE+ +P+F L ++ NL L
Sbjct: 246 LP-----DEISG-LEQLESKLT-YEKLMEWTSSENMRERKVEVYLPRFKLEEKYNLKSVL 298
Query: 248 SDLGVKDLFS-PGADLSRLTDS-HIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPL 305
+G+ D+FS ADLS ++ S + A+HK+ ++++E+GT AAAAT S P+
Sbjct: 299 KAMGMTDIFSESKADLSGISSSKSLYLSKAIHKSYVEVNEEGTEAAAATGAGIVEKSLPV 358
Query: 306 EPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337
+ A+HPFL+F+ + +ILF G F+ P
Sbjct: 359 -SEEFRADHPFLFFIRHNKTNTILFFGRFSSP 389
|
Ovalbumin, the major protein component of avian egg white, is a non-inhibitory member of SERine Proteinase INhibitorS (serpins). In contrast, SCCA1 inhibits cysteine proteinases such as cathepsin S, K, L, and papain, a so called cross-class serpin. Length = 389 |
| >gnl|CDD|227163 COG4826, COG4826, Serine protease inhibitor [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 1e-42
Identities = 99/374 (26%), Positives = 166/374 (44%), Gaps = 50/374 (13%)
Query: 2 FTFDLLTVLNNAN-KGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
F FDL + L + +N+ SP+S+ A+ Y + +T+ + V P N L
Sbjct: 45 FAFDLYSELAKQEGEAENILFSPYSVSAAMAMCYEGAEGSTKEQMSNVFYFPINKTVLKV 104
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKE----CMTAIFPSEIQSMDFGN 116
+ + L + + DS + N ++V + P+KE + + +E+ ++DF N
Sbjct: 105 ----REKSLNDKINSPNDS-YELETANALWVQEDYPLKENYVNNVRNYYDAEVTNLDFVN 159
Query: 117 EVEAAR-AINSWVAQETKNNIKDLIATGQVNSRTNLVL---------WL----------- 155
+ +A+R IN WV ++T IKDL+ + T LVL W
Sbjct: 160 KPDASRDTINKWVEEKTNGKIKDLVPEDYIGPDTRLVLTNAIYFNGKWWPEFDKQMTGKR 219
Query: 156 ---PSTQESIIIITVLSSE-------LNAHILEVPYKGGNMSMFFLLPPFASQDGVGDIL 205
P+ E + + A I+E+PYKG ++SM+ +LP + +
Sbjct: 220 TFYPAKGEDKSVDMMSICGDFNYGETSKAKIVELPYKGDDLSMYIVLPK-------DNNI 272
Query: 206 AALKKDPT--SFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLS 263
+ + T + + ++ VE+ IPKF + L L ++GV D F A+ S
Sbjct: 273 TEFENNFTLEKYTELKSNMEDQDEVEVEIPKFKFETKTELKDALIEMGVVDAFENTANFS 332
Query: 264 RLTDSHIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDK 323
++D + D H+A +D+DE+GT AAAATAV V + +HPFL+ + D+
Sbjct: 333 GISDRRLEISDVFHQAFIDVDEEGTEAAAATAVVFKAVCAKGGWVEFVVDHPFLFVIEDR 392
Query: 324 EIQSILFAGVFNEP 337
ILF G P
Sbjct: 393 RSGCILFIGKVVNP 406
|
Length = 410 |
| >gnl|CDD|238999 cd02044, ov-serpin, ovalbumin family of serpins (ov-serpins) | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-40
Identities = 91/381 (23%), Positives = 170/381 (44%), Gaps = 61/381 (16%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
F D+ L+ + +NVF SP +I +L Y + +T + +VL +N+ + +
Sbjct: 7 AFAVDVFKELSKKSALQNVFFSPIAIMSSLAMVYLGAKGSTANQIGKVLHF-DNVKDVHS 65
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKE----CMTAIFPSEIQSMDFGN 116
+ L+ + + N+++ + + E++++DF +
Sbjct: 66 ----SFQTLLSDINKLNSF-YSLKLVNRLYGEKRYNFLPEFLSSTKKPYAKELETVDFKD 120
Query: 117 EVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL---------WLPSTQES---II 163
+ E R INSW+ +TK I++L+ V+S+T +V+ W+ E
Sbjct: 121 KAEETRGQINSWIKDQTKGKIENLLPENSVDSQTAMVVVNAAYFKGKWMKKFSEEETKES 180
Query: 164 IITVLSSE--------------------LNAHILEVPYKGGNMSMFFLLPPFASQDGVGD 203
V +E L ILE+P+ ++SMF LLP +
Sbjct: 181 PFRVNKTETKPVQMMYMEATFNMGNIESLKMKILELPFANKDLSMFILLPDEVT------ 234
Query: 204 ILAALKKDPTSFKRFTE--DSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPG 259
L L+ + ++++ + + V++ +P+F + + +L L LG+KD FS G
Sbjct: 235 GLEKLESE-INYEKLNKWTSPSTMAEAKVKVYLPRFKMEKMYDLKSVLESLGMKDAFSEG 293
Query: 260 -ADLSRLTDSH-IAFGDAVHKARLDLDEQGTTAAAAT-AVFAFRSSRPLEPVRYEANHPF 316
A+ S ++++ +A + +HKA L+++E GT AA T AV RS + + A+HPF
Sbjct: 294 RANFSGMSETKGLALSNVIHKASLEINEDGTEAAEVTGAVMLQRSVKE----EFNADHPF 349
Query: 317 LYFLVDKEIQSILFAGVFNEP 337
L+ + + ILF G F+ P
Sbjct: 350 LFIIRHNKTNCILFFGKFSSP 370
|
Family of closely related proteins, whose members can be secreted (ovalbumin), cytosolic (leukocyte elastase inhibitor, LEI), or targeted to both compartments (plasminogen activator inhibitor 2, PAI-2). This subgroup corresponds to clade B of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants can cause blood clotting disorders, emphysema, cirrhosis, and dementia. Length = 370 |
| >gnl|CDD|239004 cd02049, bacterial_SERPIN, SERine Proteinase INhibitors (serpins), prokaryotic subgroup | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 5e-37
Identities = 92/379 (24%), Positives = 150/379 (39%), Gaps = 70/379 (18%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPE-NLDKLD 59
F F L + LN + KN+F+SP SI AL Y ++ T + + L L +L+ L+
Sbjct: 7 RFGFKLFSELNKEDVEKNIFISPLSIALALSMTYNGADGTTRKEMLKALGLDNIDLEDLN 66
Query: 60 TMNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKECMTAI----FPSEIQSMDFG 115
+ M++L D + N I++ +K + + + +DF
Sbjct: 67 SALATLMDQL-----NTHDKTVELIIANSIWIEPGFTLKPDFLQTIKDYYQAYVLELDF- 120
Query: 116 NEVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVLWL----------------PSTQ 159
AA IN WV ++TK I ++ + V++L ST
Sbjct: 121 QSPAAAEEINRWVKEKTKGKIDKIVD----KIDPDDVMFLINAVYFKGDWQEPFDKQSTY 176
Query: 160 ESIII--------ITVLSSELNAHILE--------VPYKGGNMSMFFLLPPFASQDGVGD 203
E+ + +S N LE +PY G +SM+ LP
Sbjct: 177 EAPFYLPDGSTKEVPFMSRTGNFRYLETPGFQAVRLPYGDGRLSMYVFLP---------- 226
Query: 204 ILAALKKDPTSFKRFT--EDSQNL------KPVEIAIPKFSLTQEMNLIPTLSDLGVKDL 255
F + E + + +++P+F L E+ L L LG+++
Sbjct: 227 ---KENVSLREFVKTLTAEKWRKWIEQFRMREGSLSLPRFQLEYEIELRDALKALGMEEA 283
Query: 256 FSPGADLSRLTDSHIAFGDAV-HKARLDLDEQGTTAAAATAVFAFRSSRPL-EPVRYEAN 313
F+P A + V HK ++++E+GT AAAAT+V +S P EP A+
Sbjct: 284 FTPDAADFSKLGEGNLYISKVIHKTFIEVNEEGTEAAAATSVEITETSAPAGEPFTMVAD 343
Query: 314 HPFLYFLVDKEIQSILFAG 332
PFL+ + D SILF G
Sbjct: 344 RPFLFAIRDNRTGSILFMG 362
|
Little information about specific functions is available for this subgroup, most likely they are inhibitory members of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors. Length = 364 |
| >gnl|CDD|239003 cd02048, neuroserpin, Neuroserpin is a inhibitory member of the SERine Proteinase INhibitor (serpin) family that reacts preferentially with tissue-type plasminogen activator (tPA) | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 4e-31
Identities = 92/380 (24%), Positives = 157/380 (41%), Gaps = 53/380 (13%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
E + DL L + + +N+ SP S AL + + ++ L D L
Sbjct: 6 ELSVDLYNALRASKEDENIIFSPLSTALALGMVELGAKGSALKEIRHSLGY----DGLKN 61
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKE----CMTAIFPSEIQSMDFGN 116
+ K + + + F N +++ + VKE F + ++ +DF
Sbjct: 62 GEEFSFLKDLSSMITAKEKEYVFNLANSLYLQNGFHVKEKFLQSNKKYFNAAVKLVDFSQ 121
Query: 117 EVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------W------------- 154
A IN WV T N IKD+ ++ T LVL W
Sbjct: 122 VKAVAEHINKWVENHTNNKIKDMFSSRDFTPLTRLVLVNALYFKGNWKSQFRPENTRTFS 181
Query: 155 LPSTQESIIIITVL-----------SSELNA-----HILEVPYKGGNMSMFFLLPPFASQ 198
ES + I ++ S N +LE+PY+G +S+ +L Q
Sbjct: 182 FTKDDESEVQIPMMYQQGEFYYGEFSDGSNEAGGIYQVLELPYEGDEISLMIILS---RQ 238
Query: 199 DGVGDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSP 258
+ L L K P + + + VE+ +P+F + Q+++L L +LG+ ++FS
Sbjct: 239 EVPLATLEPLVKAPLIEEWANSVKK--QKVEVYLPRFKVEQKIDLKDVLKNLGITEIFSG 296
Query: 259 GADLSRLTDS-HIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFL 317
GADLS ++DS + HK L+++E+G+ AAA++ + A L P + +HPF
Sbjct: 297 GADLSGISDSKELYVSKVFHKVFLEVNEEGSEAAASSGMIAISRMAVLYP-QVIVDHPFF 355
Query: 318 YFLVDKEIQSILFAGVFNEP 337
+ + ++ SILF G P
Sbjct: 356 FLIRNRRTGSILFMGRVMHP 375
|
It is located in neurons in regions of the brain where tPA is also found, suggesting that neuroserpin is the selective inhibitor of tPA in the central nervous system (CNS). This subgroup corresponds to clade I of the serpin superfamily. Length = 388 |
| >gnl|CDD|238998 cd02043, plant_SERPIN, SERine Proteinase INhibitors (serpins), plant specific subgroup | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 4e-30
Identities = 106/377 (28%), Positives = 166/377 (44%), Gaps = 55/377 (14%)
Query: 8 TVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKME 67
V A KG NV SP SI AL + T L L P + D+L +
Sbjct: 13 HVAAAAGKGSNVIFSPLSINVALSLVAAGARGETLDQLLSFLGSP-STDELHAV----AA 67
Query: 68 KLIQGLRANADS--GLTFTSTNKIFVNDKIPVK----ECMTAIFPSEIQSMDFGNEVEAA 121
++ + A+A + G + N ++V+ + +K + + +E + +DF + E
Sbjct: 68 SIVDLVLADASASGGPRLSFANGVWVDKSLSLKPSFKDLAANSYKAEARPVDFRTKAEEV 127
Query: 122 RA-INSWVAQETKNNIKDLIATGQVNSRTNLVL---------W-----LPSTQESI---- 162
R +NSWV + T IKD++ G V+S T LVL W T++
Sbjct: 128 RREVNSWVEKATNGLIKDILPPGSVDSSTKLVLANALYFKGAWSSKFDASDTKDRDFHLL 187
Query: 163 ----IIITVLSSELNAHI--------LEVPYKGGN------MSMFFLLPPFASQDGVGDI 204
+ + +SSE + ++ L +PYK G SM+ LP +DG+ D+
Sbjct: 188 DGTSVRVPFMSSEKDQYVAAFDGFKVLRLPYKRGGHDDARQFSMYIYLP--DKKDGLADL 245
Query: 205 LAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSR 264
L L +P R S+ + IPKF + L LG+ F PG L
Sbjct: 246 LEKLVSEPGFLDRHIPASEQ-EVGAFMIPKFKFSFGFEASEVLKKLGLTLPFDPGGALLS 304
Query: 265 L--TDSHIAFGDAV-HKARLDLDEQGTTAAAATA-VFAFRSSRPLEPVRYEANHPFLYFL 320
+ + + +V HKA +++DE+GT AAAATA V + SS P PV + A+HPFL+ +
Sbjct: 305 MSSPEGENLYVSSVYHKACVEVDEEGTEAAAATAVVMSGTSSPPPRPVDFVADHPFLFLI 364
Query: 321 VDKEIQSILFAGVFNEP 337
+ + +LF G P
Sbjct: 365 REDKTGVVLFLGQVMNP 381
|
It has been suggested that plant serpins play a role in defense against insect predators. This subgroup corresponds to clade P of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Length = 381 |
| >gnl|CDD|239000 cd02045, antithrombin-III_like, Antithrombin is a serine proteinase inhibitor (serpin) which controls the process of coagulation | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 7e-29
Identities = 92/362 (25%), Positives = 161/362 (44%), Gaps = 50/362 (13%)
Query: 14 NKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGL 73
+ +N+F+SP SI A + NT L +V + +K + KL L
Sbjct: 25 SNDENIFLSPLSISTAFAMTKLGACNNTLEQLMEVFQFDTISEKTSDQVHFFFAKLNCRL 84
Query: 74 RANADSGLTFTSTNKIFVNDKIPVKECMTAI----FPSEIQSMDFGNEVEAAR-AINSWV 128
A+ S N++F + + E I + +++ +DF + E +R IN W+
Sbjct: 85 YRKANKSSELISANRLFGDKSLTFNETYQDISEIVYGAKLWPLDFKEKPELSRITINEWI 144
Query: 129 AQETKNNIKDLIATGQVNSRTNLVL-----------------------WLPSTQESIIII 165
A +T+N I D+I G +++ T LVL + + E +
Sbjct: 145 ANKTENRITDVIPEGAIDTNTVLVLVNAIYFKGLWKSKFDKENTRKDLFHKAPGEKCPVP 204
Query: 166 TVLS---------SELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDILAALKKDPTSFK 216
+ E +LE+PYKG +++M +LP G L+ ++++ T
Sbjct: 205 MMYQESKFRYAKIPEDKVQVLELPYKGDDITMVLILPK------EGTTLSEVEQNLTL-D 257
Query: 217 RFTEDSQNLKPVEIA--IPKFSLTQEMNLIPTLSDLGVKDLFSP-GADLSRLTD---SHI 270
+ +K +A IP+F + ++ L +G++DLFSP A L + + +
Sbjct: 258 KLQGWLDAMKETTLAVQIPRFRVEDSFSVKEQLQKMGLEDLFSPENAKLPGIVAGGRTDL 317
Query: 271 AFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILF 330
DA HKA L+++E+G+ A+AATAV S + + + AN PFL F+ + I +I+F
Sbjct: 318 YVSDAFHKAFLEVNEEGSEASAATAVVITGRSLNINRIIFVANRPFLLFIREVAINAIIF 377
Query: 331 AG 332
G
Sbjct: 378 MG 379
|
It is the most important anticoagulant molecule in mammalian circulation systems, controlled by its interaction with the co-factor, heparin, which accelerates its interaction with target proteases, such as thrombin and factor Xa. This subgroup corresponds to clade C of the serpin superfamily. Length = 381 |
| >gnl|CDD|239006 cd02051, PAI-1_nexin-1, Plasminogen activator inhibitor-1_like | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 8e-26
Identities = 96/372 (25%), Positives = 158/372 (42%), Gaps = 66/372 (17%)
Query: 13 ANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQG 72
A +NV VSP I L ++ T+ L+ V+R N V K K +
Sbjct: 25 ARPQENVVVSPHGIASVLGMLQLGADGKTKKQLQTVMRYKIN-------GVAKALKKLNK 77
Query: 73 L---RANADSGLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARAIN 125
+ N D T+ N +F ++ +F E++S+DF + AA +IN
Sbjct: 78 AIVSKKNKD---IVTTANAVFAQSGFKMEVPFVPRNKEVFQCEVKSVDFSDPETAAFSIN 134
Query: 126 SWVAQETKNNIKDLIATGQ-VNSRTNLVL---------W----LPST------------- 158
WV ETK I +L++ ++ T LVL W P +
Sbjct: 135 DWVKNETKGMIDNLLSPDLADDALTRLVLVNALYFKGLWKSRFQPESTKKRTFHAGDGKT 194
Query: 159 -------QESIIIITVLSS--ELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDILAALK 209
Q S+ S+ L +I+E+PY G ++SM LP S I
Sbjct: 195 YQVPMLAQLSVFRSGSASTPNGLWYNIIELPYHGESISMLIALPTEKSTPLSAIIPHIST 254
Query: 210 KDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPG-ADLSRLTDS 268
K S+ + K +++ +PKF++ E +L L LG+ D+F A+ ++++ S
Sbjct: 255 KTIQSWMG----TMVPKRMQLVLPKFTVEAETDLKEPLKALGITDMFDQSKANFTKISRS 310
Query: 269 ---HIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEI 325
H++ A+ KA+++++E GT A+AAT S P + + PFL+F+
Sbjct: 311 ESLHVS--HALQKAKIEVNEDGTKASAATTAILIARSSPPW---FIVDRPFLFFIRHNPT 365
Query: 326 QSILFAGVFNEP 337
+ILF G N+P
Sbjct: 366 GTILFMGQINKP 377
|
Plasminogen activator inhibitor-1 (PAI-1) is the primary, fast-acting inhibitor of plasminogen activators. It is often bound to vitronectin, an abundant component of the extracellular matrix in many tissues. Protease nexin-1 is a potent serpin able to inhibit thrombin, plasmin, and plasminogen activators. PAI-1 and nexin-1 are members of the serpin superfamily and represent clade E. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Length = 377 |
| >gnl|CDD|239012 cd02057, maspin_like, Maspin (mammary serine proteinase inhibitor), a member of the serpin superfamily, with a multitude of effects on cells and tissues at an assortment of developmental stages | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 6e-23
Identities = 92/386 (23%), Positives = 167/386 (43%), Gaps = 71/386 (18%)
Query: 2 FTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLD----- 56
F DL L NV SP + +L A + +T + +VL D
Sbjct: 8 FAVDLFKKLCEKEPTGNVVFSPICLSTSLALAQVGAKGDTANEIGKVLHFENVKDVPFGF 67
Query: 57 KLDTMNVYKME-----KLIQGLRANADSGLTFTSTNKIFVND-KIPVKECMTAIFPSEIQ 110
+ T +V K+ KLI+ R D L + F+N K P +P E++
Sbjct: 68 QTVTSDVSKLSSFYSLKLIK--RLYVDKSLNLS---TDFINSTKRP--------YPKELE 114
Query: 111 SMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL---------WLPSTQE 160
++DF +++E R IN+ + + T + ++++ VN +T +++ W+ E
Sbjct: 115 TVDFKDKLEETRGQINNSIKELTDGHFENILNENSVNDQTKILVVNAAYFVGNWMKKFPE 174
Query: 161 SII-------------------IITVLS----SELNAHILEVPYKGGNMSMFFLLPPFAS 197
S + S ELN ILE+P++ ++SM LLP
Sbjct: 175 SETKECPFRVNKTETKPVQMMNLEATFSMGYIDELNTKILELPFQNKHLSMLILLPKDIE 234
Query: 198 QDGVGDILAALKKD--PTSFKRFTEDSQ--NLKPVEIAIPKFSLTQEMNLIPTLSDLGVK 253
+ G L L+K S ++T S N K V++++PKF + + ++L L LG+K
Sbjct: 235 DESTG--LEKLEKQLTSESLSQWTNPSMMANAK-VKVSLPKFKVEKMIDLKAMLESLGLK 291
Query: 254 DLFSPGA-DLSRLTDSH-IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYE 311
+F+ A D S ++++ +A + +HK L+++E G + + +
Sbjct: 292 HIFNEDASDFSGMSETKGVALSNVIHKVCLEVNEDGGESIEVPG-----ARILQHKDEFN 346
Query: 312 ANHPFLYFLVDKEIQSILFAGVFNEP 337
A+HPF++ + + ++I+F G F P
Sbjct: 347 ADHPFIFIIRHNKTRNIIFFGRFCSP 372
|
Maspin has tumor suppressing activity against breast and prostate cancer. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Length = 372 |
| >gnl|CDD|239010 cd02055, PZI, Protein Z-dependent protease inhibitor (ZPI) is a member of the serpin superfamily of proteinase inhibitors (clade A10) | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 7e-23
Identities = 94/373 (25%), Positives = 154/373 (41%), Gaps = 60/373 (16%)
Query: 2 FTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTM 61
F F+LL + + G N+ SPF + A+ + TE + + L +L L
Sbjct: 9 FGFNLLRKIAMKHDG-NIIFSPFGMSLAMAGLLLAAEGETERQIAKAL----HLHALKDR 63
Query: 62 NVYKMEKLIQGLRANADSG--LTFTSTNKIFVNDKIPVKECMTAI----FPSEIQSMDFG 115
+ + L +GL+ N L FT F++ VKE + F E MDF
Sbjct: 64 DPGLLPALFKGLKDNISRNEELGFTQGIFAFIHKDFDVKEAFFNLSKQYFDMECLCMDFQ 123
Query: 116 NEVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------WL----------- 155
N +A IN + +ETK I +L +++ + L+L WL
Sbjct: 124 NASQAKFLINHNIKKETKGKIPELFD--EIDPESKLILLDYIFFKGKWLTPFDPEFTEID 181
Query: 156 ------------PSTQESIIIITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGD 203
P + + H++++PYKG +M ++ + D
Sbjct: 182 TFHIDKYKSIKVPMMFGADKFASTFDENFRCHVIKLPYKG-KATMLIVIM-----EKGED 235
Query: 204 ILAALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGAD 261
LA +D + N+K ++I PKF L Q+ + L LG+K++F+P AD
Sbjct: 236 HLAL--EDHLTMDLVESWLANMKSRNMDIFFPKFKLDQKYEMHELLRALGIKNIFAPFAD 293
Query: 262 LSRL--TDSHIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYF 319
LS L H+ + KA +++DE+GT AAAA S P PV + + PF +
Sbjct: 294 LSELLADGKHLQVSQVLQKAVIEVDEKGTEAAAAIGSEIIAFSMP--PV-IKVDRPFHFM 350
Query: 320 LVDKEIQSILFAG 332
+ ++ +LF G
Sbjct: 351 IFEETFGMLLFIG 363
|
ZPI inhibits coagulation factor Xa , dependent on protein Z (PZ), a vitamin K-dependent plasma protein. ZPI also inhibits factor XIa in a process that does not require PZ. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Length = 365 |
| >gnl|CDD|239007 cd02052, PEDF, Pigment epithelium-derived factor (PEDF)_like | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 2e-22
Identities = 92/385 (23%), Positives = 167/385 (43%), Gaps = 81/385 (21%)
Query: 2 FTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTM 61
F +DL + + NVF+SP SI AL + + TE+ + + L + L+ +
Sbjct: 22 FGYDLYRQQASRDPTANVFLSPLSIATALSQLSLGAGERTESQIHRALYY-DLLNDPELH 80
Query: 62 NVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKECMTAIFPSEIQSMDFGNEVEAA 121
+ YK L+ L A A S ++I + K+ ++ ++F N+VE +
Sbjct: 81 DTYK--DLLASLTAPAKG---LKSASRILLERKLRLR-------------LEFVNQVEKS 122
Query: 122 ---------------RAINSWVAQETKNNI----KDLIA------------TGQ----VN 146
+ IN WV Q+T + K++ GQ +
Sbjct: 123 YGERPRILAGNALDLQEINDWVQQQTGGKVDRFVKEIPRNVSILLLGSAYFKGQWITKFD 182
Query: 147 SRTNLVLWLPSTQESIIIITVLS-----------SELNAHILEVPYKGGNMSMFFLLPPF 195
R ++ ++ +++ ++S S+LN I ++P GG +S+ F LP
Sbjct: 183 KRNTVLTDFHLDEQRTVVVPMMSDPNAPVRYGLDSDLNCKIAQLPLTGG-VSIMFFLPDK 241
Query: 196 ASQDGVGDILAALKKDPTSFKRFTED-SQNLKPVE--IAIPKFSLTQEMNLIPTLSDLGV 252
+Q+ L +++ TS F D + LK V+ + +PK L+ E L+P+L +L +
Sbjct: 242 VTQN-----LTLIEESLTS--EFVHDIDRELKTVKAVLTLPKLKLSYETELLPSLQELKL 294
Query: 253 KDLFSPGADLSRLTDSHIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEA 312
+ LF+ D +++T I HKA L+L+E G A ++ P+ Y
Sbjct: 295 QSLFAS-PDFTKITSKPIKLSHVHHKAVLELNEDGAETAPTPGS----ATALTFPLEYHV 349
Query: 313 NHPFLYFLVDKEIQSILFAGVFNEP 337
+ PFL+ L D++ ++LF G +P
Sbjct: 350 DRPFLFVLRDEDTGALLFIGKVLDP 374
|
PEDF is non-inhibitory member of the Serpin superfamily. It exhibits neurotrophic, neuroprotective and antiangiogenic properties and is widely expressed in the developing and adult nervous systems. This subgroup corresponds to clade F1 of the serpin superfamily. Length = 374 |
| >gnl|CDD|239008 cd02053, alpha2AP, Alpha2-antiplasmin (alpha2AP) is the primary inhibitor of plasmin, a proteinase that digests fibrin, the main component of blood clots | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 1e-21
Identities = 86/368 (23%), Positives = 155/368 (42%), Gaps = 63/368 (17%)
Query: 2 FTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTM 61
F+ DLL+ + + N+ +SP SI AL + TE L + L E+L L
Sbjct: 8 FSTDLLSEVAQESTKPNLILSPLSIALALSHLALGAQNETEQRLLKTLHA-ESLPCLH-- 64
Query: 62 NVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKECMT----AIFPSEIQSMDFGNE 117
+ + +L Q L ++++ +KE ++ ++ S+ G +
Sbjct: 65 --HLLSRLRQDL-----GPGALRLATRMYLQKGFEIKESFLEESEKLYGAKPVSLT-GTK 116
Query: 118 VEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------W-------------- 154
+ IN WV + T+ I + ++ + T L+L W
Sbjct: 117 EDDLANINKWVKEATEGQIPNFLS--DLPHDTVLLLLNAIHFKGFWRNKFDPSLTQRDAF 174
Query: 155 LPSTQESIIIITVLSS----------ELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDI 204
++ + + +S + + + P+KG NMS F +L P V +
Sbjct: 175 HLDDDFTVSVEMMQASTYPLRWFHLEQPEIQVAKFPFKG-NMS-FVVLMPTPFTWNVSQV 232
Query: 205 LAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSR 264
LA L D ++R ++ +P ++ +PK L ++ L LS LG+++LF DLS
Sbjct: 233 LANLNWD-DLYRRLPKE----RPTKVKLPKLKLDYQLELNEALSQLGLQELFQ-APDLSG 286
Query: 265 LTDSHIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKE 324
++D + H++ L+L E+G A+AAT+V RS + N PFL+F+ +
Sbjct: 287 ISDEPLFVSSVQHQSTLELSEKGVEASAATSVATSRSLS-----SFSVNRPFLFFIFEDT 341
Query: 325 IQSILFAG 332
+ LF G
Sbjct: 342 MGLPLFMG 349
|
Alpha2-Antiplasmin forms an inactive 1 : 1 stoichiometric complex with plasmin. It also rapidly crosslinks to fibrin during blood clotting by activated coagulation factor XIII, and as a consequence fibrin becomes more resistant to fibrinolysis. Therefore alpha2AP is important in modulating the effectiveness and persistence of fibrin with respect to its susceptibility to digestion and removal by plasmin. This subgroup corresponds to clade F2 of the serpin superfamily. Length = 351 |
| >gnl|CDD|239002 cd02047, HCII, Heparin cofactor II (HCII) inhibits thrombin, the final protease of the coagulation cascade | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 94/379 (24%), Positives = 162/379 (42%), Gaps = 58/379 (15%)
Query: 2 FTFDLLTVL-NNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLD---K 57
F F+L VL + N N+ ++P I A+ T+ + L + ++ K
Sbjct: 72 FGFNLYRVLKDQVNTSDNILLAPVGISTAMGMISLGLKGQTQEQVLSTLGFKDFVNASSK 131
Query: 58 LDTMNVYKM-EKLIQGL-RANADSGLTFTSTNKIFVNDKIPV----KECMTAIFPSEIQS 111
+ V+ + KL L R N G T S N +++ P+ K + + +E Q
Sbjct: 132 YEITTVHNLFRKLTHRLFRRNF--GYTLRSVNDLYIKKDFPILLDFKNNVKTYYFAEAQI 189
Query: 112 MDFGNEVEAARAINSWVAQETKNNIKDLIA----------------------------TG 143
DF + + N+ + + TK IK+ + T
Sbjct: 190 ADFSDPAFITKT-NNRIQKLTKGLIKEALENVDPATLMMILNCIYFKGTWENKFPVEMTH 248
Query: 144 QVNSRTN--LVLWLPSTQESIIIITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGV 201
N R N V+ +P Q + EL+ IL++PY G N+SM ++P S
Sbjct: 249 NRNFRLNEKEVVKVPMMQTKGNFLAAADPELDCDILQLPYVG-NISMLIVVPHKLSG--- 304
Query: 202 GDILAALKKD--PTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPG 259
+ L+K P +R+ + N + E+ +PKF L + NLI +L +G+ DLF+
Sbjct: 305 ---MKTLEKQITPQVVERWQKSMTN-RTREVVLPKFKLEKNYNLIESLKLMGITDLFTEK 360
Query: 260 ADLSRLTDSHIAFGDAVHKARLDLDEQGTTAAAATAV-FAFRSSRPLEPVRYEANHPFLY 318
+++ ++D IA H+ + ++E+GT AAA T V F S++ VR+ + PFL+
Sbjct: 361 GNMAGVSDEKIAIDLFKHQGTITVNEEGTEAAAVTTVGFMPLSTQ----VRFIVDRPFLF 416
Query: 319 FLVDKEIQSILFAGVFNEP 337
+ + +LF G P
Sbjct: 417 LIYEHRTNCLLFMGRVANP 435
|
HCII is allosterically activated by binding to cell surface glycosaminoglycans (GAGs). The specificity of HCII for thrombin is conferred by a highly acidic hirudin-like N-terminal tail, which becomes available after GAG binding for interaction with the anion-binding exosite I of thrombin. This subgroup corresponds to clade D of the serpin superfamily. Length = 436 |
| >gnl|CDD|239005 cd02050, C1_inh, C1 inhibitor (C1-Inh) is a protease inhibitor of the serpin family | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 4e-16
Identities = 87/362 (24%), Positives = 139/362 (38%), Gaps = 78/362 (21%)
Query: 17 KNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRAN 76
N+ SP SI L + T+ L+ +L P + + ++ L+
Sbjct: 21 TNLLFSPVSIALLLSHLLLGARGKTQRRLESILSYPHDF--------ACVHSALKKLKNK 72
Query: 77 ADSGLTFTSTNKIFVNDKIPVKECMTAIFPSEIQSMDF---------GNEVEAARAINSW 127
S ++IF + + ++E T +S F N INSW
Sbjct: 73 LG----LLSASQIFHHPDLHLRESFTN------ESWQFYKARPRELSNNSELNLEMINSW 122
Query: 128 VAQETKNNIKDLIATGQVNSRTNLVL---------W-LPSTQESIIIITVLSSELNAHIL 177
VA+ T N I L+ + S T LVL W + +L + N +
Sbjct: 123 VAKATNNKIPRLLD--SLPSETRLVLLNAVYFQAQWKKKFDTKHT---VLLPFKRNGDPV 177
Query: 178 EVP------YK------------------GGNMSMFFLLPPFASQDGVGDILAALKKDPT 213
+VP Y G +S+ L+P +D + + AL P
Sbjct: 178 KVPVMYSKKYPVASFTDPRLKAQVGRLELSGGLSLVVLVPRGPKED-LEAVERAL--TPP 234
Query: 214 SFKRFTEDSQNLKPV--EIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-DSHI 270
+F E P E+ +P+ L ++++ + LG+ LF A+L L D +
Sbjct: 235 AFLAMLEKMAANTPQRTEVTLPRIKLDLAVDMVALMHKLGLFGLFL-DANLCGLYQDPEL 293
Query: 271 AFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILF 330
A A H+A L L E+G AAAATA R++ + +EA PFL+ L D + + LF
Sbjct: 294 AVDAAQHRAVLTLTEKGVEAAAATATSFARTA-----LSFEALQPFLFVLWDDQAKVPLF 348
Query: 331 AG 332
G
Sbjct: 349 MG 350
|
It plays a pivotal role in regulating the activation of the classical complement pathway and of the contact system, via regulating bradykinin formation, inhibiting factor XII and kallikrein of the contact system, and via acting on factor XI in the coagulation cascade. This subgroup corresponds to clade G of the serpin superfamily. Length = 352 |
| >gnl|CDD|239009 cd02054, angiotensinogen, Angiotensinogen is part of the renin-angiotensin system (RAS), which plays an important role in blood pressure regulation, renal haemodynamics, fluid and electrolyte homeostasis | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 81/371 (21%), Positives = 143/371 (38%), Gaps = 58/371 (15%)
Query: 10 LNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLP---ENLD---KLDTMNV 63
L+ N +SP S++ L + Y ++K T +L+ +L LP +N D ++D V
Sbjct: 17 LSELWVHTNTLLSPTSVFGTLASLYLGASKKTADSLQALLGLPWKSKNSDCTSRVDGHKV 76
Query: 64 YKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKECM---TAIFP--SEIQSMDFGNEV 118
+ IQ L L ++ F I + + A F S +S+DF
Sbjct: 77 LSTLQAIQSLVDAQGRQLLLSTVVWTFTAPGIHLSQPFVQGLADFSDASFPRSVDFTEPD 136
Query: 119 EAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL--------------WLPSTQESII- 163
A IN++V + +K + ++ ++L+ L QE +
Sbjct: 137 VAEEKINNFVQATSDGKVKSSLK--GLSPDSDLLFATSVHFQGNWKTASQLEEPQEFWVD 194
Query: 164 IITVLSSELNAH---------------ILEVPYKGGNMSMFFLLPPFASQDGVGDILAAL 208
T +S + +H I ++P + + P S + + L
Sbjct: 195 NNTSVSVPMLSHTGTFKYLSDIQDNFSITQLPL-SKRACLLLVQPHEGSD--LDKVEGKL 251
Query: 209 KKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT 266
+ +S +NL P +E+ +PKFSL +L L+ + + L A+LS+L+
Sbjct: 252 PQQNSS-----NWLKNLSPRTIELTLPKFSLQGSYDLQDLLAQMELPALLGSEANLSKLS 306
Query: 267 DSHIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQ 326
+ G ++K +L E GT +T LE N PFL+ + +
Sbjct: 307 NDRFTVGKVLNKVFFELSEDGTEVQESTQ--QLNKPEVLE---VTLNRPFLFAVYEANSN 361
Query: 327 SILFAGVFNEP 337
+ILF G P
Sbjct: 362 AILFLGRVTNP 372
|
It is also involved in normal and abnormal growth processes. The growth promoting actions of angiotensin have been shown in a variety of cells and tissues. This subgroup represents clade A8 of the serpin superfamily. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Length = 372 |
| >gnl|CDD|165258 PHA02948, PHA02948, serine protease inhibitor-like protein; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 47/175 (26%), Positives = 80/175 (45%), Gaps = 17/175 (9%)
Query: 165 ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDILAALKKDPTSFKRFTEDSQ- 223
IT+ E + ++ +PYK N+SM+ +GD + T+ K SQ
Sbjct: 214 ITIDDEEYD--MVRLPYKDANISMYL---------AIGDNMTHFTDSITAAKLDYWSSQL 262
Query: 224 NLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSP-GADLSRLTDSHIAFGDAVHKARLD 282
K + +P+FS+ + + I +++++ +F+P A +T + A++D
Sbjct: 263 GNKVYNLKLPRFSIENKRD-IKSIAEMMAPSMFNPDNASFKHMTRDPLYIYKMFQNAKID 321
Query: 283 LDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337
+DEQGT A A+T + A S P E E N PF++ + ILF G P
Sbjct: 322 VDEQGTVAEASTIMVATARSSPEE---LEFNTPFVFIIRHDITGFILFMGKVESP 373
|
Length = 373 |
| >gnl|CDD|239001 cd02046, hsp47, Heat shock protein 47 (Hsp47), also called colligin, because of its collagen binding ability, is a chaperone specific for procollagen | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 5e-06
Identities = 78/367 (21%), Positives = 145/367 (39%), Gaps = 52/367 (14%)
Query: 4 FDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNV 63
F+L + +N+ +SP + +L +T + K VL + DKL +V
Sbjct: 12 FNLYHAMAKDKGVENILLSPVVVASSLGLVSMGGKASTASQAKAVL----SADKLKDEHV 67
Query: 64 YK-MEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKECMTAI----FPSEIQSMDFGNEV 118
+ + +L+ + + +T+ N+++ + + + E ++F ++
Sbjct: 68 HTGLSELLNEVSNSTARNVTWKIGNRLYGPSSVSFADDFVKNSKKHYNYEHSKINFRDKR 127
Query: 119 EAARAINSWVAQETKNNI----KDLIATG---------------------QVNSRTNLV- 152
A +IN W AQ T + KD+ T V++R +V
Sbjct: 128 SALNSINEWAAQTTDGKLPEVTKDVEKTDGALIVNAMFFKPHWDEKFHHKMVDNRGFMVT 187
Query: 153 ----LWLPSTQESIIIITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDILAAL 208
+ +P + + E I+E+P SM F++P + L L
Sbjct: 188 RSYTVSVPMMHRTGLYGYYDDEENKLQIVEMPLAHKLSSMIFIMPYHV------EPLERL 241
Query: 209 KKDPTSFKRFTEDSQ-NLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPG-ADLSRLT 266
+K T + T S+ + V I++PK SL +L L DLG+ + ADLS+++
Sbjct: 242 EKLLTREQLKTWISKMKKRAVAISLPKVSLEVSHDLQKHLGDLGLTEAIDKSKADLSKIS 301
Query: 267 -DSHIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEI 325
+ + H A L+ D +G + P + A+HPF++ + D +
Sbjct: 302 GKKDLYLSNVFHAAALEWDTEGNPFDPDI----YGREEMRNPKLFYADHPFIFLVKDNKT 357
Query: 326 QSILFAG 332
SILF G
Sbjct: 358 NSILFIG 364
|
It has been shown to be essential for collagen biosynthesis, but its exact function is still unclear. Hsp47 is a non-inhibitory member of the SERPIN superfamily and corresponds to clade H. Length = 366 |
| >gnl|CDD|165039 PHA02660, PHA02660, serpin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 74/301 (24%), Positives = 117/301 (38%), Gaps = 65/301 (21%)
Query: 88 KIFVNDKIPVKECMTAIFPS---EIQSMDFGNEVEAAR-AINSWVAQETKNNIKD----- 138
K++V+ +P+ A ++ D N E R +IN WV ++T NI +
Sbjct: 78 KVYVDSHLPIHSAFVASMNDMGIDVILADLANHAEPIRRSINEWVYEKT--NIINFLHYM 135
Query: 139 ------LIATGQVNSRTNLVLWLPSTQESIIIITVLSSEL----------------NAHI 176
+I Q N T I I +S + ++I
Sbjct: 136 PDTSILIINAVQFNGLWKYPFLRKKTTMDIFNIDKVSFKYVNMMTTKGIFNAGRYHQSNI 195
Query: 177 LEVPYKGGNMS-MFFLLPPFASQDGVGDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKF 235
+E+PY + S M+ + P S D + + + D + K F S+ K +EI+IPKF
Sbjct: 196 IEIPYDNCSRSHMWIVFPDAISNDQLNQLENMMHGD--TLKAFKHASRK-KYLEISIPKF 252
Query: 236 SLTQEMNLIPTLSDLGVKDLFSPGADLSRLTDSHIAFGDA-----------VHKARLDLD 284
+ N L G+K LF+ +LSR+ I GD K L++D
Sbjct: 253 RIEHSFNAEHLLPSAGIKTLFT-NPNLSRM----ITQGDKEDDLYPLPPSLYQKIILEID 307
Query: 285 EQGTTAAAATAVFAFRSSRPLEP-----VRYEA---NHPFLYFLVDKEIQSILFAGVFNE 336
E+GT R + E R E+ N PF+ F+++ E ILF G +
Sbjct: 308 EEGTNTKNIAK--KMRRNPQDEDTQQHLFRIESIYVNRPFI-FIIEYE-NEILFIGRISI 363
Query: 337 P 337
P
Sbjct: 364 P 364
|
Length = 364 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 342 | |||
| COG4826 | 410 | Serine protease inhibitor [Posttranslational modif | 100.0 | |
| cd02054 | 372 | angiotensinogen Angiotensinogen is part of the ren | 100.0 | |
| cd02048 | 388 | neuroserpin Neuroserpin is a inhibitory member of | 100.0 | |
| cd02044 | 370 | ov-serpin ovalbumin family of serpins (ov-serpins) | 100.0 | |
| KOG2392|consensus | 380 | 100.0 | ||
| cd02059 | 389 | ovalbumin_like The ovalbumin_like group of serpins | 100.0 | |
| cd02057 | 372 | maspin_like Maspin (mammary serine proteinase inhi | 100.0 | |
| cd02045 | 381 | antithrombin-III_like Antithrombin is a serine pro | 100.0 | |
| cd02047 | 436 | HCII Heparin cofactor II (HCII) inhibits thrombin, | 100.0 | |
| smart00093 | 359 | SERPIN SERine Proteinase INhibitors. | 100.0 | |
| cd02058 | 380 | PAI-2 Plasminogen Activator Inhibitor-2 (PAI-2). P | 100.0 | |
| cd02046 | 366 | hsp47 Heat shock protein 47 (Hsp47), also called c | 100.0 | |
| cd00172 | 364 | SERPIN SERine Proteinase INhibitors (serpins) exhi | 100.0 | |
| cd02056 | 361 | alpha-1-antitrypsin_like alpha-1-antitrypsin_like. | 100.0 | |
| PF00079 | 371 | Serpin: Serpin (serine protease inhibitor); InterP | 100.0 | |
| cd02049 | 364 | bacterial_SERPIN SERine Proteinase INhibitors (ser | 100.0 | |
| cd02051 | 377 | PAI-1_nexin-1 Plasminogen activator inhibitor-1_li | 100.0 | |
| cd02052 | 374 | PEDF Pigment epithelium-derived factor (PEDF)_like | 100.0 | |
| cd02043 | 381 | plant_SERPIN SERine Proteinase INhibitors (serpins | 100.0 | |
| cd02055 | 365 | PZI Protein Z-dependent protease inhibitor (ZPI) i | 100.0 | |
| PHA02948 | 373 | serine protease inhibitor-like protein; Provisiona | 100.0 | |
| cd02053 | 351 | alpha2AP Alpha2-antiplasmin (alpha2AP) is the prim | 100.0 | |
| cd02050 | 352 | C1_inh C1 inhibitor (C1-Inh) is a protease inhibit | 100.0 | |
| PHA02660 | 364 | serpin-like protein; Provisional | 100.0 |
| >COG4826 Serine protease inhibitor [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-72 Score=482.87 Aligned_cols=328 Identities=30% Similarity=0.519 Sum_probs=294.4
Q ss_pred ChHHHHHHHHhhcC-CCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCC
Q psy7902 1 EFTFDLLTVLNNAN-KGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADS 79 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~-~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~ 79 (342)
.||++||..+.+.. ..+|+.|||+||+.++||-|.||.|.|++||..+++++. ++..+...++ .+...+.+++.+
T Consensus 44 aF~FdlyS~~~~~~~~~~Ni~fSPySV~~AmAmcY~GaeGsTkeqmsnvfyfp~--n~~vl~~~~~--~~nd~i~sp~~~ 119 (410)
T COG4826 44 AFAFDLYSELAKQEGEAENILFSPYSVSAAMAMCYEGAEGSTKEQMSNVFYFPI--NKTVLKVREK--SLNDKINSPNDS 119 (410)
T ss_pred chhHHHHHHHHhhcccccceeeccHHHHHHHHHHhcccCcchHHHHHhheeccc--cchHhhhhHH--hhcccccCCccc
Confidence 49999999999744 679999999999999999999999999999999999995 4556666664 555556666667
Q ss_pred ceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE-
Q psy7902 80 GLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL- 153 (342)
Q Consensus 80 ~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl- 153 (342)
++|..+|++|+++++++++.|.. +|.+++..+||.++|+.++. ||+|++++|+|+|+++++++.+.++++++|
T Consensus 120 -y~le~AnalWvqedyplke~yv~n~r~yy~aevtnlDF~~~p~~s~dtINkWvEekT~gkIkdlVp~~~i~~d~rlvlt 198 (410)
T COG4826 120 -YELETANALWVQEDYPLKENYVNNVRNYYDAEVTNLDFVNKPDASRDTINKWVEEKTNGKIKDLVPEDYIGPDTRLVLT 198 (410)
T ss_pred -hhhhhhhhHHHhcCCCCCHHHHHHHHhhhhcceeecccccCchHHHHHHHHHHHHhhcchHhhcCCccccCCceeEEEE
Confidence 99999999999999999999964 88899999999999999999 999999999999999999999999999998
Q ss_pred --------ecc---------------CCceEEec------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHHHH
Q psy7902 154 --------WLP---------------STQESIII------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDI 204 (342)
Q Consensus 154 --------W~~---------------~~~~~~V~------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~~l 204 (342)
|.. .+....|+ .|.|.+..++++|||||++.++||+|+||++. ++.++
T Consensus 199 nAiYFnGkW~~efDk~~t~krtFy~a~~~d~sv~mMs~~g~fny~et~kakiveLPy~gd~lSmYIvLPk~n---Ni~~F 275 (410)
T COG4826 199 NAIYFNGKWWPEFDKQMTGKRTFYPAKGEDKSVDMMSICGDFNYGETSKAKIVELPYKGDDLSMYIVLPKDN---NITEF 275 (410)
T ss_pred eeEEEcCeeccccchhhccceeeecCChhhhcchhHHhcCCCCcccCcCceEEEcccCCCceEEEEEeeCCC---ChHHH
Confidence 765 12233444 78888999999999999999999999999985 99999
Q ss_pred HHHhcCCchHHHHHhhhcCCCe-eEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCCCCCeeecceeeeEEEEe
Q psy7902 205 LAALKKDPTSFKRFTEDSQNLK-PVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLTDSHIAFGDAVHKARLDL 283 (342)
Q Consensus 205 ~~~L~~~~~~l~~~~~~~l~~~-~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~~~~l~ls~v~q~~~i~v 283 (342)
++.|+.+ .+.+|..+ |+.+ .+++.||||+.+++..|+++|.+||+-++|+..||||||+..+|+|++|+|+++|+|
T Consensus 276 e~nft~e--~y~elk~~-m~~~~~v~v~iPkFkfetk~el~~aLieMGvvdAF~n~AnFSgI~~~~L~Is~V~Hqa~idv 352 (410)
T COG4826 276 ENNFTLE--KYTELKSN-MEDQDEVEVEIPKFKFETKTELKDALIEMGVVDAFENTANFSGISDRRLEISDVFHQAFIDV 352 (410)
T ss_pred HhhccHH--HHHHHHhc-CCccceEEEEecceeeeehhhhhHHHHHhhHHHHhhcccCcccccCCcccHHHHhhhhheec
Confidence 9999999 99999999 6777 899999999999999999999999999999977999999976799999999999999
Q ss_pred cCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCCCC
Q psy7902 284 DEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEPPN 339 (342)
Q Consensus 284 ~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~~ 339 (342)
+|+|++|+|+|++.+...+....-.+|++||||+|+|.|+.||.|||||+|.+|..
T Consensus 353 ~EeGteAaAAT~v~~~a~~~~~~~~e~~vD~PFlf~i~D~~s~~IlFiG~Vv~P~~ 408 (410)
T COG4826 353 DEEGTEAAAATAVVFKAVCAKGGWVEFVVDHPFLFVIEDRRSGCILFIGKVVNPEY 408 (410)
T ss_pred cccchhhhhhceeeeeeeeecccceEEEecCceEEEEecCCcceEEEEeeecCCCC
Confidence 99999999999877665554444569999999999999999999999999999975
|
|
| >cd02054 angiotensinogen Angiotensinogen is part of the renin-angiotensin system (RAS), which plays an important role in blood pressure regulation, renal haemodynamics, fluid and electrolyte homeostasis | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-69 Score=506.95 Aligned_cols=320 Identities=20% Similarity=0.374 Sum_probs=277.1
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCC---------hHHHHHHhhHHHHHH
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLD---------KLDTMNVYKMEKLIQ 71 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~---------~~~~~~~~~~~~~l~ 71 (342)
+||++||+++....+++|+++||+||+.+|+|++.||+|+|++||.++||++.... ..++...++ .+..
T Consensus 8 ~f~~~l~~~l~~~~~~~N~v~SP~Si~~aL~ml~~GA~G~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 85 (372)
T cd02054 8 VLGLRMYGMLSELWVHTNTLLSPTSVFGTLASLYLGASKKTADSLQALLGLPWKSKNSDCTSRVDGHKVLSTLQ--AIQS 85 (372)
T ss_pred HHHHHHHHHHHhhCCCCCEEEChHHHHHHHHHHHcCCCccHHHHHHHHhCCCcccccccccccccHHHHHHHHH--HHHH
Confidence 49999999998767789999999999999999999999999999999999975311 123444444 4444
Q ss_pred HhhhCCCCceEEEEEeeeeccCCCCchhhHhh----hcCCc-eEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCC
Q psy7902 72 GLRANADSGLTFTSTNKIFVNDKIPVKECMTA----IFPSE-IQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQV 145 (342)
Q Consensus 72 ~l~~~~~~~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~-~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i 145 (342)
.+...+.. ..+..+|++|++++++++++|.+ +|+++ ++.+||+ +++.+++ ||+||+++|+|+|++++ .++
T Consensus 86 ~~~~~~~~-~~l~~a~~i~~~~~~~l~~~f~~~~~~~y~a~~~~~vdF~-~~~~a~~~IN~WV~~~T~g~I~~ll--~~~ 161 (372)
T cd02054 86 LVDAQGRQ-LLLSTVVWTFTAPGIHLSQPFVQGLADFSDASFPRSVDFT-EPDVAEEKINNFVQATSDGKVKSSL--KGL 161 (372)
T ss_pred HHcCCCCc-cEEEEEEEEEecCCCCccHHHHHHHHHHhCcccceeecCC-ChHHHHHHHHHHHHHHhcCchhhhc--cCC
Confidence 44433334 67999999999999999999976 79987 9999995 6777777 99999999999999999 468
Q ss_pred CCCceEEE---------ecc-------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCC
Q psy7902 146 NSRTNLVL---------WLP-------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPF 195 (342)
Q Consensus 146 ~~~t~lvl---------W~~-------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~ 195 (342)
+++|.++| |++ +++.++|| .|.+.+++++++++|||+ ++++|+||||++
T Consensus 162 ~~~t~lvLvNaiyFkg~W~~~F~~~~T~~f~~~~~~~~~V~mM~~~~~~~y~~~~~~~~~vleLPy~-~~~sm~iiLP~~ 240 (372)
T cd02054 162 SPDSDLLFATSVHFQGNWKTASQLEEPQEFWVDNNTSVSVPMLSHTGTFKYLSDIQDNFSITQLPLS-KRACLLLVQPHE 240 (372)
T ss_pred CCCCeEEEEEEEEEEHhhcCCCCcccceeEEeCCCCEEEEeeeeccCcEEEEEecCCCcEEEEEeeC-CCeEEEEEeCCC
Confidence 88999888 887 34456676 566677889999999996 579999999998
Q ss_pred CCCCcHHHHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCCCCCeeecce
Q psy7902 196 ASQDGVGDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLTDSHIAFGDA 275 (342)
Q Consensus 196 ~~~~~l~~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~~~~l~ls~v 275 (342)
+ .+|.++++.|+.+ .+..|..+ +..+.|+|.||||+|++++||+++|++||++++|+..|||++|++.+++|++|
T Consensus 241 ~--~~l~~l~~~L~~~--~l~~~~~~-~~~~~v~v~lPkF~i~~~~~L~~~L~~lGi~~~F~~~Adfs~i~~~~l~vs~v 315 (372)
T cd02054 241 G--SDLDKVEGKLPQQ--NSSNWLKN-LSPRTIELTLPKFSLQGSYDLQDLLAQMELPALLGSEANLSKLSNDRFTVGKV 315 (372)
T ss_pred C--CCHHHHHHhhCHH--HHHHHHHh-CCceEEEEECCeEEEEEEeccHHHHHHcCCcccccCccccccccCCCceeeee
Confidence 7 7999999999987 89999988 68899999999999999999999999999999998789999999667999999
Q ss_pred eeeEEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCC
Q psy7902 276 VHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337 (342)
Q Consensus 276 ~q~~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P 337 (342)
+|++.|+|||+|++|+|+|.+.. .+ .+.+|++||||+|+|+|+.|+.|||+|+|.+|
T Consensus 316 ~hka~ieVdE~GteAaaat~~~~----~~-~~~~f~~drPF~f~I~d~~t~~iLF~G~v~~P 372 (372)
T cd02054 316 LNKVFFELSEDGTEVQESTQQLN----KP-EVLEVTLNRPFLFAVYEANSNAILFLGRVTNP 372 (372)
T ss_pred eeeEEEEEccCceeccccccccc----CC-CCceEEecCCEEEEEEECCCCcEEEEEEecCC
Confidence 99999999999999999997531 12 25689999999999999999999999999998
|
It is also involved in normal and abnormal growth processes. The growth promoting actions of angiotensin have been shown in a variety of cells and tissues. This subgroup represents clade A8 of the serpin superfamily. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. |
| >cd02048 neuroserpin Neuroserpin is a inhibitory member of the SERine Proteinase INhibitor (serpin) family that reacts preferentially with tissue-type plasminogen activator (tPA) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-70 Score=514.60 Aligned_cols=330 Identities=25% Similarity=0.434 Sum_probs=286.6
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCCc
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADSG 80 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 80 (342)
+||++||+++...++++|+|+||+||+.+|+||+.||+|+|++||.++||++.. ...+....++ .++..+......
T Consensus 6 ~Fa~~l~~~~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~el~~~L~~~~~-~~~~~~~~~~--~~~~~~~~~~~~- 81 (388)
T cd02048 6 ELSVDLYNALRASKEDENIIFSPLSTALALGMVELGAKGSALKEIRHSLGYDGL-KNGEEFSFLK--DLSSMITAKEKE- 81 (388)
T ss_pred HHHHHHHHHhhccCCCCcEEEChHHHHHHHHHHhhhcCCcHHHHHHHHhCCCCC-ChHHHHHHHH--HHHHHhccCCCc-
Confidence 599999999988778899999999999999999999999999999999999864 2334444454 455555444444
Q ss_pred eEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE--
Q psy7902 81 LTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL-- 153 (342)
Q Consensus 81 ~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl-- 153 (342)
..++++|++|++++++++++|.+ +|+++++.+||. +++.+++ ||+|++++|+|+|++++++.+++++|.+++
T Consensus 82 ~~l~~an~i~v~~~~~l~~~f~~~~~~~f~~~~~~vdF~-~~~~~~~~IN~wv~~~T~g~I~~l~~~~~l~~~t~lvlvN 160 (388)
T cd02048 82 YVFNLANSLYLQNGFHVKEKFLQSNKKYFNAAVKLVDFS-QVKAVAEHINKWVENHTNNKIKDMFSSRDFTPLTRLVLVN 160 (388)
T ss_pred cchHHhhhhHhhcCCCccHHHHHHHHHHhcCeeEEECCC-ChHHHHHHHHHHHHHhccCchhhcCCCccCCHHHHHHhhh
Confidence 77999999999999999999976 899999999995 6666776 999999999999999998888999888877
Q ss_pred -------ecc---------------CCceEEec--------ceeecCC------CCeEEEEeecCCCceEEEEEeCCCCC
Q psy7902 154 -------WLP---------------STQESIII--------ITVLSSE------LNAHILEVPYKGGNMSMFFLLPPFAS 197 (342)
Q Consensus 154 -------W~~---------------~~~~~~V~--------~~~~~~~------~~~~vvelP~~~~~~sm~iilP~~~~ 197 (342)
|++ +++.+.|| +|++.++ +++++++|||++++++|+||||++.
T Consensus 161 ai~Fkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~~~y~~~~~~~~~~~~~~~vv~LPy~~~~~sm~iiLP~~~- 239 (388)
T cd02048 161 ALYFKGNWKSQFRPENTRTFSFTKDDESEVQIPMMYQQGEFYYGEFSDGSNEAGGIYQVLELPYEGDEISLMIILSRQE- 239 (388)
T ss_pred eEEEeeeccCCCCHHHCeeccEEECCCceEEeehhcccCcEEEEeccccccccccCcEEEEEecCCCceEEEEEccCCC-
Confidence 887 34556677 4555666 7899999999988999999999987
Q ss_pred CCcHHHHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC-CCCeeeccee
Q psy7902 198 QDGVGDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-DSHIAFGDAV 276 (342)
Q Consensus 198 ~~~l~~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~-~~~l~ls~v~ 276 (342)
.+|.+++++|+.. .+..|..+ ++.+.++|.||||++++++||+++|++||++++|+.+|||++|+ +++++|++++
T Consensus 240 -~~l~~l~~~l~~~--~l~~~~~~-~~~~~v~l~lPkF~i~~~~~l~~~L~~lGi~~~F~~~adfs~i~~~~~l~vs~v~ 315 (388)
T cd02048 240 -VPLATLEPLVKAP--LIEEWANS-VKKQKVEVYLPRFKVEQKIDLKDVLKNLGITEIFSGGADLSGISDSKELYVSKVF 315 (388)
T ss_pred -CCHHHHHHHhChH--HHHHHHHh-CceeEEEEEccEEEEEEEechHHHHHHcCCchhhcCccCcccccCCCCeEEEEEE
Confidence 7999999999988 99999988 69999999999999999999999999999999999889999999 6779999999
Q ss_pred eeEEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCCCCCC
Q psy7902 277 HKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEPPNKE 341 (342)
Q Consensus 277 q~~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~~~~ 341 (342)
|++.|+|||+|++|+|+|.+.....+.+ .+.+|+|||||+|+|+|+.|+.|||+|+|.+|...+
T Consensus 316 hka~ieV~E~Gt~a~a~t~~~~~~~~~~-~~~~f~~nrPF~f~I~d~~t~~iLF~G~v~~P~~~~ 379 (388)
T cd02048 316 HKVFLEVNEEGSEAAASSGMIAISRMAV-LYPQVIVDHPFFFLIRNRRTGSILFMGRVMHPETMT 379 (388)
T ss_pred eeeEEEECCCcceehhhcccccccccCC-CCceEEecCCEEEEEEECCCCeEEEEEEecCCCccc
Confidence 9999999999999999987543322222 235899999999999999999999999999998654
|
It is located in neurons in regions of the brain where tPA is also found, suggesting that neuroserpin is the selective inhibitor of tPA in the central nervous system (CNS). This subgroup corresponds to clade I of the serpin superfamily. |
| >cd02044 ov-serpin ovalbumin family of serpins (ov-serpins) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-69 Score=508.68 Aligned_cols=323 Identities=26% Similarity=0.520 Sum_probs=288.5
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCCc
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADSG 80 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 80 (342)
+||++||+++....+++|+|+||+||+.+|+||+.||+|+|++||.++||++. ..+++..|+ .++..+...+..
T Consensus 7 ~F~~~l~~~~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~el~~~L~~~~---~~~~~~~~~--~~~~~~~~~~~~- 80 (370)
T cd02044 7 AFAVDVFKELSKKSALQNVFFSPIAIMSSLAMVYLGAKGSTANQIGKVLHFDN---VKDVHSSFQ--TLLSDINKLNSF- 80 (370)
T ss_pred HHHHHHHHHHhhcCCCCcEEECHHHHHHHHHHHhhhcCCcHHHHHHHHhCCCC---HHHHHHHHH--HHHHHHhcCCCC-
Confidence 59999999998877889999999999999999999999999999999999973 356777776 677666655455
Q ss_pred eEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE--
Q psy7902 81 LTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL-- 153 (342)
Q Consensus 81 ~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl-- 153 (342)
..++++|++|++++++++++|.+ +|+++++.+||.++++.+++ ||+|++++|+|+|++++++.++++++.+++
T Consensus 81 ~~l~~a~~~~~~~~~~l~~~f~~~~~~~~~~~~~~vdF~~~~~~a~~~IN~wv~~~T~g~I~~lv~~~~l~~~t~lvlvn 160 (370)
T cd02044 81 YSLKLVNRLYGEKRYNFLPEFLSSTKKPYAKELETVDFKDKAEETRGQINSWIKDQTKGKIENLLPENSVDSQTAMVVVN 160 (370)
T ss_pred ceEeeeeehhhcCCCcccHHHHHHHHHhhccceEeccccCCHHHHHHHHHHHHHHhcCCchhhcCCCCCCCcchhheeee
Confidence 78999999999999999999976 79999999999766777777 999999999999999998889999998887
Q ss_pred -------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHHH
Q psy7902 154 -------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGD 203 (342)
Q Consensus 154 -------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~~ 203 (342)
|++ +++++.|| +|++.+++++++|+|||++++++|+||||++. .+|.+
T Consensus 161 ai~Fkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vv~LPy~~~~~sm~iiLP~~~--~~l~~ 238 (370)
T cd02044 161 AAYFKGKWMKKFSEEETKESPFRVNKTETKPVQMMYMEATFNMGNIESLKMKILELPFANKDLSMFILLPDEV--TGLEK 238 (370)
T ss_pred eeeEcccccCCCChhhCccCcCCcCCCcEEEeeCccccCceeeEEcCCCCeEEEEcccCCCceEEEEEcCCCC--CcHHH
Confidence 887 34456676 67778999999999999988999999999997 79999
Q ss_pred HHHHhcCCchHHHHHhh--hcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCC-CCCCCCCC-CCCeeecceeeeE
Q psy7902 204 ILAALKKDPTSFKRFTE--DSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSP-GADLSRLT-DSHIAFGDAVHKA 279 (342)
Q Consensus 204 l~~~L~~~~~~l~~~~~--~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~-~ad~s~i~-~~~l~ls~v~q~~ 279 (342)
+++.|+.+ .+..|.. . ++.+.|+|.||||++++++||++.|++||++++|++ .|||++|+ .++++|++|+|++
T Consensus 239 l~~~l~~~--~l~~~~~~~~-~~~~~v~l~lPkF~i~~~~~l~~~L~~mGl~~~F~~~~Adfs~ms~~~~l~vs~v~qka 315 (370)
T cd02044 239 LESEINYE--KLNKWTSPST-MAEAKVKVYLPRFKMEKMYDLKSVLESLGMKDAFSEGRANFSGMSETKGLALSNVIHKA 315 (370)
T ss_pred HHHHhCHH--HHHHhhcccc-ceeeEEEEEeeEEEEeeEEccHHHHHHcCchhhCCCCCCChhhcCCCCCeeEeeeeEee
Confidence 99999987 8988875 4 577899999999999999999999999999999998 59999999 6779999999999
Q ss_pred EEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCC
Q psy7902 280 RLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337 (342)
Q Consensus 280 ~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P 337 (342)
.|+|||+|++|+|+|......++ .+.+|++||||+|+|+|+.|+.|||+|+|.+|
T Consensus 316 ~ievdE~Gt~aaa~t~~~~~~~~---~~~~f~~drPF~f~I~~~~t~~iLF~G~v~~P 370 (370)
T cd02044 316 SLEINEDGTEAAEVTGAVMLQRS---VKEEFNADHPFLFIIRHNKTNCILFFGKFSSP 370 (370)
T ss_pred EEEECCCccccccccceeeeccC---CCCeEEeeCCEEEEEEECCCCeEEEEEEecCC
Confidence 99999999999999976443332 24789999999999999999999999999998
|
Family of closely related proteins, whose members can be secreted (ovalbumin), cytosolic (leukocyte elastase inhibitor, LEI), or targeted to both compartments (plasminogen activator inhibitor 2, PAI-2). This subgroup corresponds to clade B of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants can cause blood clotting disorders, emphysema, cirrhosis, and dementia. |
| >KOG2392|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-69 Score=503.61 Aligned_cols=328 Identities=32% Similarity=0.540 Sum_probs=296.2
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCCc
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADSG 80 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 80 (342)
+|+++||+.+....+++|++|||+||..+|+|++.||+|.|++||+++|+++.......++..|+ .++........+
T Consensus 13 ~f~~~l~~~~~~~~~~~Ni~fSP~SI~~aL~m~~lGa~g~T~~qi~~~L~~~~~~~~~~~~~~~~--~~~~~~~~~~~~- 89 (380)
T KOG2392|consen 13 DFALDLYRQLAKSAPDENVVFSPLSISSALAMVSLGAKGETADQILKALHFNSTDEENEVHESFQ--SLLLLLNSTESG- 89 (380)
T ss_pred HHHHHHHHHHHhhCCCCCEEEChHHHHHHHHHHHhcCCccHHHHHHHHhCCCCCcchHHHHHHHH--HHHHHhccccCC-
Confidence 59999999999877899999999999999999999999999999999999997533567888886 555434344445
Q ss_pred eEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE--
Q psy7902 81 LTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL-- 153 (342)
Q Consensus 81 ~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl-- 153 (342)
+.++++|++|+++++.+.++|.+ +|++++..+||.++++.+++ ||.|++++|+|+|.+++++.++++.|.+++
T Consensus 90 ~~l~~an~l~~~~~~~~~~~f~~~~~~~y~a~~~~~dF~~~~e~~~~~IN~wv~~~T~gkI~~ll~~~~~~~~t~lvLvN 169 (380)
T KOG2392|consen 90 YELKLANRLFVSKSLKLLQKFLELVKKLYKAEAESLDFSNDTEEAAKEINEWVEEHTNGKIKDLLSPDSIDSLTVLVLVN 169 (380)
T ss_pred ceEEEeeeheecCCccccHHHHHHHHHHHhCcceeecCccChHHHHHHHHHHHHHHcCCchhhhcCCCCCCcchhheeee
Confidence 89999999999999999999975 89999999999756788888 999999999999999999999988888887
Q ss_pred -------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHHH
Q psy7902 154 -------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGD 203 (342)
Q Consensus 154 -------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~~ 203 (342)
|+. +++.++|| .|.+..++.|++++|||.+.+++|+|+||++. .+|.+
T Consensus 170 aiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~VpmM~~~~~f~~~~~~~l~~~vl~LpY~~~~~sm~i~LP~~~--~gL~~ 247 (380)
T KOG2392|consen 170 AIYFKGKWEKKFDKELTKESDFFLSEGTSVKVPMMHQEGSFRYAEDEDLFAVVLELPYKGSNLSMLILLPDER--DGLKE 247 (380)
T ss_pred hheeehhhcCCCChhhccccccEECCCeEEEeechhccCccceEEeCCcceEEEECccCCCCeEEEEEeCCCC--CCHHH
Confidence 877 45677888 57789999999999999988999999999998 79999
Q ss_pred HHHHhcCCchHHHHHh-hhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCC-CCCCCCCC-CCCeeecceeeeEE
Q psy7902 204 ILAALKKDPTSFKRFT-EDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSP-GADLSRLT-DSHIAFGDAVHKAR 280 (342)
Q Consensus 204 l~~~L~~~~~~l~~~~-~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~-~ad~s~i~-~~~l~ls~v~q~~~ 280 (342)
++++|+.+ .+..|. .+ +..+.|+|.||||+++.++||+++|++|||+++|++ .|||++|+ +.+++|++++|++.
T Consensus 248 le~~L~~~--~~~~~~~~~-~~~~~v~v~lPKfkie~~~dL~~~L~~lGi~~~F~~~~adls~ls~~~~l~vs~v~Hka~ 324 (380)
T KOG2392|consen 248 LEKKLTSE--TLVEWLFSR-MSEKVVEVSLPKFKIEFDYDLKEVLKQLGITDIFSESKADLSGLSESSNLYISKVIHKAF 324 (380)
T ss_pred HHHHhChh--hHHHhhhhh-hhceeEEEECCCEEEEEEechHHHHHHcCChhccCCCccccccCccCCCeeeeeeeEEEE
Confidence 99999998 999999 67 689999999999999999999999999999999999 59999999 66899999999999
Q ss_pred EEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCC
Q psy7902 281 LDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337 (342)
Q Consensus 281 i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P 337 (342)
|||||+|++|+|+|.+....++.+. +.+|.|||||+|+|+|+.|+.|||+|+|.+|
T Consensus 325 ieV~E~GteAaaat~~~~~~~~~~~-~~~f~adhPFlF~I~~~~t~~iLF~G~v~~P 380 (380)
T KOG2392|consen 325 IEVDEEGTEAAAATAVEIVLRSLPP-PEEFVADHPFLFVIRDNKTGSILFLGRVVDP 380 (380)
T ss_pred EEECCCCchhhhhhhhHHhhccCCC-CCeEECCCCEEEEEEECCCCcEEEEEEccCC
Confidence 9999999999999997766555433 6899999999999999999999999999998
|
|
| >cd02059 ovalbumin_like The ovalbumin_like group of serpins contains ovalbumin, the squamous cell carcinoma antigen 1 (SCCA1) and other closely related serpins of clade B of the serpin superfamily | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-68 Score=505.38 Aligned_cols=329 Identities=31% Similarity=0.560 Sum_probs=289.0
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCC--------------ChHHHHHHhhH
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENL--------------DKLDTMNVYKM 66 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~--------------~~~~~~~~~~~ 66 (342)
+||++||+++..+.+++|+|+||+||+.+|+||+.||+|+|++||.++||++... ...+++..|+
T Consensus 7 ~Fa~~l~~~~~~~~~~~N~v~SP~si~~~L~~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 85 (389)
T cd02059 7 EFCFDLFKELKKNHKNKNIFFSPLSISSALGMVLLGARDDTAAQIEKVLHFDHASGSGSSKPAASAQCNQSGGVHSQFK- 85 (389)
T ss_pred HHHHHHHHHHhhcCCCCCEEECHHHHHHHHHHHhcccCCcHHHHHHHHhCCCccccccccccccccccccHHHHHHHHH-
Confidence 5999999999887788999999999999999999999999999999999997421 1235677776
Q ss_pred HHHHHHhhhCCCCceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCcc
Q psy7902 67 EKLIQGLRANADSGLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIA 141 (342)
Q Consensus 67 ~~~l~~l~~~~~~~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~ 141 (342)
.++..+.....+ ..++++|++|++++++++++|.+ +|+++++.+||.+.++.+++ ||+|++++|+|+|.++++
T Consensus 86 -~l~~~~~~~~~~-~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~vdF~~~~~~~~~~IN~wv~~~T~g~I~~~~~ 163 (389)
T cd02059 86 -DLLSQINKPNDD-YELSIANRLYGEKTYPFHQEYLDCVEKLYRAKLEPVDFQNAAEASRKKINSWVESQTNGKIKNLFG 163 (389)
T ss_pred -HHHHHHcCCCCC-cEEEEeeehhhhCCCCccHHHHHHHHHHhcCeeEEEcCCCCHHHHHHHHHHHHHHhccchhhhcCC
Confidence 667666554455 88999999999999999999975 89999999999766666766 999999999999999999
Q ss_pred CCCCCCCceEEE---------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEE
Q psy7902 142 TGQVNSRTNLVL---------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMF 189 (342)
Q Consensus 142 ~~~i~~~t~lvl---------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~ 189 (342)
+.++++++.+++ |++ +++.+.|| +|++.+++++++|+|||++++++|+
T Consensus 164 ~~~i~~~t~lvlvna~~Fkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~~~~~~~~~~~~~vl~LPy~~~~~sm~ 243 (389)
T cd02059 164 KGTIDSSTVLVLVNAIYFKGKWEKKFEKENTVDAPFKLNENENKPVQMMYQIGKFKLASIEEPKMKILELPYAGGGLSMI 243 (389)
T ss_pred CCCCCcccceeeEeeeEEeeeccCCCCcccCccCccEeCCCceEEeehhcccCcEEEEEeCCCCcEEEEeecCCCceEEE
Confidence 889999999887 877 34456677 5678899999999999998899999
Q ss_pred EEeCCCCCCCcHHHHHHHhcCCchHHHHHhh-hcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCC-CCCCCCCC-
Q psy7902 190 FLLPPFASQDGVGDILAALKKDPTSFKRFTE-DSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSP-GADLSRLT- 266 (342)
Q Consensus 190 iilP~~~~~~~l~~l~~~L~~~~~~l~~~~~-~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~-~ad~s~i~- 266 (342)
||||++. .+|.+++++|+.+ .+..|.. ..++.+.|+|.||||++++++||++.|++||++++|++ .|||++|+
T Consensus 244 iiLP~~~--~~L~~l~~~l~~~--~l~~~~~~~~~~~~~v~l~lPkF~i~~~~dl~~~L~~mGi~~~F~~~~adfs~~~~ 319 (389)
T cd02059 244 VLLPDEI--SGLEQLESKLTYE--KLMEWTSSENMRERKVEVYLPRFKLEEKYNLKSVLKAMGMTDIFSESKADLSGISS 319 (389)
T ss_pred EEccCCC--CCHHHHHHHhCHH--HHHHhhhhhcceeeEEEEECCCEEeeeeecHHHHHHHcCCccccCCccccccccCC
Confidence 9999987 7999999999987 8888863 22678899999999999999999999999999999998 59999999
Q ss_pred CCCeeecceeeeEEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCC
Q psy7902 267 DSHIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337 (342)
Q Consensus 267 ~~~l~ls~v~q~~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P 337 (342)
+++++|++++|++.|+|||+|++|+++|.+....++. +.+.+|++||||+|+|+|+.|+.|||+|+|.+|
T Consensus 320 ~~~l~v~~v~hka~ieV~E~G~~a~a~t~~~~~~~~~-~~~~~f~~nrPF~f~I~~~~t~~iLF~G~v~~P 389 (389)
T cd02059 320 SKSLYLSKAIHKSYVEVNEEGTEAAAATGAGIVEKSL-PVSEEFRADHPFLFFIRHNKTNTILFFGRFSSP 389 (389)
T ss_pred CCCceEeeeeeeEEEEECCCceeecccccceeeecCC-CCCceEEecCCEEEEEEECCCCeEEEEEEecCC
Confidence 6789999999999999999999999999865443332 345789999999999999999999999999998
|
Ovalbumin, the major protein component of avian egg white, is a non-inhibitory member of SERine Proteinase INhibitorS (serpins). In contrast, SCCA1 inhibits cysteine proteinases such as cathepsin S, K, L, and papain, a so called cross-class serpin. |
| >cd02057 maspin_like Maspin (mammary serine proteinase inhibitor), a member of the serpin superfamily, with a multitude of effects on cells and tissues at an assortment of developmental stages | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-69 Score=504.85 Aligned_cols=324 Identities=22% Similarity=0.459 Sum_probs=282.0
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCCc
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADSG 80 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 80 (342)
+||++||+++...++++|+|+||+||+.+|+||+.||+|+|++||.++||++. ..+++..++ .+...++.....
T Consensus 7 ~F~~~l~~~~~~~~~~~Nvv~SP~si~~aL~ml~~Ga~g~T~~el~~~L~~~~---~~~~~~~~~--~~~~~~~~~~~~- 80 (372)
T cd02057 7 AFAVDLFKKLCEKEPTGNVVFSPICLSTSLALAQVGAKGDTANEIGKVLHFEN---VKDVPFGFQ--TVTSDVSKLSSF- 80 (372)
T ss_pred HHHHHHHHHHhccCCCCcEEECHHHHHHHHHHHHhhcCCcHHHHHHHHhCCCC---hhHHHHHHH--HHHHHHhcCCcc-
Confidence 59999999998777889999999999999999999999999999999999974 245666665 555555443344
Q ss_pred eEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE--
Q psy7902 81 LTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL-- 153 (342)
Q Consensus 81 ~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl-- 153 (342)
..++++|++|++++++++++|.+ +|++++..+||.++++.+++ ||+||+++|+|+|++++++.+++++|.+++
T Consensus 81 ~~l~~an~l~v~~~~~~~~~f~~~~~~~y~~~~~~vdF~~~~~~a~~~IN~wv~~~T~g~I~~l~~~~~i~~~t~l~lvN 160 (372)
T cd02057 81 YSLKLIKRLYVDKSLNLSTDFINSTKRPYPKELETVDFKDKLEETRGQINNSIKELTDGHFENILNENSVNDQTKILVVN 160 (372)
T ss_pred chhHhhhhhhhhCCCCccHHHHHHHHHHhcCeeEEecCCCCHHHHHHHHHHHHHHhccChhhhcCCCCCCCCCCceeeee
Confidence 67999999999999999999975 79999999999777777777 999999999999999998888999999888
Q ss_pred -------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCC--CCCcH
Q psy7902 154 -------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFA--SQDGV 201 (342)
Q Consensus 154 -------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~--~~~~l 201 (342)
|++ +++.+.|| .|++.++++|++++|||++++++|+|+||++. ...+|
T Consensus 161 a~yFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vv~LPy~~~~~sm~iiLP~~~~~~~~~L 240 (372)
T cd02057 161 AAYFVGNWMKKFPESETKECPFRVNKTETKPVQMMNLEATFSMGYIDELNTKILELPFQNKHLSMLILLPKDIEDESTGL 240 (372)
T ss_pred hheeccccCCCCCccccccCCCEECCCceEeeEhhheeceEEeEEeCCcCceEEEeecCCCCEEEEEEecCccccccccH
Confidence 986 23446676 57788999999999999988999999999851 02589
Q ss_pred HHHHHHhcCCchHHHHHhhh-cCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCC-CCCCCCCC-CCCeeecceeee
Q psy7902 202 GDILAALKKDPTSFKRFTED-SQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSP-GADLSRLT-DSHIAFGDAVHK 278 (342)
Q Consensus 202 ~~l~~~L~~~~~~l~~~~~~-~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~-~ad~s~i~-~~~l~ls~v~q~ 278 (342)
.++++.|+.+ .+..|... .+..+.|+|.||||+++.++||+++|++||++++|++ .|||++|+ +++++|++|+|+
T Consensus 241 ~~l~~~l~~~--~l~~~~~~~~~~~~~v~l~lPKF~i~~~~~l~~~L~~lGi~~~F~~~~adfs~i~~~~~l~vs~v~hk 318 (372)
T cd02057 241 EKLEKQLTSE--SLSQWTNPSMMANAKVKVSLPKFKVEKMIDLKAMLESLGLKHIFNEDASDFSGMSETKGVALSNVIHK 318 (372)
T ss_pred HHHHHhcChh--HHHHhhchhcceeEEEEEECCcEEEEEEechHHHHHHcCChhhcCCcccccccccCCCceEEEeeeee
Confidence 9999999988 89888632 2467899999999999999999999999999999998 69999999 667999999999
Q ss_pred EEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCC
Q psy7902 279 ARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337 (342)
Q Consensus 279 ~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P 337 (342)
+.|||||+|++|+++|..... ..+..|+|||||+|+|+|+.|+.|||+|+|.+|
T Consensus 319 ~~ieVdE~Gt~a~a~t~~~~~-----~~~~~f~~nrPF~f~I~d~~t~~iLF~G~v~~p 372 (372)
T cd02057 319 VCLEVNEDGGESIEVPGARIL-----QHKDEFNADHPFIFIIRHNKTRNIIFFGRFCSP 372 (372)
T ss_pred eEEEECCCCeecchhcceecc-----CCCCeEEeeCCEEEEEEECCCCeEEEEEEecCC
Confidence 999999999999998864321 124589999999999999999999999999998
|
Maspin has tumor suppressing activity against breast and prostate cancer. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. |
| >cd02045 antithrombin-III_like Antithrombin is a serine proteinase inhibitor (serpin) which controls the process of coagulation | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-68 Score=503.31 Aligned_cols=326 Identities=27% Similarity=0.492 Sum_probs=283.8
Q ss_pred ChHHHHHHHHhhc-CCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCC--ChHHHHHHhhHHHHHHHhh-hC
Q psy7902 1 EFTFDLLTVLNNA-NKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENL--DKLDTMNVYKMEKLIQGLR-AN 76 (342)
Q Consensus 1 ~Fa~~l~~~l~~~-~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~--~~~~~~~~~~~~~~l~~l~-~~ 76 (342)
+||++||+++... .+++|+++||+||+.+|+||+.||+|+|++||.++||++... ...+++..+. .+...+. ..
T Consensus 11 ~Fa~~l~~~l~~~~~~~~Niv~SP~si~~aL~ml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~--~l~~~~~~~~ 88 (381)
T cd02045 11 RFALAFYKHLADSKSNDENIFLSPLSISTAFAMTKLGACNNTLEQLMEVFQFDTISEKTSDQVHFFFA--KLNCRLYRKA 88 (381)
T ss_pred HHHHHHHHHHhcccCCCCCEEECcHHHHHHHHHHhhhcCCcHHHHHHHHhCCCccccccHHHHHHHHH--HHHHHHhccc
Confidence 5999999999865 478999999999999999999999999999999999997421 2335666665 5555552 22
Q ss_pred CCCceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceE
Q psy7902 77 ADSGLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNL 151 (342)
Q Consensus 77 ~~~~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~l 151 (342)
+.+ ..+.++|++|++++++++++|.+ +|+++++.+||.++++.+++ ||+|++++|+|+|++++++.+++++|.+
T Consensus 89 ~~~-~~l~~an~l~~~~~~~l~~~f~~~~~~~y~~~~~~vdF~~~~~~~~~~IN~wv~~~T~g~I~~ll~~~~l~~~t~l 167 (381)
T cd02045 89 NKS-SELISANRLFGDKSLTFNETYQDISEIVYGAKLWPLDFKEKPELSRITINEWIANKTENRITDVIPEGAIDTNTVL 167 (381)
T ss_pred CCc-chhhhhhhhhhcCCCchhHHHHHHHHHhhcCeeEEecCCCCHHHHHHHHHHHHHHHHhhHHHhhCCCCCCCCccce
Confidence 334 67999999999999999999976 79999999999777888877 9999999999999999988899999998
Q ss_pred EE---------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCC
Q psy7902 152 VL---------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQD 199 (342)
Q Consensus 152 vl---------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~ 199 (342)
++ |++ +++.+.|| +|++.+++++++++|||++++++|+||||++. .
T Consensus 168 vlvna~~Fkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~~~y~~~~~~~~~~l~LPy~~~~~sm~iilP~~~--~ 245 (381)
T cd02045 168 VLVNAIYFKGLWKSKFDKENTRKDLFHKAPGEKCPVPMMYQESKFRYAKIPEDKVQVLELPYKGDDITMVLILPKEG--T 245 (381)
T ss_pred eeEeeeEEeccccCCCCcccCcccccCcCCCcEEEEeccCccceeeeEecCCCCcEEEEeecCCCceEEEEEeCCCC--C
Confidence 87 877 34556677 56778899999999999988999999999987 7
Q ss_pred cHHHHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCC-CCCCCCCC-C--CCeeecce
Q psy7902 200 GVGDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSP-GADLSRLT-D--SHIAFGDA 275 (342)
Q Consensus 200 ~l~~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~-~ad~s~i~-~--~~l~ls~v 275 (342)
+|.+++++|+.+ .+..|+.+ ++.+.|+|.||||+++.++||+++|++||++++|++ +|||++|+ . .+++|++|
T Consensus 246 ~l~~l~~~l~~~--~l~~~~~~-~~~~~v~v~lPkF~i~~~~~l~~~L~~lGi~~~F~~~~Adfs~i~~~~~~~l~vs~v 322 (381)
T cd02045 246 TLSEVEQNLTLD--KLQGWLDA-MKETTLAVQIPRFRVEDSFSVKEQLQKMGLEDLFSPENAKLPGIVAGGRTDLYVSDA 322 (381)
T ss_pred CHHHHHHhcCHH--HHHHHHHh-CcCcEEEEECCCEEEeeEecHHHHHHHcCCcccCCCCCCCccccccCCCCCceeecc
Confidence 999999999988 99999988 688999999999999999999999999999999998 79999998 3 46999999
Q ss_pred eeeEEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEE
Q psy7902 276 VHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVF 334 (342)
Q Consensus 276 ~q~~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v 334 (342)
+|++.|+|||+|++|+|+|.+....++.+..+.+|++||||+|+|+|+.|+.|||+|+|
T Consensus 323 ~hka~ieV~E~GteAaaat~~~~~~~s~~~~~~~f~~nrPF~f~I~d~~t~~iLF~G~v 381 (381)
T cd02045 323 FHKAFLEVNEEGSEASAATAVVITGRSLNINRIIFVANRPFLLFIREVAINAIIFMGRV 381 (381)
T ss_pred ceeeEEEECCCCeehhhhhhhhhhhccCCCCCCEEEeeCCEEEEEEECCCCcEEEEEeC
Confidence 99999999999999999997654433333344689999999999999999999999996
|
It is the most important anticoagulant molecule in mammalian circulation systems, controlled by its interaction with the co-factor, heparin, which accelerates its interaction with target proteases, such as thrombin and factor Xa. This subgroup corresponds to clade C of the serpin superfamily. |
| >cd02047 HCII Heparin cofactor II (HCII) inhibits thrombin, the final protease of the coagulation cascade | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-67 Score=502.13 Aligned_cols=323 Identities=25% Similarity=0.450 Sum_probs=282.5
Q ss_pred ChHHHHHHHHhhc-CCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCC------CChHHHHHHhhHHHHHHHh
Q psy7902 1 EFTFDLLTVLNNA-NKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPEN------LDKLDTMNVYKMEKLIQGL 73 (342)
Q Consensus 1 ~Fa~~l~~~l~~~-~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~------~~~~~~~~~~~~~~~l~~l 73 (342)
+||++||+++... ++++|+++||+||+.+|+||+.||+|+|++||.++||++.. ....+++..|+ .+.+.+
T Consensus 71 ~Fa~~L~~~l~~~~~~~~Niv~SP~SI~~aLaml~~GA~G~T~~ql~~~Lg~~~~~~~~~~~~~~~~~~~~~--~l~~~l 148 (436)
T cd02047 71 NFGFNLYRVLKDQVNTSDNILLAPVGISTAMGMISLGLKGQTQEQVLSTLGFKDFVNASSKYEITTVHNLFR--KLTHRL 148 (436)
T ss_pred HHHHHHHHHHhhccCCCCcEEEChHHHHHHHHHHHhhcccHHHHHHHHHhcccccccccccccHHHHHHHHH--HHHHHh
Confidence 4999999999864 57899999999999999999999999999999999999741 01235677776 666666
Q ss_pred hhCCCCceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHHHHHHHHHhcccccccCccCCCCCCCc
Q psy7902 74 RANADSGLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARAINSWVAQETKNNIKDLIATGQVNSRT 149 (342)
Q Consensus 74 ~~~~~~~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~iN~wv~~~T~g~i~~~~~~~~i~~~t 149 (342)
.....+ +.++++|++|++++++++++|++ +|+++++.+||+ ++..+.+||+||+++|+|+|++++ .+++++|
T Consensus 149 ~~~~~~-~~L~~an~l~v~~~~~l~~~F~~~~~~~y~a~v~~vdF~-~~~~~~~IN~wV~~~T~g~I~~~l--~~i~~~t 224 (436)
T cd02047 149 FRRNFG-YTLRSVNDLYIKKDFPILLDFKNNVKTYYFAEAQIADFS-DPAFITKTNNRIQKLTKGLIKEAL--ENVDPAT 224 (436)
T ss_pred hcCCCC-cEEeeeeehhhhCCCCccHHHHHHHHHHhcCceEEeCCC-CHHHHHHHHHHHHHhcCCcccccc--ccCCccc
Confidence 554445 78999999999999999999976 799999999995 566554599999999999999999 4788889
Q ss_pred eEEE---------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCC
Q psy7902 150 NLVL---------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFAS 197 (342)
Q Consensus 150 ~lvl---------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~ 197 (342)
.++| |+. +++.++|| .|++.++++|++++|||++ ++||+|+||++.
T Consensus 225 ~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~MM~~~~~~~y~~~~~l~~~vleLPy~~-~~SM~iiLP~~~- 302 (436)
T cd02047 225 LMMILNCIYFKGTWENKFPVEMTHNRNFRLNEKEVVKVPMMQTKGNFLAAADPELDCDILQLPYVG-NISMLIVVPHKL- 302 (436)
T ss_pred ceeeeeeeEEechhhCcCCcccccCcCCEeCCCCEEEEehhcccceEEEEEcCCcCcEEEEecCCC-CeeEEEEeCccc-
Confidence 8887 876 34566777 5677889999999999976 699999999987
Q ss_pred CCcHHHHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCCCCCeeecceee
Q psy7902 198 QDGVGDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLTDSHIAFGDAVH 277 (342)
Q Consensus 198 ~~~l~~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~~~~l~ls~v~q 277 (342)
.+|.+++++|+.. .+..|.++ |..+.++|.||||++++++||+++|++||++++|+.+|||++|++++++|++|+|
T Consensus 303 -~gL~~l~~~L~~~--~l~~~~~~-~~~~~v~v~LPKFkie~~~dL~~~L~~lGi~~lF~~~adfs~is~~~l~vs~v~h 378 (436)
T cd02047 303 -SGMKTLEKQITPQ--VVERWQKS-MTNRTREVVLPKFKLEKNYNLIESLKLMGITDLFTEKGNMAGVSDEKIAIDLFKH 378 (436)
T ss_pred -CCHHHHHHHhCHH--HHHHHHHh-CceeEEEEEeccEEEEeeecHHHHHHhcChhhhcCCcccccccCCCCeEEEeeee
Confidence 8999999999987 89999988 6889999999999999999999999999999999988999999966799999999
Q ss_pred eEEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCCC
Q psy7902 278 KARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEPP 338 (342)
Q Consensus 278 ~~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~ 338 (342)
++.|+|||+|++|+|+|.+...+.+ .+..|++||||+|+|+|+.|+.|||+|+|.+|.
T Consensus 379 ka~IeVdE~GteAaa~T~~~~~~~~---~~~~f~~drPFlf~I~d~~t~~iLF~G~v~~P~ 436 (436)
T cd02047 379 QGTITVNEEGTEAAAVTTVGFMPLS---TQVRFIVDRPFLFLIYEHRTNCLLFMGRVANPS 436 (436)
T ss_pred eeEEEEcCCcccchhccccccccCC---CCcEEEeeCCEEEEEEECCCCcEEEEEEecCCC
Confidence 9999999999999999976544322 246899999999999999999999999999994
|
HCII is allosterically activated by binding to cell surface glycosaminoglycans (GAGs). The specificity of HCII for thrombin is conferred by a highly acidic hirudin-like N-terminal tail, which becomes available after GAG binding for interaction with the anion-binding exosite I of thrombin. This subgroup corresponds to clade D of the serpin superfamily. |
| >smart00093 SERPIN SERine Proteinase INhibitors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-67 Score=494.90 Aligned_cols=319 Identities=35% Similarity=0.592 Sum_probs=280.4
Q ss_pred HHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCC-ChHHHHHHhhHHHHHHHhhhCCCCceE
Q psy7902 4 FDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENL-DKLDTMNVYKMEKLIQGLRANADSGLT 82 (342)
Q Consensus 4 ~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~-~~~~~~~~~~~~~~l~~l~~~~~~~~~ 82 (342)
++||+++...++++|+|+||+||+.+|+|++.||+|+|++||.++||++... +..++++.|+ .++..+...+.. ..
T Consensus 1 ~~l~~~l~~~~~~~N~v~SP~si~~~L~ml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~--~l~~~l~~~~~~-~~ 77 (359)
T smart00093 1 FDLYKELAKESPDKNIFFSPVSISSALAMLSLGAKGSTATQILEVLGFNLTELSEADIHQGFQ--HLLQLLNRPDSQ-LE 77 (359)
T ss_pred ChHHHHHhccCCCCeEEEChHHHHHHHHHHHcccCchHHHHHHHHcCCCCCCCCHHHHHHHHH--HHHHHHhCCCCc-ce
Confidence 4799999887788999999999999999999999999999999999998642 2346777776 677777654444 78
Q ss_pred EEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE----
Q psy7902 83 FTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL---- 153 (342)
Q Consensus 83 l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl---- 153 (342)
++++|++|++++++++++|.+ +|+++++.+||++.++.+++ ||+|++++|+|+|+++++ ++++++.+++
T Consensus 78 l~~an~i~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~a~~~IN~wv~~~T~g~I~~~~~--~i~~~t~lvlvnai 155 (359)
T smart00093 78 LKTANALFVDKSLKLKDSFLEDIKKLYGAEVQSVDFSDKAEEAKKQINDWVEKKTQGKIKDLLS--DLDSDTRLVLVNAI 155 (359)
T ss_pred EEeeeeehccCCCchhHHHHHHHHHHhcCeeEEecCCCCHHHHHHHHHHHHHHhhhchHHHhcc--cCCCCceEEEEeeE
Confidence 999999999999999999976 79999999999655665666 999999999999999995 5888999887
Q ss_pred -----ecc---------------CCceEEec------c---eeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHHHH
Q psy7902 154 -----WLP---------------STQESIII------I---TVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDI 204 (342)
Q Consensus 154 -----W~~---------------~~~~~~V~------~---~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~~l 204 (342)
|++ +++.+.|| . |++.+++++++++|||++ +++|+|+||+++ +|.++
T Consensus 156 yFkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~~~~y~~~~~~~~~vv~Lpy~~-~~sm~iilP~~~---~l~~l 231 (359)
T smart00093 156 YFKGKWKTPFDPELTREEDFHVDETTTVKVPMMSQTGRTFNYGHDEELNCQVLELPYKG-NASMLIILPDEG---GLEKL 231 (359)
T ss_pred EEeeECCCCCCcccceecccEeCCCeEEEEeceeccCceeEEEEcCCCCcEEEEEecCC-CeeEEEEccCcc---HHHHH
Confidence 877 34456666 3 455688999999999986 799999999874 89999
Q ss_pred HHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC-CCCeeecceeeeEEEEe
Q psy7902 205 LAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-DSHIAFGDAVHKARLDL 283 (342)
Q Consensus 205 ~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~-~~~l~ls~v~q~~~i~v 283 (342)
+++|+.. .+..|..+ +..+.|+|+||||++++++||+++|++||++++|+..|||++|+ +++++|++|+|++.|+|
T Consensus 232 ~~~l~~~--~l~~~~~~-~~~~~v~l~lPkf~i~~~~~l~~~L~~lGl~~~F~~~adfs~i~~~~~l~vs~v~hka~ieV 308 (359)
T smart00093 232 EKALTPE--TLKKWMKS-LTKRSVELYLPKFKIEGTYDLKDVLEKLGITDLFSNKADLSGISEDKDLKVSKVLHKAVLEV 308 (359)
T ss_pred HHhhCHH--HHHHHHHh-ccceEEEEEccEEEEEEEecHHHHHHHcCcchhccCccCcccccCCCCeEEEeeeeEEEEEE
Confidence 9999987 99999988 68899999999999999999999999999999999779999999 67899999999999999
Q ss_pred cCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCC
Q psy7902 284 DEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337 (342)
Q Consensus 284 ~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P 337 (342)
||+|++|+|+|.+....++. +.+|++||||+|+|+|+.|+.|||+|+|.+|
T Consensus 309 dE~Gt~aaa~t~~~~~~~~~---~~~f~~drPF~f~I~~~~t~~iLF~G~v~~P 359 (359)
T smart00093 309 NEEGTEAAAATGVIAVPRSL---PPEFKANRPFLFLIRDNKTGSILFMGKVVNP 359 (359)
T ss_pred cCCCccccccccccccccCC---CceEEecCCEEEEEEECCCCeEEEEEecCCC
Confidence 99999999999865443332 3789999999999999999999999999998
|
|
| >cd02058 PAI-2 Plasminogen Activator Inhibitor-2 (PAI-2) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-68 Score=500.78 Aligned_cols=331 Identities=32% Similarity=0.562 Sum_probs=288.9
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCC-ChHHHHHHhhHHHHHHHhhhCCCC
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENL-DKLDTMNVYKMEKLIQGLRANADS 79 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~-~~~~~~~~~~~~~~l~~l~~~~~~ 79 (342)
+||++||+++....+++|+|+||+||+.+|+||+.||+|+|++||.++||++... +..+++..|+ .++..+...+..
T Consensus 7 ~F~~~l~~~~~~~~~~~N~v~SP~si~~aL~~l~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~--~l~~~~~~~~~~ 84 (380)
T cd02058 7 SFALNLFKKLAESSPTKNIFFSPWSISSALAMVYLGAKGNTAAQMAKVLQFNEVGGNSEDIHSGFQ--SLLSEINKPGTN 84 (380)
T ss_pred HHHHHHHHHHhhcCCCCcEEECHHHHHHHHHHHhcccCCcHHHHHHHHhCcCccccchHHHHHHHH--HHHHHHhCCCCc
Confidence 5999999999887788999999999999999999999999999999999997542 1356777776 677777655555
Q ss_pred ceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE-
Q psy7902 80 GLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL- 153 (342)
Q Consensus 80 ~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl- 153 (342)
..++++|++|++++++++++|.+ +|++++..+||.++++.+++ ||+|++++|+|+|++++++.++++++.+++
T Consensus 85 -~~l~~~n~l~~~~~~~l~~~f~~~~~~~~~~~~~~vdF~~~~~~a~~~IN~wv~~~T~g~I~~~~~~~~i~~~t~lvlv 163 (380)
T cd02058 85 -YLLKSANRLYGEKTYPFLEKFLQLTQKYYQAEPQAVDFVEAAEQARKEINSWVERQTEGKIQNLLPPGSVDSLTRLVLV 163 (380)
T ss_pred -cEeehhhhhhhcCCCcHhHHHHHHHHhhhcCceEEecCCCCHHHHHHHHHHHHHHhcccchhhcCCcCCCChhHHhHhh
Confidence 78999999999999999999976 79999999999766777777 999999999999999998888998998876
Q ss_pred --------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCC--CCc
Q psy7902 154 --------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFAS--QDG 200 (342)
Q Consensus 154 --------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~--~~~ 200 (342)
|++ +++.+.|| +|.+.+++++++++|||+++++||+||||++.. ..+
T Consensus 164 na~~Fkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vv~LPy~~~~~sm~iiLP~~~~~~~~~ 243 (380)
T cd02058 164 NAIYFKGNWEEKFLKENTRERPFRLNKNTTKPVQMMFLKKKFPITYIEELKAQVLELPYVGKELSMFILLPDEIEDVTTG 243 (380)
T ss_pred heeEEccccCCCCCcccCCcccccCCCCceEEeechhhcCceeeEEcCCCCcEEEEccCCCCceEEEEEeccccccccch
Confidence 877 34456676 577889999999999999889999999998731 047
Q ss_pred HHHHHHHhcCCchHHHHHhh-hcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCC-CCCCCCCC-CCCeeecceee
Q psy7902 201 VGDILAALKKDPTSFKRFTE-DSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSP-GADLSRLT-DSHIAFGDAVH 277 (342)
Q Consensus 201 l~~l~~~L~~~~~~l~~~~~-~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~-~ad~s~i~-~~~l~ls~v~q 277 (342)
|.+++++|+.. .+..|.. ..++.+.++|.||||++++++||++.|++||++++|++ .|||++|+ +++++|++++|
T Consensus 244 L~~l~~~l~~~--~l~~~~~~~~~~~~~v~l~lPKF~i~~~~~l~~~L~~lGl~~~F~~~~adfs~i~~~~~l~vs~v~h 321 (380)
T cd02058 244 LEKLEKELTYE--KLNEWTSPEMMEEYEVEVYLPKFKLEESYDLKSTLSSMGMEDAFDPGKADFSGMSSANDLFLSKVFH 321 (380)
T ss_pred HHHHHHHhCHH--HHHHhhhhhcceeeEEEEEeeEEEEeeeeccHHHHHHcCccccCCcccccccCCCCCCCCcccccce
Confidence 99999999987 8988864 22578899999999999999999999999999999998 59999999 67899999999
Q ss_pred eEEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCC
Q psy7902 278 KARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337 (342)
Q Consensus 278 ~~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P 337 (342)
++.|+|||+|++|+++|......++. ..+.+|++||||+|+|+|+.|+.|||+|+|.+|
T Consensus 322 k~~ieV~E~G~~a~a~t~~~~~~~~~-~~~~~f~~nrPF~f~I~d~~t~~iLF~G~v~~P 380 (380)
T cd02058 322 KAFVEVNEEGTEAAAATAAIMMLRCL-MPSPRFNADHPFLFFIRHNKTNTILFFGRFCSP 380 (380)
T ss_pred eeEEEECCCCcccccccchheeeccC-CCCCeEEEECCEEEEEEECCCCeEEEEEEecCC
Confidence 99999999999999998764433322 235789999999999999999999999999998
|
PAI-2 is a serine protease inhibitor that belongs to the ov-serpin branch of the serpin superfamily. It is is an effective inhibitor of urinary plasminogen activator (urokinase or uPA) and is involved in cell differentiation, tissue growth and regeneration. |
| >cd02046 hsp47 Heat shock protein 47 (Hsp47), also called colligin, because of its collagen binding ability, is a chaperone specific for procollagen | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-67 Score=494.23 Aligned_cols=318 Identities=20% Similarity=0.360 Sum_probs=276.7
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCC-CC
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANA-DS 79 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~-~~ 79 (342)
+||++||+++...++++|+|+||+||+.+|+|++.||+|+|++||.++|+++.. ...+++..++ +++..+.... .+
T Consensus 9 ~f~~~l~~~~~~~~~~~N~v~SP~si~~aLa~l~~Ga~g~T~~ql~~~L~~~~~-~~~~~~~~~~--~l~~~l~~~~~~~ 85 (366)
T cd02046 9 GLAFNLYHAMAKDKGVENILLSPVVVASSLGLVSMGGKASTASQAKAVLSADKL-KDEHVHTGLS--ELLNEVSNSTARN 85 (366)
T ss_pred HHHHHHHHHhhccCCCCeEEEChHHHHHHHHHHHhhcCccHHHHHHHHhCCCCC-CcHHHHHHHH--HHHHHhhcCCCCC
Confidence 599999999998778899999999999999999999999999999999999743 2346777775 6666664332 34
Q ss_pred ceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE-
Q psy7902 80 GLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL- 153 (342)
Q Consensus 80 ~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl- 153 (342)
..++++|++|++++++++++|.+ +|+++++.+||. +++.+++ ||+||+++|+|+|++++ .+++++|.+++
T Consensus 86 -~~l~~an~~~~~~~~~l~~~F~~~~~~~y~~~~~~vdF~-~~~~a~~~IN~wv~~~T~g~I~~~~--~~i~~~t~l~lv 161 (366)
T cd02046 86 -VTWKIGNRLYGPSSVSFADDFVKNSKKHYNYEHSKINFR-DKRSALNSINEWAAQTTDGKLPEVT--KDVEKTDGALIV 161 (366)
T ss_pred -cEEEEeeehhhcCCCChhHHHHHHHHHHhcCeeEEecCC-ChHHHHHHHHHHHHHhcCCchhHhh--ccCCcchHhhhh
Confidence 78999999999999999999976 799999999995 5666776 99999999999999998 56888888776
Q ss_pred --------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHH
Q psy7902 154 --------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVG 202 (342)
Q Consensus 154 --------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~ 202 (342)
|++ +++.+.|| .|++.+++++++++|||++++++|+||||+++ .+|.
T Consensus 162 naiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~~~y~~~~~~~~~vl~LPy~~~~~sm~iiLP~~~--~~L~ 239 (366)
T cd02046 162 NAMFFKPHWDEKFHHKMVDNRGFMVTRSYTVSVPMMHRTGLYGYYDDEENKLQIVEMPLAHKLSSMIFIMPYHV--EPLE 239 (366)
T ss_pred heEEEcchhcCCCCHHhceeccEEeCCCeEEEhhHhhccCceeeEEeCCCCeEEEEEEcCCCcEEEEEEecCCC--CCHH
Confidence 987 34456677 55566779999999999988999999999987 7999
Q ss_pred HHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCC-CCCCCCCC-CCCeeecceeeeEE
Q psy7902 203 DILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSP-GADLSRLT-DSHIAFGDAVHKAR 280 (342)
Q Consensus 203 ~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~-~ad~s~i~-~~~l~ls~v~q~~~ 280 (342)
++++.|+.+ .+..|..+ +..+.|+|.||||+++.++||+++|++||++++|++ .|||++|+ .++++|++++|++.
T Consensus 240 ~l~~~L~~~--~l~~~~~~-~~~~~v~l~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfs~i~~~~~l~vs~v~hka~ 316 (366)
T cd02046 240 RLEKLLTRE--QLKTWISK-MKKRAVAISLPKVSLEVSHDLQKHLGDLGLTEAIDKSKADLSKISGKKDLYLSNVFHAAA 316 (366)
T ss_pred HHHHHhCHH--HHHHHHHh-cceeEEEEEcceEEeeEEEcHHHHHHHcCCccccCCCCCCcccCCCCCceeeeeeEEEEE
Confidence 999999988 89999888 699999999999999999999999999999999986 69999999 56899999999999
Q ss_pred EEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEE
Q psy7902 281 LDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVF 334 (342)
Q Consensus 281 i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v 334 (342)
|||||+|++|++++... .....+..|+|||||+|+|+|..|+.|||+|+|
T Consensus 317 ieV~E~G~~aaa~~~~~----~~~~~~~~f~~nrPF~f~I~~~~t~~iLF~G~v 366 (366)
T cd02046 317 LEWDTEGNPFDPDIYGR----EEMRNPKLFYADHPFIFLVKDNKTNSILFIGRL 366 (366)
T ss_pred EEECCCcchhhhhhhhc----ccCCCCCEEEecCCEEEEEEECCCCcEEEEEeC
Confidence 99999999987654211 112235789999999999999999999999996
|
It has been shown to be essential for collagen biosynthesis, but its exact function is still unclear. Hsp47 is a non-inhibitory member of the SERPIN superfamily and corresponds to clade H. |
| >cd00172 SERPIN SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-67 Score=494.55 Aligned_cols=323 Identities=35% Similarity=0.620 Sum_probs=288.4
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCCc
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADSG 80 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 80 (342)
+||++||+++...++++|+|+||+||+.+|+||+.||+|+|++||.++||++.. +..+++..++ .++..+......
T Consensus 4 ~Fa~~l~~~~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~el~~~L~~~~~-~~~~~~~~~~--~~~~~l~~~~~~- 79 (364)
T cd00172 4 DFALDLYKQLAKSEPDENVVFSPLSIASALALLYLGAGGETREQLRKVLGLPSL-DDEDVHQAFK--SLLSSLKDSEKG- 79 (364)
T ss_pred hHHHHHHHHHhhcCCCCCEEEcHHHHHHHHHHHhhhcCchHHHHHHHHhCCCCC-CHHHHHHHHH--HHHHHHhCCCCC-
Confidence 599999999998767899999999999999999999999999999999999852 4567888886 777777655445
Q ss_pred eEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE--
Q psy7902 81 LTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL-- 153 (342)
Q Consensus 81 ~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl-- 153 (342)
..++++|++|++++++++++|.+ +|+++++.+||. +++.+++ ||+|++++|+|+|+++++++++++++.+++
T Consensus 80 ~~l~~an~~~~~~~~~~~~~f~~~~~~~~~~~~~~~dF~-~~~~a~~~IN~wv~~~T~g~I~~~~~~~~i~~~t~l~lvn 158 (364)
T cd00172 80 VELKLANRLFVQKGLTVKEDFLDLAKKYYDAEVESVDFA-NPEAAAAQINNWVEEKTNGKIKDLLSPDALDPDTRLVLVN 158 (364)
T ss_pred ceeeeehhhhhhCCCchhHHHHHHHHHHhcCeeEEEcCC-ChHHHHHHHHHHHHhhhcccchhhCCCCCCCcccceeeee
Confidence 78999999999999999999975 799999999995 4566776 999999999999999998888999999888
Q ss_pred -------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHHH
Q psy7902 154 -------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGD 203 (342)
Q Consensus 154 -------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~~ 203 (342)
|++ +++.+.|| +|++.+++++++|+|||+++++||+||||+++ .+|.+
T Consensus 159 ai~Fkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~l~~~vv~lpy~~~~~sm~iilP~~~--~~l~~ 236 (364)
T cd00172 159 AIYFKGKWKTPFDPELTRKRPFYVSEGESVQVPMMYQTGKFRYAEDEELDAQVLELPYKGSDLSMLIILPKEV--TGLAE 236 (364)
T ss_pred heeeeeccCCCCChhhceecccEeCCCcEEEEeCccccCcEEEEEcCccCcEEEEeecCCCceEEEEEecCCC--CcHHH
Confidence 877 34456777 67778888999999999988999999999987 79999
Q ss_pred HHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC-CCCeeecceeeeEEEE
Q psy7902 204 ILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-DSHIAFGDAVHKARLD 282 (342)
Q Consensus 204 l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~-~~~l~ls~v~q~~~i~ 282 (342)
++++|+.. .+..|.++ ++.+.|+|.||||++++++||++.|++||++++|++.+|+++|+ +++++|++|+|++.|+
T Consensus 237 l~~~l~~~--~l~~~~~~-~~~~~v~l~lPkF~i~~~~~l~~~L~~~Gl~~~F~~~a~~~~~~~~~~l~v~~v~hk~~ie 313 (364)
T cd00172 237 LEEKLSAE--KLDDLLSN-LKEREVEVTLPKFKIESSLDLKEVLQALGITDLFSPSADLSSISSDEPLYVSKVIHKAFIE 313 (364)
T ss_pred HHHhcCHH--HHHHHHHh-CCeEEEEEEeeEEEEeeeeCcHHHHHHcCCccccCCccccccCCCCCCeEEEeeeeeeEEE
Confidence 99999987 99999988 68899999999999999999999999999999999889999998 7889999999999999
Q ss_pred ecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEE
Q psy7902 283 LDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVF 334 (342)
Q Consensus 283 v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v 334 (342)
|||+|++|+++|.+..... ....+..|++||||+|+|+|+.|+.|||+|+|
T Consensus 314 vdE~Gt~aaa~t~~~~~~~-~~~~~~~f~~drPF~f~I~~~~t~~iLF~G~v 364 (364)
T cd00172 314 VNEEGTEAAAATAVSIVPR-RPSPPVEFKADRPFLFLIRDDTTGTILFLGRV 364 (364)
T ss_pred ECCCceehhcccceeeccc-cCCCCCEEEEECCEEEEEEECCCCeEEEEEEC
Confidence 9999999999998654332 12346799999999999999999999999997
|
Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants have been associated with blood clotting disorders, emphysema, cirrhosis, and dementia. |
| >cd02056 alpha-1-antitrypsin_like alpha-1-antitrypsin_like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-67 Score=492.73 Aligned_cols=319 Identities=32% Similarity=0.503 Sum_probs=282.0
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCC-ChHHHHHHhhHHHHHHHhhhCCCC
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENL-DKLDTMNVYKMEKLIQGLRANADS 79 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~-~~~~~~~~~~~~~~l~~l~~~~~~ 79 (342)
+||++||+++....+++|+|+||+||+.+|+||+.||+|+|++||.++||++... +..+++..|+ .++..+.....+
T Consensus 4 ~F~~~l~~~~~~~~~~~N~v~SP~si~~~L~ml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~--~l~~~l~~~~~~ 81 (361)
T cd02056 4 DFAFRLYRQLASESPSKNIFFSPVSISTALAMLSLGARSSTLAQILEGLGFNLTEISEEEIHQGFQ--HLLHLLNQPDSG 81 (361)
T ss_pred HHHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHCccchhHHHHHHHHhcCCccCCCHHHHHHHHH--HHHHHHcCCCCc
Confidence 5999999999887788999999999999999999999999999999999997542 3456778786 777777655445
Q ss_pred ceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE-
Q psy7902 80 GLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL- 153 (342)
Q Consensus 80 ~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl- 153 (342)
..+.++|++|++++++++++|.+ +|+++++.+||. +++.+++ ||+|++++|+|+|+++++ ++++++.+++
T Consensus 82 -~~l~~an~l~~~~~~~~~~~f~~~~~~~y~~~~~~~dF~-~~~~~~~~IN~wv~~~T~g~I~~~~~--~i~~~t~lvlv 157 (361)
T cd02056 82 -LQLNMGNALFLDKRLKPLDKFLEDVKHLYESEAFSTDFQ-DSAEAKKQINDYVEKKTHGKIVDLVK--DLDSDTVMVLV 157 (361)
T ss_pred -ceEEeeeehhhhCCCChhHHHHHHHHHHhcCceEeeCCC-ChHHHHHHHHHHHHHHhhhhHHhhcC--CCCCCceEEEE
Confidence 78999999999999999999976 899999999995 6666666 999999999999999994 6888999887
Q ss_pred --------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHH
Q psy7902 154 --------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVG 202 (342)
Q Consensus 154 --------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~ 202 (342)
|++ +++.+.|| +|++.+++++++|+|||++ +++|+||||+++ +|.
T Consensus 158 na~~Fk~~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~l~~~~veLPy~~-~~sm~iiLP~~~---~l~ 233 (361)
T cd02056 158 NYIYFKGKWEKPFDPELTQEEDFFVDEKTTVKVPMMHQTGRYDYLHDSELSCTVVQMPYKG-NATAFFVLPDEG---KMK 233 (361)
T ss_pred EEEeeeehccCCCCcccCcccCCEeCCCcEEEeecccccCcEeeEEcCCCCcEEEEEecCC-CcEEEEEecCcc---hHH
Confidence 876 34456666 5777888999999999965 699999999874 799
Q ss_pred HHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC-CCCeeecceeeeEEE
Q psy7902 203 DILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-DSHIAFGDAVHKARL 281 (342)
Q Consensus 203 ~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~-~~~l~ls~v~q~~~i 281 (342)
++++.|+.+ .+.+|... +..+.|+|+||||++++++||+++|++||++++|+..|||++|+ +++++|++|+|++.|
T Consensus 234 ~l~~~l~~~--~l~~~~~~-~~~~~v~v~lPkF~i~~~~~l~~~L~~~Gi~~~F~~~adfs~i~~~~~l~vs~v~qk~~i 310 (361)
T cd02056 234 QVEAALSRD--TLKKWSKL-LSKRSVDLYLPKFSISGTYNLKDILPKMGITDVFSDKADLSGITEQPNLKVSKAVHKAVL 310 (361)
T ss_pred HHHHhhCHH--HHHHHHHh-CceeEEEEEeeeEEEeeeechHHHHHhcChhhhcCCcCCccccCCCCCEEEEeeeeeeEE
Confidence 999999988 99999988 69999999999999999999999999999999998789999999 688999999999999
Q ss_pred EecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEE
Q psy7902 282 DLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVF 334 (342)
Q Consensus 282 ~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v 334 (342)
+|||+|++|+|+|.+....++. .+.+|+|||||+|+|+|+.|+.|||+|+|
T Consensus 311 ev~E~Gt~aaa~t~~~~~~~~~--~~~~f~~drPF~f~I~~~~t~~iLF~G~v 361 (361)
T cd02056 311 DVDEKGTEAAAATGVEITPMSA--LPPILKFNRPFLLLIFDRTTESILFLGKV 361 (361)
T ss_pred EEcCCCcccccccchhhhcccC--CCCEEEEeCCEEEEEEECCCCcEEEEEeC
Confidence 9999999999999865443332 45789999999999999999999999997
|
This family contains a variety of different members of clade A of the serpin superfamily. They include the classical serine proteinase inhibitors, alpha-1-antitrypsin and alpha-1-antichymotrypsin, protein C inhibitor, kallistatin, and noninhibitory serpins, like corticosteroid and thyroxin binding globulins. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants have been associated with blood clotting disorders, emphysema, cirrhosis, and dementia. |
| >PF00079 Serpin: Serpin (serine protease inhibitor); InterPro: IPR023796 Peptide proteinase inhibitors can be found as single domain proteins or as single or multiple domains within proteins; these are referred to as either simple or compound inhibitors, respectively | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-66 Score=491.20 Aligned_cols=325 Identities=34% Similarity=0.639 Sum_probs=290.8
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhh-CCCC
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRA-NADS 79 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~-~~~~ 79 (342)
+||++||+.+....+++|+|+||+||+.+|+||+.||+|+|++||.++||++.. +..+++..|+ .++..+.. ....
T Consensus 5 ~f~~~L~~~~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~-~~~~~~~~~~--~l~~~l~~~~~~~ 81 (371)
T PF00079_consen 5 QFALKLFKALSKSNPDENFVFSPLSIYSALAMLYLGASGETRKELRKVLGLPGS-DDEEIHEYFK--KLLQSLNSSPSDN 81 (371)
T ss_dssp HHHHHHHHHHHHHSTTSSEEE-HHHHHHHHHHHHHTSCHHHHHHHHHHTTCTTS-THHHHHHHHH--HHHHHHHSCSTSS
T ss_pred HHHHHHHHHHHhhCCCCcEEEChHHHHHHHHHHHhhccCCHHHHHHHHhhhccc-ccccchhhhh--hhhhhhhcccccc
Confidence 599999999999888999999999999999999999999999999999999864 5677888887 77788876 4445
Q ss_pred ceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE-
Q psy7902 80 GLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL- 153 (342)
Q Consensus 80 ~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl- 153 (342)
..++++|++|++++++++++|.+ +|+++++.+||. ++..+++ ||+|++++|+|+|+++++++++++++.+++
T Consensus 82 -~~~~~~~~l~~~~~~~~~~~f~~~~~~~~~~~~~~~df~-~~~~~~~~IN~wv~~~T~g~I~~~v~~~~i~~~t~~vli 159 (371)
T PF00079_consen 82 -PQLKLANKLFVDKNLPLKPEFKKTLKKYFNAEVESVDFS-DPPQAAKEINKWVSEKTNGKIKNLVSPNDIDPDTRLVLI 159 (371)
T ss_dssp -SEEEEEEEEEEETTSEBEHHHHHHHHHHHSEEEEEEETT-SHHHHHHHHHHHHHHHTTTSSSTSSSTTSSSTTEEEEEE
T ss_pred -ccceeeeeeecccccccccccchhhhhcccccccccccc-ccchhhhhhcchhhhhccceeeccccccchhhHHHHhhc
Confidence 88999999999999999999976 799999999995 4554666 999999999999999998888999999988
Q ss_pred --------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHH
Q psy7902 154 --------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVG 202 (342)
Q Consensus 154 --------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~ 202 (342)
|+. +++.+.|+ +|++.+++++++|+|||++ +++|+||||+++ .+|.
T Consensus 160 na~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~~l~~~~v~Lp~~~-~~sm~iilP~~~--~~l~ 236 (371)
T PF00079_consen 160 NAIYFKGKWKYPFDPENTEKRPFYVSDGKSVSVPMMHQSGRFRYAEDEDLDAQVVELPYKG-NFSMLIILPDEG--DGLD 236 (371)
T ss_dssp EEEEEEEEBSSTEEGGGEEEEEEECSSSEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBST-SEEEEEEEESST--TTHH
T ss_pred ccccccccccccccccccccccccccccccceEEEEecccccccccccccceeEEEecccc-ceeeEEEEeccc--cchh
Confidence 876 34555666 6777889999999999966 999999999987 7899
Q ss_pred HHHHHhcCCchHHHHHhhhcCCCeeEE--EEeeeeEEeeccchHHHHhhCCCccCCC-CCCCCCCCC-CCCeeecceeee
Q psy7902 203 DILAALKKDPTSFKRFTEDSQNLKPVE--IAIPKFSLTQEMNLIPTLSDLGVKDLFS-PGADLSRLT-DSHIAFGDAVHK 278 (342)
Q Consensus 203 ~l~~~L~~~~~~l~~~~~~~l~~~~v~--l~lPkF~i~~~~dl~~~L~~lG~~~~F~-~~ad~s~i~-~~~l~ls~v~q~ 278 (342)
+++++|+.. .+..|+++ ++.+.++ |.||||++++++||++.|++||++++|+ ..|||++|+ +++++|++++|+
T Consensus 237 ~l~~~l~~~--~l~~~~~~-~~~~~~~~~l~lPkf~i~~~~dl~~~L~~lGi~~~F~~~~adfs~i~~~~~~~v~~v~qk 313 (371)
T PF00079_consen 237 ELEKKLTSE--RLQEIISN-LKMRKVDEELSLPKFKIESSIDLKELLKKLGIKDLFDPDSADFSGISDDEPLYVSDVIQK 313 (371)
T ss_dssp HHHHHHSHH--HHHHHHHH-CEEEEEEEEEEEEEEEEEEEEEHHHHHHHTTTTGGGSTTTSSCTTTBSSSTEEEEEEEEE
T ss_pred hhhhhcccc--cccccccc-cccccccceeeecccccccccccceeeehhhcccccccccccccccccceeeeeeeccce
Confidence 999999988 89999999 6888888 9999999999999999999999999999 479999999 899999999999
Q ss_pred EEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCC
Q psy7902 279 ARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337 (342)
Q Consensus 279 ~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P 337 (342)
+.|+|||+|++|+|+|.+ .........+.+|++||||+|+|+|+.||.|||+|+|.||
T Consensus 314 ~~i~v~E~G~~a~a~t~~-~~~~~~~~~~~~f~~drPF~f~I~~~~t~~iLF~G~v~~P 371 (371)
T PF00079_consen 314 AVIEVDEEGTEAAAATAV-MASISSPPPPIEFIADRPFLFFIRDRSTGSILFMGKVVDP 371 (371)
T ss_dssp EEEEEESSEEEEEEEEEE-EEEESSSSSSEEEECSSEEEEEEEETTTTEEEEEEEESST
T ss_pred eeeccccccccccccccc-cccccccccCcEEEEcCCEEEEEEECCCCcEEEEEEecCC
Confidence 999999999999999943 2333345578999999999999999999999999999999
|
In many cases they are synthesised as part of a larger precursor protein, either as a prepropeptide or as an N-terminal domain associated with an inactive peptidase or zymogen. This domain prevents access of the substrate to the active site. Removal of the N-terminal inhibitor domain either by interaction with a second peptidase or by autocatalytic cleavage activates the zymogen. Other inhibitors interact direct with proteinases using a simple noncovalent lock and key mechanism; while yet others use a conformational change-based trapping mechanism that depends on their structural and thermodynamic properties. Serpins (SERine Proteinase INhibitors) [, , ] belong to MEROPS inhibitor family I4, clan ID. Serpins are proteins that are primarily known as irreversible serine protease inhibitors active against S1 (IPR001254 from INTERPRO), S8 (IPR000209 from INTERPRO) and C14 (IPR002398 from INTERPRO) peptidases. There are both extra- and intra-cellular serpins, which are found in all groups of organisms with the notable exception of fungi [, ]. In contrast to "rigid" proteinase inhibitors, such as those of the Kunitz or Kazal families, the serpins are metastable proteins (active-state proteins) which interact with their substrate and irreversibly trap the acyl intermediate as a result of a major conformational change []; they are best described as suicide substrate inhibitors. The common structure of these proteins is a multi-domain fold containing a bundle of 8 or 9 alpha helices and a beta sandwich formed by 3 beta sheets. The reactive centre loop (RCL) is found in the C-terminal part of these proteins. Serpins and their homologues are a group of high molecular weight (40 to 50 kDa) structurally related proteins involved in a number of fundamental biological processes such as blood coagulation, complement activation, fibrinolysis, angiogenesis, inflammation, tumour suppression and hormone transport. All known serpins have been classified into 16 clades and 10 orphan sequences; the vertebrate serpins can be conveniently classified into six sub-groups []. In human plasma they represent approximately 2% of the total protein, of which 70% is alpha-1-antitrypsin. On the basis of strong sequence similarities, a number of proteins with no known inhibitory activity also belong to this family, these include: angiotensinogen, corticosteroid-binding globulin and thyroxin-binding globulin []. This entry represents the structural domain of serpins. It consists of a cluster of helices and a beta-sandwich.; PDB: 3PZF_A 3B9F_I 1MTP_A 1SNG_A 1ANT_I 2ZNH_B 1BR8_I 1SR5_A 1E03_L 1AZX_L .... |
| >cd02049 bacterial_SERPIN SERine Proteinase INhibitors (serpins), prokaryotic subgroup | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-67 Score=490.23 Aligned_cols=321 Identities=26% Similarity=0.487 Sum_probs=281.7
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCCc
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADSG 80 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 80 (342)
+||++||+++....+++|+|+||+||+.+|+||+.||+|+|++||.++||++.. +..+++..++ .++..+...+.+
T Consensus 7 ~F~~~l~~~~~~~~~~~N~v~SP~si~~~L~~l~~Ga~g~T~~ql~~~L~~~~~-~~~~~~~~~~--~l~~~l~~~~~~- 82 (364)
T cd02049 7 RFGFKLFSELNKEDVEKNIFISPLSIALALSMTYNGADGTTRKEMLKALGLDNI-DLEDLNSALA--TLMDQLNTHDKT- 82 (364)
T ss_pred HHHHHHHHHHhhcCCCCCEEECHHHHHHHHHHHhhhcCchHHHHHHHHhCCCCC-CHHHHHHHHH--HHHHHHhcCCCC-
Confidence 599999999988778899999999999999999999999999999999999854 4557777776 666666554445
Q ss_pred eEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE--
Q psy7902 81 LTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL-- 153 (342)
Q Consensus 81 ~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl-- 153 (342)
..++++|++|++++++++++|.+ +|+++++.+||. ++. +++ ||+|++++|+|+|++++. .++++|.+++
T Consensus 83 ~~l~~an~i~~~~~~~~~~~f~~~~~~~~~~~v~~~dF~-~~~-a~~~IN~wv~~~T~g~I~~~~~--~i~~~t~lvlvn 158 (364)
T cd02049 83 VELIIANSIWIEPGFTLKPDFLQTIKDYYQAYVLELDFQ-SPA-AAEEINRWVKEKTKGKIDKIVD--KIDPDDVMFLIN 158 (364)
T ss_pred cEEEeehhhHhhCCCCccHHHHHHHHHhhcccceeeCCC-CHH-HHHHHHHHHHHhhcChHHHhcC--CCCCCceEEEEe
Confidence 78999999999999999999976 899999999995 565 555 999999999999999995 4889999887
Q ss_pred -------ecc---------------CCceEEec------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHHHHH
Q psy7902 154 -------WLP---------------STQESIII------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDIL 205 (342)
Q Consensus 154 -------W~~---------------~~~~~~V~------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~~l~ 205 (342)
|++ +++.+.|| .|.|.+..++++++|||++++++|+||||++. .+|.+++
T Consensus 159 a~~fk~~W~~~F~~~~T~~~~F~~~~~~~~~v~mM~~~~~~~y~~~~~~~~l~Lpy~~~~~sm~iiLP~~~--~~l~~l~ 236 (364)
T cd02049 159 AVYFKGDWQEPFDKQSTYEAPFYLPDGSTKEVPFMSRTGNFRYLETPGFQAVRLPYGDGRLSMYVFLPKEN--VSLREFV 236 (364)
T ss_pred eEEEeeeecCCCChhhcccCcCCCCCCCEEECcccCCcCcEeeEEcCCCeEEEeecCCCcEEEEEEecCCC--CCHHHHH
Confidence 887 34456676 45566666789999999888999999999997 7999999
Q ss_pred HHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCC-CCCCCCCCCCCeeecceeeeEEEEec
Q psy7902 206 AALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSP-GADLSRLTDSHIAFGDAVHKARLDLD 284 (342)
Q Consensus 206 ~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~-~ad~s~i~~~~l~ls~v~q~~~i~v~ 284 (342)
++|+.. .+.+|..+ +..+.|+|.||||++++++||+++|++||++++|++ .+||+++++++++|++++|++.|+||
T Consensus 237 ~~l~~~--~~~~~~~~-~~~~~v~v~lPkF~i~~~~~L~~~L~~mGi~~~F~~~~a~~s~~~~~~l~vs~v~hka~iev~ 313 (364)
T cd02049 237 KTLTAE--KWRKWIEQ-FRMREGSLSLPRFQLEYEIELRDALKALGMEEAFTPDAADFSKLGEGNLYISKVIHKTFIEVN 313 (364)
T ss_pred HHhCHH--HHHHHHHh-CceeEEEEEeeeEEccceechHHHHHHCcccccCCCCcCCCCCCCCCCeEEEeeeeeEEEEEc
Confidence 999987 89999988 699999999999999999999999999999999997 69999998668999999999999999
Q ss_pred CCCccccccchhhhcccCCC-CCCceEEecCCeEEEEEeCCCCcEEEEEEE
Q psy7902 285 EQGTTAAAATAVFAFRSSRP-LEPVRYEANHPFLYFLVDKEIQSILFAGVF 334 (342)
Q Consensus 285 E~G~~a~a~t~~~~~~~~~~-~~~~~f~~drPFlf~I~~~~t~~ilf~G~v 334 (342)
|+|++|+|+|.+.....+.+ ..+.+|++||||+|+|+|+.|+.|||+|+|
T Consensus 314 E~G~~a~a~t~~~~~~~~~~~~~~~~f~~nrPF~f~I~d~~t~~iLF~G~v 364 (364)
T cd02049 314 EEGTEAAAATSVEITETSAPAGEPFTMVADRPFLFAIRDNRTGSILFMGAV 364 (364)
T ss_pred cCceeecccceeeeeeccCCCCCCceEEeeCCEEEEEEECCCCcEEEEEeC
Confidence 99999999988654433322 345789999999999999999999999996
|
Little information about specific functions is available for this subgroup, most likely they are inhibitory members of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors. |
| >cd02051 PAI-1_nexin-1 Plasminogen activator inhibitor-1_like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-67 Score=492.71 Aligned_cols=322 Identities=27% Similarity=0.479 Sum_probs=279.6
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCCc
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADSG 80 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 80 (342)
+||++||+++....+++|+++||+||+.+|+||+.||+|+|+.||.++||++. .++.+.++ .+...+......
T Consensus 13 ~F~~~l~~~~~~~~~~~N~v~SP~si~~~L~~l~~GA~g~T~~el~~~L~~~~----~~~~~~~~--~l~~~l~~~~~~- 85 (377)
T cd02051 13 DFGIQVFNQVAQARPQENVVVSPHGIASVLGMLQLGADGKTKKQLQTVMRYKI----NGVAKALK--KLNKAIVSKKNK- 85 (377)
T ss_pred HHHHHHHHHHHhcCCCCcEEECcHHHHHHHHHHHhhcCCcHHHHHHHHhCCCh----hHHHHHHH--HHHHHHhccCCc-
Confidence 59999999998878899999999999999999999999999999999999974 34555554 555556444334
Q ss_pred eEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCC-CCCCCceEEE-
Q psy7902 81 LTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATG-QVNSRTNLVL- 153 (342)
Q Consensus 81 ~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~-~i~~~t~lvl- 153 (342)
..++++|++|++++++++++|.+ +|+++++.+||. +++.+++ ||+|++++|+|+|++++.+. .++++|.+++
T Consensus 86 ~~l~~an~i~~~~~~~l~~~f~~~~~~~f~a~~~~vdF~-~~~~a~~~IN~Wv~~~T~g~I~~~l~~~~~i~~~t~l~lv 164 (377)
T cd02051 86 DIVTTANAVFAQSGFKMEVPFVPRNKEVFQCEVKSVDFS-DPETAAFSINDWVKNETKGMIDNLLSPDLADDALTRLVLV 164 (377)
T ss_pred cchHHHHHHHhcCCCchhHHHHHHHHHHhcCeeEEECCC-CHHHHHHHHHHHHHHhcCCCccccCCCCCCCCccceEEEE
Confidence 67899999999999999999975 799999999995 6777777 99999999999999999876 6788888887
Q ss_pred --------ecc---------------CCceEEec--------ceeecC---CCCeEEEEeecCCCceEEEEEeCCCCCCC
Q psy7902 154 --------WLP---------------STQESIII--------ITVLSS---ELNAHILEVPYKGGNMSMFFLLPPFASQD 199 (342)
Q Consensus 154 --------W~~---------------~~~~~~V~--------~~~~~~---~~~~~vvelP~~~~~~sm~iilP~~~~~~ 199 (342)
|++ +++.+.|| +|++.+ ++++++++|||+++++||+|+||++. ..
T Consensus 165 nai~Fkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~~~~vv~LPy~~~~~sm~iiLP~~~-~~ 243 (377)
T cd02051 165 NALYFKGLWKSRFQPESTKKRTFHAGDGKTYQVPMLAQLSVFRSGSASTPNGLWYNIIELPYHGESISMLIALPTEK-ST 243 (377)
T ss_pred eeeEeeeeecCCCChhhCcccccCcCCCcEEeehhhcccCceeeEeeccccccccEEEEEecCCCeEEEEEEecccc-CC
Confidence 887 34456677 344433 35689999999989999999999865 24
Q ss_pred cHHHHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCC-CCCCCCCC-CCCeeecceee
Q psy7902 200 GVGDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSP-GADLSRLT-DSHIAFGDAVH 277 (342)
Q Consensus 200 ~l~~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~-~ad~s~i~-~~~l~ls~v~q 277 (342)
+|.+++++|+.+ .+..|.+. ++.+.|+|.||||++++++||++.|++||++++|++ .|||++|+ .++++|++++|
T Consensus 244 ~L~~l~~~l~~~--~l~~~~~~-~~~~~v~v~lPkF~i~~~~~L~~~L~~lGl~~~F~~~~Adfs~i~~~~~l~v~~v~h 320 (377)
T cd02051 244 PLSAIIPHISTK--TIQSWMGT-MVPKRMQLVLPKFTVEAETDLKEPLKALGITDMFDQSKANFTKISRSESLHVSHALQ 320 (377)
T ss_pred CHHHHHHhcCHH--HHHHHHHh-CCceEEEEEccCEEEEEecChHHHHHHCCCcccccCCCCCcccccCCCCEEEEeEEE
Confidence 799999999987 89999888 689999999999999999999999999999999997 79999999 67899999999
Q ss_pred eEEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCC
Q psy7902 278 KARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337 (342)
Q Consensus 278 ~~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P 337 (342)
++.|+|||+|++|+|+|.+....++. +.+|++||||+|+|+|+.|+.|||+|+|.+|
T Consensus 321 ka~iev~E~Gt~aaa~t~~~~~~~~~---~~~f~~drPF~f~I~~~~t~~~LF~G~v~~P 377 (377)
T cd02051 321 KAKIEVNEDGTKASAATTAILIARSS---PPWFIVDRPFLFFIRHNPTGTILFMGQINKP 377 (377)
T ss_pred EEEEEECCCccchhhhcceeeeccCC---CCeEEeeCCEEEEEEeCCCCcEEEEEEecCC
Confidence 99999999999999998764443332 4689999999999999999999999999998
|
Plasminogen activator inhibitor-1 (PAI-1) is the primary, fast-acting inhibitor of plasminogen activators. It is often bound to vitronectin, an abundant component of the extracellular matrix in many tissues. Protease nexin-1 is a potent serpin able to inhibit thrombin, plasmin, and plasminogen activators. PAI-1 and nexin-1 are members of the serpin superfamily and represent clade E. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. |
| >cd02052 PEDF Pigment epithelium-derived factor (PEDF)_like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-66 Score=489.09 Aligned_cols=316 Identities=25% Similarity=0.460 Sum_probs=276.4
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCCc
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADSG 80 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 80 (342)
+||++||+++....+++|+++||+||+.+|+||+.||+|+|++||.++||++.. +..++++.++ +++..+...+
T Consensus 21 ~Fa~~l~~~l~~~~~~~Nvv~SP~si~~~L~ml~~GA~g~T~~ql~~~L~~~~~-~~~~~~~~~~--~l~~~l~~~~--- 94 (374)
T cd02052 21 NFGYDLYRQQASRDPTANVFLSPLSIATALSQLSLGAGERTESQIHRALYYDLL-NDPELHDTYK--DLLASLTAPA--- 94 (374)
T ss_pred HHHHHHHHHHhccCCCCcEEEChHHHHHHHHHHHhccChHHHHHHHHHhCCCCC-ChHHHHHHHH--HHHHHhcCCC---
Confidence 599999999998778899999999999999999999999999999999999753 3456788886 7777775432
Q ss_pred eEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE--
Q psy7902 81 LTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL-- 153 (342)
Q Consensus 81 ~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl-- 153 (342)
..++++|++|++++++++++|.+ .|+++++.+|| + ++ +++ ||+|++++|+|+|+++++ ++++++.+++
T Consensus 95 ~~l~~an~i~v~~~~~l~~~f~~~~~~~~~~~~~~~~~-~-~~-~~~~IN~wv~~~T~g~I~~~l~--~i~~~t~l~lvN 169 (374)
T cd02052 95 KGLKSASRILLERKLRLRLEFVNQVEKSYGERPRILAG-N-AL-DLQEINDWVQQQTGGKVDRFVK--EIPRNVSILLLG 169 (374)
T ss_pred ccchhhhHHHHhCCCchhHHHHHHHHHHhhCccccccC-C-HH-HHHHHHHHHHHhhcCcHHHhCC--CCCCccceEEEe
Confidence 45899999999999999999975 78999999998 3 33 455 999999999999999995 5888899887
Q ss_pred -------ecc---------------CCceEEec---------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHH
Q psy7902 154 -------WLP---------------STQESIII---------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVG 202 (342)
Q Consensus 154 -------W~~---------------~~~~~~V~---------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~ 202 (342)
|++ ++++++|| +|++.+++++++|+|||++ ++||+||||++. ..+|.
T Consensus 170 a~yFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~y~~~~~~~~~vveLPy~~-~~sm~iiLP~~~-~~~L~ 247 (374)
T cd02052 170 SAYFKGQWITKFDKRNTVLTDFHLDEQRTVVVPMMSDPNAPVRYGLDSDLNCKIAQLPLTG-GVSIMFFLPDKV-TQNLT 247 (374)
T ss_pred eEEEechhcCCCCcccCccccEEcCCCcEEEEEeeccCCcceeeEEcCCCCcEEEEEecCC-CeEEEEEecCCC-CCCHH
Confidence 876 34556676 5677888999999999976 799999999875 12699
Q ss_pred HHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCCCCCeeecceeeeEEEE
Q psy7902 203 DILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLTDSHIAFGDAVHKARLD 282 (342)
Q Consensus 203 ~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~~~~l~ls~v~q~~~i~ 282 (342)
.++++|+.+ .++.|..+ ++.+.|+|.||||+++.++||+++|++||++++|+. |||++|++.+++|++|+|++.|+
T Consensus 248 ~l~~~l~~~--~~~~~~~~-~~~~~v~v~lPKF~i~~~~~l~~~L~~lGl~~~F~~-adfs~i~~~~l~v~~v~hk~~ie 323 (374)
T cd02052 248 LIEESLTSE--FVHDIDRE-LKTVKAVLTLPKLKLSYETELLPSLQELKLQSLFAS-PDFTKITSKPIKLSHVHHKAVLE 323 (374)
T ss_pred HHHhhcCHH--HHHHHHHh-CeEEEEEEECccEEEEEEechHHHHHhcCCcccccc-cchhhccccceEeEeeEEEEEEE
Confidence 999999987 88888887 689999999999999999999999999999999996 99999996579999999999999
Q ss_pred ecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCC
Q psy7902 283 LDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337 (342)
Q Consensus 283 v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P 337 (342)
|||+|++|+|+|.+... .+ .+.+|++||||+|+|+|+.|+.|||+|+|.+|
T Consensus 324 VdE~Gt~aaa~t~~~~~-~~---~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P 374 (374)
T cd02052 324 LNEDGAETAPTPGSATA-LT---FPLEYHVDRPFLFVLRDEDTGALLFIGKVLDP 374 (374)
T ss_pred ECCCccccccccccccc-cC---CCeEEEeeCCEEEEEEECCCCcEEEEEEecCC
Confidence 99999999999975432 11 35789999999999999999999999999998
|
PEDF is non-inhibitory member of the Serpin superfamily. It exhibits neurotrophic, neuroprotective and antiangiogenic properties and is widely expressed in the developing and adult nervous systems. This subgroup corresponds to clade F1 of the serpin superfamily. |
| >cd02043 plant_SERPIN SERine Proteinase INhibitors (serpins), plant specific subgroup | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-66 Score=488.73 Aligned_cols=328 Identities=29% Similarity=0.468 Sum_probs=276.3
Q ss_pred ChHHHHHHHHhhcC-CCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhh---C
Q psy7902 1 EFTFDLLTVLNNAN-KGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRA---N 76 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~-~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~---~ 76 (342)
+||++||+++.... +++|+|+||+||+.+|+||+.||+|+|++||.++||++. ..+++..++ .+...+.. .
T Consensus 5 ~~~~~l~~~~~~~~~~~~N~v~SP~si~~aL~ml~~GA~g~T~~ql~~~L~~~~---~~~~~~~~~--~l~~~~~~~~~~ 79 (381)
T cd02043 5 LVAMRLSGHVAAAAGKGSNVIFSPLSINVALSLVAAGARGETLDQLLSFLGSPS---TDELHAVAA--SIVDLVLADASA 79 (381)
T ss_pred HHHHHHHHHHhccCCCCCcEEECHHHHHHHHHHHhcccCCcHHHHHHHHhCCCC---hHHHHHHHH--HHHHHHhhhccc
Confidence 49999999999874 789999999999999999999999999999999999973 345666665 55554432 1
Q ss_pred CCCceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceE
Q psy7902 77 ADSGLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNL 151 (342)
Q Consensus 77 ~~~~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~l 151 (342)
... ..++++|++|++++++++++|.+ +|+++++.+||.++++.+++ ||+||+++|+|+|++++++.+++++|.+
T Consensus 80 ~~~-~~l~~an~l~~~~~~~~~~~f~~~~~~~y~~~~~~vdF~~~~~~a~~~IN~wv~~~T~g~I~~~~~~~~i~~~t~l 158 (381)
T cd02043 80 SGG-PRLSFANGVWVDKSLSLKPSFKDLAANSYKAEARPVDFRTKAEEVRREVNSWVEKATNGLIKDILPPGSVDSSTKL 158 (381)
T ss_pred CCC-cEEehhhhHHHhCCCCcCHHHHHHHHhhhhccceeecCCCCHHHHHHHHHHHHHHHhcChHHhhCCCCCcCCCceE
Confidence 224 67999999999999999999976 79999999999767787777 9999999999999999988899999998
Q ss_pred EE---------ecc---------------CCceEEec------ceeecCCCCeEEEEeecCCC------ceEEEEEeCCC
Q psy7902 152 VL---------WLP---------------STQESIII------ITVLSSELNAHILEVPYKGG------NMSMFFLLPPF 195 (342)
Q Consensus 152 vl---------W~~---------------~~~~~~V~------~~~~~~~~~~~vvelP~~~~------~~sm~iilP~~ 195 (342)
++ |++ +++++.|| .+.+....++++|+|||+++ ++||+||||++
T Consensus 159 ~lvnai~Fkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~~~~~~~~~~~~veLPy~~~~~~~~~~~sm~iiLP~~ 238 (381)
T cd02043 159 VLANALYFKGAWSSKFDASDTKDRDFHLLDGTSVRVPFMSSEKDQYVAAFDGFKVLRLPYKRGGHDDARQFSMYIYLPDK 238 (381)
T ss_pred EEEeeeEEeeeeccCCccccCccccceeCCCCeEEeeeeeccCcccccccCCCEEEEcCCCCCCCCCCCcEEEEEEccCC
Confidence 87 886 34455666 22333334699999999765 59999999998
Q ss_pred CCCCcHHHHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC---CCCeee
Q psy7902 196 ASQDGVGDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT---DSHIAF 272 (342)
Q Consensus 196 ~~~~~l~~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~---~~~l~l 272 (342)
. .+|.+++++|+..++.+..|... ++.+.++|.||||++++++||+++|++||++++|++.++++++. .++++|
T Consensus 239 ~--~~L~~l~~~l~~~~~~~~~~~~~-~~~~~v~l~lPKF~i~~~~dl~~~L~~mGl~~~F~~~~~~~~~~~~~~~~l~v 315 (381)
T cd02043 239 K--DGLADLLEKLVSEPGFLDRHIPA-SEQEVGAFMIPKFKFSFGFEASEVLKKLGLTLPFDPGGALLSMSSPEGENLYV 315 (381)
T ss_pred C--CCHHHHHHhhccChhhhhhhccc-ceeeEEEEEcccEEEEeecchHHHHHHCCCccccCCccccccCccCCCCCeeE
Confidence 7 79999999997652236666666 57788999999999999999999999999999999867777764 367999
Q ss_pred cceeeeEEEEecCCCccccccchhhhcccCC-CCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCC
Q psy7902 273 GDAVHKARLDLDEQGTTAAAATAVFAFRSSR-PLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337 (342)
Q Consensus 273 s~v~q~~~i~v~E~G~~a~a~t~~~~~~~~~-~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P 337 (342)
++|+|++.|+|||+|++|+|+|.+.....+. +..+.+|++||||+|+|+|+.|+.|||+|+|.+|
T Consensus 316 s~v~hka~ieVdE~Gt~aaa~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~iLF~G~v~~P 381 (381)
T cd02043 316 SSVYHKACVEVDEEGTEAAAATAVVMSGTSSPPPRPVDFVADHPFLFLIREDKTGVVLFLGQVMNP 381 (381)
T ss_pred EeeeeEEEEEECCCcceehhccceeeccccCCCCCCceEEecCCEEEEEEECCCCcEEEEEEecCC
Confidence 9999999999999999999999865443332 2345789999999999999999999999999998
|
It has been suggested that plant serpins play a role in defense against insect predators. This subgroup corresponds to clade P of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. |
| >cd02055 PZI Protein Z-dependent protease inhibitor (ZPI) is a member of the serpin superfamily of proteinase inhibitors (clade A10) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-65 Score=476.17 Aligned_cols=315 Identities=26% Similarity=0.442 Sum_probs=269.3
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCC--ChHHHHHHhhHHHHHHHhhhCCC
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENL--DKLDTMNVYKMEKLIQGLRANAD 78 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~--~~~~~~~~~~~~~~l~~l~~~~~ 78 (342)
+||++||+++... +++|+|+||+||+.+|+|++.||+|+|+.||.++||++... +..+++..|+ .+...+.. +
T Consensus 8 ~Fa~~l~~~~~~~-~~~Nvv~SP~si~~aL~ml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~~~~--~l~~~~~~-~- 82 (365)
T cd02055 8 NFGFNLLRKIAMK-HDGNIIFSPFGMSLAMAGLLLAAEGETERQIAKALHLHALKDRDPGLLPALFK--GLKDNISR-N- 82 (365)
T ss_pred HHHHHHHHHHhcC-CCCcEEEChHHHHHHHHHHHhhcCchHHHHHHHHcCCCCCccccHHHHHHHHH--HHHHHhcC-C-
Confidence 5999999999864 57899999999999999999999999999999999997531 2234555565 45544432 2
Q ss_pred CceEEEEEee--eeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceE
Q psy7902 79 SGLTFTSTNK--IFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNL 151 (342)
Q Consensus 79 ~~~~l~~~n~--l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~l 151 (342)
..+.++++ +|++++++++++|.+ +|++++..+||+ +++.+++ ||+|++++|+|+|++++ .+++++|.+
T Consensus 83 --~~~~l~~~~~~~v~~~~~l~~~F~~~~~~~y~~~~~~vdF~-~~~~a~~~IN~wv~~~T~g~I~~~~--~~i~~~t~l 157 (365)
T cd02055 83 --EELGFTQGIFAFIHKDFDVKEAFFNLSKQYFDMECLCMDFQ-NASQAKFLINHNIKKETKGKIPELF--DEIDPESKL 157 (365)
T ss_pred --cceehHHHHHHHHHCCCCccHHHHHHHHHHhcCeeEEECCC-ChHHHHHHHHHHHHHhhcchHHHHh--hcCCccchh
Confidence 23455555 599999999999976 899999999995 5666666 99999999999999999 578889998
Q ss_pred EE---------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCC
Q psy7902 152 VL---------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQD 199 (342)
Q Consensus 152 vl---------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~ 199 (342)
++ |+. +++.+.|| +|.+++++++++++|||++ +++|+||||+++ .
T Consensus 158 ~lvnai~Fkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vv~LPy~~-~~sm~iiLP~~~--~ 234 (365)
T cd02055 158 ILLDYIFFKGKWLTPFDPEFTEIDTFHIDKYKSIKVPMMFGADKFASTFDENFRCHVIKLPYKG-KATMLIVIMEKG--E 234 (365)
T ss_pred hhhHHHHHHHHHhCCCChhhCccceEEcCCCcEEEehhhcccCceeeEEeCCCCeEEEEeeeCC-CcEEEEEEcCCC--C
Confidence 87 877 34556777 5677899999999999975 689999999987 7
Q ss_pred cHHHHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC--CCCeeecceee
Q psy7902 200 GVGDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT--DSHIAFGDAVH 277 (342)
Q Consensus 200 ~l~~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~--~~~l~ls~v~q 277 (342)
+|.++++.|+.+ .+.+|..+ ++.+.|+|.||||++++++||+++|++||++++|+..|||++|+ +++++|++++|
T Consensus 235 ~l~~l~~~l~~~--~l~~~~~~-~~~~~v~l~lPKF~i~~~~~l~~~L~~lGi~~~F~~~adls~i~~~~~~l~vs~v~h 311 (365)
T cd02055 235 DHLALEDHLTMD--LVESWLAN-MKSRNMDIFFPKFKLDQKYEMHELLRALGIKNIFAPFADLSELLADGKHLQVSQVLQ 311 (365)
T ss_pred CHHHHHHHhhHH--HHHHHHHh-ccceEEEEEEEEEEEEEEeehHHHHHHcCcchhhcCcCCcccccCCCCcEEEEeeeE
Confidence 899999999987 89999988 69999999999999999999999999999999999789999986 46799999999
Q ss_pred eEEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEE
Q psy7902 278 KARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVF 334 (342)
Q Consensus 278 ~~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v 334 (342)
++.|+|||+|++|+|+|.......+. +..|++||||+|+|+|+.++.|||+|+|
T Consensus 312 ka~ievdE~Gt~aaa~t~~~~~~~~~---~~~f~~nrPF~f~I~~~~~~~~LF~G~v 365 (365)
T cd02055 312 KAVIEVDEKGTEAAAAIGSEIIAFSM---PPVIKVDRPFHFMIFEETFGMLLFIGRV 365 (365)
T ss_pred EEEEEEccCCchhhhhhcceecccCC---CCeEEeeCCEEEEEEECCCCcEEEEEeC
Confidence 99999999999999999754333222 3579999999999999999999999996
|
ZPI inhibits coagulation factor Xa , dependent on protein Z (PZ), a vitamin K-dependent plasma protein. ZPI also inhibits factor XIa in a process that does not require PZ. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. |
| >PHA02948 serine protease inhibitor-like protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-64 Score=472.41 Aligned_cols=313 Identities=20% Similarity=0.361 Sum_probs=266.3
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCC-CC
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANA-DS 79 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~-~~ 79 (342)
+||++||+++...++++|++|||+||+.+|+|++.||+|+|++||.++||++. .+++..++ +++..+.... .+
T Consensus 23 ~f~~~l~~~l~~~~~~~Nv~~SP~Si~~aL~ml~~GA~G~T~~el~~~L~~~~----~~~~~~~~--~l~~~~~~~~~~~ 96 (373)
T PHA02948 23 NAGILAYKNIQDGNEDDNIVFSPFGYSFSMFMSLLPASGNTRVELLKTMDLRK----RDLGPAFT--ELISGLAKLKTSK 96 (373)
T ss_pred HHHHHHHHHHHhcCCCCCEEEchHHHHHHHHHHHhccCCcHHHHHHHHhCCCc----hhHHHHHH--HHHHHHhcccccC
Confidence 59999999998877789999999999999999999999999999999999973 24566665 5665554322 22
Q ss_pred ceE-EEEEeeeeccCCCCchhhHhh-hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE---
Q psy7902 80 GLT-FTSTNKIFVNDKIPVKECMTA-IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL--- 153 (342)
Q Consensus 80 ~~~-l~~~n~l~~~~~~~l~~~f~~-~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl--- 153 (342)
.. +.++|++|+++++.++++|.+ +|.++++.+||. +.+++ ||+||+++| +|.+++++.+++++|.++|
T Consensus 97 -~~~~~~an~~~v~~~~~~~~~f~~~~~~~~v~~vdF~---~~a~~~IN~WV~~~T--~I~~~~~~~~i~~~t~lvLvNa 170 (373)
T PHA02948 97 -YTYTDLTYQSFVDNTVCIKPSYYQQYHRFGLYRLNFR---RDAVNKINSIVERRS--GMSNVVDSTMLDNNTLWAIINT 170 (373)
T ss_pred -cchHHHHHHHHHhcCCCccHHHHHHHhhCceEecCcc---HHHHHHHHHHHHhcC--CCcccCCCCCCCCCceEEEEEE
Confidence 33 368899999999999999987 677899999994 24555 999999998 5999998888999999888
Q ss_pred ------ecc--------------CCceEEec------c----eeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHHH
Q psy7902 154 ------WLP--------------STQESIII------I----TVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGD 203 (342)
Q Consensus 154 ------W~~--------------~~~~~~V~------~----~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~~ 203 (342)
|++ .++++.|| . |.+.++.++++++|||+++++||+|+||+ ++.+
T Consensus 171 iyFkg~W~~~F~~~~T~~~~F~~~~~~~~V~mM~~~~~~~~~~~~~~~~~~~vl~LPY~~~~~sM~iiLP~-----~l~~ 245 (373)
T PHA02948 171 IYFKGTWQYPFDITKTHNASFTNKYGTKTVPMMNVVTKLQGNTITIDDEEYDMVRLPYKDANISMYLAIGD-----NMTH 245 (373)
T ss_pred EEEeeeecCCCCcccCeeceeEeCCCCEEchhheeccccccceeeccCcCceEEEEecCCCcEEEEEEcCC-----cHHH
Confidence 987 12245666 1 34567889999999999889999999994 4788
Q ss_pred HHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCC-CCCCCCCCCCCeeecceeeeEEEE
Q psy7902 204 ILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSP-GADLSRLTDSHIAFGDAVHKARLD 282 (342)
Q Consensus 204 l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~-~ad~s~i~~~~l~ls~v~q~~~i~ 282 (342)
+++.|+.+ .+..|..+ +..+.|+|.||||++++++||+++|+ +|++++|++ .|||++|++++++|++|+|++.|+
T Consensus 246 l~~~l~~~--~l~~~~~~-~~~~~v~v~lPKFki~~~~~L~~~L~-~~i~~~F~~~~Adfs~is~~~l~vs~v~hka~Ie 321 (373)
T PHA02948 246 FTDSITAA--KLDYWSSQ-LGNKVYNLKLPRFSIENKRDIKSIAE-MMAPSMFNPDNASFKHMTRDPLYIYKMFQNAKID 321 (373)
T ss_pred HHHHhCHH--HHHHHHHh-CcceEEEEEeeCEeeeeeccHHHHHH-hhhHhhCCCCcCchhhhccCceEEEeeEEEEEEE
Confidence 99999887 89999888 68899999999999999999999995 679999987 699999996679999999999999
Q ss_pred ecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCC
Q psy7902 283 LDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337 (342)
Q Consensus 283 v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P 337 (342)
|||+|++|+|+|.+....++ .+.+|++||||+|+|+|+.|+.|||+|+|.+|
T Consensus 322 VdE~GteAaAaT~~~~~~~~---~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P 373 (373)
T PHA02948 322 VDEQGTVAEASTIMVATARS---SPEELEFNTPFVFIIRHDITGFILFMGKVESP 373 (373)
T ss_pred ECCCceEEeecceeeeeccC---CCCeEEeeCCEEEEEEECCCCcEEEEEEecCC
Confidence 99999999999975433222 24579999999999999999999999999998
|
|
| >cd02053 alpha2AP Alpha2-antiplasmin (alpha2AP) is the primary inhibitor of plasmin, a proteinase that digests fibrin, the main component of blood clots | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-64 Score=468.47 Aligned_cols=306 Identities=26% Similarity=0.443 Sum_probs=258.7
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCCc
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADSG 80 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 80 (342)
+||++||+++..+++++|+|+||+||+.+|+|++.||+|+|++||.++||++.. ...+ +++..+.....+
T Consensus 7 ~F~~~l~~~~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~el~~~L~~~~~---~~~~------~~~~~l~~~~~~- 76 (351)
T cd02053 7 GFSTDLLSEVAQESTKPNLILSPLSIALALSHLALGAQNETEQRLLKTLHAESL---PCLH------HLLSRLRQDLGP- 76 (351)
T ss_pred hHHHHHHHHHHhhCCCCcEEECcHHHHHHHHHHHhhcChHHHHHHHHhcCCCCh---HHHH------HHHHHHhccCCc-
Confidence 599999999998778899999999999999999999999999999999999732 2222 344444443344
Q ss_pred eEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE--
Q psy7902 81 LTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL-- 153 (342)
Q Consensus 81 ~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl-- 153 (342)
..++++|++|++++++++++|.+ .|++++ +||..+++.+++ ||+|++++|+|+|++++ .+++++|.+++
T Consensus 77 ~~l~~an~i~v~~~~~~~~~f~~~~~~~~~~~~--~~~~~~~~~~~~~IN~wv~~~T~g~I~~~~--~~~~~~t~~vlvN 152 (351)
T cd02053 77 GALRLATRMYLQKGFEIKESFLEESEKLYGAKP--VSLTGTKEDDLANINKWVKEATEGQIPNFL--SDLPHDTVLLLLN 152 (351)
T ss_pred cEeehhhHHHHhCCCchhHHHHHHHHHHcCCEE--eecCCCCHHHHHHHHHHHHHhccCchhHhc--CCCCcchHhheee
Confidence 77999999999999999999976 788875 566434556666 99999999999999999 47888898877
Q ss_pred -------ecc---------------CCceEEec---------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCC-cH
Q psy7902 154 -------WLP---------------STQESIII---------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQD-GV 201 (342)
Q Consensus 154 -------W~~---------------~~~~~~V~---------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~-~l 201 (342)
|++ +++++.|| +|.+.+++++++++|||++ ++||+|+||++. . +|
T Consensus 153 aiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~~vleLPy~~-~~Sm~iiLP~~~--~~~l 229 (351)
T cd02053 153 AIHFKGFWRNKFDPSLTQRDAFHLDDDFTVSVEMMQASTYPLRWFHLEQPEIQVAKFPFKG-NMSFVVLMPTPF--TWNV 229 (351)
T ss_pred EEEEeeeecCCCChhcCeecceEECCCceEEeehhcccccceeeEecCCCCeEEEEEecCC-CeEEEEEecccc--cccH
Confidence 987 34556666 3456789999999999986 599999999885 4 59
Q ss_pred HHHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCCCCCeeecceeeeEEE
Q psy7902 202 GDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLTDSHIAFGDAVHKARL 281 (342)
Q Consensus 202 ~~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~~~~l~ls~v~q~~~i 281 (342)
.+++++|+.. .+..+. ++.+.++|+||||++++++||+++|++||++++|+. |||++|++++++|++++|++.|
T Consensus 230 ~~~~~~l~~~--~l~~~~---~~~~~v~v~lPKFki~~~~~L~~~L~~lGi~~~F~~-adfs~i~~~~~~vs~v~hka~i 303 (351)
T cd02053 230 SQVLANLNWD--DLYRRL---PKERPTKVKLPKLKLDYQLELNEALSQLGLQELFQA-PDLSGISDEPLFVSSVQHQSTL 303 (351)
T ss_pred HHHHHhCCHH--HHHHhh---ccceEEEEEccCEEEEeeechHHHHHhCCchhcccc-ccccccCCCCceeeeeeEEEEE
Confidence 9999999876 666544 245678999999999999999999999999999996 9999999667999999999999
Q ss_pred EecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEE
Q psy7902 282 DLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVF 334 (342)
Q Consensus 282 ~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v 334 (342)
||||+|++|+|+|.+.... + ...|++||||+|+|+|+.|+.|||+|+|
T Consensus 304 eVdE~Gt~aaa~t~~~~~~-~----~~~f~~drPF~f~I~~~~t~~~LF~G~v 351 (351)
T cd02053 304 ELSEKGVEASAATSVATSR-S----LSSFSVNRPFLFFIFEDTMGLPLFMGSV 351 (351)
T ss_pred EECCCcceehhcceeeccc-c----cCeEEcCCCEEEEEEECCCCCEEEEEeC
Confidence 9999999999999764332 1 2489999999999999999999999996
|
Alpha2-Antiplasmin forms an inactive 1 : 1 stoichiometric complex with plasmin. It also rapidly crosslinks to fibrin during blood clotting by activated coagulation factor XIII, and as a consequence fibrin becomes more resistant to fibrinolysis. Therefore alpha2AP is important in modulating the effectiveness and persistence of fibrin with respect to its susceptibility to digestion and removal by plasmin. This subgroup corresponds to clade F2 of the serpin superfamily. |
| >cd02050 C1_inh C1 inhibitor (C1-Inh) is a protease inhibitor of the serpin family | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-63 Score=464.32 Aligned_cols=307 Identities=28% Similarity=0.442 Sum_probs=262.5
Q ss_pred ChHHHHHHHHhhcC-CCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCC
Q psy7902 1 EFTFDLLTVLNNAN-KGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADS 79 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~-~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~ 79 (342)
+||++||+++.... +++|+|+||+||+.+|+||+.||+|+|++||.++||++.. ..+++..++ + +.. .
T Consensus 4 ~F~~~l~~~~~~~~~~~~N~v~SP~si~~aL~ml~~GA~g~T~~ql~~~L~~~~~--~~~~~~~~~--~----l~~---~ 72 (352)
T cd02050 4 EFSLKLYQHLSESAKPDTNLLFSPVSIALLLSHLLLGARGKTQRRLESILSYPHD--FACVHSALK--K----LKN---K 72 (352)
T ss_pred hHHHHHHHHHhhccCCCCCEEEChHHHHHHHHHHhcccCccHHHHHHHhcCCCCc--hhHHHHHHH--H----hhh---c
Confidence 59999999998766 7899999999999999999999999999999999999853 334444443 2 221 2
Q ss_pred ceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE-
Q psy7902 80 GLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL- 153 (342)
Q Consensus 80 ~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl- 153 (342)
..+.++|++|++++++++++|.+ +|++++..+||. ++.+++ ||+|++++|+|+|++++ .+++++|.+++
T Consensus 73 -~~l~~an~i~~~~~~~l~~~f~~~~~~~y~~~~~~~~~~--~~~a~~~IN~wv~~~T~g~I~~~~--~~i~~~t~l~lv 147 (352)
T cd02050 73 -LGLLSASQIFHHPDLHLRESFTNESWQFYKARPRELSNN--SELNLEMINSWVAKATNNKIPRLL--DSLPSETRLVLL 147 (352)
T ss_pred -chhHHHHHHHHhCCCCccHHHHHHHHHHhCCcceeecCC--hHHHHHHHHHHHHHHhcchHHHHh--cccCCCceEEEE
Confidence 44888999999999999999976 799999999983 355666 99999999999999999 57889999887
Q ss_pred --------ecc--------------CCceEEec---------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHH
Q psy7902 154 --------WLP--------------STQESIII---------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVG 202 (342)
Q Consensus 154 --------W~~--------------~~~~~~V~---------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~ 202 (342)
|++ +++.+.|| .|.+.+++++++++|||+ +++||+|+||++. ..+|.
T Consensus 148 naiyFkg~W~~~F~~~~T~~~~F~~~~~~~~V~mM~~~~~~~~~~~~~~l~~~v~~lp~~-~~~sm~iiLP~~~-~~~l~ 225 (352)
T cd02050 148 NAVYFQAQWKKKFDTKHTVLLPFKRNGDPVKVPVMYSKKYPVASFTDPRLKAQVGRLELS-GGLSLVVLVPRGP-KEDLE 225 (352)
T ss_pred eeEEEeeecCCCCCcccCccCceeECCceEEeeEeecCccceeeEEcCCcCeEEEEecCC-CceEEEEEeeCCC-CCCHH
Confidence 887 23456666 234568899999999996 5799999999864 25899
Q ss_pred HHHHHhcCCchHHHHHhhhcC---CCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC-CCCeeecceeee
Q psy7902 203 DILAALKKDPTSFKRFTEDSQ---NLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-DSHIAFGDAVHK 278 (342)
Q Consensus 203 ~l~~~L~~~~~~l~~~~~~~l---~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~-~~~l~ls~v~q~ 278 (342)
+++++|+.+ .+..|..+ + ..+.++|.||||++++++||+++|++||++++|+. |||++|+ +.+++|++++|+
T Consensus 226 ~l~~~l~~~--~~~~~~~~-l~~~~~~~v~l~lPKF~i~~~~dl~~~L~~lGi~~~F~~-adfs~i~~~~~l~v~~v~hk 301 (352)
T cd02050 226 AVERALTPP--AFLAMLEK-MAANTPQRTEVTLPRIKLDLAVDMVALMHKLGLFGLFLD-ANLCGLYQDPELAVDAAQHR 301 (352)
T ss_pred HHHHhcCHH--HHHHHHHh-hhhcCceEEEEEcceEEEeeccchHHHHHHcCChhhccc-cchhhccCCCCeEEEeeEEe
Confidence 999999987 89999876 4 35789999999999999999999999999999985 9999999 678999999999
Q ss_pred EEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEE
Q psy7902 279 ARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVF 334 (342)
Q Consensus 279 ~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v 334 (342)
+.|+|||+|++|+|+|.+...+ .+..|++||||+|+|+|+.|+.|||+|+|
T Consensus 302 ~~ieVdE~Gt~Aaa~t~~~~~~-----~~~~f~~drPF~f~I~~~~t~~~LF~G~v 352 (352)
T cd02050 302 AVLTLTEKGVEAAAATATSFAR-----TALSFEALQPFLFVLWDDQAKVPLFMGRV 352 (352)
T ss_pred eEEEECCCchhhhhhccccccc-----ccceEEcCCCEEEEEEECCCCceEEEEeC
Confidence 9999999999999999754332 13589999999999999999999999996
|
It plays a pivotal role in regulating the activation of the classical complement pathway and of the contact system, via regulating bradykinin formation, inhibiting factor XII and kallikrein of the contact system, and via acting on factor XI in the coagulation cascade. This subgroup corresponds to clade G of the serpin superfamily. |
| >PHA02660 serpin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-61 Score=447.06 Aligned_cols=299 Identities=23% Similarity=0.403 Sum_probs=247.2
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCCc
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADSG 80 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 80 (342)
+||++||+.+. ++|+++||+||+.+|+|++.||+|+|+.||.++||+... + +. .
T Consensus 17 ~f~~~l~~~~~----~~Nvv~SP~Si~~aL~ml~~GA~G~T~~el~~~L~~~~~-~---~~-----------------~- 70 (364)
T PHA02660 17 DLGFCILKSLH----RFNIVFSPESLKAFLHVLYLGSERETKNELSKYIGHAYS-P---IR-----------------K- 70 (364)
T ss_pred HHHHHHHHhcC----CCCEEEChHHHHHHHHHHHhhcCchHHHHHHHHhCcccc-c---cc-----------------h-
Confidence 49999999994 489999999999999999999999999999999998632 1 00 0
Q ss_pred eEEEEEeeeeccCCCCchhhHhh---hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE---
Q psy7902 81 LTFTSTNKIFVNDKIPVKECMTA---IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL--- 153 (342)
Q Consensus 81 ~~l~~~n~l~~~~~~~l~~~f~~---~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl--- 153 (342)
..+..+|++|++++++++++|.+ .|+++++.+||.++++.+++ ||+||+++|+ |.+++ +++++|.++|
T Consensus 71 ~~l~~an~l~v~~~~~l~~~F~~~~~~~~~~v~~vdF~~~~~~a~~~IN~WV~~~T~--I~~~~---~~~~~t~l~LvNa 145 (364)
T PHA02660 71 NHIHNITKVYVDSHLPIHSAFVASMNDMGIDVILADLANHAEPIRRSINEWVYEKTN--IINFL---HYMPDTSILIINA 145 (364)
T ss_pred hhHHHHHHHHHhcCCchhHHHHHHHHHcCCceEEeccccCHHHHHHHHHHHHHhccC--Ccccc---ccCCCchhhhhhh
Confidence 11345789999999999999976 58999999999766777777 9999999999 99987 4678899887
Q ss_pred ------ecc---------------CCceEEec------ceeecCCCCeEEEEeecCCC-ceEEEEEeCCCCCCCcHHHHH
Q psy7902 154 ------WLP---------------STQESIII------ITVLSSELNAHILEVPYKGG-NMSMFFLLPPFASQDGVGDIL 205 (342)
Q Consensus 154 ------W~~---------------~~~~~~V~------~~~~~~~~~~~vvelP~~~~-~~sm~iilP~~~~~~~l~~l~ 205 (342)
|++ +++.+.|| .|.|....++++++|||+++ .++|+|+||++.+..+|.+++
T Consensus 146 iyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~vleLPY~~~~~~sM~iiLP~~~~~~~L~~l~ 225 (364)
T PHA02660 146 VQFNGLWKYPFLRKKTTMDIFNIDKVSFKYVNMMTTKGIFNAGRYHQSNIIEIPYDNCSRSHMWIVFPDAISNDQLNQLE 225 (364)
T ss_pred hhcccHhhcCCCcccCcccccccCCCceEeceeccccCeeeeeecCCCeEEECccCCCCceEEEEEeeCCcccchHHHHH
Confidence 987 34456676 34443445789999999864 579999999874124799999
Q ss_pred HHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC-CC----Cee--ecceeee
Q psy7902 206 AALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-DS----HIA--FGDAVHK 278 (342)
Q Consensus 206 ~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~-~~----~l~--ls~v~q~ 278 (342)
+.|+.+ .+..|... +..+.|+|.||||+++.++||+++|++||++++|+. |||++|+ .. +++ +++|+|+
T Consensus 226 ~~l~~~--~l~~~~~~-~~~~~v~l~LPKFki~~~~~L~~~L~~lGi~~~F~~-Adfs~i~~~~~~~~~l~~~vs~v~hk 301 (364)
T PHA02660 226 NMMHGD--TLKAFKHA-SRKKYLEISIPKFRIEHSFNAEHLLPSAGIKTLFTN-PNLSRMITQGDKEDDLYPLPPSLYQK 301 (364)
T ss_pred HhhhHH--HHHHHHhh-CceeEEEEEccceEeeeeechHHHHHHcCchhhccc-cCccccccCCCcccccccccccceEe
Confidence 999988 89888877 688999999999999999999999999999999985 9999998 32 477 7999999
Q ss_pred EEEEecCCCccccccchhhhcccCCC-------CCCceEEecCCeEEEEEeCCCCcEEEEEEEcCC
Q psy7902 279 ARLDLDEQGTTAAAATAVFAFRSSRP-------LEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337 (342)
Q Consensus 279 ~~i~v~E~G~~a~a~t~~~~~~~~~~-------~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P 337 (342)
+.|+|||+|++|+|+|..... ...+ ..+.+|++||||+|+|++ ++.|||+|+|.+|
T Consensus 302 a~ieVdE~GteAaaat~~~~~-~~~~~~~~~~~~~~~~f~~drPFlf~I~~--~~~iLF~G~v~~P 364 (364)
T PHA02660 302 IILEIDEEGTNTKNIAKKMRR-NPQDEDTQQHLFRIESIYVNRPFIFIIEY--ENEILFIGRISIP 364 (364)
T ss_pred eEEEECCCCcHHHHhhhhhhh-cccccccccccCCCceEEcCCCEEEEEec--CCeEEEEEEecCC
Confidence 999999999999988743111 1100 013579999999999997 4899999999998
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 342 | ||||
| 2zv6_A | 401 | Crystal Structure Of Human Squamous Cell Carcinoma | 8e-27 | ||
| 2dut_A | 423 | Crystal Structure Of A M-Loop Deletion Variant Of M | 1e-26 | ||
| 1by7_A | 382 | Human Plasminogen Activator Inhibitor-2. Loop (66-9 | 4e-26 | ||
| 2arq_A | 382 | Human Plasminogen Activator Inhibitor-2.[loop (66-9 | 8e-26 | ||
| 2ol2_A | 395 | High Resolution Structure Of Native Pci In Space Gr | 1e-25 | ||
| 2hi9_A | 363 | Crystal Structure Of Human Native Protein C Inhibit | 1e-25 | ||
| 2h4r_A | 415 | Crystal Structure Of Wildtype Ment In The Native Co | 3e-25 | ||
| 2vdx_A | 373 | Crystal Structure Of The Reactive Loop Cleaved Cort | 9e-24 | ||
| 3vvj_A | 392 | Structure Of Ovalbumin From Emu (Dromaius Novaeholl | 4e-23 | ||
| 1ova_C | 386 | Crystal Structure Of Uncleaved Ovalbumin At 1.95 An | 1e-22 | ||
| 1jti_A | 385 | Loop-Inserted Structure Of P1-P1' Cleaved Ovalbumin | 1e-22 | ||
| 1ova_B | 386 | Crystal Structure Of Uncleaved Ovalbumin At 1.95 An | 2e-22 | ||
| 1ova_A | 386 | Crystal Structure Of Uncleaved Ovalbumin At 1.95 An | 2e-22 | ||
| 1uhg_A | 385 | Crystal Structure Of S-ovalbumin At 1.9 Angstrom Re | 4e-22 | ||
| 1k9o_I | 378 | Crystal Structure Of Michaelis Serpin-Trypsin Compl | 2e-21 | ||
| 4bb2_A | 340 | Crystal Structure Of Cleaved Corticosteroid-binding | 4e-21 | ||
| 1sek_A | 378 | The Structure Of Active Serpin K From Manduca Sexta | 4e-21 | ||
| 2h4q_A | 382 | Crystal Structure Of A M-Loop Deletion Variant Of M | 6e-21 | ||
| 4ga7_A | 389 | Crystal Structure Of Human Serpinb1 Mutant Length = | 1e-20 | ||
| 2gd4_I | 443 | Crystal Structure Of The Antithrombin-S195a Factor | 2e-20 | ||
| 3dlw_A | 411 | Antichymotrypsin Length = 411 | 4e-20 | ||
| 1qmn_A | 401 | Alpha1-Antichymotrypsin Serpin In The Delta Conform | 4e-20 | ||
| 3nda_A | 377 | Crystal Structure Of Serpin From Tick Ixodes Ricinu | 5e-20 | ||
| 2h4p_A | 394 | Crystal Structure Of Wildtype Ment In The Cleaved C | 6e-20 | ||
| 3kcg_I | 432 | Crystal Structure Of The Antithrombin-Factor Ixa- P | 8e-20 | ||
| 1lq8_A | 346 | Crystal Structure Of Cleaved Protein C Inhibitor Le | 8e-20 | ||
| 1ath_A | 432 | The Intact And Cleaved Human Antithrombin Iii Compl | 1e-19 | ||
| 2b4x_L | 427 | Crystal Structure Of Antithrombin-Iii Length = 427 | 1e-19 | ||
| 1dzg_I | 432 | N135q-S380c-Antithrombin-Iii Length = 432 | 1e-19 | ||
| 1dzh_I | 432 | P14-Fluorescein-N135q-S380c-Antithrombin-Iii Length | 2e-19 | ||
| 2hij_I | 432 | Crystal Structure Of P14 Alanine Variant Of Antithr | 2e-19 | ||
| 1tb6_I | 432 | 2.5a Crystal Structure Of The Antithrombin-Thrombin | 2e-19 | ||
| 2b4x_I | 427 | Crystal Structure Of Antithrombin-Iii Length = 427 | 2e-19 | ||
| 1att_A | 429 | Crystal Structure Of Cleaved Bovine Antithrombin Ii | 3e-19 | ||
| 4eb1_I | 440 | Hyperstable In-Frame Insertion Variant Of Antithrom | 5e-19 | ||
| 3dy0_A | 336 | Crystal Structure Of Cleaved Pci Bound To Heparin L | 9e-19 | ||
| 1oyh_I | 432 | Crystal Structure Of P13 Alanine Variant Of Antithr | 1e-18 | ||
| 3caa_A | 341 | Cleaved Antichymotrypsin A347r Length = 341 | 3e-18 | ||
| 1as4_A | 341 | Cleaved Antichymotrypsin A349r Length = 341 | 3e-18 | ||
| 4caa_A | 341 | Cleaved Antichymotrypsin T345r Length = 341 | 3e-18 | ||
| 1hp7_A | 394 | A 2.1 Angstrom Structure Of An Uncleaved Alpha-1-An | 3e-18 | ||
| 2ach_A | 360 | Crystal Structure Of Cleaved Human Alpha1-antichymo | 3e-18 | ||
| 3fgq_A | 397 | Crystal Structure Of Native Human Neuroserpin Lengt | 3e-18 | ||
| 3f5n_A | 407 | Structure Of Native Human Neuroserpin Length = 407 | 4e-18 | ||
| 1qlp_A | 394 | 2.0 Angstrom Structure Of Intact Alpha-1-Antitrypsi | 7e-18 | ||
| 3ne4_A | 424 | 1.8 Angstrom Structure Of Intact Native Wild-Type A | 7e-18 | ||
| 2qug_A | 394 | Crystal Structure Of Alpha-1-Antitrypsin, Crystal F | 8e-18 | ||
| 1kct_A | 394 | Alpha1-Antitrypsin Length = 394 | 9e-18 | ||
| 3t1p_A | 371 | Crystal Structure Of An Alpha-1-Antitrypsin Trimer | 1e-17 | ||
| 3dru_A | 404 | Crystal Structure Of Gly117phe Alpha1-Antitrypsin L | 2e-17 | ||
| 3drm_A | 404 | 2.2 Angstrom Crystal Structure Of Thr114phe Alpha1- | 3e-17 | ||
| 1hle_A | 345 | Crystal Structure Of Cleaved Equine Leucocyte Elast | 4e-17 | ||
| 1psi_A | 394 | Intact Recombined Alpha1-Antitrypsin Mutant Phe 51 | 4e-17 | ||
| 1oo8_A | 394 | Crystal Structure Of A1pi-Pittsburgh In The Native | 5e-17 | ||
| 1iz2_A | 394 | Interactions Causing The Kinetic Trap In Serpin Pro | 6e-17 | ||
| 3lw2_A | 379 | Mouse Plasminogen Activator Inhibitor-1 (Pai-1) Len | 9e-17 | ||
| 1atu_A | 374 | Uncleaved Alpha-1-Antitrypsin Length = 374 | 9e-17 | ||
| 3eox_A | 379 | High Quality Structure Of Cleaved Pai-1-Stab Length | 9e-17 | ||
| 1db2_A | 377 | Crystal Structure Of Native Plasminogen Activator I | 9e-17 | ||
| 4if8_A | 414 | Structure Of Vaspin Length = 414 | 1e-16 | ||
| 1yxa_A | 398 | Serpina3n, A Murine Orthologue Of Human Antichymotr | 4e-16 | ||
| 3cvm_A | 392 | High Resolution Structure Of A Stable Plasminogen A | 9e-16 | ||
| 1b3k_A | 379 | Plasminogen Activator Inhibitor-1 Length = 379 | 9e-16 | ||
| 3ut3_A | 375 | A Novel Pai-i Inhibitor And Its Structural Mechanis | 1e-15 | ||
| 1dvm_A | 379 | Active Form Of Human Pai-1 Length = 379 | 1e-15 | ||
| 1c5g_A | 402 | Plasminogen Activator Inhibitor-1 Length = 402 | 3e-15 | ||
| 2r9y_A | 430 | Structure Of Antiplasmin Length = 430 | 3e-15 | ||
| 1dvn_A | 379 | Latent Form Of Plasminogen Activator Inhibitor-1 (P | 3e-15 | ||
| 4aqh_A | 383 | Plasminogen Activator Inhibitor Type-1 In Complex W | 3e-15 | ||
| 1a7c_A | 379 | Human Plasminogen Activator Inhibitor Type-1 In Com | 3e-15 | ||
| 3h5c_A | 423 | X-Ray Structure Of Protein Z-Protein Z Inhibitor Co | 5e-15 | ||
| 3q02_A | 379 | Crystal Structure Of Plasminogen Activator Inhibito | 7e-15 | ||
| 3pzf_A | 397 | 1.75a Resolution Structure Of Serpin-2 From Anophel | 8e-15 | ||
| 3f1s_A | 385 | Crystal Structure Of Protein Z Complexed With Prote | 8e-15 | ||
| 2v95_A | 371 | Struture Of Corticosteroid-Binding Globulin In Comp | 1e-14 | ||
| 1xqg_A | 389 | 3.10 A Crystal Structure Of Maspin, Space Group P 4 | 2e-14 | ||
| 1jmo_A | 480 | Crystal Structure Of The Heparin Cofactor Ii-S195a | 2e-14 | ||
| 1jmj_A | 480 | Crystal Structure Of Native Heparin Cofactor Ii Len | 2e-14 | ||
| 3r4l_A | 379 | Human Very Long Half Life Plasminogen Activator Inh | 2e-14 | ||
| 4afx_A | 387 | Crystal Structure Of The Reactive Loop Cleaved Zpi | 3e-14 | ||
| 3f02_A | 359 | Cleaved Human Neuroserpin Length = 359 | 4e-14 | ||
| 3ozq_A | 376 | Crystal Structure Of Serpin48, Which Is A Highly Sp | 5e-14 | ||
| 7api_A | 347 | The S Variant Of Human Alpha1-Antitrypsin, Structur | 8e-14 | ||
| 3ndd_A | 343 | Cleaved Antitrypsin With P10 Pro, And P9-P6 Asp Len | 9e-14 | ||
| 1d5s_A | 334 | Crystal Structure Of Cleaved Antitrypsin Polymer Le | 9e-14 | ||
| 1ezx_A | 335 | Crystal Structure Of A Serpin:protease Complex Leng | 9e-14 | ||
| 3ndf_A | 343 | Cleaved Antitrypsin With P8-P6 Asp Length = 343 | 1e-13 | ||
| 1xu8_A | 380 | The 2.8 A Structure Of A Tumour Suppressing Serpin | 1e-13 | ||
| 1wz9_A | 375 | The 2.1 A Structure Of A Tumour Suppressing Serpin | 2e-13 | ||
| 2ceo_A | 379 | Thyroxine-Binding Globulin Complex With Thyroxine L | 2e-13 | ||
| 2d26_A | 358 | Active Site Distortion Is Sufficient For Proteinase | 4e-13 | ||
| 4ajt_A | 427 | The Cystal Structure Of Mouse Protein-Z Dependent P | 5e-13 | ||
| 4dy0_A | 379 | Crystal Structure Of Native Protease Nexin-1 With H | 2e-12 | ||
| 9pai_A | 346 | Cleaved Substrate Variant Of Plasminogen Activator | 3e-12 | ||
| 1jjo_C | 261 | Crystal Structure Of Mouse Neuroserpin (Cleaved For | 4e-12 | ||
| 1qmb_A | 326 | Cleaved Alpha-1-Antitrypsin Polymer Length = 326 | 4e-12 | ||
| 1f0c_A | 305 | Structure Of The Viral Serpin Crma Length = 305 | 4e-12 | ||
| 1c8o_A | 300 | 2.9 A Structure Of Cleaved Viral Serpin Crma Length | 8e-12 | ||
| 2riv_A | 343 | Crystal Structure Of The Reactive Loop Cleaved Huma | 1e-11 | ||
| 2riw_A | 338 | The Reactive Loop Cleaved Human Thyroxine Binding G | 2e-11 | ||
| 2xn6_A | 350 | Crystal Structure Of Thyroxine-Binding Globulin Com | 2e-11 | ||
| 2xn5_A | 350 | Crystal Structure Of Thyroxine-Binding Globulin Com | 2e-11 | ||
| 1sng_A | 370 | Structure Of A Thermophilic Serpin In The Native St | 3e-11 | ||
| 1imv_A | 398 | 2.85 A Crystal Structure Of Pedf Length = 398 | 3e-10 | ||
| 1mtp_A | 323 | The X-Ray Crystal Structure Of A Serpin From A Ther | 5e-10 | ||
| 1m93_B | 245 | 1.65 A Structure Of Cleaved Viral Serpin Crma Lengt | 1e-09 | ||
| 3le2_A | 393 | Structure Of Arabidopsis Atserpin1. Native Stressed | 1e-08 | ||
| 3sto_A | 406 | Serpin From The Trematode Schistosoma Haematobium L | 8e-08 | ||
| 2oay_A | 390 | Crystal Structure Of Latent Human C1-Inhibitor Leng | 3e-07 | ||
| 2vh4_A | 381 | Structure Of A Loop C-sheet Serpin Polymer Length = | 1e-05 | ||
| 2pef_A | 373 | Crystal Structure Of A Thermophilic Serpin, Tengpin | 1e-05 | ||
| 2pee_A | 387 | Crystal Structure Of A Thermophilic Serpin, Tengpin | 1e-05 |
| >pdb|2ZV6|A Chain A, Crystal Structure Of Human Squamous Cell Carcinoma Antigen 1 Length = 401 | Back alignment and structure |
|
| >pdb|2DUT|A Chain A, Crystal Structure Of A M-Loop Deletion Variant Of Ment In The Native Conformation Length = 423 | Back alignment and structure |
|
| >pdb|1BY7|A Chain A, Human Plasminogen Activator Inhibitor-2. Loop (66-98) Deletion Mutant Length = 382 | Back alignment and structure |
|
| >pdb|2ARQ|A Chain A, Human Plasminogen Activator Inhibitor-2.[loop (66-98) Deletion Mutant] Complexed With Peptide N-Acetyl-Teaaagdggvmtgr-Oh Length = 382 | Back alignment and structure |
|
| >pdb|2OL2|A Chain A, High Resolution Structure Of Native Pci In Space Group P21 Length = 395 | Back alignment and structure |
|
| >pdb|2HI9|A Chain A, Crystal Structure Of Human Native Protein C Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2H4R|A Chain A, Crystal Structure Of Wildtype Ment In The Native Conformation Length = 415 | Back alignment and structure |
|
| >pdb|2VDX|A Chain A, Crystal Structure Of The Reactive Loop Cleaved Corticosteroid Binding Globulin Length = 373 | Back alignment and structure |
|
| >pdb|3VVJ|A Chain A, Structure Of Ovalbumin From Emu (Dromaius Novaehollandiae) Length = 392 | Back alignment and structure |
|
| >pdb|1OVA|C Chain C, Crystal Structure Of Uncleaved Ovalbumin At 1.95 Angstroms Resolution Length = 386 | Back alignment and structure |
|
| >pdb|1JTI|A Chain A, Loop-Inserted Structure Of P1-P1' Cleaved Ovalbumin Mutant R339t Length = 385 | Back alignment and structure |
|
| >pdb|1OVA|B Chain B, Crystal Structure Of Uncleaved Ovalbumin At 1.95 Angstroms Resolution Length = 386 | Back alignment and structure |
|
| >pdb|1OVA|A Chain A, Crystal Structure Of Uncleaved Ovalbumin At 1.95 Angstroms Resolution Length = 386 | Back alignment and structure |
|
| >pdb|1UHG|A Chain A, Crystal Structure Of S-ovalbumin At 1.9 Angstrom Resolution Length = 385 | Back alignment and structure |
|
| >pdb|1K9O|I Chain I, Crystal Structure Of Michaelis Serpin-Trypsin Complex Length = 378 | Back alignment and structure |
|
| >pdb|4BB2|A Chain A, Crystal Structure Of Cleaved Corticosteroid-binding Globulin In Complex With Progesterone Length = 340 | Back alignment and structure |
|
| >pdb|1SEK|A Chain A, The Structure Of Active Serpin K From Manduca Sexta And A Model For Serpin-Protease Complex Formation Length = 378 | Back alignment and structure |
|
| >pdb|2H4Q|A Chain A, Crystal Structure Of A M-Loop Deletion Variant Of Ment In The Cleaved Conformation Length = 382 | Back alignment and structure |
|
| >pdb|4GA7|A Chain A, Crystal Structure Of Human Serpinb1 Mutant Length = 389 | Back alignment and structure |
|
| >pdb|2GD4|I Chain I, Crystal Structure Of The Antithrombin-S195a Factor Xa-Pentasaccharide Complex Length = 443 | Back alignment and structure |
|
| >pdb|3DLW|A Chain A, Antichymotrypsin Length = 411 | Back alignment and structure |
|
| >pdb|1QMN|A Chain A, Alpha1-Antichymotrypsin Serpin In The Delta Conformation (Partial Loop Insertion) Length = 401 | Back alignment and structure |
|
| >pdb|3NDA|A Chain A, Crystal Structure Of Serpin From Tick Ixodes Ricinus Length = 377 | Back alignment and structure |
|
| >pdb|2H4P|A Chain A, Crystal Structure Of Wildtype Ment In The Cleaved Conformation Length = 394 | Back alignment and structure |
|
| >pdb|3KCG|I Chain I, Crystal Structure Of The Antithrombin-Factor Ixa- Pentasaccharide Complex Length = 432 | Back alignment and structure |
|
| >pdb|1LQ8|A Chain A, Crystal Structure Of Cleaved Protein C Inhibitor Length = 346 | Back alignment and structure |
|
| >pdb|1ATH|A Chain A, The Intact And Cleaved Human Antithrombin Iii Complex As A Model For Serpin-Proteinase Interactions Length = 432 | Back alignment and structure |
|
| >pdb|2B4X|L Chain L, Crystal Structure Of Antithrombin-Iii Length = 427 | Back alignment and structure |
|
| >pdb|1DZG|I Chain I, N135q-S380c-Antithrombin-Iii Length = 432 | Back alignment and structure |
|
| >pdb|1DZH|I Chain I, P14-Fluorescein-N135q-S380c-Antithrombin-Iii Length = 432 | Back alignment and structure |
|
| >pdb|2HIJ|I Chain I, Crystal Structure Of P14 Alanine Variant Of Antithrombin Length = 432 | Back alignment and structure |
|
| >pdb|1TB6|I Chain I, 2.5a Crystal Structure Of The Antithrombin-Thrombin-Heparin Ternary Complex Length = 432 | Back alignment and structure |
|
| >pdb|2B4X|I Chain I, Crystal Structure Of Antithrombin-Iii Length = 427 | Back alignment and structure |
|
| >pdb|1ATT|A Chain A, Crystal Structure Of Cleaved Bovine Antithrombin Iii At 3.2 Angstroms Resolution Length = 429 | Back alignment and structure |
|
| >pdb|4EB1|I Chain I, Hyperstable In-Frame Insertion Variant Of Antithrombin Length = 440 | Back alignment and structure |
|
| >pdb|3DY0|A Chain A, Crystal Structure Of Cleaved Pci Bound To Heparin Length = 336 | Back alignment and structure |
|
| >pdb|1OYH|I Chain I, Crystal Structure Of P13 Alanine Variant Of Antithrombin Length = 432 | Back alignment and structure |
|
| >pdb|3CAA|A Chain A, Cleaved Antichymotrypsin A347r Length = 341 | Back alignment and structure |
|
| >pdb|1AS4|A Chain A, Cleaved Antichymotrypsin A349r Length = 341 | Back alignment and structure |
|
| >pdb|4CAA|A Chain A, Cleaved Antichymotrypsin T345r Length = 341 | Back alignment and structure |
|
| >pdb|1HP7|A Chain A, A 2.1 Angstrom Structure Of An Uncleaved Alpha-1-Antitrypsin Shows Variability Of The Reactive Center And Other Loops Length = 394 | Back alignment and structure |
|
| >pdb|2ACH|A Chain A, Crystal Structure Of Cleaved Human Alpha1-antichymotrypsin At 2.7 Angstroms Resolution And Its Comparison With Other Serpins Length = 360 | Back alignment and structure |
|
| >pdb|3FGQ|A Chain A, Crystal Structure Of Native Human Neuroserpin Length = 397 | Back alignment and structure |
|
| >pdb|3F5N|A Chain A, Structure Of Native Human Neuroserpin Length = 407 | Back alignment and structure |
|
| >pdb|1QLP|A Chain A, 2.0 Angstrom Structure Of Intact Alpha-1-Antitrypsin: A Canonical Template For Active Serpins Length = 394 | Back alignment and structure |
|
| >pdb|3NE4|A Chain A, 1.8 Angstrom Structure Of Intact Native Wild-Type Alpha-1-Antitrypsin Length = 424 | Back alignment and structure |
|
| >pdb|2QUG|A Chain A, Crystal Structure Of Alpha-1-Antitrypsin, Crystal Form A Length = 394 | Back alignment and structure |
|
| >pdb|1KCT|A Chain A, Alpha1-Antitrypsin Length = 394 | Back alignment and structure |
|
| >pdb|3T1P|A Chain A, Crystal Structure Of An Alpha-1-Antitrypsin Trimer Length = 371 | Back alignment and structure |
|
| >pdb|3DRU|A Chain A, Crystal Structure Of Gly117phe Alpha1-Antitrypsin Length = 404 | Back alignment and structure |
|
| >pdb|3DRM|A Chain A, 2.2 Angstrom Crystal Structure Of Thr114phe Alpha1- Antitrypsin Length = 404 | Back alignment and structure |
|
| >pdb|1HLE|A Chain A, Crystal Structure Of Cleaved Equine Leucocyte Elastase Inhibitor Determined At 1.95 Angstroms Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1PSI|A Chain A, Intact Recombined Alpha1-Antitrypsin Mutant Phe 51 To Leu Length = 394 | Back alignment and structure |
|
| >pdb|1OO8|A Chain A, Crystal Structure Of A1pi-Pittsburgh In The Native Conformation Length = 394 | Back alignment and structure |
|
| >pdb|1IZ2|A Chain A, Interactions Causing The Kinetic Trap In Serpin Protein Folding Length = 394 | Back alignment and structure |
|
| >pdb|3LW2|A Chain A, Mouse Plasminogen Activator Inhibitor-1 (Pai-1) Length = 379 | Back alignment and structure |
|
| >pdb|1ATU|A Chain A, Uncleaved Alpha-1-Antitrypsin Length = 374 | Back alignment and structure |
|
| >pdb|3EOX|A Chain A, High Quality Structure Of Cleaved Pai-1-Stab Length = 379 | Back alignment and structure |
|
| >pdb|1DB2|A Chain A, Crystal Structure Of Native Plasminogen Activator Inhibitor- 1 Length = 377 | Back alignment and structure |
|
| >pdb|4IF8|A Chain A, Structure Of Vaspin Length = 414 | Back alignment and structure |
|
| >pdb|1YXA|A Chain A, Serpina3n, A Murine Orthologue Of Human Antichymotrypsin Length = 398 | Back alignment and structure |
|
| >pdb|3CVM|A Chain A, High Resolution Structure Of A Stable Plasminogen Activator Inhibitor Type-1 In Its Protease Cleaved Form Length = 392 | Back alignment and structure |
|
| >pdb|1B3K|A Chain A, Plasminogen Activator Inhibitor-1 Length = 379 | Back alignment and structure |
|
| >pdb|3UT3|A Chain A, A Novel Pai-i Inhibitor And Its Structural Mechanism Length = 375 | Back alignment and structure |
|
| >pdb|1DVM|A Chain A, Active Form Of Human Pai-1 Length = 379 | Back alignment and structure |
|
| >pdb|1C5G|A Chain A, Plasminogen Activator Inhibitor-1 Length = 402 | Back alignment and structure |
|
| >pdb|2R9Y|A Chain A, Structure Of Antiplasmin Length = 430 | Back alignment and structure |
|
| >pdb|1DVN|A Chain A, Latent Form Of Plasminogen Activator Inhibitor-1 (Pai-1) Length = 379 | Back alignment and structure |
|
| >pdb|4AQH|A Chain A, Plasminogen Activator Inhibitor Type-1 In Complex With The Inhibitor Az3976 Length = 383 | Back alignment and structure |
|
| >pdb|1A7C|A Chain A, Human Plasminogen Activator Inhibitor Type-1 In Complex With A Pentapeptide Length = 379 | Back alignment and structure |
|
| >pdb|3H5C|A Chain A, X-Ray Structure Of Protein Z-Protein Z Inhibitor Complex Length = 423 | Back alignment and structure |
|
| >pdb|3Q02|A Chain A, Crystal Structure Of Plasminogen Activator Inhibitor-1 In A Metastable Active Conformation. Length = 379 | Back alignment and structure |
|
| >pdb|3PZF|A Chain A, 1.75a Resolution Structure Of Serpin-2 From Anopheles Gambiae Length = 397 | Back alignment and structure |
|
| >pdb|3F1S|A Chain A, Crystal Structure Of Protein Z Complexed With Protein Z-Dependent Inhibitor Length = 385 | Back alignment and structure |
|
| >pdb|2V95|A Chain A, Struture Of Corticosteroid-Binding Globulin In Complex With Cortisol Length = 371 | Back alignment and structure |
|
| >pdb|1XQG|A Chain A, 3.10 A Crystal Structure Of Maspin, Space Group P 4 21 2 Length = 389 | Back alignment and structure |
|
| >pdb|1JMO|A Chain A, Crystal Structure Of The Heparin Cofactor Ii-S195a Thrombin Complex Length = 480 | Back alignment and structure |
|
| >pdb|1JMJ|A Chain A, Crystal Structure Of Native Heparin Cofactor Ii Length = 480 | Back alignment and structure |
|
| >pdb|3R4L|A Chain A, Human Very Long Half Life Plasminogen Activator Inhibitor Type-1 Length = 379 | Back alignment and structure |
|
| >pdb|4AFX|A Chain A, Crystal Structure Of The Reactive Loop Cleaved Zpi In I2 Space Group Length = 387 | Back alignment and structure |
|
| >pdb|3F02|A Chain A, Cleaved Human Neuroserpin Length = 359 | Back alignment and structure |
|
| >pdb|3OZQ|A Chain A, Crystal Structure Of Serpin48, Which Is A Highly Specific Serpin In The Insect Tenebrio Molitor Length = 376 | Back alignment and structure |
|
| >pdb|7API|A Chain A, The S Variant Of Human Alpha1-Antitrypsin, Structure And Implications For Function And Metabolism Length = 347 | Back alignment and structure |
|
| >pdb|3NDD|A Chain A, Cleaved Antitrypsin With P10 Pro, And P9-P6 Asp Length = 343 | Back alignment and structure |
|
| >pdb|1D5S|A Chain A, Crystal Structure Of Cleaved Antitrypsin Polymer Length = 334 | Back alignment and structure |
|
| >pdb|1EZX|A Chain A, Crystal Structure Of A Serpin:protease Complex Length = 335 | Back alignment and structure |
|
| >pdb|3NDF|A Chain A, Cleaved Antitrypsin With P8-P6 Asp Length = 343 | Back alignment and structure |
|
| >pdb|1XU8|A Chain A, The 2.8 A Structure Of A Tumour Suppressing Serpin Length = 380 | Back alignment and structure |
|
| >pdb|1WZ9|A Chain A, The 2.1 A Structure Of A Tumour Suppressing Serpin Length = 375 | Back alignment and structure |
|
| >pdb|2CEO|A Chain A, Thyroxine-Binding Globulin Complex With Thyroxine Length = 379 | Back alignment and structure |
|
| >pdb|2D26|A Chain A, Active Site Distortion Is Sufficient For Proteinase Inhibit Second Crystal Structure Of Covalent Serpin-Proteinase Complex Length = 358 | Back alignment and structure |
|
| >pdb|4AJT|A Chain A, The Cystal Structure Of Mouse Protein-Z Dependent Protease Inhibitor(Mzpi) Length = 427 | Back alignment and structure |
|
| >pdb|4DY0|A Chain A, Crystal Structure Of Native Protease Nexin-1 With Heparin Length = 379 | Back alignment and structure |
|
| >pdb|9PAI|A Chain A, Cleaved Substrate Variant Of Plasminogen Activator Inhibitor-1 Length = 346 | Back alignment and structure |
|
| >pdb|1JJO|C Chain C, Crystal Structure Of Mouse Neuroserpin (Cleaved Form) Length = 261 | Back alignment and structure |
|
| >pdb|1QMB|A Chain A, Cleaved Alpha-1-Antitrypsin Polymer Length = 326 | Back alignment and structure |
|
| >pdb|1F0C|A Chain A, Structure Of The Viral Serpin Crma Length = 305 | Back alignment and structure |
|
| >pdb|1C8O|A Chain A, 2.9 A Structure Of Cleaved Viral Serpin Crma Length = 300 | Back alignment and structure |
|
| >pdb|2RIV|A Chain A, Crystal Structure Of The Reactive Loop Cleaved Human Thyroxine Binding Globulin Length = 343 | Back alignment and structure |
|
| >pdb|2RIW|A Chain A, The Reactive Loop Cleaved Human Thyroxine Binding Globulin Complexed With Thyroxine Length = 338 | Back alignment and structure |
|
| >pdb|2XN6|A Chain A, Crystal Structure Of Thyroxine-Binding Globulin Complexed With Thyroxine-Fluoresein Length = 350 | Back alignment and structure |
|
| >pdb|2XN5|A Chain A, Crystal Structure Of Thyroxine-Binding Globulin Complexed With Furosemide Length = 350 | Back alignment and structure |
|
| >pdb|1SNG|A Chain A, Structure Of A Thermophilic Serpin In The Native State Length = 370 | Back alignment and structure |
|
| >pdb|1IMV|A Chain A, 2.85 A Crystal Structure Of Pedf Length = 398 | Back alignment and structure |
|
| >pdb|1MTP|A Chain A, The X-Ray Crystal Structure Of A Serpin From A Thermophilic Prokaryote Length = 323 | Back alignment and structure |
|
| >pdb|1M93|B Chain B, 1.65 A Structure Of Cleaved Viral Serpin Crma Length = 245 | Back alignment and structure |
|
| >pdb|3LE2|A Chain A, Structure Of Arabidopsis Atserpin1. Native Stressed Conforma Length = 393 | Back alignment and structure |
|
| >pdb|3STO|A Chain A, Serpin From The Trematode Schistosoma Haematobium Length = 406 | Back alignment and structure |
|
| >pdb|2OAY|A Chain A, Crystal Structure Of Latent Human C1-Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2VH4|A Chain A, Structure Of A Loop C-sheet Serpin Polymer Length = 381 | Back alignment and structure |
|
| >pdb|2PEF|A Chain A, Crystal Structure Of A Thermophilic Serpin, Tengpin, In The Latent State Length = 373 | Back alignment and structure |
|
| >pdb|2PEE|A Chain A, Crystal Structure Of A Thermophilic Serpin, Tengpin, In The Native State Length = 387 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2h4r_A MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 2.70A {Gallus gallus} PDB: 2dut_A Length = 415 | Back alignment and structure |
|---|
Score = 266 bits (681), Expect = 1e-86
Identities = 100/402 (24%), Positives = 172/402 (42%), Gaps = 68/402 (16%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
FT DL LN N+ KN+F SP+SI AL Y + +T + +VL E + +
Sbjct: 15 NFTVDLFNKLNETNRDKNIFFSPWSISSALALTYLAAKGSTAREMAEVLHFTEAVRAESS 74
Query: 61 MNVYKMEKLIQGLRA----------------------NADSGLTFTSTNKIFVNDKIPVK 98
+ R + + S N+I+V +
Sbjct: 75 SVARPSRGRPKRRRMDPEHEQAENIHSGFKELLTAFNKPRNNYSLRSANRIYVEKTYALL 134
Query: 99 E----CMTAIFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL 153
+ +E Q ++F E +R IN+WV ++T++ IK+L+++ V + T L+L
Sbjct: 135 PTYLQLSKKYYKAEPQKVNFKTAPEQSRKEINTWVEKQTESKIKNLLSSDDVKATTRLIL 194
Query: 154 ---------WLP-----STQESI------IIITV------------LSSELNAHILEVPY 181
W T V + ++N ++E+PY
Sbjct: 195 VNAIYFKAEWEVKFQAEKTSIQPFRLSKNKSKPVKMMYMRDTFPVLIMEKMNFKMIELPY 254
Query: 182 KGGNMSMFFLLP--PFASQDGVGDILAALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSL 237
+SMF LLP G+ + L + DS+ + V++ +PKFSL
Sbjct: 255 VKRELSMFILLPDDIKDGTTGLEQLEREL--TYERLSEWA-DSKMMTETLVDLHLPKFSL 311
Query: 238 TQEMNLIPTLSDLGVKDLFSPGADLSRLTDSH-IAFGDAVHKARLDLDEQGTTAAAATAV 296
++L TL ++G+ F+ AD +TD +A +H++ + +DE+GT AAAATAV
Sbjct: 312 EDRIDLRDTLRNMGMTTAFTTNADFRGMTDKKDLAISKVIHQSFVAVDEKGTEAAAATAV 371
Query: 297 -FAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337
+F +S ++++ +HPF +F+ + ++ILF G F P
Sbjct: 372 IISFTTSVINHVLKFKVDHPFHFFIRHNKSKTILFFGRFCCP 413
|
| >3nda_A Serpin-2; vaccination target, TICK, hydrolase inhibitor; HET: 1PE; 1.80A {Ixodes ricinus} Length = 377 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 9e-86
Identities = 98/376 (26%), Positives = 163/376 (43%), Gaps = 52/376 (13%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPE-NLDKLD 59
F LL L + KNVF SP+S+ A+ A+ + T+ L Q L + +L
Sbjct: 13 RFGLRLLRALP-SGPEKNVFFSPYSVSTAMGMAFAGARGQTQQELSQGLGFSDVDLTDAG 71
Query: 60 TMNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKE----CMTAIFPSEIQSMDFG 115
++ Y + L+ + S T N + + + + + F +E+ +DF
Sbjct: 72 VLDAYT--HHTERLK-STPSNSTLDVANAAAIQRTLALLNSYESALQSSFGAELHKVDFA 128
Query: 116 NEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL---------WL-----PSTQE 160
E +AA +N+WV ++T + I+ L ++ T LVL W T++
Sbjct: 129 GEPQAAVDFVNNWVKRKTHDKIEKLFN-EPLDPDTLLVLLNAIYFKGEWNTAFVKEHTEK 187
Query: 161 SI------IIITV------------LSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVG 202
+ V +L ++E+PY+G + +M LLP GV
Sbjct: 188 RQFFNGGVTPVEVDTMRLEARIKYRFFDDLQVEVVELPYRGLDYTMAILLP--KENTGVE 245
Query: 203 DILAALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGA 260
+ L + RF +L+ + + +PKF L + +L L LG+K +F GA
Sbjct: 246 GLKQNL-----TIDRFQNYLSDLRERKITVLLPKFKLETKYSLKAPLQSLGIKQIFESGA 300
Query: 261 DLSRLTDSHIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFL 320
DLS + D + HKA ++++E+GT AAA T V S EPV + +HPFL+F+
Sbjct: 301 DLSGINDGSLRVSAVEHKAVVEVNEEGTVAAATTGVVIVPYSLGPEPVVFRVDHPFLFFI 360
Query: 321 VDKEIQSILFAGVFNE 336
+ I F G N+
Sbjct: 361 RNTRTDDIFFVGQVNK 376
|
| >3kcg_I Antithrombin-III, ATIII; michaelis complex, blood coagulation, calcium, disulfide bond, EGF-like domain, glycoprotein, hemophilia, hydrolase; HET: NAG FUC MAN NTP; 1.70A {Homo sapiens} PDB: 1e04_I* 1ath_A 1ant_L* 1br8_L 1azx_I* 1dzh_L* 1e03_L* 1dzg_L* 1e05_L* 1jvq_L* 1lk6_L* 1nq9_I* 1oyh_L* 1r1l_L* 1sr5_A* 2ant_L* 2beh_L* 2hij_L* 2znh_A* 3evj_I* ... Length = 432 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 5e-85
Identities = 91/380 (23%), Positives = 161/380 (42%), Gaps = 50/380 (13%)
Query: 1 EFTFDLL-TVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLD 59
F + ++ N N+F+SP SI A + +T L +V + +K
Sbjct: 57 RFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTS 116
Query: 60 TMNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKE----CMTAIFPSEIQSMDFG 115
+ KL L A+ S N++F + + E ++ +++Q +DF
Sbjct: 117 DQIHFFFAKLNCRLYRKANKASKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFK 176
Query: 116 NEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL---------WL-----PSTQE 160
E +RA IN WV+ +T+ I D+I + +N T LVL W +T++
Sbjct: 177 ENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRK 236
Query: 161 SIIIIT-----------------VLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGD 203
+ +LE+P+KG +++M +LP + +
Sbjct: 237 ELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILP--KPEKSLAK 294
Query: 204 ILAALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPG-A 260
+ L + + E L+ + + +P+F + +L L D+G+ DLFSP +
Sbjct: 295 VEKEL-----TPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKS 349
Query: 261 DLSRLTDSH---IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFL 317
L + + DA HKA L+++E+G+ AAA+TAV S V ++AN PFL
Sbjct: 350 KLPGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVTFKANRPFL 409
Query: 318 YFLVDKEIQSILFAGVFNEP 337
F+ + + +I+F G P
Sbjct: 410 VFIREVPLNTIIFMGRVANP 429
|
| >2zv6_A Serpin B3; serine proteinase inhibitor, reactive site loop, acetylation, alternative splicing, cytoplasm, polymorphism, protease inhibitor; 2.70A {Homo sapiens} Length = 401 | Back alignment and structure |
|---|
Score = 260 bits (667), Expect = 9e-85
Identities = 109/388 (28%), Positives = 169/388 (43%), Gaps = 58/388 (14%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
+F FDL +K N+F SP SI AL + NT +K+VL + +
Sbjct: 21 KFMFDLFQQFRK-SKENNIFYSPISITSALGMVLLGAKDNTAQQIKKVLHFDQVTENTTG 79
Query: 61 MNVYKM-----------EKLIQGLRANADSGLTFTSTNKIFVNDKIPVKE----CMTAIF 105
+KL+ + NK+F + + +
Sbjct: 80 KAATYHVDRSGNVHHQFQKLLTEFN-KSTDAYELKIANKLFGEKTYLFLQEYLDAIKKFY 138
Query: 106 PSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL---------WL 155
+ ++S+DF N E +R INSWV +T IK+LI G + S T LVL W
Sbjct: 139 QTSVESVDFANAPEESRKKINSWVESQTNEKIKNLIPEGNIGSNTTLVLVNAIYFKGQWE 198
Query: 156 -----PSTQESI------IIITV------------LSSELNAHILEVPYKGGNMSMFFLL 192
T+E ++ ++ A +LE+PYKG ++SM LL
Sbjct: 199 KKFNKEDTKEEKFWPNKNTYKSIQMMRQYTSFHFASLEDVQAKVLEIPYKGKDLSMIVLL 258
Query: 193 PPFASQDGVGDILAALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDL 250
P DG+ + L +T QN++ V++ +P+F + + +L TL +
Sbjct: 259 P--NEIDGLQKLEEKL--TAEKLMEWT-SLQNMRETRVDLHLPRFKVEESYDLKDTLRTM 313
Query: 251 GVKDLFSPGADLSRLTDSH-IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVR 309
G+ D+F+ ADLS +T S + +HKA +++ E+G AAAATAV F SS
Sbjct: 314 GMVDIFNGDADLSGMTGSRGLVLSGVLHKAFVEVTEEGAEAAAATAVVGFGSSPTSTNEE 373
Query: 310 YEANHPFLYFLVDKEIQSILFAGVFNEP 337
+ NHPFL+F+ + SILF G F+ P
Sbjct: 374 FHCNHPFLFFIRQNKTNSILFYGRFSSP 401
|
| >1uhg_A Ovalbumin, S-ovalbumin; allergen, egg white protein, serpin; HET: SEP NAG; 1.90A {Gallus gallus} SCOP: e.1.1.1 PDB: 1ova_A* 1jti_A Length = 385 | Back alignment and structure |
|---|
Score = 257 bits (660), Expect = 6e-84
Identities = 79/386 (20%), Positives = 160/386 (41%), Gaps = 58/386 (15%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
EF FD+ L + +N+F P +I AL Y + +T + +V+R + D+
Sbjct: 9 EFCFDVFKELKVHHANENIFYCPIAIMSALAMVYLGAKDSTRTQINKVVRFDKLPGFGDS 68
Query: 61 MNVYKME---------KLIQGLRANADSGLTFTSTNKIFVNDKIPV----KECMTAIFPS 107
+ ++ + + +F+ ++++ ++ P+ +C+ ++
Sbjct: 69 IEAQCGTSVNVHSSLRDILNQIT-KPNDVYSFSLASRLYAEERYPILPEYLQCVKELYRG 127
Query: 108 EIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL---------WL-- 155
++ ++F + AR INSWV +T I++++ V+S+T +VL W
Sbjct: 128 GLEPINFQTAADQARELINSWVESQTNGIIRNVLQPSSVDSQTAMVLVNAIVFKGLWEKA 187
Query: 156 ---PSTQESI------IIITV------------LSSELNAHILEVPYKGGNMSMFFLLPP 194
TQ V + ILE+P+ G MSM LLP
Sbjct: 188 FKDEDTQAMPFRVTEQESKPVQMMYQIGLFRVASMASEKMKILELPFASGTMSMLVLLP- 246
Query: 195 FASQDGVGDILAALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGV 252
G+ + + + + +T S ++ +++ +P+ + ++ NL L +G+
Sbjct: 247 -DEVSGLEQLESII--NFEKLTEWTS-SNVMEERKIKVYLPRMKMEEKYNLTSVLMAMGI 302
Query: 253 KDLFSPGADLSRLTDSH-IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYE 311
D+FS A+LS ++ + + AVH A +++E G + +S +
Sbjct: 303 TDVFSSSANLSGISSAESLKISQAVHAAHAEINEAGREVVGSAEAGVDAASV---SEEFR 359
Query: 312 ANHPFLYFLVDKEIQSILFAGVFNEP 337
A+HPFL+ + ++LF G P
Sbjct: 360 ADHPFLFCIKHIATNAVLFFGRCVSP 385
|
| >3sto_A Serine protease inhibitor; serpin fold, hydrolase inhibitor; 2.41A {Schistosoma haematobium} Length = 406 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 1e-82
Identities = 82/389 (21%), Positives = 138/389 (35%), Gaps = 59/389 (15%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQAL--LTAYFISNKNTEANLKQVLRLPENLDKL 58
FT L+ + G N P I L L + T + + +RL
Sbjct: 21 AFTHAYLSTVTADFGGDNFLTCPLGILFTLGILLGSGGAQGRTGYQIGKTMRLKSTSSSW 80
Query: 59 DTMNVYK-MEKLIQGLRA---------NADSGLTFTSTNKIFVNDKIPVKE----CMTAI 104
++ + M+ L Q L N + IFV V+ +
Sbjct: 81 NSSEAQQEMKSLYQELNNSLTSEKTFLNEKEENVVRISTGIFVEKTYEVERRFNESIAND 140
Query: 105 FPSEIQSMDFGNEVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------WL 155
E++ +DF N A IN WV Q++ ++ + T ++L W
Sbjct: 141 SEGELKQVDFSNRTSATVDINDWVDQQSNGLLEKFFT-DDIPDDTAMILVNVFYFRDFWQ 199
Query: 156 P-----STQESI------IIITV------------LSSELNAHILEVPYKGGNMSMFFLL 192
T++ ITV + I+ P + +L
Sbjct: 200 SPFEPHYTRKEDFYISPDRQITVDMMTQEGVMKYGKFEDEGFEIVSKPLNNTRFTFVIVL 259
Query: 193 PPFASQDGVGDILAALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDL 250
P + + L K +E +NLK V + +PKF+L ++L+PTL +
Sbjct: 260 P--LEKWSLNGATELL----NGNKVLSEYVKNLKETTVSLRLPKFTLKNTLDLVPTLKSI 313
Query: 251 GVKDLFSPG-ADLSRLTDSH-IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPV 308
GV DLF P +DLS +T + + + + L L+E G A T+ S + V
Sbjct: 314 GVVDLFDPVKSDLSGITPNPNLYVNEFIQTNVLKLNESGIEATTVTSPIFVPFSAIIPEV 373
Query: 309 RYEANHPFLYFLVDKEIQSILFAGVFNEP 337
+ HPF+ F+ D+++ + A P
Sbjct: 374 DFHVTHPFICFIYDQQLTMPIMAAKVMNP 402
|
| >1sek_A Serpin K; serine protease inhibitor, protease; 2.10A {Manduca sexta} SCOP: e.1.1.1 PDB: 1k9o_I Length = 378 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 3e-82
Identities = 105/378 (27%), Positives = 167/378 (44%), Gaps = 57/378 (15%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
+FT + + + AN G+NV +S FS+ L S + L + L LP + T
Sbjct: 17 QFTAQMFSEVVKANPGQNVVLSAFSVLPPLGQLALASVGESHDELLRALALPNDNV---T 73
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKE----CMTAIFPSEIQSMDFGN 116
+V+ L +G+ A G+ +KI+V + + + +F SE+Q++DF
Sbjct: 74 KDVFA--DLNRGV--RAVKGVDLKMASKIYVAKGLELNDDFAAVSRDVFGSEVQNVDFVK 129
Query: 117 EVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------WL-----PSTQESI 162
VEAA AIN WV +T N IK+L+ ++ T VL W T +
Sbjct: 130 SVEAAGAINKWVEDQTNNRIKNLVDPDALDETTRSVLVNAIYFKGSWKDKFNKERTMDRD 189
Query: 163 ------IIITV------------LSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDI 204
I V EL+A ++E+ Y+G SM +LP DG+ +
Sbjct: 190 FHVSKDKTIKVPTMIGKKDVRYADVPELDAKMIEMSYEGDQASMIIILP--NQVDGITAL 247
Query: 205 LAALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPG-AD 261
L K + + L VEI +PKF + +L LS++ +K LF+PG A
Sbjct: 248 EQKL----KDPKALSRAEERLYNTEVEIYLPKFKIETTTDLKEVLSNMNIKKLFTPGAAR 303
Query: 262 LSRLTDSH--IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYF 319
L L + + A+ KA ++++E+G AAAA A S P + E N PF +
Sbjct: 304 LENLLKTKESLYVDAAIQKAFIEVNEEGAEAAAANAFKITTYSFHFVP-KVEINKPFFFS 362
Query: 320 LVDKEIQSILFAGVFNEP 337
L ++ +F+GV +P
Sbjct: 363 LKYN--RNSMFSGVCVQP 378
|
| >1wz9_A Maspin precursor; serpin, tumor suppressor, serpinb5, signaling protein; HET: CME; 2.10A {Homo sapiens} PDB: 1xu8_A 1xqg_A 1xqj_A Length = 375 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 4e-82
Identities = 76/380 (20%), Positives = 159/380 (41%), Gaps = 57/380 (15%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
F DL L NV SP + +L A + +T + QVL + D
Sbjct: 10 AFAVDLFKQLCEKEPLGNVLFSPICLSTSLSLAQVGAKGDTANEIGQVLHFE---NVKDV 66
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPV----KECMTAIFPSEIQSMDFGN 116
++ + + S + +++V+ + + + E++++DF +
Sbjct: 67 PFGFQ--TVTSDVN-KLSSFYSLKLIKRLYVDKSLNLSTEFISSTKRPYAKELETVDFKD 123
Query: 117 EVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL---------WL-----PSTQES 161
++E + IN+ + T + ++++A VN +T +++ W+ T+E
Sbjct: 124 KLEETKGQINNSIKDLTDGHFENILADNSVNDQTKILVVNAAYFVGKWMKKFPESETKEC 183
Query: 162 I------IIITV------------LSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGD 203
V +N I+E+P++ ++SMF LLP + G
Sbjct: 184 PFRLNKTDTKPVQMMNMEATFCMGNIDSINCKIIELPFQNKHLSMFILLPKDVEDESTG- 242
Query: 204 ILAALKK--DPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPG 259
L ++K + S ++T + + V+++IPKF + + ++ L +LG+K +FS
Sbjct: 243 -LEKIEKQLNSESLSQWT-NPSTMANAKVKLSIPKFKVEKMIDPKACLENLGLKHIFSED 300
Query: 260 -ADLSRLTDSH-IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFL 317
+D S ++++ +A + +HK L++ E G + + A+HPF+
Sbjct: 301 TSDFSGMSETKGVALSNVIHKVCLEITEDGGDSIEVPGARILQH-----KDELNADHPFI 355
Query: 318 YFLVDKEIQSILFAGVFNEP 337
Y + + ++I+F G F P
Sbjct: 356 YIIRHNKTRNIIFFGKFCSP 375
|
| >1yxa_A Serine (OR cysteine) proteinase inhibitor, clade 3N; serpin, antichymotrypsin, protease inhibitor, reactive centr plasma, hydrolase inhibitor; 2.10A {Mus musculus} Length = 398 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 6e-82
Identities = 97/376 (25%), Positives = 164/376 (43%), Gaps = 50/376 (13%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
+F F L L N N+ SP SI AL + NT + + L+ NL +
Sbjct: 33 DFAFSLYKELVLKNPDTNIVFSPLSISAALALVSLGAKGNTLEEILEGLKF--NLTETSE 90
Query: 61 MNVYK-MEKLIQGLRANADSGLTFTSTNKIFVNDKIPVK----ECMTAIFPSEIQSMDFG 115
++++ L+Q L + ++ + +F+ + + E ++ +E + DF
Sbjct: 91 ADIHQGFGHLLQRLN-QPKDQVQISTGSALFIEKRQQILTEFQEKAKTLYQAEAFTADFQ 149
Query: 116 NEVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------WL----PS----- 157
+A + IN +V ++T+ IK+L+ ++ RT +VL W P
Sbjct: 150 QPRQAKKLINDYVRKQTQGMIKELV--SDLDKRTLMVLVNYIYFKAKWKVPFDPLDTFKS 207
Query: 158 ---------------TQESIIIITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVG 202
+ E + EL+ ++E+ Y G N S F+LP Q +
Sbjct: 208 EFYCGKRRPVIVPMMSMEDLTTPYFRDEELSCTVVELKYTG-NASALFILPD---QGRMQ 263
Query: 203 DILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADL 262
+ A+L P + +++ + E+ +PKFS++ + +L LS LG++++FS ADL
Sbjct: 264 QVEASL--QPETLRKWKNSLKPRMIDELHLPKFSISTDYSLEDVLSKLGIREVFSTQADL 321
Query: 263 SRLTDSH-IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLV 321
S +T + + VHKA LD+ E GT AAAAT V S L P+ N PFL +
Sbjct: 322 SAITGTKDLRVSQVVHKAVLDVAETGTEAAAATGVKFVPMSAKLYPLTVYFNRPFLIMIF 381
Query: 322 DKEIQSILFAGVFNEP 337
D E + F P
Sbjct: 382 DTETEIAPFIAKIANP 397
|
| >3f5n_A Neuroserpin; cleaved form, fenib, human, tissue PLAS activator, hydrolase inhibitor; 3.15A {Homo sapiens} Length = 407 | Back alignment and structure |
|---|
Score = 252 bits (647), Expect = 1e-81
Identities = 82/382 (21%), Positives = 157/382 (41%), Gaps = 57/382 (14%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
+ + ++ L + +N+ SP SI A+ + +T+ ++ + L +
Sbjct: 25 DLSVNMYNRLRATGEDENILFSPLSIALAMGMMELGAQGSTQKEIRHSMGYDS-LKNGEE 83
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKEC----MTAIFPSEIQSMDFGN 116
+ K + + +S N +FV + V E M F + + +DF
Sbjct: 84 FSFLK--EFSNMVT-AKESQYVMKIANSLFVQNGFHVNEEFLQMMKKYFNAAVNHVDFSQ 140
Query: 117 EVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------WLP-----STQESI 162
V A IN WV T N +KDL++ ++ T L L W +T+
Sbjct: 141 NVAVANYINKWVENNTNNLVKDLVSPRDFDAATYLALINAVYFKGNWKSQFRPENTRTFS 200
Query: 163 ------------------------IIITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQ 198
+ +LE+PY+G +SM +L +
Sbjct: 201 FTKDDESEVQIPMMYQQGEFYYGEFSDGSNEAGGIYQVLEIPYEGDEISMMLVLSR--QE 258
Query: 199 DGVGDILAALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGVKDLF 256
+ + + + E + ++K VE+ +P+F++ QE++L L LG+ ++F
Sbjct: 259 VPLATLEPLV-----KAQLVEEWANSVKKQKVEVYLPRFTVEQEIDLKDVLKALGITEIF 313
Query: 257 SPGADLSRLTDSH-IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHP 315
A+L+ L+D+ I A+HK+ L+++E+G+ AAA + + A L P + +HP
Sbjct: 314 IKDANLTGLSDNKEIFLSKAIHKSFLEVNEEGSEAAAVSGMIAISRMAVLYP-QVIVDHP 372
Query: 316 FLYFLVDKEIQSILFAGVFNEP 337
F + + ++ +ILF G P
Sbjct: 373 FFFLIRNRRTGTILFMGRVMHP 394
|
| >2arr_A Plasminogen activator inhibitor-2; serpin, peptide binding, hydrolase inhibitor-PEPT complex; 1.55A {Homo sapiens} PDB: 2arq_A 1jrr_A 1by7_A Length = 382 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 3e-81
Identities = 100/381 (26%), Positives = 164/381 (43%), Gaps = 52/381 (13%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
F +L L A+ +N+F+SP+SI + Y S +TE + VL+ E D
Sbjct: 10 LFALNLFKHLAKASPTQNLFLSPWSISSTMAMVYMGSRGSTEDQMASVLQFNEVGAAADK 69
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKE----CMTAIFPSEIQSMDFGN 116
++ L + + S NK+F +E + SE Q++DF
Sbjct: 70 IH-SSFRSLSSAIN-ASTGNYLLESVNKLFGEKSASFREEYIRLCQKYYSSEPQAVDFLE 127
Query: 117 EVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL---------WL----PS----- 157
E AR INSWV +TK I +L+ G V+ T +VL W
Sbjct: 128 CAEEARKKINSWVKTQTKGKIPNLLPEGSVDGDTRMVLVNAVYFKGKWKTPFEKKLNGLF 187
Query: 158 ---------------TQESIIIITVLSSELNAHILEVPYKGGNMSMFFLLP--PFASQDG 200
+ I + +L A ILE+PY G ++SMF LLP G
Sbjct: 188 PFRVNSAQRTPVQMMYLREKLNIGYIE-DLKAQILELPYAG-DVSMFLLLPDEIADVSTG 245
Query: 201 VGDILAALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSP 258
+ + + + ++T + VE+ IP+F L + L L +G++D F+
Sbjct: 246 LELLESEI--TYDKLNKWT-SKDKMAEDEVEVYIPQFKLEEHYELRSILRSMGMEDAFNK 302
Query: 259 G-ADLSRLTDSH-IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPF 316
G A+ S +++ + + + H+A +D++E+GT AAA T + ++ A+HPF
Sbjct: 303 GRANFSGMSERNDLFLSEVFHQAMVDVNEEGTEAAAGTGGVMTGRTGH-GGPQFVADHPF 361
Query: 317 LYFLVDKEIQSILFAGVFNEP 337
L+ ++ K ILF G F+ P
Sbjct: 362 LFLIMHKITNCILFFGRFSSP 382
|
| >3pzf_A Serpin 2; protease inhibitor, melanization, hydrolase inhibito; 1.75A {Anopheles gambiae} Length = 397 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 3e-80
Identities = 80/387 (20%), Positives = 151/387 (39%), Gaps = 65/387 (16%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNK-------NTEANLKQVLRLPE 53
EF + + N NV +SPFS+ L Y S+ NT+ L V++
Sbjct: 24 EFDLMFVKEIF-KNHNSNVVLSPFSVKILLTLIYEASDTSFGNAVSNTKRELSSVIQND- 81
Query: 54 NLDKLDTMNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVK----ECMTAIFPSEI 109
+ T + YK +L++ + + FV+D I V + + + +
Sbjct: 82 --NIDHTRSYYK--QLLESAQ-QDNKDYDLNIATNFFVDDFIEVINKYQQIANTHYHAML 136
Query: 110 QSMDFGNEVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------WL----- 155
+ + + N + A IN+WV++ T +++++ + + L W
Sbjct: 137 EKVSYSNPTQTAATINNWVSEHTNGRLREIVTPDSLEG-AVITLVNVIYFKGLWTYPFPE 195
Query: 156 PSTQESI------IIITV------------LSSELNAHILEVPYKGGNMSMFFLLPPFAS 197
+ S++L A IL +PY+G ++M+F+LP
Sbjct: 196 VANNVKPFYGTRGKPTNAQYMEQNGQFYYDNSADLGAQILRLPYRGNKLAMYFILP--NP 253
Query: 198 QDGVGDILAALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGVKDL 255
+ V +L + + + ++ V + +PKF L L +G++++
Sbjct: 254 DNTVNQVLDRI-----NSASLHQALWYMEENEVNVTLPKFKFDFSEQLNEPLQQVGIREI 308
Query: 256 FSPGADLSRLTDSHIAFGD-----AVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRY 310
FS A L L A + KA + ++E G+ A AAT + +
Sbjct: 309 FSQNASLPLLARGRGARDEVRVSRIFQKAGITINELGSEAYAATEIQLVNKFGGDGVQIF 368
Query: 311 EANHPFLYFLVDKEIQSILFAGVFNEP 337
AN PF++F+ D+ + ++LFAG P
Sbjct: 369 NANRPFIFFIEDETLGTMLFAGKIENP 395
|
| >2vdx_A Corticosteroid-binding globulin; transport protein, cortisol binding globulin, glycoprotein, lipid-binding, disease mutation, CBG, SERP cleaved; 1.84A {Homo sapiens} PDB: 2vdy_A* Length = 373 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 6e-80
Identities = 104/377 (27%), Positives = 168/377 (44%), Gaps = 57/377 (15%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
+F F L L + KN+F+SP SI AL + +T A L Q L NL +
Sbjct: 13 DFAFSLYKHLVALSPKKNIFISPVSISMALAMLSLGTCGHTRAQLLQGLGF--NLTERSE 70
Query: 61 MNVYKM-EKLIQGLRANADSGLTFTSTNKIFVNDKIPVKE----CMTAIFPSEIQSMDFG 115
+++ + L Q +D+ L T N +F++ + + E + + SE+ +M+F
Sbjct: 71 TEIHQGFQHLHQLFA-KSDTSLEMTMGNALFLDGSLELLESFSADIKHYYESEVLAMNFQ 129
Query: 116 NEVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------WL-----PSTQES 161
+ A+R INS+V +T+ I DL ++S LVL W ST+E
Sbjct: 130 DWATASRQINSYVKNKTQGKIVDLF--SGLDSPAILVLVNYIFFKGTWTQPFDLASTREE 187
Query: 162 I------IIITV------------LSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGD 203
++ V SEL ++++ Y G N ++FF+LP + +
Sbjct: 188 NFYVDETTVVKVPMMLQSSTISYLHDSELPCQLVQMNYVG-NGTVFFILP---DKGKMNT 243
Query: 204 ILAALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGAD 261
++AAL S S L V++ IPK +++ +L L ++G+ DLF+ A+
Sbjct: 244 VIAAL-----SRDTINRWSAGLTSSQVDLYIPKVTISGVYDLGDVLEEMGIADLFTTQAN 298
Query: 262 LSRLTDSH-IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFL 320
SR+T + VHKA L L+E+GT AA A + A S+P+ N PF+ +
Sbjct: 299 FSRITQDAQLKSSKVVHKAVLQLNEEGTEAAGAMFLEAIPRSKPIILR---FNQPFIIMI 355
Query: 321 VDKEIQSILFAGVFNEP 337
D S LF P
Sbjct: 356 FDHFTWSSLFLARVMNP 372
|
| >1qmn_A AACT, alpha-1-antichymotrypsin; serpin, serine proteinase inhibitor, partial loop insertion, loop-sheet polymerization, emphysema, disease mutation; 2.27A {Homo sapiens} SCOP: e.1.1.1 PDB: 3dlw_A Length = 401 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 2e-79
Identities = 104/377 (27%), Positives = 170/377 (45%), Gaps = 51/377 (13%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
+F F L L KNV SP SI AL ++ T + + L+ NL +
Sbjct: 33 DFAFSLYKQLVLKAPDKNVIFSPPSISTALAFLSLGAHNTTLTEILKGLKF--NLTETSE 90
Query: 61 MNVYK-MEKLIQGLRANADSGLTFTSTNKIFVNDKIPVK----ECMTAIFPSEIQSMDFG 115
+++ + L++ L + L + N +FV +++ + E ++ SE + DF
Sbjct: 91 AEIHQSFQHLLRTLN-QSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQ 149
Query: 116 NEVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------WLP-----STQES 161
+ A + IN +V T+ I DLI ++S+T +VL W T +S
Sbjct: 150 DSAAAKKLINDYVKNGTRGKITDLI--KDLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQS 207
Query: 162 I------IIITV-------------LSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVG 202
+ V EL+ ++E+ Y G N S F+LP QD +
Sbjct: 208 RFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVELKYTG-NASALFILPD---QDKME 263
Query: 203 DILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADL 262
++ A L P + KR+ + + + E+ +PKFS++++ NL L LG+++ F+ ADL
Sbjct: 264 EVEAML--LPETLKRWRDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADL 321
Query: 263 SRLTDSH-IAFGDAVHKARLDLDEQGTTAAAATAV-FAFRSSRPLEPVRYEANHPFLYFL 320
S +T + +A VHKA LD+ E+GT A+AATAV S+ N PFL +
Sbjct: 322 SGITGARNLAVSQVVHKAVLDVFEEGTEASAATAVKITLLSALVETRTIVRFNRPFLMII 381
Query: 321 VDKEIQSILFAGVFNEP 337
V + Q+I F P
Sbjct: 382 VPTDTQNIFFMSKVTNP 398
|
| >3b9f_I Protein C inhibitor; michaelis complex, acute phase, blood coagulation, cleavage of basic residues, disease mutation; HET: NAG FUC SGN IDS; 1.60A {Homo sapiens} PDB: 2ol2_A* Length = 395 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 3e-79
Identities = 102/377 (27%), Positives = 171/377 (45%), Gaps = 57/377 (15%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
+FTFDL L +A +N+F SP SI +L + +T+ + + L L NL K
Sbjct: 36 DFTFDLYRALASAAPSQNIFFSPVSISMSLAMLSLGAGSSTKMQILEGLGL--NLQKSSE 93
Query: 61 MNVYKM-EKLIQGLRANADSGLTFTSTNKIFVNDKIPVKE----CMTAIFPSEIQSMDFG 115
+++ ++L+Q L G + N +F + + +++ M ++ ++ +F
Sbjct: 94 KELHRGFQQLLQELN-QPRDGFQLSLGNALFTDLVVDLQDTFVSAMKTLYLADTFPTNFR 152
Query: 116 NEVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------WL-----PSTQES 161
+ A + IN +VA++TK I DL+ ++S +++ W TQE
Sbjct: 153 DSAGAMKQINDYVAKQTKGKIVDLLK--NLDSNAVVIMVNYIFFKAKWETSFNHKGTQEQ 210
Query: 162 IIIIT------------------VLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGD 203
+T +L L+ ++ VPY+G N + F+LP + +
Sbjct: 211 DFYVTSETVVRVPMMSREDQYHYLLDRNLSCRVVGVPYQG-NATALFILPS---EGKMQQ 266
Query: 204 ILAALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGAD 261
+ L S K + + K +E+ +PKFS+ L L LG+ ++F+ AD
Sbjct: 267 VENGL-----SEKTLRKWLKMFKKRQLELYLPKFSIEGSYQLEKVLPSLGISNVFTSHAD 321
Query: 262 LSRLTDSH-IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFL 320
LS +++ I + VHKA +++DE GT AAAAT S L R N PFL F+
Sbjct: 322 LSGISNHSNIQVSEMVHKAVVEVDESGTRAAAATGTIFTFRSARLNSQRLVFNRPFLMFI 381
Query: 321 VDKEIQSILFAGVFNEP 337
VD +ILF G N P
Sbjct: 382 VDN---NILFLGKVNRP 395
|
| >2ceo_A Thyroxine-binding globulin; transport, serpin, hormone trans thyroxine, disease mutation, glycoprotein; HET: T44; 2.80A {Homo sapiens} Length = 379 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 5e-79
Identities = 89/378 (23%), Positives = 158/378 (41%), Gaps = 54/378 (14%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
+F F+L KN+F SP SI AL+ F + +T+ + + L +
Sbjct: 12 DFAFNLYRRFTVETPDKNIFFSPVSISAALVMLSFGACCSTQTEIVETLGFNLTDTPMVE 71
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKE----CMTAIFPSEIQSMDFGN 116
+ + + LI L L N +F+ + + ++ +E+ S DF N
Sbjct: 72 IQ-HGFQHLICSLN-FPKKELELQIGNALFIGKHLKPLAKFLNDVKTLYETEVFSTDFSN 129
Query: 117 EVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------WLP-----STQESI 162
A + INS V +TK + LI + T +VL W T++S
Sbjct: 130 ISAAKQEINSHVEMQTKGKVVGLIQ--DLKPNTIMVLVNYIHFKAQWANPFDPSKTEDSS 187
Query: 163 I-------IITV------------LSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGD 203
+ V + ELN +L++ Y +++F L + +
Sbjct: 188 SFLIDKTTTVQVPMMHQMEQYYHLVDMELNCTVLQMDYSKNALALFVLPK----EGQMES 243
Query: 204 ILAALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGAD 261
+ AA+ S K + ++ L+ V++ +PKFS++ +L TL +G++ +S AD
Sbjct: 244 VEAAM-----SSKTLKKWNRLLQKGWVDLFVPKFSISATYDLGATLLKMGIQHAYSENAD 298
Query: 262 LSRLT-DSHIAFGDAVHKARLDLDEQGTTAAAATAV-FAFRSSRPLEPVRYEANHPFLYF 319
S LT D+ + +A HKA L + E+GT AAA V + + + + F+
Sbjct: 299 FSGLTEDNGLKLSNAAHKAVLHIGEKGTEAAAVPEVELSDQPENTFLHPIIQIDRSFMLL 358
Query: 320 LVDKEIQSILFAGVFNEP 337
++++ +SILF G P
Sbjct: 359 ILERSTRSILFLGKVVNP 376
|
| >1lj5_A Plasminogen activator inhibitor-1; beta-barrell, blood clotting; 1.80A {Homo sapiens} SCOP: e.1.1.1 PDB: 1dvn_A 1c5g_A 1a7c_A* 3q02_A 3q03_A 3r4l_A* 1oc0_A 1b3k_A 3pb1_I 1dvm_A 3eox_A 3cvm_A 1db2_A 9pai_A 3lw2_A 9pai_B Length = 379 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 6e-79
Identities = 87/380 (22%), Positives = 154/380 (40%), Gaps = 57/380 (15%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
+F + + A+K +NV SP+ + L + T+ ++ + +D
Sbjct: 14 DFGVRVFQQVAQASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGF--KIDDKGM 71
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKEC----MTAIFPSEIQSMDFGN 116
+ L + L + ++T+ IFV + + + +F S ++ +DF
Sbjct: 72 APALR--HLYKELM-GPWNKDEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSE 128
Query: 117 EVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------WL-----PSTQESI 162
A IN WV TK I +L+ G V+ T LVL W ST +
Sbjct: 129 VERARFIINDWVKTHTKGMISNLLGKGAVDQLTRLVLVNALYFNGQWKTPFPDSSTHRRL 188
Query: 163 ------IIITV------------LSSELNAH---ILEVPYKGGNMSMFFLLPPFASQDGV 201
++V + + H ILE+PY G +SMF P + + +
Sbjct: 189 FHKSDGSTVSVPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAAP-YEKEVPL 247
Query: 202 GDILAALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPG 259
+ L S + + N+ + +PKFSL E++L L +LG+ D+F
Sbjct: 248 SALTNIL-----SAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQF 302
Query: 260 -ADLSRLTDSH-IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFL 317
AD + L+D + A+ K +++++E GT A+++TAV P + PFL
Sbjct: 303 QADFTSLSDQEPLHVAQALQKVKIEVNESGTVASSSTAVIVSARMAP---EEIIMDRPFL 359
Query: 318 YFLVDKEIQSILFAGVFNEP 337
+ + ++LF G EP
Sbjct: 360 FVVRHNPTGTVLFMGQVMEP 379
|
| >3ne4_A Alpha-1-antitrypsin; serpin, LUNG disease, liver disease, polymerisation, hydrolase inhibitor; 1.81A {Homo sapiens} PDB: 1qlp_A 2qug_A 3cwl_A 3cwm_A* 1psi_A 3drm_A 1kct_A 3dru_A 1hp7_A 1iz2_A* 1oph_A 1oo8_A 1atu_A 1d5s_B 1qmb_B Length = 424 | Back alignment and structure |
|---|
Score = 244 bits (626), Expect = 2e-78
Identities = 96/380 (25%), Positives = 169/380 (44%), Gaps = 57/380 (15%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
EF F L L + + N+F SP SI A + +T + + L NL ++
Sbjct: 62 EFAFSLYRQLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNF--NLTEIPE 119
Query: 61 MNVYKM-EKLIQGLRANADSGLTFTSTNKIFVNDKIPVKE----CMTAIFPSEIQSMDFG 115
+++ ++L++ L DS L T+ N +F+++ + + + + ++ SE +++FG
Sbjct: 120 AQIHEGFQELLRTLN-QPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFG 178
Query: 116 NEVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------WLP-----STQES 161
+ EA + IN +V + T+ I DL+ +++ T L W T+E
Sbjct: 179 DTEEAKKQINDYVEKGTQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEVKDTEEE 236
Query: 162 I------IIITV------------LSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGD 203
+ V +L++ +L + Y G N + F LP + +
Sbjct: 237 DFHVDQVTTVKVPMMKRLGMFNIQHCKKLSSWVLLMKYLG-NATAIFFLP---DEGKLQH 292
Query: 204 ILAALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGAD 261
+ L + T+ +N + +PK S+T +L L LG+ +FS GAD
Sbjct: 293 LENEL-----THDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSNGAD 347
Query: 262 LSRLTDSH-IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFL 320
LS +T+ + AVHKA L +DE+GT AA A + A S P E + N PF++ +
Sbjct: 348 LSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPE---VKFNKPFVFLM 404
Query: 321 VDKEIQSILFAGVFNEPPNK 340
+++ +S LF G P K
Sbjct: 405 IEQNTKSPLFMGKVVNPTQK 424
|
| >4dy0_A GLIA-derived nexin; serpin, protease inhibitor, thrombin, cell surface, hydrolas inhibitor; HET: IDS SGN; 2.35A {Homo sapiens} PDB: 4dy7_C Length = 379 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 3e-78
Identities = 81/382 (21%), Positives = 157/382 (41%), Gaps = 61/382 (15%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
+ + + N+ +SP I L ++ T+ L V+R N
Sbjct: 14 NTGIQVFNQIVKSRPHDNIVISPHGIASVLGMLQLGADGRTKKQLAMVMRYGVN----GV 69
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKEC----MTAIFPSEIQSMDFGN 116
+ K K+ + + + + T N +FV + ++ +F E+++++F +
Sbjct: 70 GKILK--KINKAIV-SKKNKDIVTVANAVFVKNASEIEVPFVTRNKDVFQCEVRNVNFED 126
Query: 117 EVEAARAINSWVAQETKNNIKDLIATGQVNS-RTNLVL---------WL-----PSTQES 161
A +IN+WV ET++ I +L++ ++ T LVL W +T++
Sbjct: 127 PASACDSINAWVKNETRDMIDNLLSPDLIDGVLTRLVLVNAVYFKGLWKSRFQPENTKKR 186
Query: 162 I---------------------IIITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDG 200
T ++L + +E+PY G ++SM LP +S
Sbjct: 187 TFVAADGKSYQVPMLAQLSVFRCGSTSAPNDLWYNFIELPYHGESISMLIALPTESS-TP 245
Query: 201 VGDILAALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSP 258
+ I+ + S K + P V++ +PKF+ + +L L LG+ D+F
Sbjct: 246 LSAIIPHI-----STKTIDSWMSIMVPKRVQVILPKFTAVAQTDLKEPLKVLGITDMFDS 300
Query: 259 G-ADLSRLTDSH--IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHP 315
A+ +++T + + KA++++ E GT A+AAT S P + + P
Sbjct: 301 SKANFAKITTGSENLHVSHILQKAKIEVSEDGTKASAATTAILIARSS---PPWFIVDRP 357
Query: 316 FLYFLVDKEIQSILFAGVFNEP 337
FL+F+ ++LF G N+P
Sbjct: 358 FLFFIRHNPTGAVLFMGQINKP 379
|
| >1sng_A COG4826: serine protease inhibitor; serine protease inhibitor (serpin), native state., hydrolase inhibitor; 1.76A {Thermobifida fusca} SCOP: e.1.1.1 Length = 370 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 3e-78
Identities = 82/373 (21%), Positives = 138/373 (36%), Gaps = 61/373 (16%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
EF L L A V SP+S+ AL + T L +L
Sbjct: 16 EFALHLHRRLAEAVPDGEVIWSPYSVAXALGVLAAGARATTRTELTTLLGTDP------- 68
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKE----CMTAIFPSEIQSMDFGN 116
L+ L S ++V+ +PV+ M S++++ DF
Sbjct: 69 ------APLLAALDRAVTDSPDLASRTVLWVSADVPVRSSFRATMHDRPDSDVRTADFRT 122
Query: 117 EVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL---------WL-----PSTQES 161
E RA +N+ +A T+ I++L+ G V +L W T+
Sbjct: 123 NPEGVRATVNADIADATRGMIRELLPQGAVTPDLRAILTNALWAKARWTTPFEAHLTRAG 182
Query: 162 IIII---TV------------LSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDILA 206
++ ++ + +++ LLPP + A
Sbjct: 183 TFRTPRGPKRVPFMHRTKTMPYATARGWRMVTLHA-HDELAVDVLLPPG------TNAAA 235
Query: 207 ALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT 266
S + VE+A+P+F LTQ L+ L++ GV+ LF+ ADLS ++
Sbjct: 236 VPTAP--LLTALHRRSASTS-VELALPRFELTQPHQLVEVLAEAGVRTLFTASADLSGIS 292
Query: 267 DSHIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSR--PLEPVRYEANHPFLYFLVDKE 324
+ +H+ARL +DE+G AAATA + P +R+ + PF + +
Sbjct: 293 TVPLYVDTVIHQARLRVDERGAEGAAATAAMMLLAGAMPPRRTIRFSVDRPFHIVVRRR- 351
Query: 325 IQSILFAGVFNEP 337
+ILF G +P
Sbjct: 352 -GAILFLGSIADP 363
|
| >1jmo_A HC-II, heparin cofactor II, HLS2, serin; serpin, thrombin, protease, inhibition, inhibitor, blood CLO; HET: TYS NDG NAG; 2.20A {Homo sapiens} SCOP: e.1.1.1 PDB: 1jmj_A* Length = 480 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 8e-78
Identities = 77/379 (20%), Positives = 153/379 (40%), Gaps = 56/379 (14%)
Query: 1 EFTFDLLTVL-NNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLD 59
+F F+L VL + N N+F++P I A+ T + +L + ++
Sbjct: 113 KFAFNLYRVLKDQVNTFDNIFIAPVGISTAMGMISLGLKGETHEQVHSILHFKDFVNASS 172
Query: 60 TMNVYKMEKLIQGLRA---NADSGLTFTSTNKIFVNDKIPVK----ECMTAIFPSEIQSM 112
+ + L + L + G T S N +++ + P+ + + +E Q
Sbjct: 173 KYEITTIHNLFRKLTHRLFRRNFGYTLRSVNDLYIQKQFPILLDFKTKVREYYFAEAQIA 232
Query: 113 DFGNEVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------WLP-----ST 158
DF + ++ N+ + + TK IKD + ++ T +++ W+ T
Sbjct: 233 DFSDPAFISK-TNNHIMKLTKGLIKDAL--ENIDPATQMMILNCIYFKGSWVNKFPVEMT 289
Query: 159 QESI------IIITV------------LSSELNAHILEVPYKGGNMSMFFLLPPFASQDG 200
++ V EL+ IL++ Y G +SM ++P G
Sbjct: 290 HNHNFRLNEREVVKVSMMQTKGNFLAANDQELDCDILQLEYVG-GISMLIVVP--HKMSG 346
Query: 201 VGDILAALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSP 258
+ + A L + + +++ E+ +PKF L + NL+ +L +G++ LF
Sbjct: 347 MKTLEAQL-----TPRVVERWQKSMTNRTREVLLPKFKLEKNYNLVESLKLMGIRMLFDK 401
Query: 259 GADLSRLTDSHIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLY 318
+++ ++D IA H+ + ++E+GT A T V S VR+ + PFL+
Sbjct: 402 NGNMAGISDQRIAIDLFKHQGTITVNEEGTQATTVTTVGFMPLS---TQVRFTVDRPFLF 458
Query: 319 FLVDKEIQSILFAGVFNEP 337
+ + +LF G P
Sbjct: 459 LIYEHRTSCLLFMGRVANP 477
|
| >4au2_A HSP47, serpin peptidase inhibitor, clade H (heat shock P 47), member 1, (collagen binding...; chaperone-peptide complex; 2.30A {Canis lupus familiaris} PDB: 4au3_A 4au4_A 4awr_A 4au3_B Length = 392 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 5e-77
Identities = 63/377 (16%), Positives = 127/377 (33%), Gaps = 56/377 (14%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
F L + +N+ +SP + +L T + K VL + L +
Sbjct: 15 GLAFSLYQAMAKDQAVENILLSPVVVASSLGLVSLGGKATTASQAKAVLSAEQ-LRDEEV 73
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKE----CMTAIFPSEIQSMDFGN 116
+L++ L + +T+ ++++ + E + E ++F +
Sbjct: 74 HAGLG--ELLRSLSNSTARNVTWKLGSRLYGPSSVSFAEDFVRSSKQHYNCEHSKINFRD 131
Query: 117 EVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------WL-----PSTQESI 162
+ A ++IN W AQ T + ++ V +L W
Sbjct: 132 KRSALQSINEWAAQTTDGKLPEVT--KDVERTDGALLVNAMFFKPHWDEKFHHKMVDNRG 189
Query: 163 ------IIITV------------LSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDI 204
+ V + I+E+P S+ L+P + + +
Sbjct: 190 FMVTRSYTVGVTMMHRTGLYNYYDDEKEKLQIVEMPLAHKLSSLIILMP--HHVEPLERL 247
Query: 205 LAALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPG-AD 261
L + ++ ++ V I++PK + +L L+ LG+ + AD
Sbjct: 248 EKLL-----TKEQLKIWMGKMQKKAVAISLPKGVVEVTHDLQKHLAGLGLTEAIDKNKAD 302
Query: 262 LSRLTDSH-IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFL 320
LSR++ + H + D +G S P + A+HPF++ +
Sbjct: 303 LSRMSGKKDLYLASVFHATAFEWDTEGNPFDQDIYGREELRS----PKLFYADHPFIFLV 358
Query: 321 VDKEIQSILFAGVFNEP 337
D + S+LF G P
Sbjct: 359 RDTQSGSLLFIGRLVRP 375
|
| >2v95_A Corticosteroid-binding globulin; transport protein, CBG, RCL, serpin, secreted, transport, glycoprotein, lipid-binding, glucocorticoids; HET: HCY; 1.93A {Rattus norvegicus} Length = 371 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 6e-77
Identities = 90/376 (23%), Positives = 147/376 (39%), Gaps = 59/376 (15%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
+F F+L L N KN +SP SI AL S + Q L NL +
Sbjct: 15 DFAFNLYQRLVALNPDKNTLISPVSISMALAMVSLGSAQTQ---SLQSLGF--NLTETSE 69
Query: 61 MNVYKM-EKLIQGLRANADSGLTFTSTNKIFVNDKIPVKE----CMTAIFPSEIQSMDFG 115
+++ + L L+ +D+GL N +F+ K+ +K+ + + SE ++DF
Sbjct: 70 AEIHQSFQYLNYLLK-QSDTGLEMNMGNAMFLLQKLKLKDSFLADVKQYYESEALAIDFE 128
Query: 116 NEVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------WLP-----STQES 161
+ +A++ IN V +T+ I+ + + ++S + +L W +T+E
Sbjct: 129 DWTKASQQINQHVKDKTQGKIEHVFS--DLDSPASFILVNYIFLRGIWELPFSPENTREE 186
Query: 162 I------IIITV------------LSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGD 203
+ V S ++++ Y G + F L Q +
Sbjct: 187 DFYVNETSTVKVPMMVQSGSIGYFRDSVFPCQLIQMDYVGNGTAFFILPD----QGQMDT 242
Query: 204 ILAALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGAD 261
++AAL S + + P V + IPKFS++ +L L DL +KDL + +D
Sbjct: 243 VIAAL-----SRDTIDRWGKLMTPRQVNLYIPKFSMSDTYDLKDVLEDLNIKDLLTNQSD 297
Query: 262 LSRLTDSHIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLV 321
S T VHKA L LDE + S PL+ N PF+ L
Sbjct: 298 FSGNTKDVPLTLTMVHKAMLQLDEGNVLPNSTNGAPLHLRSEPLDIK---FNKPFILLLF 354
Query: 322 DKEIQSILFAGVFNEP 337
DK S L P
Sbjct: 355 DKFTWSSLMMSQVVNP 370
|
| >3le2_A Serpin-ZX; apoplast, glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase; 2.20A {Arabidopsis thaliana} Length = 393 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 2e-76
Identities = 84/386 (21%), Positives = 153/386 (39%), Gaps = 53/386 (13%)
Query: 1 EFTFDLL-TVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLD 59
+ + +L V+ ++ NV SP SI L S T+ + L+ + D+L+
Sbjct: 14 QVSMNLAKHVITTVSQNSNVIFSPASINVVLSIIAAGSAGATKDQILSFLKFS-STDQLN 72
Query: 60 TMNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVK----ECMTAIFPSEIQSMDFG 115
+ + + ++ +A+ G + N +++ + K + + + + DF
Sbjct: 73 SFSSEIVSAVLA--DGSANGGPKLSVANGAWIDKSLSFKPSFKQLLEDSYKAASNQADFQ 130
Query: 116 NEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL---------WL-----PSTQE 160
++ A +NSW +ET I +++ G +S T L+ W TQE
Sbjct: 131 SKAVEVIAEVNSWAEKETNGLITEVLPEGSADSMTKLIFANALYFKGTWNEKFDESLTQE 190
Query: 161 SI------IIITV----------LSSELNAHILEVPY----KGGNMSMFFLLPPFASQDG 200
+T +S+ +L +PY SM+F LP + +G
Sbjct: 191 GEFHLLDGNKVTAPFMTSKKKQYVSAYDGFKVLGLPYLQGQDKRQFSMYFYLP--DANNG 248
Query: 201 VGDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGA 260
+ D+L + P Q K E IPKF + + L LG+ FS
Sbjct: 249 LSDLLDKIVSTPGFLDNHIPRRQV-KVREFKIPKFKFSFGFDASNVLKGLGLTSPFSGEE 307
Query: 261 DLSRLTDSHIAFGD-----AVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYE--AN 313
L+ + +S + HKA ++++E+GT AAAA+A +E + A+
Sbjct: 308 GLTEMVESPEMGKNLCVSNIFHKACIEVNEEGTEAAAASAGVIKLRGLLMEEDEIDFVAD 367
Query: 314 HPFLYFLVDKEIQSILFAGVFNEPPN 339
HPFL + + +LF G +P +
Sbjct: 368 HPFLLVVTENITGVVLFIGQVVDPLH 393
|
| >2r9y_A Alpha-2-antiplasmin; inhibitory serpin, plasmin inhibitor, AC phase, glycoprotein, protease inhibitor, secreted, serine P inhibitor, sulfation; 2.65A {Mus musculus} Length = 430 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 8e-76
Identities = 85/374 (22%), Positives = 151/374 (40%), Gaps = 62/374 (16%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
FT DL +++ + N+ +SP S+ AL + T +L +VL +
Sbjct: 27 AFTTDLFSLVAQTSTSSNLVLSPLSVALALSHLALGAQNQTLHSLHRVLHMNTGSC---- 82
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVK----ECMTAIFPSEIQSMDFGN 116
+ L+ T +I++ P+K E +F ++ +
Sbjct: 83 -----LPHLLSHFY-QNLGPGTIRLAARIYLQKGFPIKDDFLEQSERLFGAKPVKLTGKQ 136
Query: 117 EVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL----------------------- 153
E E IN WV + T+ I+D ++ ++ T L+L
Sbjct: 137 E-EDLANINQWVKEATEGKIEDFLS--ELPDSTVLLLLNAIHFHGFWRTKFDPSLTQKDF 193
Query: 154 -WLPST---------QESIIIITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGD 203
L S + L + + P+K NMS ++P + V +
Sbjct: 194 FHLDERFTVSVDMMHAVSYPLRWFLLEQPEIQVAHFPFKN-NMSFVVVMPT-YFEWNVSE 251
Query: 204 ILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLS 263
+LA L ++ S +P ++ +PK L Q+++L+ TLS LG+++LF G DL
Sbjct: 252 VLANL-----TWDTLYHPSLQERPTKVWLPKLHLQQQLDLVATLSQLGLQELFQ-GPDLR 305
Query: 264 RLTDSHIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDK 323
+++ ++ H++ ++L E G AAAAT+V R S + N PFL+F+++
Sbjct: 306 GISEQNLVVSSVQHQSTMELSEAGVEAAAATSVAMNRMSLS----SFTVNRPFLFFIMED 361
Query: 324 EIQSILFAGVFNEP 337
I LF G P
Sbjct: 362 TIGVPLFVGSVRNP 375
|
| >3f1s_A Protein Z-dependent protease inhibitor; PZ, ZPI, complex, serpin, protease inhibitor, protease, GLYC secreted, serine protease inhibitor, blood coagulation; HET: FLC NAG; 2.30A {Homo sapiens} PDB: 3h5c_A* Length = 385 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 2e-75
Identities = 84/377 (22%), Positives = 147/377 (38%), Gaps = 56/377 (14%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
F F LL ++ + G N+ SPF + A+ + TE +K+ L L
Sbjct: 22 NFGFSLLRKISMRHDG-NMVFSPFGMSLAMTGLMLGATGPTETQIKRGLHLQALKPTKPG 80
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVK----ECMTAIFPSEIQSMDFGN 116
+ + L + L + + L T + F++ VK F +E M+F N
Sbjct: 81 LLPSLFKGLRETL--SRNLELGLTQGSFAFIHKDFDVKETFFNLSKRYFDTECVPMNFRN 138
Query: 117 EVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------WLP-----STQESI 162
+A R +N ++ +ET+ I L ++N T L+L WL T+
Sbjct: 139 ASQAKRLMNHYINKETRGKIPKLF--DEINPETKLILVDYILFKGKWLTPFDPVFTEVDT 196
Query: 163 ------IIITV------------LSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDI 204
I V H+L++PY+G N +M +L +
Sbjct: 197 FHLDKYKTIKVPMMYGAGKFASTFDKNFRCHVLKLPYQG-NATMLVVLME--KMGDHLAL 253
Query: 205 LAALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADL 262
L + +N+K +E+ PKF L Q+ + L +G++ +FSP ADL
Sbjct: 254 EDYL-----TTDLVETWLRNMKTRNMEVFFPKFKLDQKYEMHELLRQMGIRRIFSPFADL 308
Query: 263 SRLTDSH--IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFL 320
S L+ + + + + +++DE+GT A A S P + + PF + +
Sbjct: 309 SELSATGRNLQVSRVLQRTVIEVDERGTEAVAGILSEITAYSMPPV---IKVDRPFHFMI 365
Query: 321 VDKEIQSILFAGVFNEP 337
++ +LF G P
Sbjct: 366 YEETSGMLLFLGRVVNP 382
|
| >2pef_A Serine protease inhibitor; serpin; 1.60A {Thermoanaerobacter tengcongensis} PDB: 2vh4_A 2pee_A Length = 373 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 2e-75
Identities = 75/377 (19%), Positives = 141/377 (37%), Gaps = 59/377 (15%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
+F+ +L + +N +SP S AL ++ T A +++ L +++ L+
Sbjct: 15 DFSIELFKNS--IDDKENSLISPLSAMLALAMTANGADNETLAQMEKALGKDISIEDLNK 72
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDK-IPVKE----CMTAIFPSEIQSMDFG 115
+ ++ L + T N I+ + + + + ++I F
Sbjct: 73 Y----LYTYMKKL--PNEEKSKLTIANSIWFKENDFMPSKDFLQIIADYYKADIFKAAFD 126
Query: 116 NEVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------WLP-----STQES 161
+ IN+WV +T I ++ +++ + L W S E
Sbjct: 127 SS--TVSDINNWVKSKTNGMIDKIL--NKIDPEDVMYLINAVAFDAEWETVYEKASVHED 182
Query: 162 I---------------IIITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDILA 206
I + E NA PY + S +LP V + +
Sbjct: 183 IFTDVYGNRQKVEFMNSEENLYIEEENAVGFVKPYAKNHYSFVAILP--DENISVNEYIK 240
Query: 207 ALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPG-ADLS 263
L + ++F + +N K V ++PKF + + TL LG+ D F P AD S
Sbjct: 241 TL-----TGQKFIDLIKNAKITLVRASLPKFKYEYTIKMNETLESLGMTDAFLPDKADFS 295
Query: 264 RLTDS---HIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFL 320
+L S ++ + +HK + +DE GT A A T+V + P+ + N PF++ +
Sbjct: 296 KLGKSDIGNLYISEVLHKTFISVDELGTKAGAVTSVDITAAGIPVNFKTVKLNRPFIFAI 355
Query: 321 VDKEIQSILFAGVFNEP 337
+D +F G
Sbjct: 356 IDNSTNLPIFIGTVLSL 372
|
| >3ozq_A Serpin48; SPE, hydrolase I; 1.90A {Tenebrio molitor} Length = 376 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 4e-75
Identities = 86/379 (22%), Positives = 158/379 (41%), Gaps = 62/379 (16%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
FT + + + N VSPFS L A +T ++QVL + +K +
Sbjct: 17 SFTPSVYKEVL-KTEKANFLVSPFSAATLLALAQSGCRGDTAEEIRQVLHFVGDREKAEG 75
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKE----CMTAIFPSEIQSMDFGN 116
+++++ L + T + NKI+V V+E ++ ++ +++DF
Sbjct: 76 ----AVKEVLSKLT---NEEYTLHTANKIYVKTNFSVREEFQKIAVEVYGAQSENVDFSE 128
Query: 117 EVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------WLP----------- 156
+ +AA+ +N+WV ++T++ I++L+ +N+ T +VL WL
Sbjct: 129 KNDAAKLMNAWVEEQTQHKIQNLVDPEILNNLTRVVLINALYFNAKWLVPFPPFHTRKSD 188
Query: 157 --------------STQESIIIITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVG 202
E L+A +LE+P+KG S+ +L +G+
Sbjct: 189 FHKSAKEVVQVDTMYLDEQYFNYYECH-HLDAKLLELPFKG-GASLTIVLS--NQIEGLV 244
Query: 203 DILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADL 262
+ + + + V +A+PKF + ++ L LGVK F ADL
Sbjct: 245 SLESKI-----KRSFLPHNLTKQL-VNVALPKFKIESTVDFKKVLKKLGVKKAFGDEADL 298
Query: 263 SRLTDS--HIAFGDAVHKARLDLDEQGTTAAAATAV-FAFRSSR-PLEPVRYEANHPFLY 318
S + + + V K+ +D+ E+G AAAAT + P P ++ +HPF++
Sbjct: 299 SGIAGEKGDLVISNIVQKSFIDVSEEGVEAAAATYIPVILPEMALPDSPKQFIVDHPFIF 358
Query: 319 FLVDKEIQSILFAGVFNEP 337
++ K ILFAG
Sbjct: 359 YIKVK--GMILFAGRVTTL 375
|
| >1imv_A PEDF, pigment epithelium-derived factor; serpin, angiogenesis, signaling protein; HET: NAG; 2.85A {Homo sapiens} SCOP: e.1.1.1 Length = 398 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 6e-75
Identities = 73/376 (19%), Positives = 146/376 (38%), Gaps = 59/376 (15%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
F +DL V ++ + NV +SP S+ AL +++ TE+ + + L + D
Sbjct: 40 NFGYDLYRVRSSMSPTTNVLLSPLSVATALSALSLGADERTESIIHRALYYDL-ISSPDI 98
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKE----CMTAIFPSEIQSMDFGN 116
YK +L+ + S ++I K+ +K + + + + +
Sbjct: 99 HGTYK--ELLDTVT---APQKNLKSASRIVFEKKLRIKSSFVAPLEKSYGTRPRVLTGNP 153
Query: 117 EVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------WL-----PSTQESI 162
+ IN+WV + K + ++ +++L W+ T
Sbjct: 154 R-LDLQEINNWVQAQMKGKLARST--KEIPDEISILLLGVAHFKGQWVTKFDSRKTSLED 210
Query: 163 ------IIITV-------------LSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGD 203
+ V L S+L+ I ++P G +MS+ F LP + +
Sbjct: 211 FYLDEERTVRVPMMSDPKAVLRYGLDSDLSCKIAQLPLTG-SMSIIFFLPLKVT-QNLTL 268
Query: 204 ILAALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGAD 261
I +L + + + + LK + +PK L+ E + +L ++ ++ LF D
Sbjct: 269 IEESL-----TSEFIHDIDRELKTVQAVLTVPKLKLSYEGEVTKSLQEMKLQSLFD-SPD 322
Query: 262 LSRLTDSHIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLV 321
S++T I H+A + +E G + + + PL+ Y N PF++ L
Sbjct: 323 FSKITGKPIKLTQVEHRAGFEWNEDGAGTTPSPGLQPAHLTFPLD---YHLNQPFIFVLR 379
Query: 322 DKEIQSILFAGVFNEP 337
D + ++LF G +P
Sbjct: 380 DTDTGALLFIGKILDP 395
|
| >2oay_A C1-inhibitor, plasma protease C1 inhibitor, C1 INH, C1INH; latent serpin, RCL insertion, immune system,hydrolase inhibi; HET: NAG; 2.35A {Homo sapiens} Length = 390 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 5e-72
Identities = 78/377 (20%), Positives = 150/377 (39%), Gaps = 66/377 (17%)
Query: 1 EFTFDLLTVLNNANK-GKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLD 59
+F+ L + K N+ SPFSI L + +NT+ NL+ +L P++ +
Sbjct: 38 DFSLKLYHAFSAMKKVETNMAFSPFSIASLLTQVLLGAGENTKTNLESILSYPKDFTCV- 96
Query: 60 TMNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVK----ECMTAIFPSEIQSMDFG 115
+ ++G + TS ++IF + + ++ ++ S + +
Sbjct: 97 -------HQALKGF-----TTKGVTSVSQIFHSPDLAIRDTFVNASRTLYSSSPRVLSNN 144
Query: 116 NEVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------------------- 153
++ IN+WVA+ T N I L+ + S T LVL
Sbjct: 145 SD-ANLELINTWVAKNTNNKISRLL--DSLPSDTRLVLLNAIYLSAKWKTTFDPKKTRME 201
Query: 154 --WLPST--------QESIIIITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGD 203
++ + + + L A + ++ N+S+ L+P + + D
Sbjct: 202 PFHFKNSVIKVPMMNSKKYPVAHFIDQTLKAKVGQLQLSH-NLSLVILVPQ-NLKHRLED 259
Query: 204 ILAALKKDPTSFKRFTEDSQNLK--PVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGAD 261
+ AL P+ FK E + K P + +P+ +T +++ + L D +
Sbjct: 260 MEQAL--SPSVFKAIMEKLEMSKFQPTLLTLPRIKVTTSQDMLSIMEKLEFFDFSY-DLN 316
Query: 262 LSRLTDSH-IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFL 320
L LT+ + H+ L+L E G AAAA+A+ R+ + +E PFL+ L
Sbjct: 317 LCGLTEDPDLQVSAMQHQTVLELTETGVEAAAASAISVART-----LLVFEVQQPFLFML 371
Query: 321 VDKEIQSILFAGVFNEP 337
D++ + +F G +P
Sbjct: 372 WDQQHKFPVFMGRVYDP 388
|
| >2wxw_A Angiotensinogen, serpin A8; glycoprotein, hypertension, vasoconstrictor, renin, serpins, vasoactive, hormone; 3.30A {Homo sapiens} PDB: 2x0b_B Length = 453 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 1e-71
Identities = 51/386 (13%), Positives = 129/386 (33%), Gaps = 65/386 (16%)
Query: 1 EFTFDLLTVLNNANK--GKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPE-NLDK 57
F + + + +SP +++ L + Y + +T L+ +L +P + +
Sbjct: 80 FLGFRIYGMHSELWGVVHGATVLSPTAVFGTLASLYLGALDHTADRLQAILGVPWKDKNC 139
Query: 58 LDTMNVYKMEKLIQGL--------RANADSGLTFTSTNKIFVNDKIPVKE----CMTAIF 105
++ +K+ +Q + RA++ + L ++ +F + +K+ +
Sbjct: 140 TSRLDAHKVLSALQAVQGLLVAQGRADSQAQLLLSTVVGVFTAPGLHLKQPFVQGLALYT 199
Query: 106 PSEI-QSMDFGNEVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL----------- 153
P + +S+DF AA I+ ++ T + + + L
Sbjct: 200 PVVLPRSLDFTELDVAAEKIDRFMQAVTGWKTGCSLM--GASVDSTLAFNTYVHFQGKMK 257
Query: 154 -----------WLPST---------QESIIIITVLSSELNAHILEVPYKGGNMSMFFLLP 193
W+ ++ + N + +VP+ + + + P
Sbjct: 258 GFSLLAEPQEFWVDNSTSVSVPMLSGMGTFQHWSDI-QDNFSVTQVPFTE-SACLLLIQP 315
Query: 194 PFASQDGVGDILAALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLG 251
+ + + + L P + + +P+ L +L L+
Sbjct: 316 --HYASDLDKVEGLT-----FQQNSLNWMKKLSPRTIHLTMPQLVLQGSYDLQDLLAQAE 368
Query: 252 VKDLFSPGADLSRLTDSHIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYE 311
+ + +L +L++ I G+ ++ +L+ +T E +
Sbjct: 369 LPAILHTELNLQKLSNDRIRVGEVLNSIFFELEADEREPTESTQQLNKP-----EVLEVT 423
Query: 312 ANHPFLYFLVDKEIQSILFAGVFNEP 337
N PFL+ + D+ ++ F G P
Sbjct: 424 LNRPFLFAVYDQSATALHFLGRVANP 449
|
| >2wxy_C Angiotensinogen, serpin A8; glycoprotein, hypertension, vasoconstrictor, renin, serpins, vasoactive, hormone; 2.10A {Mus musculus} PDB: 2wxx_A 2wy0_C 2wxz_A 2wxz_C 2wy1_A Length = 453 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 1e-70
Identities = 67/385 (17%), Positives = 142/385 (36%), Gaps = 62/385 (16%)
Query: 1 EFTFDLLTVLNNANKG-KNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPEN----L 55
F + +LN A G +SP +++ L++ Y S T + L+ +L +P
Sbjct: 79 FVGFRMYKMLNEAGSGASGAILSPPALFGTLVSFYLGSLDPTASQLQTLLDVPVKEGDCT 138
Query: 56 DKLDTMNVYKMEKLIQGL-----RANADSGLTFTSTNKIFVNDKIPVKE----CMTAIFP 106
+LD V + +QGL +++ + L + +F +K + P
Sbjct: 139 SRLDGHKVLAALRAVQGLLVTQGGSSSQTPLLQSIVVGLFTAPGFRLKHSFVQSLALFTP 198
Query: 107 SEI-QSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL---------W- 154
+ +S+D + A IN ++ T + + V++ + L+
Sbjct: 199 ALFPRSLDLSTDPVLATEKINRFIKAVTGWKMNLPL--EGVSTDSTLLFNTYVHFQGTMR 256
Query: 155 ----LPSTQESII----IITV------------LSSELNAHILEVPYKGGNMSMFFLLPP 194
LP E + ++V ++ N + VP G ++ + P
Sbjct: 257 GFSQLPGVHEFWVDNSISVSVPMISGTGNFQHWSDAQNNFSVTCVPL-GERATLLLIQP- 314
Query: 195 FASQDGVGDILAALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGV 252
+ + A + +N P + + +P+ + NL L++ +
Sbjct: 315 -HCISDLDRVEALI-----FQNDLLTWIENPPPRAIRLTLPQLEIRGSYNLQDLLAEDKL 368
Query: 253 KDLFSPGADLSRLTDSHIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEA 312
L A+L+ + D++ G+ ++ L+L G T+V S E +
Sbjct: 369 PTLLGAEANLNNIGDTNPRVGEVLNSILLELKA-GEEEQPTTSVQQPGSP---EALDVTL 424
Query: 313 NHPFLYFLVDKEIQSILFAGVFNEP 337
+ PFL+ + +++ ++ F G N P
Sbjct: 425 SSPFLFAIYEQDSGTLHFLGRVNNP 449
|
| >2h4p_A MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 1.70A {Gallus gallus} PDB: 2h4q_A Length = 394 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 2e-69
Identities = 87/361 (24%), Positives = 150/361 (41%), Gaps = 67/361 (18%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
FT DL LN N+ KN+F SP+SI AL Y + +T + +VL E + +
Sbjct: 35 NFTVDLFNKLNETNRDKNIFFSPWSISSALALTYLAAKGSTAREMAEVLHFTEAVRAESS 94
Query: 61 MNVYKMEKLIQGLRA----------------------NADSGLTFTSTNKIFVNDKIPVK 98
+ R + + S N+I+V +
Sbjct: 95 SVARPSRGRPKRRRMDPEHEQAENIHSGFKELLTAFNKPRNNYSLRSANRIYVEKTYALL 154
Query: 99 E----CMTAIFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL 153
+ +E Q ++F E +R IN+WV ++T++ IK+L+++ V + T L+L
Sbjct: 155 PTYLQLSKKYYKAEPQKVNFKTAPEQSRKEINTWVEKQTESKIKNLLSSDDVKATTRLIL 214
Query: 154 ---------WLP-----STQESIIIIT------------------VLSSELNAHILEVPY 181
W T ++ ++ ++N ++E+PY
Sbjct: 215 VNAIYFKAEWEVKFQAEKTSIQPFRLSKNKSKPVKMMYMRDTFPVLIMEKMNFKMIELPY 274
Query: 182 KGGNMSMFFLLP--PFASQDGVGDILAALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSL 237
+SMF LLP G+ + L + DS+ + V++ +PKFSL
Sbjct: 275 VKRELSMFILLPDDIKDGTTGLEQLEREL--TYERLSEWA-DSKMMTETLVDLHLPKFSL 331
Query: 238 TQEMNLIPTLSDLGVKDLFSPGADLSRLTDSH-IAFGDAVHKARLDLDEQGTTAAAATAV 296
++L TL ++G+ F+ AD +TD +A +H++ + +DE+GT AAAATAV
Sbjct: 332 EDRIDLRDTLRNMGMTTAFTTNADFRGMTDKKDLAISKVIHQSFVAVDEKGTEAAAATAV 391
Query: 297 F 297
Sbjct: 392 I 392
|
| >1hle_A Horse leukocyte elastase inhibitor; hydrolase inhibitor(serine proteinase); 1.95A {Equus caballus} SCOP: e.1.1.1 Length = 345 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 4e-68
Identities = 91/339 (26%), Positives = 150/339 (44%), Gaps = 52/339 (15%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
F DL LN ++ N+F+SP SI AL + + NT A + + L D
Sbjct: 11 HFAVDLFRALNESDPTGNIFISPLSISSALAMIFLGTRGNTAAQVSKALYFDT---VEDI 67
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKE----CMTAIFPSEIQSMDFGN 116
+ ++ L + + N+++ ++ +E+ S+DF
Sbjct: 68 HSRFQ--SLNADIN-KPGAPYILKLANRLYGEKTYNFLADFLASTQKMYGAELASVDFQQ 124
Query: 117 EVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL---------WL-----PSTQES 161
E AR IN WV +T+ I +L+ G V++ T LVL W +T+++
Sbjct: 125 APEDARKEINEWVKGQTEGKIPELLVKGMVDNMTKLVLVNAIYFKGNWQQKFMKEATRDA 184
Query: 162 I------IIITV------------LSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGD 203
TV +L +LE+PY+G +SM LLP + G
Sbjct: 185 PFRLNKKDTKTVKMMYQKKKFPYNYIEDLKCRVLELPYQGKELSMIILLPDDIEDESTG- 243
Query: 204 ILAALKK--DPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPG 259
L ++K + +T +NL V + +P+F L + +L L+ LGV+DLF+ G
Sbjct: 244 -LEKIEKQLTLDKLREWT-KPENLYLAEVNVHLPRFKLEESYDLTSHLARLGVQDLFNRG 301
Query: 260 -ADLSRLTDSH-IAFGDAVHKARLDLDEQGTTAAAATAV 296
ADLS ++ + + +HK+ +DL+E+GT AAAATA
Sbjct: 302 KADLSGMSGARDLFVSKIIHKSFVDLNEEGTEAAAATAG 340
|
| >3f02_A Neuroserpin; cleaved form, fenib, human, disease MUT glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase inhibitor; 1.80A {Homo sapiens} PDB: 3fgq_A 1jjo_C 1jjo_A Length = 359 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 1e-67
Identities = 71/341 (20%), Positives = 141/341 (41%), Gaps = 56/341 (16%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
+ + ++ L + +N+ SP SI A+ + +T+ ++ + L +
Sbjct: 25 DLSVNMYNRLRATGEDENILFSPLSIALAMGMMELGAQGSTQKEIRHSMGYDS-LKNGEE 83
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKEC----MTAIFPSEIQSMDFGN 116
+ K + + +S N +FV + V E M F + + +DF
Sbjct: 84 FSFLK--EFSNMVT-AKESQYVMKIANSLFVQNGFHVNEEFLQMMKKYFNAAVNHVDFSQ 140
Query: 117 EVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------WLP-----STQESI 162
V A IN WV T N +KDL++ ++ T L L W +T+
Sbjct: 141 NVAVANYINKWVENNTNNLVKDLVSPRDFDAATYLALINAVYFKGNWKSQFRPENTRTFS 200
Query: 163 ------IIITV------------------LSSELNAHILEVPYKGGNMSMFFLLPPFASQ 198
+ + + +LE+PY+G +SM +L +
Sbjct: 201 FTKDDESEVQIPMMYQQGEFYYGEFSDGSNEAGGIYQVLEIPYEGDEISMMLVLSR--QE 258
Query: 199 DGVGDILAALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGVKDLF 256
+ + + + E + ++K VE+ +P+F++ QE++L L LG+ ++F
Sbjct: 259 VPLATLEPLV-----KAQLVEEWANSVKKQKVEVYLPRFTVEQEIDLKDVLKALGITEIF 313
Query: 257 SPGADLSRLTDSH-IAFGDAVHKARLDLDEQGTTAAAATAV 296
A+L+ L+D+ I A+HK+ L+++E+G+ AAA + +
Sbjct: 314 IKDANLTGLSDNKEIFLSKAIHKSFLEVNEEGSEAAAVSGM 354
|
| >1mtp_A Serine proteinase inhibitor (serpin), chain A; structural genomics, protease inhibitor; 1.50A {Thermobifida fusca} SCOP: e.1.1.1 Length = 323 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 8e-67
Identities = 74/330 (22%), Positives = 122/330 (36%), Gaps = 57/330 (17%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
EF L L A V SP+S+ AL + T L +L
Sbjct: 12 EFALHLHRRLAEAVPDGEVIWSPYSVACALGVLAAGARATTRTELTTLLGTDPA------ 65
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKE----CMTAIFPSEIQSMDFGN 116
L+ L S ++V+ +PV+ M S++++ DF
Sbjct: 66 -------PLLAALDRAVTDSPDLASRTVLWVSADVPVRSSFRATMHDRPDSDVRTADFRT 118
Query: 117 EVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL---------WL-----PSTQES 161
E RA +N+ +A T+ I++L+ G V +L W T+E
Sbjct: 119 NPEGVRATVNADIADATRGMIRELLPQGAVTPDLRAILTNALWAKARWTTPFEAHLTREG 178
Query: 162 IIII---TV------------LSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDILA 206
++ ++ + +++ LLPP + A
Sbjct: 179 TFRTPRGPKRVPFMHRTKTMPYATARGWRMVTLHA-HDELAVDVLLPPG------TNAAA 231
Query: 207 ALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT 266
S + VE+A+P+F LTQ L+ L++ GV+ LF+ ADLS ++
Sbjct: 232 VPTAP--LLTALHRRSASTS-VELALPRFELTQPHQLVEVLAEAGVRTLFTASADLSGIS 288
Query: 267 DSHIAFGDAVHKARLDLDEQGTTAAAATAV 296
+ +H+ARL +DE+G AAATA
Sbjct: 289 TVPLYVDTVIHQARLRVDERGAEGAAATAA 318
|
| >2xn6_A Thyroxine-binding globulin; transport, cleaved protein; HET: F6Y T44; 1.29A {Homo sapiens} PDB: 2xn7_A* 2xn5_A* 2riv_A 2xn3_A* 2riw_A* Length = 350 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 6e-66
Identities = 84/344 (24%), Positives = 144/344 (41%), Gaps = 53/344 (15%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
+F F+L KN+F SP SI AL+ F + +T+ + + L +
Sbjct: 17 DFAFNLYRRFTVETPDKNIFFSPVSISAALVMLSFGACCSTQTEIVETLGFNLTDTPMVE 76
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKE----CMTAIFPSEIQSMDFGN 116
+ + + LI L L N +F+ + + ++ +E+ S DF N
Sbjct: 77 IQ-HGFQHLICSLN-FPKKELELQIGNALFIGKHLKPLAKFLNDVKTLYETEVFSTDFSN 134
Query: 117 EVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------WLP-----STQESI 162
A + INS V +TK + LI + T +VL W T++S
Sbjct: 135 ISAAKQEINSHVEMQTKGKVVGLIQ--DLKPNTIMVLVNYIHFKAQWANPFDPSKTEDSS 192
Query: 163 I-------IITV------------LSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGD 203
+ V + ELN +L++ Y +++F L + +
Sbjct: 193 SFLIDKTTTVQVPMMHQMDQYYHLVDMELNCTVLQMDYSKNALALFVLPK----EGQMES 248
Query: 204 ILAALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGAD 261
+ AA+ S K + ++ L+ V++ +PKFS++ +L TL +G++ +S AD
Sbjct: 249 VEAAM-----SSKTLKKWNRLLQKGWVDLFVPKFSISATYDLGATLLKMGIQHAYSENAD 303
Query: 262 LSRLT-DSHIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRP 304
S LT D+ + +A HKA L + E+GT AA A + A S P
Sbjct: 304 FSGLTEDNGLKLSNAAHKAVLHIGEKGTEAAGAMFLEAIPRSIP 347
|
| >1as4_A Antichymotrypsin, ACT; serpin, serine protease inhibitor; 2.10A {Homo sapiens} SCOP: e.1.1.1 PDB: 2ach_A* 4caa_A 3caa_A Length = 341 | Back alignment and structure |
|---|
Score = 208 bits (533), Expect = 2e-65
Identities = 92/335 (27%), Positives = 155/335 (46%), Gaps = 50/335 (14%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
+F F L L KNV SP SI AL ++ T + + L+ NL +
Sbjct: 13 DFAFSLYKQLVLKAPDKNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKF--NLTETSE 70
Query: 61 MNVYK-MEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKE----CMTAIFPSEIQSMDFG 115
+++ + L++ L + L + N +FV +++ + + ++ SE + DF
Sbjct: 71 AEIHQSFQHLLRTLN-QSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQ 129
Query: 116 NEVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------WLP-----STQES 161
+ A + IN +V T+ I DLI ++S+T +VL W T +S
Sbjct: 130 DSAAAKKLINDYVKNGTRGKITDLIK--DLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQS 187
Query: 162 I------IIITV-------------LSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVG 202
+ V EL+ ++E+ Y G N S F+LP QD +
Sbjct: 188 RFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVELKYTG-NASALFILPD---QDKME 243
Query: 203 DILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADL 262
++ A L P + KR+ + + + E+ +PKFS++++ NL L LG+++ F+ ADL
Sbjct: 244 EVEAML--LPETLKRWRDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADL 301
Query: 263 SRLTDSH-IAFGDAVHKARLDLDEQGTTAAAATAV 296
S +T + +A VHKA LD+ E+GT A+ ATAV
Sbjct: 302 SGITGARNLAVSQVVHKAVLDVFEEGTEASRATAV 336
|
| >3ndd_A Alpha-1-antitrypsin; serpin, hydrolase inhibitor; 1.50A {Homo sapiens} PDB: 3ndf_A 7api_A* 8api_A* 9api_A* 1d5s_A 1ezx_A 3t1p_A 2d26_A 1qmb_A Length = 343 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 2e-64
Identities = 82/336 (24%), Positives = 148/336 (44%), Gaps = 54/336 (16%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
EF F L L + + N+F SP SI A + +T + + L NL ++
Sbjct: 17 EFAFSLYRQLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNF--NLTEIPE 74
Query: 61 MNVYKM-EKLIQGLRANADSGLTFTSTNKIFVNDKIPVKE----CMTAIFPSEIQSMDFG 115
+++ ++L++ L DS L T+ N +F+++ + + + + ++ SE +++FG
Sbjct: 75 AQIHEGFQELLRTLN-QPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFG 133
Query: 116 NEVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------WLP-----STQES 161
+ EA + IN +V + T+ I DL+ +++ T L W T+E
Sbjct: 134 DTEEAKKQINDYVEKGTQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEVKDTEEE 191
Query: 162 I------IIITV------------LSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGD 203
+ V + +L++ +L + Y G N + F LP + +
Sbjct: 192 DFHVDQVTTVKVPMMKRLGMFNIQHAKKLSSWVLLMKYLG-NATAIFFLP---DEGKLQH 247
Query: 204 ILAALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGAD 261
+ L + T+ +N + +PK S+T +L L LG+ +FS GAD
Sbjct: 248 LENEL-----THDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSNGAD 302
Query: 262 LSRLT-DSHIAFGDAVHKARLDLDEQGTTAAAATAV 296
LS +T ++ + AVHKA L +DE+GT AA
Sbjct: 303 LSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAPDDDD 338
|
| >3dy0_A N-terminus plasma serine protease inhibitor; serpin, blood clotting, hydrolase inhibitor; HET: IDS SGN; 1.55A {Homo sapiens} PDB: 1lq8_A* 2hi9_A* Length = 336 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 3e-64
Identities = 86/336 (25%), Positives = 153/336 (45%), Gaps = 54/336 (16%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
+FTFDL L +A +N+F SP SI +L + +T+ + + L L NL K
Sbjct: 11 DFTFDLYRALASAAPSQNIFFSPVSISMSLAMLSLGAGSSTKMQILEGLGL--NLQKSSE 68
Query: 61 MNVYKM-EKLIQGLRANADSGLTFTSTNKIFVNDKIPVKE----CMTAIFPSEIQSMDFG 115
+++ ++L+Q L G + N +F + + +++ M ++ ++ +F
Sbjct: 69 KELHRGFQQLLQELN-QPRDGFQLSLGNALFTDLVVDLQDTFVSAMKTLYLADTFPTNFR 127
Query: 116 NEVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------WL-----PSTQES 161
+ A + IN +VA++TK I DL+ ++S +++ W TQE
Sbjct: 128 DSAGAMKQINDYVAKQTKGKIVDLLK--NLDSNAVVIMVNYIFFKAKWETSFNHKGTQEQ 185
Query: 162 I------IIITV------------LSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGD 203
++ V L L+ ++ VPY+G N + F+LP + +
Sbjct: 186 DFYVTSETVVRVPMMSREDQYHYLLDRNLSCRVVGVPYQG-NATALFILPS---EGKMQQ 241
Query: 204 ILAALKKDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGAD 261
+ L S K + + K +E+ +PKFS+ L L LG+ ++F+ AD
Sbjct: 242 VENGL-----SEKTLRKWLKMFKKRQLELYLPKFSIEGSYQLEKVLPSLGISNVFTSHAD 296
Query: 262 LSRLTDSH-IAFGDAVHKARLDLDEQGTTAAAATAV 296
LS +++ I + VHKA +++DE GT AAAAT
Sbjct: 297 LSGISNHSNIQVSEMVHKAVVEVDESGTRAAAATGT 332
|
| >1f0c_A ICE inhibitor; apoptosis, caspase inhibitor, protease inhibitor, serpin, viral protein; 2.26A {Cowpox virus} SCOP: e.1.1.1 PDB: 1c8o_A Length = 305 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 3e-62
Identities = 76/335 (22%), Positives = 131/335 (39%), Gaps = 68/335 (20%)
Query: 5 DLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVY 64
D+ + ++ KG+NVF+SP SI L Y+ +N +T L + + +
Sbjct: 2 DIFREIASSMKGENVFISPPSISSVLTILYYGANGSTAEQLSKYVEKEAD---------- 51
Query: 65 KMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKECMTAIFPSEIQSMDFGNEVEAARAI 124
++F S NK++ K+ Q++DF + AI
Sbjct: 52 -----------KNKDDISFKSMNKVYGRYSAVFKDSFLRKIGDNFQTVDFTDC-RTVDAI 99
Query: 125 NSWVAQETKNNIKDLIATGQVNSRTNLVL---------WLP-----STQES--------- 161
N V T+ I L+ ++ T L+ WL T +
Sbjct: 100 NKCVDIFTEGKINPLL-DEPLSPDTCLLAISAVYFKAKWLMPFEKEFTSDYPFYVSPTEM 158
Query: 162 ------------IIIITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDILAALK 209
+V S N I+E+PY G + SM +LP + DG+ I L
Sbjct: 159 VDVSMMSMYGEAFNHASVKESFGNFSIIELPYVG-DTSMVVILP--DNIDGLESIEQNL- 214
Query: 210 KDPTSFKRFTEDSQNLKP--VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLTD 267
+ F + ++ +++ IPKF +T NL+ L LG+ ++F D S + +
Sbjct: 215 ----TDTNFKKWCDSMDAMFIDVHIPKFKVTGSYNLVDALVKLGLTEVFGSTGDYSNMCN 270
Query: 268 SHIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSS 302
S ++ +HK +D++E+ T AAAAT +
Sbjct: 271 SDVSVDAMIHKTYIDVNEEYTEAAAATCALVADCA 305
|
| >1m93_B Serine proteinase inhibitor 2; serpin, CRMA, apoptosis, ICE inhibitor, viral protein; 1.65A {Cowpox virus} SCOP: e.1.1.1 Length = 245 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 5e-51
Identities = 62/253 (24%), Positives = 107/253 (42%), Gaps = 47/253 (18%)
Query: 81 LTFTSTNKIFVNDKIPVKECMTAIFPSEIQSMDFGNEVEAARAINSWVAQETKNNIKDLI 140
++F S NK++ K+ Q++DF + AIN V T+ I L+
Sbjct: 2 ISFKSMNKVYGRYSAVFKDSFLRKIGDNFQTVDFTDS-RTVDAINKSVDIFTEGKINPLL 60
Query: 141 ATGQVNSRTNLVL---------WL----PS----------------------TQESIIII 165
++ T+L+ WL E+
Sbjct: 61 -DEPLSPDTSLLAISAVYFKAKWLMPFEKEFTSDYPFYVSPTEMVDVSMMSMYGEAFNHA 119
Query: 166 TVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDILAALKKDPTSFKRFTEDSQNL 225
+V S N I+E+PY G + SM +LP + DG+ I L + F + S ++
Sbjct: 120 SVKESFGNFSIIELPYVG-DTSMVVILP--DNIDGLESIEQNL-----TDTNFKKWSDSM 171
Query: 226 KP--VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLTDSHIAFGDAVHKARLDL 283
+++ IPKF +T NL+ L LG+ ++F D S +++S ++ +HK +D+
Sbjct: 172 DAMFIDVHIPKFKVTGSYNLVDALVKLGLTEVFGSTGDYSNMSNSDVSVDAMIHKTYIDV 231
Query: 284 DEQGTTAAAATAV 296
+E+ T AAAAT+
Sbjct: 232 NEEYTEAAAATSA 244
|
| >1m93_A Serine proteinase inhibitor 2; serpin, CRMA, apoptosis, ICE inhibitor, viral protein; 1.65A {Cowpox virus} SCOP: e.1.1.1 Length = 55 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-09
Identities = 16/53 (30%), Positives = 29/53 (54%)
Query: 5 DLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDK 57
D+ + ++ KG+NVF+SP SI L Y+ +N +T L + + + +K
Sbjct: 2 DIFREIASSMKGENVFISPPSISSVLTILYYGANGSTAEQLSKYVEKEADKNK 54
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 9e-06
Identities = 49/297 (16%), Positives = 92/297 (30%), Gaps = 80/297 (26%)
Query: 21 VSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADSG 80
+P + +++ T N K V N DKL T+ +E + L
Sbjct: 325 TNPRRL--SIIAESIRDGLATWDNWKHV-----NCDKLTTI----IESSLNVLEPAEYRK 373
Query: 81 LTFTSTNKIFVND-KIPVKECMTAIF---PSEIQSMDFGNEVEAARAINSWVAQETKNNI 136
+ F + +F IP + ++ + M N++ + +E+ +I
Sbjct: 374 M-FDRLS-VFPPSAHIPTI--LLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ-PKESTISI 428
Query: 137 KDLI--ATGQVNSRTNLVLWLPSTQESII--------------IITVLSSELNAHI---L 177
+ ++ + L SI+ I L +HI L
Sbjct: 429 PSIYLELKVKLENEYAL-------HRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHL 481
Query: 178 EVPYKGGNMSMF--------FL-------LPPFASQDGVGDILAALKKDPTSFKRF-TED 221
+ M++F FL + + + + L LK +K + ++
Sbjct: 482 KNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKF----YKPYICDN 537
Query: 222 SQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRL---TDSHIAFGDA 275
+ + AI F E NLI S DL R+ + F +A
Sbjct: 538 DPKYERLVNAILDFLPKIEENLI-----------CSKYTDLLRIALMAEDEAIFEEA 583
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.0 bits (95), Expect = 4e-04
Identities = 36/273 (13%), Positives = 74/273 (27%), Gaps = 79/273 (28%)
Query: 92 NDKIPVKECMTAIFPSEIQSMDFGNEVEAARAINSWVAQETKNNIKDLIATGQVNSRTNL 151
D + V E + + + D + + ++I +K I +I + S T
Sbjct: 19 KDILSVFE------DAFVDNFDCKDVQDMPKSI------LSKEEIDHIIMSKDAVSGTLR 66
Query: 152 VLW-LPSTQESIIIITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDILAALKK 210
+ W L S QE ++ V +L + YK FL+ P ++ +
Sbjct: 67 LFWTLLSKQEEMVQKFVEE------VLRINYK-------FLMSPIKTEQ----------R 103
Query: 211 DPT-SFKRFTE-------DSQNLKPVEIAIPK---------FSLTQEMNLI--------- 244
P+ + + E D+Q ++ + L N++
Sbjct: 104 QPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGK 163
Query: 245 -----PTLSDLGVKDLFSPGADLSRLTDSH-IAFGDAVHKARLDLDEQGTTAAAATAVFA 298
V+ + + + L+ +
Sbjct: 164 TWVALDVCLSYKVQCKMDFKI--------FWLNLKN-CNSPETVLEMLQKLLYQIDPNWT 214
Query: 299 FRSSRPLE-PVRYE-ANHPFLYFLVDKEIQSIL 329
RS +R L K ++ L
Sbjct: 215 SRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL 247
|
| >1hle_B Horse leukocyte elastase inhibitor; hydrolase inhibitor(serine proteinase); 1.95A {Equus caballus} SCOP: e.1.1.1 Length = 31 | Back alignment and structure |
|---|
Score = 37.6 bits (88), Expect = 1e-04
Identities = 11/29 (37%), Positives = 18/29 (62%)
Query: 309 RYEANHPFLYFLVDKEIQSILFAGVFNEP 337
+ A+HPF++F+ +ILF G F+ P
Sbjct: 3 NFNADHPFIFFIRHNPSANILFLGRFSSP 31
|
| >2h4p_B MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 1.70A {Gallus gallus} PDB: 2h4q_B Length = 34 | Back alignment and structure |
|---|
Score = 37.7 bits (88), Expect = 1e-04
Identities = 10/29 (34%), Positives = 19/29 (65%)
Query: 309 RYEANHPFLYFLVDKEIQSILFAGVFNEP 337
+++ +HPF +F+ + ++ILF G F P
Sbjct: 4 KFKVDHPFHFFIRHNKSKTILFFGRFCCP 32
|
| >3f02_C Neuroserpin; cleaved form, fenib, human, disease MUT glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase inhibitor; 1.80A {Homo sapiens} PDB: 1jjo_E Length = 48 | Back alignment and structure |
|---|
Score = 36.7 bits (85), Expect = 5e-04
Identities = 8/34 (23%), Positives = 15/34 (44%)
Query: 309 RYEANHPFLYFLVDKEIQSILFAGVFNEPPNKEV 342
+ +HPF + + ++ +ILF G P
Sbjct: 7 QVIVDHPFFFLIRNRRTGTILFMGRVMHPETMNT 40
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 342 | |||
| 3f5n_A | 407 | Neuroserpin; cleaved form, fenib, human, tissue PL | 100.0 | |
| 1uhg_A | 385 | Ovalbumin, S-ovalbumin; allergen, egg white protei | 100.0 | |
| 3sto_A | 406 | Serine protease inhibitor; serpin fold, hydrolase | 100.0 | |
| 4ga7_A | 389 | Leukocyte elastase inhibitor; serpin, conformation | 100.0 | |
| 3nda_A | 377 | Serpin-2; vaccination target, TICK, hydrolase inhi | 100.0 | |
| 3ne4_A | 424 | Alpha-1-antitrypsin; serpin, LUNG disease, liver d | 100.0 | |
| 2zv6_A | 401 | Serpin B3; serine proteinase inhibitor, reactive s | 100.0 | |
| 3kcg_I | 432 | Antithrombin-III, ATIII; michaelis complex, blood | 100.0 | |
| 2h4r_A | 415 | MENT, heterochromatin-associated protein MENT; ser | 100.0 | |
| 2ceo_A | 379 | Thyroxine-binding globulin; transport, serpin, hor | 100.0 | |
| 1wz9_A | 375 | Maspin precursor; serpin, tumor suppressor, serpin | 100.0 | |
| 2arr_A | 382 | Plasminogen activator inhibitor-2; serpin, peptide | 100.0 | |
| 2vdx_A | 373 | Corticosteroid-binding globulin; transport protein | 100.0 | |
| 4au2_A | 392 | HSP47, serpin peptidase inhibitor, clade H (heat s | 100.0 | |
| 3pzf_A | 397 | Serpin 2; protease inhibitor, melanization, hydrol | 100.0 | |
| 3f1s_A | 385 | Protein Z-dependent protease inhibitor; PZ, ZPI, c | 100.0 | |
| 1lj5_A | 379 | Plasminogen activator inhibitor-1; beta-barrell, b | 100.0 | |
| 4dy0_A | 379 | GLIA-derived nexin; serpin, protease inhibitor, th | 100.0 | |
| 4ajt_A | 427 | Protein Z-dependent protease inhibitor; blood clot | 100.0 | |
| 1yxa_A | 398 | Serine (OR cysteine) proteinase inhibitor, clade 3 | 100.0 | |
| 3b9f_I | 395 | Protein C inhibitor; michaelis complex, acute phas | 100.0 | |
| 3le2_A | 393 | Serpin-ZX; apoplast, glycoprotein, protease inhibi | 100.0 | |
| 1sek_A | 378 | Serpin K; serine protease inhibitor, protease; 2.1 | 100.0 | |
| 1qmn_A | 401 | AACT, alpha-1-antichymotrypsin; serpin, serine pro | 100.0 | |
| 1jmo_A | 480 | HC-II, heparin cofactor II, HLS2, serin; serpin, t | 100.0 | |
| 3ozq_A | 376 | Serpin48; SPE, hydrolase I; 1.90A {Tenebrio molito | 100.0 | |
| 2v95_A | 371 | Corticosteroid-binding globulin; transport protein | 100.0 | |
| 2wxy_C | 453 | Angiotensinogen, serpin A8; glycoprotein, hyperten | 100.0 | |
| 2pef_A | 373 | Serine protease inhibitor; serpin; 1.60A {Thermoan | 100.0 | |
| 1imv_A | 398 | PEDF, pigment epithelium-derived factor; serpin, a | 100.0 | |
| 2wxw_A | 453 | Angiotensinogen, serpin A8; glycoprotein, hyperten | 100.0 | |
| 1sng_A | 370 | COG4826: serine protease inhibitor; serine proteas | 100.0 | |
| 2r9y_A | 430 | Alpha-2-antiplasmin; inhibitory serpin, plasmin in | 100.0 | |
| 2oay_A | 390 | C1-inhibitor, plasma protease C1 inhibitor, C1 INH | 100.0 | |
| 3f02_A | 359 | Neuroserpin; cleaved form, fenib, human, disease M | 100.0 | |
| 3dy0_A | 336 | N-terminus plasma serine protease inhibitor; serpi | 100.0 | |
| 3ndd_A | 343 | Alpha-1-antitrypsin; serpin, hydrolase inhibitor; | 100.0 | |
| 2h4p_A | 394 | MENT, heterochromatin-associated protein MENT; ser | 100.0 | |
| 2xn6_A | 350 | Thyroxine-binding globulin; transport, cleaved pro | 100.0 | |
| 1hle_A | 345 | Horse leukocyte elastase inhibitor; hydrolase inhi | 100.0 | |
| 1as4_A | 341 | Antichymotrypsin, ACT; serpin, serine protease inh | 100.0 | |
| 4afx_A | 387 | Protein Z dependent protease inhibitor; hydrolase | 100.0 | |
| 1mtp_A | 323 | Serine proteinase inhibitor (serpin), chain A; str | 100.0 | |
| 1f0c_A | 305 | ICE inhibitor; apoptosis, caspase inhibitor, prote | 100.0 | |
| 1m93_B | 245 | Serine proteinase inhibitor 2; serpin, CRMA, apopt | 100.0 | |
| 1m93_A | 55 | Serine proteinase inhibitor 2; serpin, CRMA, apopt | 99.52 | |
| 2riv_B | 40 | Thyroxine-binding globulin; TBG, serpin, cleaved, | 99.46 | |
| 3ndd_B | 36 | Alpha-1-antitrypsin; serpin, hydrolase inhibitor; | 99.45 | |
| 2xn6_B | 35 | Thyroxine-binding globulin; transport, cleaved pro | 99.42 | |
| 1hle_B | 31 | Horse leukocyte elastase inhibitor; hydrolase inhi | 99.4 | |
| 1as4_B | 37 | Antichymotrypsin, ACT; serpin, serine protease inh | 99.4 | |
| 2h4p_B | 34 | MENT, heterochromatin-associated protein MENT; ser | 99.4 | |
| 4afx_B | 36 | Protein Z dependent protease inhibitor; hydrolase | 99.4 | |
| 3f02_C | 48 | Neuroserpin; cleaved form, fenib, human, disease M | 99.31 | |
| 1m93_C | 41 | Serine proteinase inhibitor 2; serpin, CRMA, apopt | 99.29 | |
| 1mtp_B | 43 | Serine proteinase inhibitor (serpin), chain B; str | 99.23 | |
| 3dy0_B | 29 | C-terminus plasma serine protease inhibitor; serpi | 99.15 |
| >3f5n_A Neuroserpin; cleaved form, fenib, human, tissue PLAS activator, hydrolase inhibitor; 3.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-75 Score=554.04 Aligned_cols=329 Identities=24% Similarity=0.433 Sum_probs=288.6
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCCc
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADSG 80 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 80 (342)
+||++||+++....+++|++|||+||+.+|+|++.||+|+|++||.++||++.. +..+++..|+ .++..+...+.+
T Consensus 25 ~Fa~~L~~~l~~~~~~~Niv~SP~SI~~aLaml~~GA~G~T~~el~~~L~~~~~-~~~~~~~~~~--~l~~~l~~~~~~- 100 (407)
T 3f5n_A 25 DLSVNMYNRLRATGEDENILFSPLSIALAMGMMELGAQGSTQKEIRHSMGYDSL-KNGEEFSFLK--EFSNMVTAKESQ- 100 (407)
T ss_dssp HHHHHHHHHHHHTTTTSCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHHCCC-----CCCHHHHH--HHHHHTTC-CCS-
T ss_pred HHHHHHHHHHHhhCCCCCEEEchHHHHHHHHHHHhhcCchHHHHHHHHhCCCCC-CHHHHHHHHH--HHHHHHhccCCC-
Confidence 499999999998778899999999999999999999999999999999999864 3345777776 777777655555
Q ss_pred eEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE--
Q psy7902 81 LTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL-- 153 (342)
Q Consensus 81 ~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl-- 153 (342)
+.+.++|++|++++++++++|++ +|+++++.+||. +++.+++ ||+||+++|+|+|++++++++++++|.++|
T Consensus 101 ~~l~~an~l~~~~~~~l~~~F~~~~~~~y~a~~~~vdF~-~~~~a~~~IN~WV~~~T~gkI~~ll~~~~l~~~t~lvLvN 179 (407)
T 3f5n_A 101 YVMKIANSLFVQNGFHVNEEFLQMMKKYFNAAVNHVDFS-QNVAVANYINKWVENNTNNLVKDLVSPRDFDAATYLALIN 179 (407)
T ss_dssp CEEEEEEEEEEETTCCBCTTHHHHHHHTSCCEEEEECTT-SHHHHHHHHHHHHHHTTTTCSCCCCCGGGCCTTCCEEEEE
T ss_pred cEEEEEEEEEEeCCCccCHHHHHHHHHhhcCceEEcCCC-ChHHHHHHHHHHHHHhhCCchhhcCCcccCCCCceEEEEE
Confidence 88999999999999999999975 899999999996 7888888 999999999999999998889999999988
Q ss_pred -------ecc---------------CCceEEec--------ceeecCCCC------eEEEEeecCCCceEEEEEeCCCCC
Q psy7902 154 -------WLP---------------STQESIII--------ITVLSSELN------AHILEVPYKGGNMSMFFLLPPFAS 197 (342)
Q Consensus 154 -------W~~---------------~~~~~~V~--------~~~~~~~~~------~~vvelP~~~~~~sm~iilP~~~~ 197 (342)
|+. +++++.|| +|+++++++ |++++|||+++++||+||||+++
T Consensus 180 aiyFkg~W~~~F~~~~T~~~~F~~~~g~~v~V~mM~~~~~f~y~~~~~l~~~~~~~~~vleLPY~~~~~sm~iiLP~~~- 258 (407)
T 3f5n_A 180 AVYFKGNWKSQFRPENTRTFSFTKDDESEVQIPMMYQQGEFYYGEFSDGSNEAGGIYQVLEIPYEGDEISMMLVLSRQE- 258 (407)
T ss_dssp EEEEECCBSSCCCGGGCEEEEEECTTSCEEEEEEEEEEEEEEEEEEECC-----CEEEEEEEEBTTSSEEEEEEECCTT-
T ss_pred eeeeecccccCCCccCceeeeEEcCCCeEEEEeEEEEeeeeeeEEccccccccCcceEEEEEECCCCcEEEEEEECCCC-
Confidence 877 35566777 577778888 99999999988999999999987
Q ss_pred CCcHHHHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC-CCCeeeccee
Q psy7902 198 QDGVGDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-DSHIAFGDAV 276 (342)
Q Consensus 198 ~~~l~~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~-~~~l~ls~v~ 276 (342)
.+|.+++++|+.+ .+.+|.+. +..+.|+|.||||++++++||+++|++||++++|+..|||++|+ +++++||+|+
T Consensus 259 -~~L~~l~~~L~~~--~l~~~~~~-~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~~Adfsgis~~~~l~vs~v~ 334 (407)
T 3f5n_A 259 -VPLATLEPLVKAQ--LVEEWANS-VKKQKVEVYLPRFTVEQEIDLKDVLKALGITEIFIKDANLTGLSDNKEIFLSKAI 334 (407)
T ss_dssp -CCGGGTGGGCCHH--HHHHHHHH-CEEEEEEEEEECEEEEEEEEHHHHHHHTTCCGGGSTTCCCTTTBSCTTCCCCEEE
T ss_pred -CCHHHHHHHhCHH--HHHHHHHh-CcceEEEEECCCEEEeeecChHHHHHhCCchhhcCCCCCcccccCCCCceeeeEE
Confidence 7999999999987 99999988 68999999999999999999999999999999999889999999 7889999999
Q ss_pred eeEEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCCCCC
Q psy7902 277 HKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEPPNK 340 (342)
Q Consensus 277 q~~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~~~ 340 (342)
|+++|+|||+|++|+|+|++.+..++.+.. ..|++||||+|+|+|+.|+.|||+|+|.+|...
T Consensus 335 hka~ieVnE~GteAAAaT~~~~~~~~~~~~-~~f~~drPFlF~I~~~~t~~iLF~G~v~~P~~~ 397 (407)
T 3f5n_A 335 HKSFLEVNEEGSEAAAVSGMIAISRMAVLY-PQVIVDHPFFFLIRNRRTGTILFMGRVMHPETM 397 (407)
T ss_dssp EEEEEEECSCBCCCCC-----CCSSSEEEE-CEEECCSCEEEEEEETTTCCEEEEEEESCCCCC
T ss_pred EEEEEEecCCccccccccceeeccccCCCC-CcEEecCCEEEEEEECCCCcEEEEEEeCCcCCC
Confidence 999999999999999999876554433222 389999999999999999999999999999754
|
| >1uhg_A Ovalbumin, S-ovalbumin; allergen, egg white protein, serpin; HET: SEP NAG; 1.90A {Gallus gallus} SCOP: e.1.1.1 PDB: 1ova_A* 1jti_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-75 Score=547.48 Aligned_cols=327 Identities=23% Similarity=0.477 Sum_probs=293.8
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCCh--------H---HHHHHhhHHHH
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDK--------L---DTMNVYKMEKL 69 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~--------~---~~~~~~~~~~~ 69 (342)
+||++||+++...++++|++|||+||+.+|+|++.||+|+|++||.++||++..... . +++..|+ .+
T Consensus 9 ~Fa~~l~~~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~--~l 86 (385)
T 1uhg_A 9 EFCFDVFKELKVHHANENIFYCPIAIMSALAMVYLGAKDSTRTQINKVVRFDKLPGFGDSIEAQCGTSVNVHSSLR--DI 86 (385)
T ss_dssp HHHHHHHHHHHHHCTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHHTCTTCTTCSHHHHTTTTSCTTTTHHHH--HH
T ss_pred HHHHHHHHHHHhcCCCCCEEECHHHHHHHHHHHHhhccCcHHHHHHHHhCCCcccccccccccccchHHHHHHHHH--HH
Confidence 499999999988778899999999999999999999999999999999999864211 3 6777786 77
Q ss_pred HHHhhhCCCCceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCC
Q psy7902 70 IQGLRANADSGLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQ 144 (342)
Q Consensus 70 l~~l~~~~~~~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~ 144 (342)
+..+...+.+ +.++++|++|++++++++++|.+ +|+++++.+||.++++.+++ ||+||+++|+|+|++++++++
T Consensus 87 ~~~l~~~~~~-~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~wV~~~T~gkI~~l~~~~~ 165 (385)
T 1uhg_A 87 LNQITKPNDV-YSFSLASRLYAEERYPILPEYLQCVKELYRGGLEPINFQTAADQARELINSWVESQTNGIIRNVLQPSS 165 (385)
T ss_dssp HHHHTSCCSS-EEEEEEEEEEEETTSCBCHHHHHHHHHHCSSCEEEECCTTTHHHHHHHHHHHHHHHTTTCSCCCSCTTS
T ss_pred HHHHhCCCCC-cEEEEEEEeeccCCCCccHHHHHHHHHHhCCEEEEecCCCCHHHHHHHHHHHHHHHhcCchhhhCCccc
Confidence 7777665555 89999999999999999999975 89999999999778888888 999999999999999999889
Q ss_pred CCCCceEEE---------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEe
Q psy7902 145 VNSRTNLVL---------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLL 192 (342)
Q Consensus 145 i~~~t~lvl---------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iil 192 (342)
++++|.++| |++ +++.+.|| +|++.++++|++++|||+++++||+|+|
T Consensus 166 l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vleLPy~~~~~sm~iiL 245 (385)
T 1uhg_A 166 VDSQTAMVLVNAIVFKGLWEKAFKDEDTQAMPFRVTEQESKPVQMMYQIGLFRVASMASEKMKILELPFASGTMSMLVLL 245 (385)
T ss_dssp SCTTCCEEEEEEEEEEECEEECCCGGGCEEEEECCCC--CEEEEEEEEEEEEEEEEEGGGTEEEEEEEBTTSSEEEEEEE
T ss_pred CCCccceEeeeeeEEeeeecCCCCcCCCcCcEEEECCCeEEEEEEEEeeceEEEEEeCCCCeEEEEeccCCCcEEEEEEe
Confidence 999999988 976 34556676 6778899999999999999899999999
Q ss_pred CCCCCCCcHHHHHHHhcCCchHHHHHhhh-cCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC-CCCe
Q psy7902 193 PPFASQDGVGDILAALKKDPTSFKRFTED-SQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-DSHI 270 (342)
Q Consensus 193 P~~~~~~~l~~l~~~L~~~~~~l~~~~~~-~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~-~~~l 270 (342)
|+++ .+|.+++++|+.+ .+..|.+. .+..+.|+|.||||++++++||+++|++||++++|+..|||++|+ ++++
T Consensus 246 P~~~--~~l~~l~~~L~~~--~l~~~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~Adfs~is~~~~l 321 (385)
T 1uhg_A 246 PDEV--SGLEQLESIINFE--KLTEWTSSNVMEERKIKVYLPRMKMEEKYNLTSVLMAMGITDVFSSSANLSGISSAESL 321 (385)
T ss_dssp ESST--TCHHHHHHHCCHH--HHHHHTSTTTCEEEEEEEEEECEEEEEEEEHHHHHHHHTCCGGGSTTCCCTTTBCSTTC
T ss_pred CCCC--CCHHHHHHHhChh--HHHHHhhhhcccceEEEEEccceeecceecHHHHHHHcChhhhhcCccccccccCCCCe
Confidence 9987 7999999999987 99999882 267889999999999999999999999999999999779999999 6789
Q ss_pred eecceeeeEEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCC
Q psy7902 271 AFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337 (342)
Q Consensus 271 ~ls~v~q~~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P 337 (342)
+|++|+|+++|+|||+|++|+|+|++.+..++. +.+|++||||+|+|+|+.|+.|||+|+|.+|
T Consensus 322 ~vs~v~hka~ieVnE~GteAaAaT~~~~~~~~~---~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P 385 (385)
T 1uhg_A 322 KISQAVHAAHAEINEAGREVVGSAEAGVDAASV---SEEFRADHPFLFCIKHIATNAVLFFGRCVSP 385 (385)
T ss_dssp CEEEEEEEEEEEECSCEEECCCHHHHHHHHTTC---CCEEECCSCEEEEEEETTTCCEEEEEEESCC
T ss_pred EEEEEEEEEEEEecCCCcccccccchheeccCC---CCEEEeeCCEEEEEEECCCCcEEEEEEcCCC
Confidence 999999999999999999999999876655442 4799999999999999999999999999998
|
| >3sto_A Serine protease inhibitor; serpin fold, hydrolase inhibitor; 2.41A {Schistosoma haematobium} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-75 Score=551.27 Aligned_cols=330 Identities=21% Similarity=0.378 Sum_probs=282.7
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHh--hcchhHHHHHHHhhCCCCCC-------ChHHHHHHhhHHHHHH
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYF--ISNKNTEANLKQVLRLPENL-------DKLDTMNVYKMEKLIQ 71 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~--ga~g~t~~ql~~~L~~~~~~-------~~~~~~~~~~~~~~l~ 71 (342)
+||++||+++....+++|++|||+||+.+|+|++. ||+|+|++||.++||++... +..+++..|+ .++.
T Consensus 21 ~Fa~~l~~~l~~~~~~~Ni~~SP~Si~~aLaml~~~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~~~~~~~~~--~l~~ 98 (406)
T 3sto_A 21 AFTHAYLSTVTADFGGDNFLTCPLGILFTLGILLGSGGAQGRTGYQIGKTMRLKSTSSSWNSSEAQQEMKSLYQ--ELNN 98 (406)
T ss_dssp HHHHHHHHHHTGGGTTSCEEECHHHHHHHHHHHHHTSCSCHHHHHHHHHHTTCSTTSSSCCHHHHHHHHHHHHH--HHHH
T ss_pred HHHHHHHHHHhhcCCCCCEEEccHHHHHHHHHHHhccccCchHHHHHHHHhCCCcccccccccCCHHHHHHHHH--HHHH
Confidence 49999999998767889999999999999999999 99999999999999998542 2357888887 7777
Q ss_pred HhhhCCC------CceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCc
Q psy7902 72 GLRANAD------SGLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLI 140 (342)
Q Consensus 72 ~l~~~~~------~~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~ 140 (342)
.+...+. + +.+.++|++|++++++++++|++ +|+++++.+|| ++++.+++ ||+||+++|+|+|++++
T Consensus 99 ~l~~~~~~~~~~~~-~~l~~an~l~~~~~~~l~~~F~~~~~~~y~a~~~~vdF-~~~~~a~~~IN~WV~~~T~gkI~~ll 176 (406)
T 3sto_A 99 SLTSEKTFLNEKEE-NVVRISTGIFVEKTYEVERRFNESIANDSEGELKQVDF-SNRTSATVDINDWVDQQSNGLLEKFF 176 (406)
T ss_dssp HHHTCEECC---CE-ESEEEEEEEEEETTSCCCHHHHHHHHTCSSEEEEEECT-TSHHHHHHHHHHHHHHHTTTCC----
T ss_pred HHhccCcccccCCC-cEEEEEeeeeecCCCccCHHHHHHHHHHhCCeEEEeCC-CChHHHHHHHHHHHHHHhcCcchhhc
Confidence 7765432 4 77999999999999999999975 89999999999 78888888 99999999999999999
Q ss_pred cCCCCCCCceEEE---------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEE
Q psy7902 141 ATGQVNSRTNLVL---------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSM 188 (342)
Q Consensus 141 ~~~~i~~~t~lvl---------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm 188 (342)
+++ ++++|.++| |++ +++.+.|| +|+++++++|++++|||++++++|
T Consensus 177 ~~~-l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~~~y~~~~~~~~~vleLPy~~~~~sm 255 (406)
T 3sto_A 177 TDD-IPDDTAMILVNVFYFRDFWQSPFEPHYTRKEDFYISPDRQITVDMMTQEGVMKYGKFEDEGFEIVSKPLNNTRFTF 255 (406)
T ss_dssp -----CCSCCEEEEEEEEECEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSTTEEE
T ss_pred cCC-CCCCceEEEEEeeEEEeecccCCCccCCcCceEECCCCeEEEEeEEEeeCceEEEEEcCCCeEEEEEecCCCcEEE
Confidence 876 999999988 877 35556777 677788999999999999889999
Q ss_pred EEEeCCCCCCCcHHHHHHHhc-CCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCC-CCCCCCCC
Q psy7902 189 FFLLPPFASQDGVGDILAALK-KDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSP-GADLSRLT 266 (342)
Q Consensus 189 ~iilP~~~~~~~l~~l~~~L~-~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~-~ad~s~i~ 266 (342)
+||||++. .+|.+++++|+ .+ .+.+|.++ +..+.|+|.||||++++++||+++|++||++++|++ .|||++|+
T Consensus 256 ~iiLP~~~--~~l~~l~~~L~~~~--~l~~~~~~-~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfsgis 330 (406)
T 3sto_A 256 VIVLPLEK--WSLNGATELLNGNK--VLSEYVKN-LKETTVSLRLPKFTLKNTLDLVPTLKSIGVVDLFDPVKSDLSGIT 330 (406)
T ss_dssp EEEEESSS--SCCTTHHHHHSSSS--CHHHHHTT-CEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGCTTTCCCTTTC
T ss_pred EEEecCCC--CCHHHHHHHcCchH--HHHHHHHh-CcEeEEEEEecCEEEeeecChhhhhhhCCchhhcCCCCCCccccc
Confidence 99999987 79999999999 87 89999988 689999999999999999999999999999999998 79999999
Q ss_pred -CCCeeecceeeeEEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCCCCC
Q psy7902 267 -DSHIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEPPNK 340 (342)
Q Consensus 267 -~~~l~ls~v~q~~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~~~ 340 (342)
.++++|++|+|+++|+|||+|++|+|+|++.+..++.+..+..|++||||+|+|+|+.|++|||+|+|.+|.++
T Consensus 331 ~~~~l~vs~v~hka~ieV~E~GteAaAaT~~~~~~~s~~~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~~ 405 (406)
T 3sto_A 331 PNPNLYVNEFIQTNVLKLNESGIEATTVTSPIFVPFSAIIPEVDFHVTHPFICFIYDQQLTMPIMAAKVMNPVLQ 405 (406)
T ss_dssp SSTTCCCSEEEEEEEEEECSSEESCCC-------CCCSCCCSEEEECCSCEEEEEEETTTTEEEEEEEESSCC--
T ss_pred CCCCceEEEEEEEEEEEecCCcccccccceeeeecccCCCCCceEEeeCCEEEEEEECCCCcEEEEEEeCCccCC
Confidence 67899999999999999999999999998766554443356899999999999999999999999999999864
|
| >4ga7_A Leukocyte elastase inhibitor; serpin, conformational change, serine protease inhibitor, Ca inhibitor, chymase inhibitor, chymotrypsin inhibitor; 2.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-75 Score=548.28 Aligned_cols=327 Identities=31% Similarity=0.534 Sum_probs=285.0
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCCc
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADSG 80 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 80 (342)
+||++||+++....+++|++|||+||+.+|+|++.||+|+|++||.++||++.. .+++..|+ .++..+...+.+
T Consensus 20 ~Fa~~L~~~l~~~~~~~Ni~~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~---~~~~~~~~--~l~~~l~~~~~~- 93 (389)
T 4ga7_A 20 RFALDLFLALSENNPAGNIFISPFSISSAMAMVFLGTRGNTAAQLSKTFHFNTV---EEVHSRFQ--SLNADINKRGAS- 93 (389)
T ss_dssp HHHHHHHHHHHHHCSSSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTGGGC---TTHHHHHH--HHHHHHTCTTCS-
T ss_pred HHHHHHHHHHhhcCCCCCEEEchHHHHHHHHHHHhhccCcHHHHHHHHhCCCCH---HHHHHHHH--HHHHHHhCCCCC-
Confidence 499999999998778899999999999999999999999999999999999843 45788887 778888665556
Q ss_pred eEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE--
Q psy7902 81 LTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL-- 153 (342)
Q Consensus 81 ~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl-- 153 (342)
+.+.++|++|++++++++++|++ +|+++++.+||.++++.+++ ||+||+++|+|+|++++++++++++|.++|
T Consensus 94 ~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~~T~g~I~~ll~~~~l~~~t~lvLvN 173 (389)
T 4ga7_A 94 YILKLANRLYGEKTYNFLPEFLVSTQKTYGADLASVDFQHASEDARKTINQWVKGQTEGKIPELLASGMVDNMTKLVLVN 173 (389)
T ss_dssp SEEEEEEEEEEETTSCBCHHHHHHHHHHTSCCEEEECHHHHHHHHHHHHHHHHHHHTTTSSTTSSCTTSSCTTCCEEEEE
T ss_pred cEEEEeeeeeecCCCccCHHHHHHHHHHhCCeeEecccccCHHHHHHHHHHHHHHhhCCchhhccCCCCCCCCceEEEEE
Confidence 89999999999999999999975 89999999999655788888 999999999999999999889999999988
Q ss_pred -------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCC--CCcH
Q psy7902 154 -------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFAS--QDGV 201 (342)
Q Consensus 154 -------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~--~~~l 201 (342)
|++ +++.+.|| +|+++++++|++++|||+++++||+||||+++. ..+|
T Consensus 174 aiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vleLPy~~~~~sm~iiLP~~~~~~~~~L 253 (389)
T 4ga7_A 174 AIYFKGNWKDKFMKEATTNAPFRLNKKDRKTVKMMYQKKKFAYGYIEDLKCRVLELPYQGEELSMVILLPDDIEDESTGL 253 (389)
T ss_dssp EEEEECCBSSCCCTTTCEEEEEEEETTEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBTTSSEEEEEEEESSCCSSSSSC
T ss_pred EEEEEeeecCCCCccCccccceEeCCCcEEEEEEEEEeeeEEEEEECCCCEEEEEEECCCCCEEEEEEecCCCccccccH
Confidence 887 34556677 578899999999999999889999999998741 0489
Q ss_pred HHHHHHhcCCchHHHHHh--hhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCC-CCCCCCCC-CCCeeecceee
Q psy7902 202 GDILAALKKDPTSFKRFT--EDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSP-GADLSRLT-DSHIAFGDAVH 277 (342)
Q Consensus 202 ~~l~~~L~~~~~~l~~~~--~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~-~ad~s~i~-~~~l~ls~v~q 277 (342)
.+++++|+.+ .+..|. .. +..+.|+|.||||++++++||+++|++||++++|++ .|||++|+ +++++||+|+|
T Consensus 254 ~~le~~L~~~--~l~~~~~~~~-~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~~~Adfsgis~~~~l~vs~v~h 330 (389)
T 4ga7_A 254 KKIEEQLTLE--KLHEWTKPEN-LDFIEVNVSLPRFKLEESYTLNSDLARLGVQDLFNSSKADLSGMSGARDIFISKIVH 330 (389)
T ss_dssp HHHHHHCCHH--HHHHHHSGGG-CEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGCTTTCCCTTTBCCSSCCEEEEEE
T ss_pred HHHHHHhCHH--HHHHHhhhhc-CcceEEEEEeccEEEEEeechHHHHHHcCcHhhcCCCcCCcccccCCCCcceeeEEE
Confidence 9999999988 999998 45 688999999999999999999999999999999996 79999999 67899999999
Q ss_pred eEEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCC
Q psy7902 278 KARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337 (342)
Q Consensus 278 ~~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P 337 (342)
+++|+|||+|++|+|+|++.+..++.+ .+..|++||||+|+|+|+.|++|||+|+|.+|
T Consensus 331 ka~ieVnE~GteAaAaT~~~~~~~s~~-~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P 389 (389)
T 4ga7_A 331 KSFVEVNEEGTEAAAATAGIATFCMDD-PEENFTADHPFLFFIRHNSSGSILFLGRFSSP 389 (389)
T ss_dssp EEEEEECSCBC----------CCCSSS-CEEEEECCSCEEEEEEETTTTEEEEEEEECCC
T ss_pred EEEEEecCCCcccccccccccccccCC-CCCcEEccCCEEEEEEECCCCcEEEEEEecCC
Confidence 999999999999999998766544433 35789999999999999999999999999998
|
| >3nda_A Serpin-2; vaccination target, TICK, hydrolase inhibitor; HET: 1PE; 1.80A {Ixodes ricinus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-75 Score=545.09 Aligned_cols=326 Identities=29% Similarity=0.516 Sum_probs=294.5
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCC-CChHHHHHHhhHHHHHHHhhhCCCC
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPEN-LDKLDTMNVYKMEKLIQGLRANADS 79 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~-~~~~~~~~~~~~~~~l~~l~~~~~~ 79 (342)
+||++||+++.... ++|++|||+||+.+|+|++.||+|+|++||.++||++.. .+..+++..|+ .++..+...+.+
T Consensus 13 ~Fa~~l~~~l~~~~-~~Ni~~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~i~~~~~--~l~~~l~~~~~~ 89 (377)
T 3nda_A 13 RFGLRLLRALPSGP-EKNVFFSPYSVSTAMGMAFAGARGQTQQELSQGLGFSDVDLTDAGVLDAYT--HHTERLKSTPSN 89 (377)
T ss_dssp HHHHHHHHHSCCBT-TBCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTTGGGTCCHHHHHHHHH--HHHHHHHHCCCS
T ss_pred HHHHHHHHHHhhcC-CCCEEEecHHHHHHHHHHHhhccchhHHHHHHHhCCCCcCCCHHHHHHHHH--HHHHHhcCCCCC
Confidence 49999999998755 899999999999999999999999999999999999853 14567888887 788888766556
Q ss_pred ceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE-
Q psy7902 80 GLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL- 153 (342)
Q Consensus 80 ~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl- 153 (342)
+.++++|++|++++++++++|.+ +|+++++.+||.++++.+++ ||+||+++|+|+|++++ +++++++|.++|
T Consensus 90 -~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~wV~~~T~g~I~~ll-~~~l~~~t~lvLv 167 (377)
T 3nda_A 90 -STLDVANAAAIQRTLALLNSYESALQSSFGAELHKVDFAGEPQAAVDFVNNWVKRKTHDKIEKLF-NEPLDPDTLLVLL 167 (377)
T ss_dssp -SEEEEEEEEEEETTCCCCHHHHHHHHHHHCCEEEEECTTTCHHHHHHHHHHHHHHHTTTSCCCSC-SSCCCTTCCEEEE
T ss_pred -cEEEEEeEEEEeCCCCchHHHHHHHHHhccCceEEecCCCCHHHHHHHHHHHHHHHhcCchhhhc-CCCCCCCceEEEE
Confidence 89999999999999999999975 89999999999778888888 99999999999999999 889999999988
Q ss_pred --------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHH
Q psy7902 154 --------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVG 202 (342)
Q Consensus 154 --------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~ 202 (342)
|++ +++++.|| +|+++++++|++++|||+++++||+||||+++ .+|.
T Consensus 168 NaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~~~~~vleLPy~~~~~sm~iiLP~~~--~~l~ 245 (377)
T 3nda_A 168 NAIYFKGEWNTAFVKEHTEKRQFFNGGVTPVEVDTMRLEARIKYRFFDDLQVEVVELPYRGLDYTMAILLPKEN--TGVE 245 (377)
T ss_dssp EEEEEEEEBSSCCCGGGCEEEEEEETTTEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBTTSSEEEEEEEESST--TCHH
T ss_pred ehheeccccccCCCCccccccceecCCCeEEEEeeEeeECeEEEEEEcCCCeEEEEEecCCCcEEEEEEEcCCC--CCHH
Confidence 877 35556777 67788899999999999988999999999987 7999
Q ss_pred HHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCCCCCeeecceeeeEEEE
Q psy7902 203 DILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLTDSHIAFGDAVHKARLD 282 (342)
Q Consensus 203 ~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~~~~l~ls~v~q~~~i~ 282 (342)
+++++|+.+ .+.+|.++ +..+.|+|.||||++++++||+++|++||++++|++.|||++|++++++||+|+|+++|+
T Consensus 246 ~l~~~L~~~--~l~~~~~~-~~~~~v~v~lPkF~i~~~~~L~~~L~~lGi~~~F~~~Adfsgis~~~l~vs~v~hka~ie 322 (377)
T 3nda_A 246 GLKQNLTID--RFQNYLSD-LRERKITVLLPKFKLETKYSLKAPLQSLGIKQIFESGADLSGINDGSLRVSAVEHKAVVE 322 (377)
T ss_dssp HHHHHCCHH--HHHHHHHH-CEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGSTTCCCHHHHSSCEEEEEEEEEEEEE
T ss_pred HHHHHhCHH--HHHHHHHh-CCeEEEEEEecceEeEeecCHHHHHHhCCchhhcCCCCCCcccCCCCceEeEEEEEEEEE
Confidence 999999988 99999988 689999999999999999999999999999999998899999997779999999999999
Q ss_pred ecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcC
Q psy7902 283 LDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNE 336 (342)
Q Consensus 283 v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~ 336 (342)
|||+|++|+|+|++.+..++.+..+..|++||||+|+|+|+.|+.|||+|+|.+
T Consensus 323 V~E~GteAaAaT~~~~~~~s~~~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~ 376 (377)
T 3nda_A 323 VNEEGTVAAATTGVVIVPYSLGPEPVVFRVDHPFLFFIRNTRTDDIFFVGQVNK 376 (377)
T ss_dssp ECSSEEEEEEEEEEEEEEC---CCCCEEECCSCEEEEEEETTTCCEEEEEEECC
T ss_pred ECCCCccccccceeeeecccCCCCCCeEEeeCCEEEEEEECCCCcEEEEEEEec
Confidence 999999999999876665554445689999999999999999999999999985
|
| >3ne4_A Alpha-1-antitrypsin; serpin, LUNG disease, liver disease, polymerisation, hydrolase inhibitor; 1.81A {Homo sapiens} PDB: 1qlp_A 2qug_A 3cwl_A 3cwm_A* 1psi_A 3drm_A 1kct_A 3dru_A 1hp7_A 1iz2_A* 1oph_A 1oo8_A 1atu_A 1d5s_B 1qmb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-74 Score=545.05 Aligned_cols=324 Identities=27% Similarity=0.480 Sum_probs=292.6
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCC-ChHHHHHHhhHHHHHHHhhhCCCC
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENL-DKLDTMNVYKMEKLIQGLRANADS 79 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~-~~~~~~~~~~~~~~l~~l~~~~~~ 79 (342)
+||++||+++...++++|++|||+||+.+|+|++.||+|+|++||.++||++... +..+++..|+ .++..+...+.+
T Consensus 62 ~Fa~~L~~~l~~~~~~~Ni~~SP~SI~~aLaml~~GA~g~T~~ql~~~L~~~~~~~~~~~i~~~f~--~ll~~l~~~~~~ 139 (424)
T 3ne4_A 62 EFAFSLYRQLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGFQ--ELLRTLNQPDSQ 139 (424)
T ss_dssp HHHHHHHHHHHHHCSSSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHH--HHHHHHTCSSCS
T ss_pred HHHHHHHHHHHhhCCCCCEEECHHHHHHHHHHHHhhcccHHHHHHHHHhCCCCCCCCHHHHHHHHH--HHHHHhcCCCCC
Confidence 4999999999987788999999999999999999999999999999999998532 4567888887 888888765555
Q ss_pred ceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE-
Q psy7902 80 GLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL- 153 (342)
Q Consensus 80 ~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl- 153 (342)
..+.++|++|++++++++++|.+ +|+++++.+||. +++.+++ ||+||+++|+|+|+++++ +++++|.++|
T Consensus 140 -~~l~~an~lf~~~~~~l~~~F~~~~~~~y~a~~~~vdF~-~~~~a~~~IN~wV~~~T~gkI~~ll~--~l~~~t~lvLv 215 (424)
T 3ne4_A 140 -LQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFG-DTEEAKKQINDYVEKGTQGKIVDLVK--ELDRDTVFALV 215 (424)
T ss_dssp -SCCEEEEEEEEETTSCBCHHHHHHHHTTTCCEEEEECTT-SHHHHHHHHHHHHHHHTTTSSCSCCC--CCCTTCCEEEE
T ss_pred -cEEEEEEEEEEcCCCCcCHHHHHHHHHhhcceEEEecCC-ChHHHHHHHHHHHHHhhCCCcccccc--CCCCcchhhhh
Confidence 78999999999999999999975 899999999995 7888888 999999999999999995 7999999988
Q ss_pred --------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHH
Q psy7902 154 --------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVG 202 (342)
Q Consensus 154 --------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~ 202 (342)
|+. +++.+.|| .|+++++++|++++|||++ +++|+||||+++ +|.
T Consensus 216 NaiyFKg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~f~y~~~~~l~~~vleLPY~~-~~sm~iiLP~~~---~l~ 291 (424)
T 3ne4_A 216 NYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHCKKLSSWVLLMKYLG-NATAIFFLPDEG---KLQ 291 (424)
T ss_dssp EEEEEECCBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEETTTTEEEEEEEETT-TEEEEEEEECTT---CHH
T ss_pred hHHhhehhhhcCCCcccceeEeeeccCCcEEEEEEEEeecceeEEEecCCCeEEEEEecCC-CeEEEEEEcCcC---CHH
Confidence 887 35556777 6778899999999999975 589999999875 899
Q ss_pred HHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC-CCCeeecceeeeEEE
Q psy7902 203 DILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-DSHIAFGDAVHKARL 281 (342)
Q Consensus 203 ~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~-~~~l~ls~v~q~~~i 281 (342)
+++++|+.+ .+.+|.+. +..+.|+|.||||+|++++||+++|++||++++|++.|||++|+ +++++||+|+|+++|
T Consensus 292 ~le~~L~~~--~l~~~~~~-l~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~Adfsgis~~~~l~Vs~v~hka~i 368 (424)
T 3ne4_A 292 HLENELTHD--IITKFLEN-EDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSNGADLSGVTEEAPLKLSKAVHKAVL 368 (424)
T ss_dssp HHHHHCCHH--HHHHHHHC-CCCEEEEEEEECEEEEEEEEHHHHHHHTTCCGGGSTTCCCTTTBSSSCCCCCEEEEEEEE
T ss_pred HHHHHhCHH--HHHHHHHh-CccceEEEEcCCEEEEeecchhhhhhhCChhhhcCCCCCcccccCCCCcceeeEEEEEEE
Confidence 999999987 99999988 79999999999999999999999999999999999889999999 688999999999999
Q ss_pred EecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCCCCC
Q psy7902 282 DLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEPPNK 340 (342)
Q Consensus 282 ~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~~~ 340 (342)
+|||+|++|+|+|++....++. +..|++||||+|+|+|+.|+.|||+|+|.+|.++
T Consensus 369 eVnE~GteAAAaT~~~~~~~s~---~~~f~~drPFlf~I~d~~t~~iLF~G~v~~P~~~ 424 (424)
T 3ne4_A 369 TIDEKGTEAAGAMFLEAIPMSI---PPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQK 424 (424)
T ss_dssp EECSSSSSSCCCCCCCCCCSSC---CCEEECCSCEEEEEEETTTCCEEEEEEESCTTC-
T ss_pred EEcCCCcccccccceeeeecCC---CCceeccCCEEEEEEECCCCeEEEEEEecCCCCC
Confidence 9999999999999876554332 4579999999999999999999999999999863
|
| >2zv6_A Serpin B3; serine proteinase inhibitor, reactive site loop, acetylation, alternative splicing, cytoplasm, polymorphism, protease inhibitor; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-75 Score=550.52 Aligned_cols=329 Identities=32% Similarity=0.550 Sum_probs=278.8
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCC-------------ChHHHHHHhhHH
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENL-------------DKLDTMNVYKME 67 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~-------------~~~~~~~~~~~~ 67 (342)
+||++||+++...++ +|++|||+||+.+|+|++.||+|+|++||.++||++... +..+++..|+
T Consensus 21 ~Fa~~l~~~l~~~~~-~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 97 (401)
T 2zv6_A 21 KFMFDLFQQFRKSKE-NNIFYSPISITSALGMVLLGAKDNTAQQIKKVLHFDQVTENTTGKAATYHVDRSGNVHHQFQ-- 97 (401)
T ss_dssp HHHHHHHHHHHHHCC-SCEEECHHHHHHHHHHHHHTCCTHHHHHHHHHTTC--------------------CTHHHHH--
T ss_pred HHHHHHHHHHhhCCC-CCEEEchHHHHHHHHHHHHhccChHHHHHHHHhCCCcccccccccccccccccHHHHHHHHH--
Confidence 499999999988677 999999999999999999999999999999999998531 0246778886
Q ss_pred HHHHHhhhCCCCceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccC
Q psy7902 68 KLIQGLRANADSGLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIAT 142 (342)
Q Consensus 68 ~~l~~l~~~~~~~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~ 142 (342)
.++..+...+.+ +.+.++|++|++++++++++|.+ +|+++++.+||.++++.+++ ||+||+++|+|+|++++++
T Consensus 98 ~l~~~l~~~~~~-~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~~T~gkI~~ll~~ 176 (401)
T 2zv6_A 98 KLLTEFNKSTDA-YELKIANKLFGEKTYLFLQEYLDAIKKFYQTSVESVDFANAPEESRKKINSWVESQTNEKIKNLIPE 176 (401)
T ss_dssp HHHHHHHSCCSS-CCEEEECCEEEETTSCCCHHHHHHHHHHHSCCEEEECTTTCHHHHHHHHHHHHHHHTTTCSCCSSCT
T ss_pred HHHHHhhCCCCC-cEEEEEEEEEecCCCChhHHHHHHHHHHhCCEEEEccCCCCHHHHHHHHHHHHHHhhCCccccccCc
Confidence 777888765555 88999999999999999999975 89999999999778888888 9999999999999999998
Q ss_pred CCCCCCceEEE---------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEE
Q psy7902 143 GQVNSRTNLVL---------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFF 190 (342)
Q Consensus 143 ~~i~~~t~lvl---------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~i 190 (342)
++++++|.++| |+. +++.+.|| +|++.++++|++++|||+++++||+|
T Consensus 177 ~~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~f~~~~~~~l~~~vleLPY~~~~~sm~i 256 (401)
T 2zv6_A 177 GNIGSNTTLVLVNAIYFKGQWEKKFNKEDTKEEKFWPNKNTYKSIQMMRQYTSFHFASLEDVQAKVLEIPYKGKDLSMIV 256 (401)
T ss_dssp TTSCTTCCEEEEEEEEECCCBSSCCCTTSEEEEEECSSSSCCEEEEEEEEEEEEEECEETTTTEEEEEEEBTTSSSEEEE
T ss_pred ccCCCcceEEEEEhheeccccCCCCCCCCceeeEEEecCCceEEeEEEeccCceeEEEeCCCCEEEEEeecCCCcEEEEE
Confidence 88999999988 876 34456666 67788999999999999998999999
Q ss_pred EeCCCCCCCcHHHHHHHhcCCchHHHHHhhh-cCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC-CC
Q psy7902 191 LLPPFASQDGVGDILAALKKDPTSFKRFTED-SQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-DS 268 (342)
Q Consensus 191 ilP~~~~~~~l~~l~~~L~~~~~~l~~~~~~-~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~-~~ 268 (342)
|||++. .+|.+++++|+.+ .+..|.+. .+..+.|+|.||||++++++||+++|++||++++|+..|||++|+ ++
T Consensus 257 iLP~~~--~~L~~le~~L~~~--~l~~~~~~~~~~~~~v~v~lPKFkie~~~dL~~~L~~lGi~~~F~~~Adfsgis~~~ 332 (401)
T 2zv6_A 257 LLPNEI--DGLQKLEEKLTAE--KLMEWTSLQNMRETRVDLHLPRFKVEESYDLKDTLRTMGMVDIFNGDADLSGMTGSR 332 (401)
T ss_dssp EEESST--TCHHHHHHHCCHH--HHHHHTCGGGCEEEEEEEEEECCEEEEEEECHHHHHHTTCCGGGSTTCCCHHHHSSS
T ss_pred EecCCC--CCHHHHHHHhCHh--HHHHHhhhcccceeEEEEEeeeEEEEEEecHHHHHHhcCccccCCCcccccccCCCC
Confidence 999987 7999999999988 99999872 267889999999999999999999999999999999779999999 68
Q ss_pred CeeecceeeeEEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCC
Q psy7902 269 HIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337 (342)
Q Consensus 269 ~l~ls~v~q~~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P 337 (342)
+++|++|+|+++|+|||+|++|+|+|++.+..++.+..+.+|++||||+|+|+|+.|+.|||+|+|.+|
T Consensus 333 ~l~vs~v~hka~ieVnE~GteAaAaT~~~~~~~~~~~~~~~f~~drPFlF~I~~~~t~~iLF~G~v~~P 401 (401)
T 2zv6_A 333 GLVLSGVLHKAFVEVTEEGAEAAAATAVVGFGSSPTSTNEEFHCNHPFLFFIRQNKTNSILFYGRFSSP 401 (401)
T ss_dssp CCCEEEEEEEEEEECCSCC-------------------CEEEECSSCEEEEECCTTTTCCCCEEEECCC
T ss_pred CeEEEEEEEEEEEEecCCCcccccccchhhccccCCCCCCEEEecCCEEEEEEECCCCeEEEEEEeCCC
Confidence 899999999999999999999999998766554443334789999999999999999999999999998
|
| >3kcg_I Antithrombin-III, ATIII; michaelis complex, blood coagulation, calcium, disulfide bond, EGF-like domain, glycoprotein, hemophilia, hydrolase; HET: NAG FUC MAN NTP; 1.70A {Homo sapiens} SCOP: e.1.1.1 PDB: 1e04_I* 1ath_A 1ant_L* 1br8_L 1azx_I* 1dzh_L* 1e03_L* 1dzg_L* 1e05_L* 1jvq_L* 1lk6_L* 1nq9_I* 1oyh_L* 1r1l_L* 1sr5_A* 2ant_L* 2beh_L* 2hij_L* 2znh_A* 3evj_I* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-74 Score=549.55 Aligned_cols=331 Identities=27% Similarity=0.479 Sum_probs=292.2
Q ss_pred ChHHHHHHHHhh-cCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCC--ChHHHHHHhhHHHHHHHhhhCC
Q psy7902 1 EFTFDLLTVLNN-ANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENL--DKLDTMNVYKMEKLIQGLRANA 77 (342)
Q Consensus 1 ~Fa~~l~~~l~~-~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~--~~~~~~~~~~~~~~l~~l~~~~ 77 (342)
+||++||+++.. ..+++|++|||+||+.+|+|+++||+|+|++||.++||++... +..+++..|+ .++..+....
T Consensus 57 ~Fa~~L~k~l~~~~~~~~Ni~~SP~SI~~aLaml~~GA~G~T~~ql~~~L~~~~~~~~~~~~i~~~f~--~l~~~l~~~~ 134 (432)
T 3kcg_I 57 RFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFA--KLNCRLYRKA 134 (432)
T ss_dssp HHHHHHHHHHHHHSCTTSCCCBCHHHHHHHHHHHHTTCCHHHHHHHHHHTTCTTSCHHHHHTHHHHHH--HHHHHHHHHH
T ss_pred HHHHHHHHHHhhccCCCCCEEEcHHHHHHHHHHHHhhcccHHHHHHHHHhCCCccccccHHHHHHHHH--HHHHHHhccc
Confidence 499999999987 4568999999999999999999999999999999999997421 2346777776 6766664432
Q ss_pred -CCceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceE
Q psy7902 78 -DSGLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNL 151 (342)
Q Consensus 78 -~~~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~l 151 (342)
.+ ..+.++|++|++++++++++|++ +|+++++.+||.++++.+++ ||+||+++|+|+|++++++++++++|.+
T Consensus 135 ~~~-~~l~~an~lf~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~~T~gkI~~ll~~~~l~~~T~l 213 (432)
T 3kcg_I 135 NKA-SKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVL 213 (432)
T ss_dssp TTT-EEEEEEEEEEEETTSCCCHHHHHHHHHHHSSCCEEECHHHHHHHHHHHHHHHHHHHTTTSSCCSSCTTSSCTTCCE
T ss_pred CCC-cEEEEEEEEEEcCCCccCHHHHHHHHHHhCCeEEeccCCCCHHHHHHHHHHHHHhhccCchhccCCcccCCCCceE
Confidence 35 88999999999999999999975 89999999999766788888 9999999999999999988889999999
Q ss_pred EE---------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCC
Q psy7902 152 VL---------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQD 199 (342)
Q Consensus 152 vl---------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~ 199 (342)
+| |+. +++.+.|| +|++.++ ++++++|||+++.++|+||||+++ .
T Consensus 214 vLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~f~y~~~~~-~~~vleLPy~~~~~sm~iiLP~~~--~ 290 (432)
T 3kcg_I 214 VLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAE-GTQVLELPFKGDDITMVLILPKPE--K 290 (432)
T ss_dssp EEEEEEEEEECBSSCCCGGGCEEEEEECTTSCEEEEEEEEEEEEEEEEECGG-GCEEEEEEBTTSSEEEEEEECCTT--S
T ss_pred EEEeHHhhhhhhhcCCCcccceeeeEEECCCeEEEEEEEEecceeeEEEecC-CcEEEEEEcCCCceEEEEEecCCC--C
Confidence 88 877 35556777 5666777 999999999999999999999998 7
Q ss_pred cHHHHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCC-CCCCCCCC-C--CCeeecce
Q psy7902 200 GVGDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSP-GADLSRLT-D--SHIAFGDA 275 (342)
Q Consensus 200 ~l~~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~-~ad~s~i~-~--~~l~ls~v 275 (342)
+|.+++++|+.+ .+.+|+++ +..+.|+|.||||++++++||+++|++||++++|++ .|||++|+ + .+++||+|
T Consensus 291 ~L~~le~~L~~~--~l~~~~~~-~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfsgis~~~~~~l~vs~v 367 (432)
T 3kcg_I 291 SLAKVEKELTPE--VLQEWLDE-LEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDA 367 (432)
T ss_dssp CHHHHHHSCCHH--HHHHHHHH-CEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGCTTTCCCTTTSCSSSSCCCCCEE
T ss_pred CHHHHHHHcCHH--HHHHHHHh-CceeeEEEEecCEEEecccchhhhHhhCCchhhccCccCCcccccccCCCCceeeeE
Confidence 999999999987 99999998 689999999999999999999999999999999995 79999998 3 67999999
Q ss_pred eeeEEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCCCCC
Q psy7902 276 VHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEPPNK 340 (342)
Q Consensus 276 ~q~~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~~~ 340 (342)
+|+++|+|||+|++|+|+|++.+..++.+..++.|+|||||+|+|+|+.|+.|||+|+|.+|.++
T Consensus 368 ~hka~ieVnE~GteAaAaT~~~~~~~s~~~~~~~F~adrPFlf~I~d~~t~~iLF~G~V~~P~~~ 432 (432)
T 3kcg_I 368 FHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANPCVK 432 (432)
T ss_dssp EEEEEEEECSCBCCCCCCCCCCCEESSCCTTCEEEECCSCCEEEEEETTTTEEEEEC-CCCCCC-
T ss_pred EEEEEEEecCCCccccccchhhcccccCCCCCcEEecCCCEEEEEEECCCCcEEEEEEeCCCCCC
Confidence 99999999999999999998766555544445889999999999999999999999999999864
|
| >2h4r_A MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 2.70A {Gallus gallus} PDB: 2dut_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-74 Score=545.53 Aligned_cols=334 Identities=28% Similarity=0.540 Sum_probs=287.7
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCC----h-------------------
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLD----K------------------- 57 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~----~------------------- 57 (342)
+||++||+++...++++|++|||+||+.+|+|++.||+|+|++||.++||++.... .
T Consensus 15 ~Fa~~l~~~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 94 (415)
T 2h4r_A 15 NFTVDLFNKLNETNRDKNIFFSPWSISSALALTYLAAKGSTAREMAEVLHFTEAVRAESSSVARPSRGRPKRRRMDPEHE 94 (415)
T ss_dssp HHHHHHHHHHHTTCSSSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTSCCC--------------------------
T ss_pred HHHHHHHHHHhccCCCCCEEEchHHHHHHHHHHHhhccchHHHHHHHHhCCCcccccccccccccccccccccccccccc
Confidence 49999999998877789999999999999999999999999999999999985310 1
Q ss_pred --HHHHHHhhHHHHHHHhhhCCCCceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHH
Q psy7902 58 --LDTMNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQ 130 (342)
Q Consensus 58 --~~~~~~~~~~~~l~~l~~~~~~~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~ 130 (342)
.+++..|+ .++..+...+.+ +.++++|++|++++++++++|.+ +|+++++.+||.++++.+++ ||+||++
T Consensus 95 ~~~~~~~~~~--~l~~~l~~~~~~-~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~ 171 (415)
T 2h4r_A 95 QAENIHSGFK--ELLTAFNKPRNN-YSLRSANRIYVEKTYALLPTYLQLSKKYYKAEPQKVNFKTAPEQSRKEINTWVEK 171 (415)
T ss_dssp -CHHHHHHHH--HHHHHHTCSSCS-SEEEEEEEEEEETTSCBCHHHHHHHHHHHSCCCEEECTTTCHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHH--HHHHHHhCCCCC-cEEEEEEeehhhCCCCcCHHHHHHHHHHhCCeEEEecCCCCHHHHHHHHHHHHHH
Confidence 56788887 777777665555 89999999999999999999975 89999999999778888888 9999999
Q ss_pred hcccccccCccCCCCCCCceEEE---------ecc---------------CCceEEec--------ceeecCCCCeEEEE
Q psy7902 131 ETKNNIKDLIATGQVNSRTNLVL---------WLP---------------STQESIII--------ITVLSSELNAHILE 178 (342)
Q Consensus 131 ~T~g~i~~~~~~~~i~~~t~lvl---------W~~---------------~~~~~~V~--------~~~~~~~~~~~vve 178 (342)
+|+|+|++++++++++++|.++| |++ +++.+.|| +|++.++++|++++
T Consensus 172 ~T~gkI~~ll~~~~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~l~~~vle 251 (415)
T 2h4r_A 172 QTESKIKNLLSSDDVKATTRLILVNAIYFKAEWEVKFQAEKTSIQPFRLSKNKSKPVKMMYMRDTFPVLIMEKMNFKMIE 251 (415)
T ss_dssp HTTTSCCCCSCGGGCCSSCCEEEEEEEEEECBBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEE
T ss_pred HhcCchhhhcCccccCCcceEEEEEhheEeceecCCCCcccCeeeEEEecCCcEEEeeEEeecCcEeEEEeCCCCEEEEE
Confidence 99999999998888999999988 876 34556676 67889999999999
Q ss_pred eecCCCceEEEEEeCCCCC--CCcHHHHHHHhcCCchHHHHHhhh-cCCCeeEEEEeeeeEEeeccchHHHHhhCCCccC
Q psy7902 179 VPYKGGNMSMFFLLPPFAS--QDGVGDILAALKKDPTSFKRFTED-SQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDL 255 (342)
Q Consensus 179 lP~~~~~~sm~iilP~~~~--~~~l~~l~~~L~~~~~~l~~~~~~-~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~ 255 (342)
|||+++++||+||||++++ ..+|.+++++|+.+ .+..|.+. .+..+.|+|.||||++++++||+++|++||++++
T Consensus 252 LPY~~~~~sm~iiLP~~~~~~~~~L~~le~~L~~~--~l~~~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~ 329 (415)
T 2h4r_A 252 LPYVKRELSMFILLPDDIKDGTTGLEQLERELTYE--RLSEWADSKMMTETLVDLHLPKFSLEDRIDLRDTLRNMGMTTA 329 (415)
T ss_dssp EEBGGGSEEEEEEEESSCCSSSSSCHHHHTTCCHH--HHHHHHTCTTCEEEEEEEEEECEEECCEEECHHHHHHTTCCGG
T ss_pred eeCCCCcEEEEEEecCCCcccccCHHHHHHHhCHh--HHHHHhhhhcccceeEEEECCeEEEeeeecHHHHHHHcChhhh
Confidence 9999889999999998730 14899999999988 99999983 1578899999999999999999999999999999
Q ss_pred CCCCCCCCCCC-CCCeeecceeeeEEEEecCCCccccccchhhhcccCCCCC-CceEEecCCeEEEEEeCCCCcEEEEEE
Q psy7902 256 FSPGADLSRLT-DSHIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLE-PVRYEANHPFLYFLVDKEIQSILFAGV 333 (342)
Q Consensus 256 F~~~ad~s~i~-~~~l~ls~v~q~~~i~v~E~G~~a~a~t~~~~~~~~~~~~-~~~f~~drPFlf~I~~~~t~~ilf~G~ 333 (342)
|+..|||++|+ +++++|++|+|+++|+|||+|++|+|+|++.+..++.+.. +..|+|||||+|+|+|+.|+.|||+|+
T Consensus 330 F~~~Adfsgis~~~~l~vs~v~hka~ieVnE~GteAaAaT~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~iLF~G~ 409 (415)
T 2h4r_A 330 FTTNADFRGMTDKKDLAISKVIHQSFVAVDEKGTEAAAATAVIISFTTSVINHVLKFKVDHPFHFFIRHNKSKTILFFGR 409 (415)
T ss_dssp GSTTCCCTTTBSSSCCCCCEEEEEEEEEECSSBSSCCC---------------CEEEECCSCEEEEEEETTTTEEEEEEE
T ss_pred hcCccccccccCCCCeEEEEEEEEEEEEecCCCcccccccchhhccccCCCCCCcEEEecCCEEEEEEECCCCcEEEEEE
Confidence 99779999999 6889999999999999999999999999876654443322 378999999999999999999999999
Q ss_pred EcCCCC
Q psy7902 334 FNEPPN 339 (342)
Q Consensus 334 v~~P~~ 339 (342)
|.+|.+
T Consensus 410 v~~P~~ 415 (415)
T 2h4r_A 410 FCCPVE 415 (415)
T ss_dssp ECSCCC
T ss_pred eCCCCC
Confidence 999974
|
| >2ceo_A Thyroxine-binding globulin; transport, serpin, hormone trans thyroxine, disease mutation, glycoprotein; HET: T44; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-73 Score=534.64 Aligned_cols=326 Identities=26% Similarity=0.423 Sum_probs=286.5
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCC-ChHHHHHHhhHHHHHHHhhhCCCC
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENL-DKLDTMNVYKMEKLIQGLRANADS 79 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~-~~~~~~~~~~~~~~l~~l~~~~~~ 79 (342)
+||++||+++...++++|++|||+||+.+|+|++.||+|+|++||.++||++... +..+++..|+ .++..+...+.+
T Consensus 12 ~Fa~~l~~~l~~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~--~l~~~l~~~~~~ 89 (379)
T 2ceo_A 12 DFAFNLYRRFTVETPDKNIFFSPVSISAALVMLSFGACCSTQTEIVETLGFNLTDTPMVEIQHGFQ--HLICSLNFPKKE 89 (379)
T ss_dssp HHHHHHHHHHHHHSTTSCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHH--HHHHHHSSCCTT
T ss_pred HHHHHHHHHHHhcCCCCCEEEchHHHHHHHHHHHhhccchHHHHHHHHhCCCCcCCCHHHHHHHHH--HHHHHhhCCCCC
Confidence 4999999999877788999999999999999999999999999999999998532 3467888887 778888665556
Q ss_pred ceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE-
Q psy7902 80 GLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL- 153 (342)
Q Consensus 80 ~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl- 153 (342)
+.++++|++|++++++++++|.+ +|+++++.+|| .+++.+++ ||+||+++|+|+|+++++ +++++|.++|
T Consensus 90 -~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF-~~~~~a~~~IN~WV~~~T~gkI~~l~~--~l~~~t~lvLv 165 (379)
T 2ceo_A 90 -LELQIGNALFIGKHLKPLAKFLNDVKTLYETEVFSTDF-SNISAAKQEINSHVEMQTKGKVVGLIQ--DLKPNTIMVLV 165 (379)
T ss_dssp -EEEEEEEEEEEETTSCBCHHHHHHHHHHHCEEEEEECT-TCHHHHHHHHHHHHHHHTTTSSCCCCC--CCCSSCCEEEE
T ss_pred -cEEEEeEhhhhhCCCChhHHHHHHHHHHhCCeeeecCC-CCHHHHHHHHHHHHHHHhCCcchhhcc--CCCCCCEEEEE
Confidence 89999999999999999999975 89999999999 57888888 999999999999999994 5999999988
Q ss_pred --------ecc----------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcH
Q psy7902 154 --------WLP----------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGV 201 (342)
Q Consensus 154 --------W~~----------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l 201 (342)
|++ +++.+.|| .|++.++++|++++|||+++ .+|+||||+++ +|
T Consensus 166 NaiyFkg~W~~~F~~~~T~~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~l~~~vleLPy~~~-~sm~iiLP~~~---~l 241 (379)
T 2ceo_A 166 NYIHFKAQWANPFDPSKTEDSSSFLIDKTTTVQVPMMHQMEQYYHLVDMELNCTVLQMDYSKN-ALALFVLPKEG---QM 241 (379)
T ss_dssp EEEEEEEBBSSCCCGGGCEEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSS-EEEEEEEECTT---CH
T ss_pred EHhhhhchhcCCCChhhCccCCceEeCCCcEEEEEEEEeeeeEeEEEeCCCCeEEEEeecCCC-eeEEEEeeCCC---cH
Confidence 876 23445666 67788999999999999775 59999999875 89
Q ss_pred HHHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC-CCCeeecceeeeEE
Q psy7902 202 GDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-DSHIAFGDAVHKAR 280 (342)
Q Consensus 202 ~~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~-~~~l~ls~v~q~~~ 280 (342)
.+++++|+.+ .+..|.+. +..+.|+|.||||++++++||+++|++||++++|+..|||++|+ +++++||+|+|+++
T Consensus 242 ~~l~~~L~~~--~l~~~~~~-~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~Adfsgis~~~~l~vs~v~hka~ 318 (379)
T 2ceo_A 242 ESVEAAMSSK--TLKKWNRL-LQKGWVDLFVPKFSISATYDLGATLLKMGIQHAYSENADFSGLTEDNGLKLSNAAHKAV 318 (379)
T ss_dssp HHHHHHCSHH--HHHHHHHH-CEEEEEEEEEECEEEEEEEETHHHHHHHTCCTTTSTTCCCTTTBSSSCCCCCEEEEEEE
T ss_pred HHHHHHhCHH--HHHHHHHh-cccCcceEECCcEEEeeeecHHHHHHhcCccccccCCCCcccCCCCCCeEEeccceeEE
Confidence 9999999987 99999998 68899999999999999999999999999999998789999999 68899999999999
Q ss_pred EEecCCCccccccchhhhcccCCCC-CCceEEecCCeEEEEEeCCCCcEEEEEEEcCCCC
Q psy7902 281 LDLDEQGTTAAAATAVFAFRSSRPL-EPVRYEANHPFLYFLVDKEIQSILFAGVFNEPPN 339 (342)
Q Consensus 281 i~v~E~G~~a~a~t~~~~~~~~~~~-~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~~ 339 (342)
|+|||+|++|+|+|++.+..++.+. .+.+|++||||+|+|+|+.|+.|||+|+|.+|..
T Consensus 319 ieVnE~GteAaAaT~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 378 (379)
T 2ceo_A 319 LHIGEKGTEAAAVPEVELSDQPENTFLHPIIQIDRSFMLLILERSTRSILFLGKVVNPTE 378 (379)
T ss_dssp EEECSSBSSCCCCCC--------CCSCSCEEECCSCEEEEEEETTTTEEEEEEEESCSBC
T ss_pred EEecCCCcccccccchhhccccCCCCCCCeEEecCCEEEEEEECCCCcEEEEEecCCCCC
Confidence 9999999999999987655444332 2478999999999999999999999999999974
|
| >1wz9_A Maspin precursor; serpin, tumor suppressor, serpinb5, signaling protein; HET: CME; 2.10A {Homo sapiens} PDB: 1xu8_A 1xqg_A 1xqj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-74 Score=540.05 Aligned_cols=321 Identities=23% Similarity=0.455 Sum_probs=280.9
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCCc
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADSG 80 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 80 (342)
+||++||+++...++++|++|||+||+.+|+|++.||+|+|++||.++||++.. .+++..|+ .++..+...+.+
T Consensus 10 ~Fa~~l~~~l~~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~---~~~~~~~~--~l~~~l~~~~~~- 83 (375)
T 1wz9_A 10 AFAVDLFKQLCEKEPLGNVLFSPICLSTSLSLAQVGAKGDTANEIGQVLHFENV---KDVPFGFQ--TVTSDVNKLSSF- 83 (375)
T ss_dssp HHHHHHHHHHHHHCTTSCCEECHHHHHHHHHHHHHHCCHHHHHHHHHHTTCTTC---SCHHHHHH--HHHHHHHHHTTT-
T ss_pred HHHHHHHHHHhccCCCCCEEECHHHHHHHHHHHHhhccCcHHHHHHHHhCCCCH---HHHHHHHH--HHHHHhhcCCCC-
Confidence 499999999987677899999999999999999999999999999999999743 46777787 777777665555
Q ss_pred eEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE--
Q psy7902 81 LTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL-- 153 (342)
Q Consensus 81 ~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl-- 153 (342)
+.++++|++|++++++++++|.+ +|+++++.+||.++++.+++ ||+||+++|+|+|++++++++++++|.++|
T Consensus 84 ~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~wV~~~T~g~I~~l~~~~~l~~~t~lvLvN 163 (375)
T 1wz9_A 84 YSLKLIKRLYVDKSLNLSTEFISSTKRPYAKELETVDFKDKLEETKGQINNSIKDLTDGHFENILADNSVNDQTKILVVN 163 (375)
T ss_dssp SEEEEEEEEEEEGGGCCCHHHHHHHTTTTTTTEEEECTTTCHHHHHHHHHHHHHHHTTTSCSCTTTTSCCCTTCCEEEEE
T ss_pred cEEEEeeeeeeeCCcchhHHHHHHHHHHhCCEEEEecCCCCHHHHHHHHHHHHHHHhcCchhhccCcccCCccchhhhee
Confidence 88999999999999999999975 89999999999778888888 999999999999999999888999999988
Q ss_pred -------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeC----CCCCCC
Q psy7902 154 -------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLP----PFASQD 199 (342)
Q Consensus 154 -------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP----~~~~~~ 199 (342)
|+. +++.+.|| +|++.++++|++++|||+++++||+|+|| ++. .
T Consensus 164 aiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vleLPy~~~~~sm~iiLP~~~~~~~--~ 241 (375)
T 1wz9_A 164 AAYFVGKWMKKFPESETKECPFRLNKTDTKPVQMMNMEATFCMGNIDSINCKIIELPFQNKHLSMFILLPKDVEDES--T 241 (375)
T ss_dssp EEEEECCBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBGGGSEEEEEEEESSCCCHH--H
T ss_pred heeeecccCCCCCccCceeeeEEeCCCeEEEEEEEEeeeeEeeEEeCCcceEEEEeecCCCeEEEEEEecCcccccC--c
Confidence 876 34556677 67889999999999999988899999999 765 6
Q ss_pred cHHHHHHHhcCCchHHHHHhh--hcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCC-CCCCCCCC-CCCeeecce
Q psy7902 200 GVGDILAALKKDPTSFKRFTE--DSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSP-GADLSRLT-DSHIAFGDA 275 (342)
Q Consensus 200 ~l~~l~~~L~~~~~~l~~~~~--~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~-~ad~s~i~-~~~l~ls~v 275 (342)
+|.+++++|+.+ .+..|.+ . +..+.|+|.||||++++++||++.|++||++++|++ .|||++|+ +++++|++|
T Consensus 242 ~l~~l~~~L~~~--~l~~~~~~~~-~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfsgis~~~~l~vs~v 318 (375)
T 1wz9_A 242 GLEKIEKQLNSE--SLSQWTNPST-MANAKVKLSIPKFKVEKMIDPKACLENLGLKHIFSEDTSDFSGMSETKGVALSNV 318 (375)
T ss_dssp HHHHHHHHCCHH--HHHHHTCGGG-CEEEEEEEEEECEEEEEEECHHHHHHHHTCCSTTCTTTCCCTTTCCCTTCCEEEE
T ss_pred cHHHHHHHhCHH--HHHHHhhhhc-ceeeeEEEEcceEEecceechHHHHhhCChhhhcCCCCCcccccCCCCCeEEEEE
Confidence 899999999987 9999988 5 678899999999999999999999999999999995 79999999 688999999
Q ss_pred eeeEEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCC
Q psy7902 276 VHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337 (342)
Q Consensus 276 ~q~~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P 337 (342)
+|+++|+|||+|++|+|+|++....++ .+|++||||+|+|+|+.|+.|||+|+|.+|
T Consensus 319 ~hka~ieV~E~GteAaAaT~~~~~~~~-----~~f~~drPFlf~I~~~~t~~iLF~G~v~~P 375 (375)
T 1wz9_A 319 IHKVCLEITEDGGDSIEVPGARILQHK-----DELNADHPFIYIIRHNKTRNIIFFGKFCSP 375 (375)
T ss_dssp EEEEEEEECSCC------------CEE-----EEEECCSCEEEEEEETTTTEEEEEEEECCC
T ss_pred EEeeeEEecCCCcccccccchhhcccC-----CEEEecCCEEEEEEECCCCcEEEEEEeCCC
Confidence 999999999999999999986554332 589999999999999999999999999998
|
| >2arr_A Plasminogen activator inhibitor-2; serpin, peptide binding, hydrolase inhibitor-PEPT complex; 1.55A {Homo sapiens} PDB: 2arq_A 1jrr_A 1by7_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-74 Score=539.01 Aligned_cols=330 Identities=31% Similarity=0.517 Sum_probs=282.4
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCC-ChHHHHHHhhHHHHHHHhhhCCCC
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENL-DKLDTMNVYKMEKLIQGLRANADS 79 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~-~~~~~~~~~~~~~~l~~l~~~~~~ 79 (342)
+||++||+++...++++|++|||+||+.+|+|++.||+|+|++||.++||++... +..+++..|+ .++..+...+.+
T Consensus 10 ~Fa~~l~~~l~~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~--~l~~~l~~~~~~ 87 (382)
T 2arr_A 10 LFALNLFKHLAKASPTQNLFLSPWSISSTMAMVYMGSRGSTEDQMASVLQFNEVGAAADKIHSSFR--SLSSAINASTGN 87 (382)
T ss_dssp HHHHHHHHHHHHHCSSSCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHHTTTTC-----CHHHHHH--HHHHHHHCCCSS
T ss_pred HHHHHHHHHHhhcCCCCCEEEchHHHHHHHHHHHhhccCcHHHHHHHHhCCCCccccHHHHHHHHH--HHHHHHhCCCCC
Confidence 4999999999887778999999999999999999999999999999999998531 1356788887 778888765556
Q ss_pred ceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE-
Q psy7902 80 GLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL- 153 (342)
Q Consensus 80 ~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl- 153 (342)
+.+.++|++|++++++++++|.+ +|+++++.+||.++++.+++ ||+||+++|+|+|++++++++++++|.++|
T Consensus 88 -~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~wV~~~T~g~I~~l~~~~~l~~~t~lvLv 166 (382)
T 2arr_A 88 -YLLESVNKLFGEKSASFREEYIRLCQKYYSSEPQAVDFLECAEEARKKINSWVKTQTKGKIPNLLPEGSVDGDTRMVLV 166 (382)
T ss_dssp -EEEEEEEEEEEETTCCCCHHHHHHHHHHHCCCCEEECHHHHHHHHHHHHHHHHHHHTTTSSCCCSCTTSSCTTEEEEEE
T ss_pred -cEEEeeeehHHhCCCCccHHHHHHHHHHhCCEEEEecCcCcHHHHHHHHHHHHHHHhcCchhhhCCCcCCCCcceEEEE
Confidence 89999999999999999999975 89999999999667788888 999999999999999999889999999988
Q ss_pred --------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCC--CCc
Q psy7902 154 --------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFAS--QDG 200 (342)
Q Consensus 154 --------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~--~~~ 200 (342)
|++ +++.+.|| +|++.++++|++++|||++ ++||+|+||+++. ..+
T Consensus 167 NaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vleLPy~~-~~sm~iiLP~~~~~~~~~ 245 (382)
T 2arr_A 167 NAVYFKGKWKTPFEKKLNGLFPFRVNSAQRTPVQMMYLREKLNIGYIEDLKAQILELPYAG-DVSMFLLLPDEIADVSTG 245 (382)
T ss_dssp EEEEEEECBSSCCEECC---EEEEEETTEEEEECEEEEEEEEEEEEEGGGTEEEEEEEBSS-SEEEEEEEEC--CCSSSS
T ss_pred EeeEecccccCCCChhhcccceEecCCCceeeeeEEeccCcEeEEEECCCCeEEEEecCCC-cEEEEEEecCCCcccccc
Confidence 876 34556777 6778899999999999988 9999999998630 048
Q ss_pred HHHHHHHhcCCchHHHHHhhh-cCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCC-CCCCCCCC-CCCeeecceee
Q psy7902 201 VGDILAALKKDPTSFKRFTED-SQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSP-GADLSRLT-DSHIAFGDAVH 277 (342)
Q Consensus 201 l~~l~~~L~~~~~~l~~~~~~-~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~-~ad~s~i~-~~~l~ls~v~q 277 (342)
|.+++++|+.+ .+..|.+. .+..+.|+|.||||++++++||++.|++||++++|++ .|||++|+ +++++|++|+|
T Consensus 246 l~~l~~~L~~~--~l~~~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfsgis~~~~l~vs~v~h 323 (382)
T 2arr_A 246 LELLESEITYD--KLNKWTSKDKMAEDEVEVYIPQFKLEEHYELRSILRSMGMEDAFNKGRANFSGMSERNDLFLSEVFH 323 (382)
T ss_dssp CHHHHHHCCHH--HHHHHHCC--CEEEEEEEEEECEEEEEEEECHHHHHHHTCCGGGCTTTCCCTTTCTTCCEEEEEEEE
T ss_pred HHHHHHHhCHH--HHHHHhhhccccceEEEEECcCEEeeccccHHHHHHhcCccccCCCCCCChhhcCCCCCeEEEEEEE
Confidence 99999999988 99999874 2577899999999999999999999999999999996 79999999 67899999999
Q ss_pred eEEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCC
Q psy7902 278 KARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337 (342)
Q Consensus 278 ~~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P 337 (342)
+++|+|||+|++|+|+|++.+..++.+ .+.+|++||||+|+|+|+.|+.|||+|+|.+|
T Consensus 324 ka~ieVnE~GteAaAaT~~~~~~~~~~-~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P 382 (382)
T 2arr_A 324 QAMVDVNEEGTEAAAGTGGVMTGRTGH-GGPQFVADHPFLFLIMHKITNCILFFGRFSSP 382 (382)
T ss_dssp EEEEEECCCBC----------CCCCCC-CSCEEECCSCEEEEEEETTTTEEEEEEEECCC
T ss_pred eeeeeecCCCcccccccchhhccccCC-CCCeEEecCCEEEEEEECCCCcEEEEEEeCCC
Confidence 999999999999999998766554433 35799999999999999999999999999998
|
| >2vdx_A Corticosteroid-binding globulin; transport protein, cortisol binding globulin, glycoprotein, lipid-binding, disease mutation, CBG, SERP cleaved; 1.84A {Homo sapiens} PDB: 2vdy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-73 Score=532.95 Aligned_cols=322 Identities=31% Similarity=0.475 Sum_probs=289.1
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCC-ChHHHHHHhhHHHHHHHhhhCCCC
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENL-DKLDTMNVYKMEKLIQGLRANADS 79 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~-~~~~~~~~~~~~~~l~~l~~~~~~ 79 (342)
+||++||+++....+++|++|||+||+.+|+|++.||+|+|++||.++||++... +..+++..|+ .++..+...+.+
T Consensus 13 ~Fa~~l~~~l~~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~--~l~~~l~~~~~~ 90 (373)
T 2vdx_A 13 DFAFSLYKHLVALSPKKNIFISPVSISMALAMLSLGTCGHTRAQLLQGLGFNLTERSETEIHQGFQ--HLHQLFAKSDTS 90 (373)
T ss_dssp HHHHHHHHHHHHHCSSSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHH--HHHHHHHSCCSS
T ss_pred HHHHHHHHHHHhcCCCCCEEEccHHHHHHHHHHHhhccchHHHHHHHHhCCCCCCCCHHHHHHHHH--HHHHHhhccCCc
Confidence 4999999999876788999999999999999999999999999999999997532 3567888887 778888765556
Q ss_pred ceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE-
Q psy7902 80 GLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL- 153 (342)
Q Consensus 80 ~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl- 153 (342)
+.++++|++|++++++++++|.+ +|+++++.+|| .+++.+++ ||+||+++|+|+|+++++ +++++|.++|
T Consensus 91 -~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF-~~~~~a~~~IN~WV~~~T~gkI~~l~~--~l~~~t~lvLv 166 (373)
T 2vdx_A 91 -LEMTMGNALFLDGSLELLESFSADIKHYYESEVLAMNF-QDWATASRQINSYVKNKTQGKIVDLFS--GLDSPAILVLV 166 (373)
T ss_dssp -CEEEEEEEEEEETTCCCCHHHHHHHHHHHCCEEEEECT-TSHHHHHHHHHHHHHHHTTTCSCCSSC--C-CCCCSEEEE
T ss_pred -ccceeEEEEEEECCCChHHHHHHHHHHHhCCeeEeecC-cchHHHHHHHHHHHHHHhcCchhhhcc--CCCCCCeEEEE
Confidence 88999999999999999999975 89999999999 47888888 999999999999999994 6999999988
Q ss_pred --------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHH
Q psy7902 154 --------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVG 202 (342)
Q Consensus 154 --------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~ 202 (342)
|++ +++.+.|| +|++.++++|++++|||++ +.+|+||||+++ +|.
T Consensus 167 NaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~l~~~vleLPy~~-~~sm~iiLP~~~---~l~ 242 (373)
T 2vdx_A 167 NYIFFKGTWTQPFDLASTREENFYVDETTVVKVPMMLQSSTISYLHDSELPCQLVQMNYVG-NGTVFFILPDKG---KMN 242 (373)
T ss_dssp EEEEEEEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEECSSSSEEEEEEEBSS-SEEEEEEEECTT---CHH
T ss_pred EHHhhhhhhhCcCCccccccceEEeCCCcEEEEEEEEeeeeEeeEEeCCCCeEEEEEecCC-CeEEEEEecCCC---CHH
Confidence 876 35566777 6778899999999999976 489999999875 799
Q ss_pred HHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC-CCCeeecceeeeEEE
Q psy7902 203 DILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-DSHIAFGDAVHKARL 281 (342)
Q Consensus 203 ~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~-~~~l~ls~v~q~~~i 281 (342)
+++++|+.+ .+..|.+. +..+.|+|.||||++++++||++.|++||++++|+..|||++|+ +++++|++|+|+++|
T Consensus 243 ~l~~~L~~~--~l~~~~~~-~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~~Adfs~is~~~~l~vs~v~hka~i 319 (373)
T 2vdx_A 243 TVIAALSRD--TINRWSAG-LTSSQVDLYIPKVTISGVYDLGDVLEEMGIADLFTTQANFSRITQDAQLKSSKVVHKAVL 319 (373)
T ss_dssp HHHHTCSHH--HHHHHHHH-CEEEEEEEEEECCEEEEEEECHHHHHHTTCCGGGSTTCCCTTTCSSCCEEEEEEEEEEEE
T ss_pred HHHHHhCHH--HHHHHHHh-hhceeeEEeeeEEEeecccchHHHHHhcCchhhccCCCCcccccCCCCeEEeeeeeeeeE
Confidence 999999987 99999998 68899999999999999999999999999999999789999999 678999999999999
Q ss_pred EecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCCC
Q psy7902 282 DLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEPP 338 (342)
Q Consensus 282 ~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~ 338 (342)
+|||+|++|+|+|++....++ .+..|++||||+|+|+|+.|+.|||+|+|.+|.
T Consensus 320 eVnE~GteAaAaT~~~~~~~~---~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~ 373 (373)
T 2vdx_A 320 QLNEEGTEAAGAMFLEAIPRS---KPIILRFNQPFIIMIFDHFTWSSLFLARVMNPV 373 (373)
T ss_dssp EECSSEEEEEEEEEEEEEEC----CCEEEECCSCEEEEEEETTTCCEEEEEEESCCC
T ss_pred EecCCcccccccccccccccC---CCceEEecCCEEEEEEECCCCcEEEEEEeCCCC
Confidence 999999999999987655443 358899999999999999999999999999994
|
| >4au2_A HSP47, serpin peptidase inhibitor, clade H (heat shock P 47), member 1, (collagen binding...; chaperone-peptide complex; 2.30A {Canis lupus familiaris} PDB: 4au3_A 4au4_A 4awr_A 4au3_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-74 Score=540.14 Aligned_cols=323 Identities=20% Similarity=0.329 Sum_probs=284.8
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCC-CC
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANA-DS 79 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~-~~ 79 (342)
+||++||++++..++++|+||||+||+.+|+|++.||+|+|++||.++||++.. +..+++..|+ +++..+.... .+
T Consensus 15 ~Fa~~L~~~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~-~~~~~~~~~~--~l~~~l~~~~~~~ 91 (392)
T 4au2_A 15 GLAFSLYQAMAKDQAVENILLSPVVVASSLGLVSLGGKATTASQAKAVLSAEQL-RDEEVHAGLG--ELLRSLSNSTARN 91 (392)
T ss_dssp HHHHHHHHHHHHCTTCCSEEECHHHHHHHHHHHHHHCCHHHHHHHHHHTTCTTS-CHHHHHHHHH--HHHHHTTC-----
T ss_pred HHHHHHHHHHhhcCCCCeEEECHHHHHHHHHHHHhhcCcHHHHHHHHhcCCCCC-CHHHHHHHHH--HHHHHHhcCCCCC
Confidence 499999999999888999999999999999999999999999999999999864 5667888886 7777774332 33
Q ss_pred ceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE-
Q psy7902 80 GLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL- 153 (342)
Q Consensus 80 ~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl- 153 (342)
..+.++|++|++++++++++|.+ +|+++++.+|| .+++.+++ ||+||+++|+|+|+++++ +++++|.++|
T Consensus 92 -~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF-~~~~~a~~~IN~WV~~~T~gkI~~l~~--~~~~~t~lvLv 167 (392)
T 4au2_A 92 -VTWKLGSRLYGPSSVSFAEDFVRSSKQHYNCEHSKINF-RDKRSALQSINEWAAQTTDGKLPEVTK--DVERTDGALLV 167 (392)
T ss_dssp -CCCEEEEEEEEETTCCCCHHHHHHHHHHHCEEEEEECT-TSHHHHHHHHHHHHHHHTTTSSCCSCS--CCCCSSSEEEE
T ss_pred -ceEEEEEEEEeecCCchhHHHHHHHHHhhCCeeEEecC-CChHHHHHHHHHHHHHhcCCCccchhc--ccCCcchhhhe
Confidence 67999999999999999999975 89999999999 47888888 999999999999999994 6899999988
Q ss_pred --------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHH
Q psy7902 154 --------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVG 202 (342)
Q Consensus 154 --------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~ 202 (342)
|+. +++.+.|| +|+++++++|++++|||+++.++|+|+||++. .++.
T Consensus 168 NAiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~~~~~~~~~~~~~vleLPy~~~~~sm~illP~~~--~~l~ 245 (392)
T 4au2_A 168 NAMFFKPHWDEKFHHKMVDNRGFMVTRSYTVGVTMMHRTGLYNYYDDEKEKLQIVEMPLAHKLSSLIILMPHHV--EPLE 245 (392)
T ss_dssp EEEEECCCBSSCCCTTSEEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBGGGSEEEEEEEESSS--CCTH
T ss_pred ehhheeccccCCCCccccccCceecCCCceeEEeeeeecceeeEEeeccCceeEEEeecCCCcEEEEEEeCCCC--CcHH
Confidence 876 35556666 67888999999999999999999999999987 7999
Q ss_pred HHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCC-CCCCCCCC-CCCeeecceeeeEE
Q psy7902 203 DILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSP-GADLSRLT-DSHIAFGDAVHKAR 280 (342)
Q Consensus 203 ~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~-~ad~s~i~-~~~l~ls~v~q~~~ 280 (342)
.+++.|+.+ .+..|... +..+.|+|.||||++++++||+++|++||++++|+. .|||++|+ +++++|++|+|+++
T Consensus 246 ~le~~l~~~--~l~~~~~~-~~~~~v~v~lPKFkie~~~dL~~~L~~lGi~~~F~~~~Adfs~is~~~~l~vs~v~hka~ 322 (392)
T 4au2_A 246 RLEKLLTKE--QLKIWMGK-MQKKAVAISLPKGVVEVTHDLQKHLAGLGLTEAIDKNKADLSRMSGKKDLYLASVFHATA 322 (392)
T ss_dssp HHHHHCCHH--HHHHHHHH-CEEEEEEEEEECEEEEEEEECHHHHHHHTCCTTTCTTTCCCHHHHSSSCCCEEEEEEEEE
T ss_pred HHHHHhhHH--HHHHHHhc-ccceEEEEEecceEEEEEechHHHHHhcCCcccCCCCCCccccCCCCCCeEEEeeEEEEE
Confidence 999999988 99999998 799999999999999999999999999999999997 69999999 78899999999999
Q ss_pred EEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCCCC
Q psy7902 281 LDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEPPN 339 (342)
Q Consensus 281 i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~~ 339 (342)
|+|||+|++|+|+|.+... ...+..|+|||||+|+|+|+.||.|||+|+|.||..
T Consensus 323 ieVnE~GteAaaat~~~~~----~~~~~~f~~drPFlf~I~d~~t~~iLF~G~v~~P~~ 377 (392)
T 4au2_A 323 FEWDTEGNPFDQDIYGREE----LRSPKLFYADHPFIFLVRDTQSGSLLFIGRLVRPKG 377 (392)
T ss_dssp EEECSCBCSCC------------CCSCEEEECCSCEEEEEEETTTCCEEEEEEESCCSS
T ss_pred EEECCCcccchhhheeccc----CCCCCEEEeeCCEEEEEEECCCCcEEEEEEEeCCCC
Confidence 9999999999998865332 234688999999999999999999999999999963
|
| >3pzf_A Serpin 2; protease inhibitor, melanization, hydrolase inhibito; 1.75A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-73 Score=534.22 Aligned_cols=325 Identities=23% Similarity=0.421 Sum_probs=282.5
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhH------HHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhh
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNT------EANLKQVLRLPENLDKLDTMNVYKMEKLIQGLR 74 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t------~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~ 74 (342)
+||++||+++.. .+++|++|||+||+.+|+|+++||+|+| .+|+.+.|+... +..+.+..|+ +++..+.
T Consensus 24 ~Fa~~L~k~l~~-~~~~Ni~~SP~SI~~aLaml~~GA~G~T~~~~~~~~~~l~~l~~~~--~~~~~~~~~~--~ll~~l~ 98 (397)
T 3pzf_A 24 EFDLMFVKEIFK-NHNSNVVLSPFSVKILLTLIYEASDTSFGNAVSNTKRELSSVIQND--NIDHTRSYYK--QLLESAQ 98 (397)
T ss_dssp HHHHHHHHHHHH-TCSSCEEECHHHHHHHHHHHHHHSGGGCC-CCCHHHHHGGGGSSTT--CHHHHHHHHH--HHHHHHH
T ss_pred HHHHHHHHHHHh-CCCCCEEEchHHHHHHHHHHHhhcCCCCccChHHHHHHHHHcCCCC--chHHHHHHHH--HHHHHHh
Confidence 499999999987 6789999999999999999999999998 777777776653 3456666676 7888887
Q ss_pred hCCCCceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCc
Q psy7902 75 ANADSGLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRT 149 (342)
Q Consensus 75 ~~~~~~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t 149 (342)
..+.+ +.+.++|++|++++++++++|++ +|+++++.+||. +++.+++ ||+||+++|+|+|+++++++.++ +|
T Consensus 99 ~~~~~-~~l~~an~lf~~~~~~l~~~F~~~~~~~y~a~~~~vdF~-~~~~a~~~IN~WV~~~T~gkI~~ll~~~~~~-~t 175 (397)
T 3pzf_A 99 QDNKD-YDLNIATNFFVDDFIEVINKYQQIANTHYHAMLEKVSYS-NPTQTAATINNWVSEHTNGRLREIVTPDSLE-GA 175 (397)
T ss_dssp CCCSS-CEEEEEEEEEEETTCCBCHHHHHHHHHHHCEEEEEECTT-SHHHHHHHHHHHHHHHTTTSCCCCCCGGGGT-TC
T ss_pred cCCCC-cEEEEeeeeeEeCCCccchHHHHHHHHHhCCeEEEeCCC-ChHHHHHHHHHHHHHHhCCcccccCCCCCcc-cc
Confidence 66556 89999999999999999999975 899999999994 6888888 99999999999999999877787 88
Q ss_pred eEEE---------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCC
Q psy7902 150 NLVL---------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFAS 197 (342)
Q Consensus 150 ~lvl---------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~ 197 (342)
.++| |++ +++.+.|| .|+++++++|++++|||+++.+||+||||+++
T Consensus 176 ~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~v~V~mM~~~~~~~y~~~~~l~~~vleLPy~~~~~sm~iiLP~~~- 254 (397)
T 3pzf_A 176 VITLVNVIYFKGLWTYPFPEVANNVKPFYGTRGKPTNAQYMEQNGQFYYDNSADLGAQILRLPYRGNKLAMYFILPNPD- 254 (397)
T ss_dssp SEEEEEEEEEEEEBSSCCCCCSCCEEEECCSSSSCEEEEEEEEEEEEEEEEETTTTEEEEEEEBTTSSEEEEEEEECTT-
T ss_pred eeEEeeheecccccCccCCcccccccccccCCCcEEEEEEEEecCCcCeEEccCCCEEEEEEEcCCCceEEEEEECCCC-
Confidence 8887 877 34556777 67778899999999999999999999999987
Q ss_pred CCcHHHHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC-CCC----eee
Q psy7902 198 QDGVGDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-DSH----IAF 272 (342)
Q Consensus 198 ~~~l~~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~-~~~----l~l 272 (342)
.+|.+++++|+.+ .+.+|.+. +..+.|+|.||||+|++++||+++|++||++++|++.|||++|+ ..+ ++|
T Consensus 255 -~~l~~le~~L~~~--~l~~~~~~-~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~~Adfsgis~~~~~~~~l~v 330 (397)
T 3pzf_A 255 -NTVNQVLDRINSA--SLHQALWY-MEENEVNVTLPKFKFDFSEQLNEPLQQVGIREIFSQNASLPLLARGRGARDEVRV 330 (397)
T ss_dssp -SCHHHHHHHCCHH--HHHHHHHT-CEEEEEEEEEECEEEEEEEESHHHHHHTTCCGGGSTTCCCTTTBCC-----CCCC
T ss_pred -CCHHHHHHhhCHH--HHHHHHhh-CceEEEEEEcCcEEEEeccChHHHHHhCCchhhcCCCCCcccccCCCCCCCceEE
Confidence 7999999999987 99999988 68999999999999999999999999999999999889999999 543 999
Q ss_pred cceeeeEEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCCC
Q psy7902 273 GDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEPP 338 (342)
Q Consensus 273 s~v~q~~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~ 338 (342)
|+|+|+++|+|||+|++|+|+|++.+...+.+..+..|++||||+|+|+|+.|+.|||+|+|.+|.
T Consensus 331 s~v~hka~ieVnE~GteAAAaT~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~ 396 (397)
T 3pzf_A 331 SRIFQKAGITINELGSEAYAATEIQLVNKFGGDGVQIFNANRPFIFFIEDETLGTMLFAGKIENPV 396 (397)
T ss_dssp CEEEEEEEEEECSSEESCCCCSCC--------CCCEEEECCSCEEEEEEETTTCCEEEEEEESSCC
T ss_pred EeEEEEEEEEECCCccccccccceeeeccccCCCCCeEEecCCEEEEEEECCCCcEEEEEEecCCc
Confidence 999999999999999999999987655432222223499999999999999999999999999996
|
| >3f1s_A Protein Z-dependent protease inhibitor; PZ, ZPI, complex, serpin, protease inhibitor, protease, GLYC secreted, serine protease inhibitor, blood coagulation; HET: FLC NAG; 2.30A {Homo sapiens} PDB: 3h5c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-73 Score=534.81 Aligned_cols=323 Identities=24% Similarity=0.410 Sum_probs=291.0
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCC-ChHHHHHHhhHHHHHHHhhhCCCC
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENL-DKLDTMNVYKMEKLIQGLRANADS 79 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~-~~~~~~~~~~~~~~l~~l~~~~~~ 79 (342)
+||++||+++....++ |++|||+||+.+|+|++.||+|+|++||.++||++... +..+++..|+ .++..+...+.+
T Consensus 22 ~Fa~~l~~~l~~~~~~-Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~--~l~~~l~~~~~~ 98 (385)
T 3f1s_A 22 NFGFSLLRKISMRHDG-NMVFSPFGMSLAMTGLMLGATGPTETQIKRGLHLQALKPTKPGLLPSLF--KGLRETLSRNLE 98 (385)
T ss_dssp HHHHHHHHHHHHHCCS-CEEECHHHHHHHHHHHTTTCCTHHHHHHHHHTTCTTCCCSSTTHHHHHH--HHHHHHHHHCSS
T ss_pred HHHHHHHHHHhhCCCC-cEEEchHHHHHHHHHHHHhcchHHHHHHHHhcCCCCCcCCHHHHHHHHH--HHHHHhhcCCCC
Confidence 4999999999886667 99999999999999999999999999999999998521 2357888887 777777665555
Q ss_pred ceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE-
Q psy7902 80 GLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL- 153 (342)
Q Consensus 80 ~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl- 153 (342)
+.++++|++|++++++++++|.+ +|+++++.+||. +++.+++ ||+||+++|+|+|++++ ++++++|.++|
T Consensus 99 -~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~-~~~~a~~~IN~WV~~~T~gkI~~l~--~~l~~~t~lvLv 174 (385)
T 3f1s_A 99 -LGLTQGSFAFIHKDFDVKETFFNLSKRYFDTECVPMNFR-NASQAKRLMNHYINKETRGKIPKLF--DEINPETKLILV 174 (385)
T ss_dssp -SCEEEEEEEEEETTSCBCHHHHHHHHHHHCEEEEEECCS-SHHHHHHHHHHHHHHHTTTSSSCCC--SCCCTTCCEEEE
T ss_pred -cEEEEEEEEEEECCCchhHHHHHHHHHHhCCeeEEeCCC-ChHHHHHHHHHHHHHHhcCchhhHh--hccCCCCeEEEE
Confidence 78999999999999999999975 899999999995 7888888 99999999999999999 78999999988
Q ss_pred --------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHH
Q psy7902 154 --------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVG 202 (342)
Q Consensus 154 --------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~ 202 (342)
|+. +++.+.|| +|++.++++|++++||| ++++||+|+||++. .+|.
T Consensus 175 NaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~l~~~vleLPy-~~~~sm~iiLP~~~--~~L~ 251 (385)
T 3f1s_A 175 DYILFKGKWLTPFDPVFTEVDTFHLDKYKTIKVPMMYGAGKFASTFDKNFRCHVLKLPY-QGNATMLVVLMEKM--GDHL 251 (385)
T ss_dssp EEEEEECCBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEETTTTEEEEEEEE-TTTEEEEEEEECTT--SCHH
T ss_pred EhhhccchhcCCCCccCccceEEEECCCEEEEEEEEeccCcccEEEeCCCCeEEEEecC-CCcEEEEEEeCCCC--CCHH
Confidence 876 35566777 67888999999999999 88999999999987 7999
Q ss_pred HHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCCC--CCeeecceeeeEE
Q psy7902 203 DILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLTD--SHIAFGDAVHKAR 280 (342)
Q Consensus 203 ~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~~--~~l~ls~v~q~~~ 280 (342)
+++++|+.+ .+.+|.+. ++.+.|+|.||||++++++||+++|++||++++|+..|||++|++ ++++|++|+|+++
T Consensus 252 ~l~~~L~~~--~l~~~~~~-~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~Adfs~is~~~~~l~vs~v~hka~ 328 (385)
T 3f1s_A 252 ALEDYLTTD--LVETWLRN-MKTRNMEVFFPKFKLDQKYEMHELLRQMGIRRIFSPFADLSELSATGRNLQVSRVLQRTV 328 (385)
T ss_dssp HHGGGCCHH--HHHHHHHT-CEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGSTTCCCTTTBCCCSCCCCCEEEEEEE
T ss_pred HHHHHhhHH--HHHHHHHh-ccceeeEEeeeEEEEEeeecHHHHHHhcCccccccCCCCcccccCCCCCeEEEEEEEeeE
Confidence 999999987 99999988 688999999999999999999999999999999997799999995 7899999999999
Q ss_pred EEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCCCC
Q psy7902 281 LDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEPPN 339 (342)
Q Consensus 281 i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~~ 339 (342)
|+|||+|++|+|+|++....+ ..+..|++||||+|+|+|+.|+.|||+|+|.+|..
T Consensus 329 ieV~E~GteAaAaT~~~~~~~---~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 384 (385)
T 3f1s_A 329 IEVDERGTEAVAGILSEITAY---SMPPVIKVDRPFHFMIYEETSGMLLFLGRVVNPTL 384 (385)
T ss_dssp EEECSCBCCCCCCCCCCCCSS---CCCCEEECCSCEEEEEEETTTCCEEEEEEESCTTC
T ss_pred EEecCCcceeccccccccccC---CCCCEEEecCCEEEEEEECCCCcEEEEEEeCCCCC
Confidence 999999999999998755433 24678999999999999999999999999999963
|
| >1lj5_A Plasminogen activator inhibitor-1; beta-barrell, blood clotting; 1.80A {Homo sapiens} SCOP: e.1.1.1 PDB: 1dvn_A 1c5g_A 1a7c_A* 3q02_A 3q03_A 3r4l_A* 1oc0_A 1b3k_A 3pb1_I 1dvm_A 3eox_A 3cvm_A 1db2_A 9pai_A 3lw2_A 9pai_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-73 Score=535.56 Aligned_cols=323 Identities=26% Similarity=0.464 Sum_probs=288.3
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCCc
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADSG 80 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 80 (342)
+||++||+++....+++|++|||+||+.+|+|++.||+|+|++||.++||++.. ..+++..|+ +++..+.....+
T Consensus 14 ~Fa~~l~~~l~~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~--~~~~~~~~~--~l~~~l~~~~~~- 88 (379)
T 1lj5_A 14 DFGVRVFQQVAQASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFKID--DKGMAPALR--HLYKELMGPWNK- 88 (379)
T ss_dssp HHHHHHHHHHHHHSTTBCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHHTSCTT--STTHHHHHH--HHHHHHHCGGGS-
T ss_pred HHHHHHHHHHhhcCCCCCEEEchHHHHHHHHHHHhhccChHHHHHHHHhCCCCC--HHHHHHHHH--HHHHHHhCCCCC-
Confidence 499999999984357899999999999999999999999999999999999864 346777786 777777655445
Q ss_pred eEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE--
Q psy7902 81 LTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL-- 153 (342)
Q Consensus 81 ~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl-- 153 (342)
..++++|++|++++++++++|.+ +|+++++.+|| .+++.+++ ||+||+++|+|+|++++++++++++|.++|
T Consensus 89 ~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF-~~~~~a~~~IN~Wv~~~T~g~I~~l~~~~~l~~~t~lvLvN 167 (379)
T 1lj5_A 89 DEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDF-SEVERARFIINDWVKTHTKGMISNLLGKGAVDQLTRLVLVN 167 (379)
T ss_dssp SEEEEEEEEEEETTSCCCTTHHHHHHHHHSCCCEEECT-TSHHHHHHHHHHHHHHTTTTSCCCSSCTTSSCTTCCEEEEE
T ss_pred cEEEEEEeeeeeCCcchhHHHHHHHHHHhCCEEEEECC-CChHHHHHHHHHHHHhhcCCccccccCcccCCCccceeeee
Confidence 78999999999999999999975 89999999999 46776777 999999999999999999888999999988
Q ss_pred -------ecc---------------CCceEEec--------cee--ecCC-CCeEEEEeecCCCceEEEEEeC-CCCCCC
Q psy7902 154 -------WLP---------------STQESIII--------ITV--LSSE-LNAHILEVPYKGGNMSMFFLLP-PFASQD 199 (342)
Q Consensus 154 -------W~~---------------~~~~~~V~--------~~~--~~~~-~~~~vvelP~~~~~~sm~iilP-~~~~~~ 199 (342)
|+. +++.+.|| +|+ +.++ ++|++++|||+++++||+|+|| ++. .
T Consensus 168 aiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~gl~~~vleLPy~~~~~sm~iiLP~~~~--~ 245 (379)
T 1lj5_A 168 ALYFNGQWKTPFPDSSTHRRLFHKSDGSTVSVPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAAPYEKE--V 245 (379)
T ss_dssp EEEEEEEBSSCCCCCTTCEEEEECTTSCEEEEEEEEEEEEEEEEEEECTTSCEEEEEEEEBTTSSEEEEEEEESSTT--S
T ss_pred eeeecccccCCCCcccccceeEEeCCCeEEEEeEEeeEeeeceeeeEcCCCCceEEEEEecCCCcEEEEEEEecCCC--C
Confidence 876 34556777 453 5677 8999999999999999999999 887 7
Q ss_pred cHHHHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCC-CCCCCCC-CCCeeecceee
Q psy7902 200 GVGDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPG-ADLSRLT-DSHIAFGDAVH 277 (342)
Q Consensus 200 ~l~~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~-ad~s~i~-~~~l~ls~v~q 277 (342)
+|.+++++|+.+ .+..|.+. +..+.|+|.||||++++++||++.|++||++++|++. |||++|+ +++++|++|+|
T Consensus 246 ~l~~l~~~L~~~--~l~~~~~~-~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfs~is~~~~l~vs~v~h 322 (379)
T 1lj5_A 246 PLSALTNILSAQ--LISHWKGN-MTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQFQADFTSLSDQEPLHVAQALQ 322 (379)
T ss_dssp CTHHHHTTCCHH--HHHHHHHH-CEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGCTTTCCCTTTCSSSCCCEEEEEE
T ss_pred CHHHHHHHhCHH--HHHHHHHh-CcceEEEEEeeEEEEeeeechHHHHHhcCCccCCCCCCCCccccCCCCCeEEeeeeE
Confidence 999999999988 99999998 6889999999999999999999999999999999974 9999999 67899999999
Q ss_pred eEEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCC
Q psy7902 278 KARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337 (342)
Q Consensus 278 ~~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P 337 (342)
+++|+|||+|++|+|+|++....++ .+.+|++||||+|+|+|+.|+.|||+|+|.+|
T Consensus 323 ka~ieV~E~GteAaAaT~~~~~~~~---~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P 379 (379)
T 1lj5_A 323 KVKIEVNESGTVASSSTAVIVSARM---APEEIIMDRPFLFVVRHNPTGTVLFMGQVMEP 379 (379)
T ss_dssp EEEEEECSSEEEEEEEEEEEESSCC---CCCCCCBCCEEEEEEEETTTTEEEEEEEEECC
T ss_pred EeEEEecCCCcCcccccceeecccC---CCCEEEecCCEEEEEEECCCCeEEEEEEecCC
Confidence 9999999999999999986544332 35689999999999999999999999999998
|
| >4dy0_A GLIA-derived nexin; serpin, protease inhibitor, thrombin, cell surface, hydrolas inhibitor; HET: IDS SGN; 2.35A {Homo sapiens} PDB: 4dy7_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-73 Score=536.65 Aligned_cols=322 Identities=24% Similarity=0.454 Sum_probs=272.1
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCCc
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADSG 80 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 80 (342)
+||++||+++.+.++++|+||||+||+.+|+|++.||+|+|++||.++||++.. ++++.++ .+...+......
T Consensus 14 ~f~~~L~~~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~----~~~~~~~--~l~~~l~~~~~~- 86 (379)
T 4dy0_A 14 NTGIQVFNQIVKSRPHDNIVISPHGIASVLGMLQLGADGRTKKQLAMVMRYGVN----GVGKILK--KINKAIVSKKNK- 86 (379)
T ss_dssp HHHHHHHHHHHHHCTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHHTSCST----TTHHHHH--HHHHHHHCGGGS-
T ss_pred HHHHHHHHHHHhhCcCCcEEECHHHHHHHHHHHHHHcChHHHHHHHHHhCCChh----HHHHHHH--HHHHHHhccCCC-
Confidence 599999999998889999999999999999999999999999999999999754 3455554 555555544444
Q ss_pred eEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCC-ceEEE-
Q psy7902 81 LTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSR-TNLVL- 153 (342)
Q Consensus 81 ~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~-t~lvl- 153 (342)
..+.++|++|++++++++++|.+ +|+++++.+|| .+++.+++ ||+||+++|+|+|+++++++.+++. |.++|
T Consensus 87 ~~l~~an~l~~~~~~~~~~~f~~~~~~~y~a~~~~vdF-~~~~~a~~~IN~wV~~~T~g~I~~ll~~~~~~~~~T~lvLv 165 (379)
T 4dy0_A 87 DIVTVANAVFVKNASEIEVPFVTRNKDVFQCEVRNVNF-EDPASACDSINAWVKNETRDMIDNLLSPDLIDGVLTRLVLV 165 (379)
T ss_dssp SCCEEEEEEEESCTTSSCHHHHHHHHHHHCEEEEECCT-TSHHHHHHHHHHHHHHHTTTCCCCCCCGGGCCTTTCCEEEE
T ss_pred ceeeeeeeeeeEccccccchhhhhhhhcCCcEEEEecc-CChHHHHHHHHHHHHHhcCCcccccCCcccCCcccceEEEE
Confidence 67999999999999999999975 89999999999 57888888 9999999999999999998888764 88887
Q ss_pred --------ecc---------------CCceEEec--------cee---ecCCCCeEEEEeecCCCceEEEEEeCCCCCCC
Q psy7902 154 --------WLP---------------STQESIII--------ITV---LSSELNAHILEVPYKGGNMSMFFLLPPFASQD 199 (342)
Q Consensus 154 --------W~~---------------~~~~~~V~--------~~~---~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~ 199 (342)
|+. +++.+.|| +|+ +.++++|++|+|||++++++|+|+||+++ ..
T Consensus 166 NaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~v~mM~~~~~~~~~~~~~~~~l~~~vl~LPy~~~~~sm~iiLP~~~-~~ 244 (379)
T 4dy0_A 166 NAVYFKGLWKSRFQPENTKKRTFVAADGKSYQVPMLAQLSVFRCGSTSAPNDLWYNFIELPYHGESISMLIALPTES-ST 244 (379)
T ss_dssp EEEEECCCBSSCCCGGGCEEEEEECTTSCEEEEEEEEEEEEEEEEEEECTTSCEEEEEEEEBTTSSEEEEEEEESST-TS
T ss_pred EEEEEEeeecCCCchhhCeeeeEEeCCCceEEeeeeEeeeeecccccccccccceEEEEeccCCCceEEEEEecCcc-cc
Confidence 876 34556666 232 34678999999999999999999999775 35
Q ss_pred cHHHHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCC-CCCCCCCC--CCCeeeccee
Q psy7902 200 GVGDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSP-GADLSRLT--DSHIAFGDAV 276 (342)
Q Consensus 200 ~l~~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~-~ad~s~i~--~~~l~ls~v~ 276 (342)
+|.++++.|+.+ .+.+|.+. +..+.|+|.||||++++++||+++|++||++++|++ .|||++|+ +++++|++|+
T Consensus 245 ~l~~~~~~l~~~--~l~~~~~~-~~~~~v~v~lPKFki~~~~~L~~~L~~lGi~~~F~~~~Adfs~is~~~~~l~vs~v~ 321 (379)
T 4dy0_A 245 PLSAIIPHISTK--TIDSWMSI-MVPKRVQVILPKFTAVAQTDLKEPLKVLGITDMFDSSKANFAKITTGSENLHVSHIL 321 (379)
T ss_dssp CGGGTSTTCCHH--HHHHHHTT-CEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGSTTTCCCTTTCC---CCCCCEEE
T ss_pred chhHhhhhcCHH--HHHHHHHh-ccceEEEEeccceEEEEEeechHhHHhCCchhhcCCCCCCcccccCCCCCeEeeeeE
Confidence 799999999988 99999998 689999999999999999999999999999999976 69999998 3679999999
Q ss_pred eeEEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCC
Q psy7902 277 HKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337 (342)
Q Consensus 277 q~~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P 337 (342)
|+++|+|||+|++|+|+|++....++ .+..|++||||+|+|+|+.|+.|||+|+|.||
T Consensus 322 hka~ieVnE~GteAaAaT~~~~~~~s---~~~~f~~drPFlf~I~d~~t~~iLF~G~v~~P 379 (379)
T 4dy0_A 322 QKAKIEVSEDGTKASAATTAILIARS---SPPWFIVDRPFLFFIRHNPTGAVLFMGQINKP 379 (379)
T ss_dssp EEEEEEECSCBC------------CC---CCCEEECCSCEEEEEEETTTTEEEEEEEESCC
T ss_pred EEEEEEECCCceeecccceeeeccCC---CCCEEEecCCEEEEEEECCCCCEEEEEEecCC
Confidence 99999999999999999987665444 35789999999999999999999999999999
|
| >4ajt_A Protein Z-dependent protease inhibitor; blood clotting, ZPI; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-73 Score=536.88 Aligned_cols=322 Identities=25% Similarity=0.453 Sum_probs=282.7
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCC--CCChHHHHHHhhHHHHHHHhhhCCC
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPE--NLDKLDTMNVYKMEKLIQGLRANAD 78 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~--~~~~~~~~~~~~~~~~l~~l~~~~~ 78 (342)
+||++||+++....++ |++|||+||+.+|+|++.||+|+|++||.++||++. ..+..+++..|+ .++..+. .+.
T Consensus 64 ~Fa~~L~~~l~~~~~~-Niv~SP~SI~~aLaml~~GA~G~T~~el~~~L~~~~~~~~~~~~i~~~f~--~l~~~l~-~~~ 139 (427)
T 4ajt_A 64 SFGFNLLRKISMRHDG-NVIFSPFGLSVAMVNLMLGTKGETKVQIENGLNLQALSQAGPLILPALFK--KVKETFS-SNR 139 (427)
T ss_dssp HHHHHHHHHHHHHCCS-CEEECHHHHHHHHHHHHHHCCTHHHHHHHHHHTCHHHHTSCTTHHHHHHH--HHHHHHH-TCT
T ss_pred HHHHHHHHHHHhcCCC-CEEEchHHHHHHHHHHHhhcCchHHHHHHHHhCCCccccCCHHHHHHHHH--HHHHHhC-CCC
Confidence 4999999999876665 999999999999999999999999999999999982 113467888887 7777776 444
Q ss_pred CceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE
Q psy7902 79 SGLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL 153 (342)
Q Consensus 79 ~~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl 153 (342)
+ +.+.++|++|++++++++++|.+ +|+++++.+|| .+++.+++ ||+||+++|+|+|++++ ++++++|.++|
T Consensus 140 ~-~~L~~an~lf~~~~~~l~~~F~~~~~~~y~a~~~~vdF-~~~~~a~~~IN~WV~~~T~gkI~~ll--~~l~~~T~lvL 215 (427)
T 4ajt_A 140 D-LGLSQGSFAFIHKDFDIKETYFNLSKKYFDIEYVSINF-QNSSQARGLINHCIVKETEGKIPKLF--DEINPETKLIL 215 (427)
T ss_dssp T-SCEEEEEEEEEETTSCCCHHHHHHHHHHSCCCEEEECT-TSHHHHHHHHHHHHHHHTTTSSCSCC--SCCCTTCCEEE
T ss_pred C-ceehhhhHHHHccCCchhHHHHHHHHHhhcceeEEcCC-CChHHHHHHHHHHHHHhhCCcccccc--cCCCCcceeEE
Confidence 5 78999999999999999999975 89999999999 68888888 99999999999999999 78999999988
Q ss_pred ---------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcH
Q psy7902 154 ---------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGV 201 (342)
Q Consensus 154 ---------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l 201 (342)
|++ +++.+.|| .|+++++++|++++|||++ ++||+||||++. .+|
T Consensus 216 vNAiyFKg~W~~~F~~~~T~~~~F~~~~g~~v~V~mM~~~~~f~~~~~~~l~~~vleLPY~~-~~sm~iiLP~~~--~~L 292 (427)
T 4ajt_A 216 VDYVLFKGKWLTPFDPSFTEADTFHLDKYRAIKVPMMYREGNFTSTFDKKFRCHILKLPYQG-NATMLVVLMEKT--GDY 292 (427)
T ss_dssp EEEEEECCCBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEEGG-GEEEEEEEECTT--SCH
T ss_pred eeeeeeeeeecCCCChhhccccceeccCCCEEEEEEEEecCceeEEEecCCceEEEEEEcCC-CeEEEEEecCCC--CCH
Confidence 877 35556777 5778899999999999987 999999999986 599
Q ss_pred HHHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCCC--CCeeecceeeeE
Q psy7902 202 GDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLTD--SHIAFGDAVHKA 279 (342)
Q Consensus 202 ~~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~~--~~l~ls~v~q~~ 279 (342)
.+++++|+.+ .+..|.++ +..+.|+|.||||+|++++||+++|++||++++|++.|||++|+. ++++||+|+|++
T Consensus 293 ~~le~~L~~~--~l~~~~~~-l~~~~v~v~LPKFki~~~~dL~~~L~~lGi~~~F~~~Adfsgis~~~~~l~Vs~v~hka 369 (427)
T 4ajt_A 293 LALEDYLTVD--LVETWLQN-MKTRKMEVFFPKFKLNQRYEMHELLKQMGIRRLFSTSADLSELSAMARNLQVSRVLQQS 369 (427)
T ss_dssp HHHTTTCCHH--HHHHHHHT-CEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGSTTCCCTTTCSSCSSCCCCEEEEEE
T ss_pred HHHHHhcCHH--HHHHHHHh-CcceEEEEeccCEEEEeccChHHHHHHcCCchhhcCCCCcccccCCCCCceEEEEEEEE
Confidence 9999999988 99999988 688999999999999999999999999999999998899999994 789999999999
Q ss_pred EEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCCCC
Q psy7902 280 RLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEPPN 339 (342)
Q Consensus 280 ~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~~ 339 (342)
+|+|||+|++|+|+|++.+..++ .+..|++||||+|+|+|+.|++|||+|+|.+|..
T Consensus 370 ~ieVnEeGteAAAaT~~~~~~~s---~p~~f~adrPFlF~I~d~~t~~iLF~G~v~~P~~ 426 (427)
T 4ajt_A 370 VLEVDERGTEAVSGTLSEIIAYS---MPPAIKVNRPFHFIIYEEMSRMLLFLGRVVNPTV 426 (427)
T ss_dssp EEEECSCBCC-------CCBCCS---SCCEEECCSCEEEEEEETTTTEEEEEEEESSCC-
T ss_pred EEEECCCcccccccceeeecccC---CCCEEEEeCCEEEEEEECCCCcEEEEEEeCCCCC
Confidence 99999999999999987655443 2468999999999999999999999999999974
|
| >1yxa_A Serine (OR cysteine) proteinase inhibitor, clade 3N; serpin, antichymotrypsin, protease inhibitor, reactive centr plasma, hydrolase inhibitor; 2.10A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-73 Score=535.08 Aligned_cols=325 Identities=28% Similarity=0.469 Sum_probs=290.0
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCC-ChHHHHHHhhHHHHHHHhhhCCCC
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENL-DKLDTMNVYKMEKLIQGLRANADS 79 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~-~~~~~~~~~~~~~~l~~l~~~~~~ 79 (342)
+||++||+++....+++|++|||+||+.+|+|++.||+|+|++||.++||++... +..+++..|+ .++..+...+.+
T Consensus 33 ~Fa~~l~~~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~--~l~~~l~~~~~~ 110 (398)
T 1yxa_A 33 DFAFSLYKELVLKNPDTNIVFSPLSISAALALVSLGAKGNTLEEILEGLKFNLTETSEADIHQGFG--HLLQRLNQPKDQ 110 (398)
T ss_dssp HHHHHHHHHHHHHSTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHH--HHHHHHSSCBTT
T ss_pred HHHHHHHHHHHhcCCCCCEEEchHHHHHHHHHHHhhcccHHHHHHHHHhCCCcccCCHHHHHHHHH--HHHHHHhCCCCC
Confidence 4999999999877788999999999999999999999999999999999997532 3567888887 777777655555
Q ss_pred ceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE-
Q psy7902 80 GLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL- 153 (342)
Q Consensus 80 ~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl- 153 (342)
+.+.++|++|++++++++++|.+ +|+++++.+|| .+++.+++ ||+||+++|+|+|+++++ +++++|.++|
T Consensus 111 -~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF-~~~~~a~~~IN~WV~~~T~gkI~~ll~--~l~~~t~lvLv 186 (398)
T 1yxa_A 111 -VQISTGSALFIEKRQQILTEFQEKAKTLYQAEAFTADF-QQPRQAKKLINDYVRKQTQGMIKELVS--DLDKRTLMVLV 186 (398)
T ss_dssp -BEEEEEEEEEEETTSCCCHHHHHHHHHHHSCEEEEECT-TSHHHHHHHHHHHHHHHTTTSSSCCCC--CCCTTCCEEEE
T ss_pred -ceeeeeeEEEEeCCCchhHHHHHHHHHHhCCceeecCC-CCHHHHHHHHHHHHHHHhcCchhhhhh--ccCCCcEEEEE
Confidence 89999999999999999999975 89999999999 57888888 999999999999999994 5999999988
Q ss_pred --------ecc---------------CCceEEec---------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcH
Q psy7902 154 --------WLP---------------STQESIII---------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGV 201 (342)
Q Consensus 154 --------W~~---------------~~~~~~V~---------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l 201 (342)
|++ +++.+.|| .|++.++++|++++|||+++ .+|+||||+++ +|
T Consensus 187 NaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~y~~~~~l~~~vleLPY~~~-~sm~iiLP~~~---~L 262 (398)
T 1yxa_A 187 NYIYFKAKWKVPFDPLDTFKSEFYCGKRRPVIVPMMSMEDLTTPYFRDEELSCTVVELKYTGN-ASALFILPDQG---RM 262 (398)
T ss_dssp EEEEEECBBSSCCCGGGCEEEEECCCCSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSS-EEEEEEEECTT---CH
T ss_pred EHHhhhhhhhCCCCcccCeeeEEEeCCCeEEEEEEEEEcCceEEEEEeCCCCeEEEEEecCCC-eeEEEEecCcC---cH
Confidence 876 34556666 46678899999999999775 59999999876 59
Q ss_pred HHHHHHhcCCchHHHHHhhhcCCCeeE-EEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC-CCCeeecceeeeE
Q psy7902 202 GDILAALKKDPTSFKRFTEDSQNLKPV-EIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-DSHIAFGDAVHKA 279 (342)
Q Consensus 202 ~~l~~~L~~~~~~l~~~~~~~l~~~~v-~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~-~~~l~ls~v~q~~ 279 (342)
.+++++|+.+ .+..|.+. +..+.| +|.||||++++++||++.|++||++++|+..|||++|+ +++++|++|+|++
T Consensus 263 ~~le~~L~~~--~l~~~~~~-~~~~~v~~v~lPKFki~~~~dL~~~L~~lGi~~~F~~~Adfsgis~~~~l~vs~v~hka 339 (398)
T 1yxa_A 263 QQVEASLQPE--TLRKWKNS-LKPRMIDELHLPKFSISTDYSLEDVLSKLGIREVFSTQADLSAITGTKDLRVSQVVHKA 339 (398)
T ss_dssp HHHHHTCSHH--HHHHHHHH-CEEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGSTTCCCHHHHSSSCCCCCEEEEEE
T ss_pred HHHHHHhCHH--HHHHHHHh-ccceeeeEEecceEEeecccchHHHHHHcCcccccCCcCCcccCCCCCCeEEEEEEEEE
Confidence 9999999987 99999998 688999 99999999999999999999999999999779999999 6789999999999
Q ss_pred EEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCCC
Q psy7902 280 RLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEPP 338 (342)
Q Consensus 280 ~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~ 338 (342)
+|+|||+|++|+|+|++.+..++.+..+.+|++||||+|+|+|+.|+.|||+|+|.+|.
T Consensus 340 ~ieVnE~GteAaAaT~~~~~~~s~~~~~~~f~~drPFlF~I~~~~t~~iLF~G~v~~P~ 398 (398)
T 1yxa_A 340 VLDVAETGTEAAAATGVKFVPMSAKLYPLTVYFNRPFLIMIFDTETEIAPFIAKIANPK 398 (398)
T ss_dssp EEEECSSBSSCCCCCSCCCCCCCCCSSCCEEECCSCEEEEEEETTTCCCSEEEEESCCC
T ss_pred EEEEcCCccccccccchhhcccccCCCCCeEEecCCEEEEEEECCCCcEEEEEEecCCC
Confidence 99999999999999987655444433468999999999999999999999999999995
|
| >3b9f_I Protein C inhibitor; michaelis complex, acute phase, blood coagulation, cleavage of basic residues, disease mutation; HET: NAG FUC SGN IDS; 1.60A {Homo sapiens} PDB: 2ol2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-72 Score=530.66 Aligned_cols=321 Identities=29% Similarity=0.498 Sum_probs=286.0
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCC-ChHHHHHHhhHHHHHHHhhhCCCC
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENL-DKLDTMNVYKMEKLIQGLRANADS 79 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~-~~~~~~~~~~~~~~l~~l~~~~~~ 79 (342)
+||++||+++....+++|++|||+||+.+|+|++.||+|+|++||.++||++... +..+++..|+ .++..+...+.+
T Consensus 36 ~Fa~~L~~~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~i~~~~~--~l~~~l~~~~~~ 113 (395)
T 3b9f_I 36 DFTFDLYRALASAAPSQNIFFSPVSISMSLAMLSLGAGSSTKMQILEGLGLNLQKSSEKELHRGFQ--QLLQELNQPRDG 113 (395)
T ss_dssp CHHHHHHHHHHHHSTTSCEEECHHHHHHHHHHHGGGCCHHHHHHHHHHTTC----CCHHHHHHHHH--HHHHHTTSCCTT
T ss_pred HHHHHHHHHHhccCCCCCEEEcHHHHHHHHHHHHHHcccHHHHHHHHHhCCCCCCCCHHHHHHHHH--HHHHHHhCCCCC
Confidence 6999999999877788999999999999999999999999999999999997532 3457888887 777877665555
Q ss_pred ceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE-
Q psy7902 80 GLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL- 153 (342)
Q Consensus 80 ~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl- 153 (342)
+.+.++|++|++++++++++|.+ +|+++++.+|| .+++.+++ ||+||+++|+|+|+++++ +++++|.++|
T Consensus 114 -~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF-~~~~~a~~~IN~WV~~~T~gkI~~ll~--~l~~~t~lvLv 189 (395)
T 3b9f_I 114 -FQLSLGNALFTDLVVDLQDTFVSAMKTLYLADTFPTNF-RDSAGAMKQINDYVAKQTKGKIVDLLK--NLDSNAVVIMV 189 (395)
T ss_dssp -CCEEEEEEEEEETTCCBCHHHHHHHHHHHCCEEEEECT-TSHHHHHHHHHHHHHHHTTTSSCCCCS--CCCTTCSEEEE
T ss_pred -ceeEEEEEEEEECCCccchHHHHHHHHHhCCEeEEcCC-CCHHHHHHHHHHHHHHHhCCchhhhcc--CCCCCceEEEE
Confidence 78999999999999999999975 89999999999 58888888 999999999999999994 5999999988
Q ss_pred --------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHH
Q psy7902 154 --------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVG 202 (342)
Q Consensus 154 --------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~ 202 (342)
|+. +++.+.|| +|++.++++|++++|||+++. +|+||||+++ +|.
T Consensus 190 NaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~f~y~~~~~l~~~vleLPY~~~~-sm~iiLP~~~---~L~ 265 (395)
T 3b9f_I 190 NYIFFKAKWETSFNHKGTQEQDFYVTSETVVRVPMMSREDQYHYLLDRNLSCRVVGVPYQGNA-TALFILPSEG---KMQ 265 (395)
T ss_dssp EEEEECCCEEECCCTTTCEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSSC-EEEEEEECTT---CHH
T ss_pred EhheeeccccCCCChhhCeeeEEEeCCCeEEEEEEEEeeeeEeEEEECCCCeEEEEEecCCCe-eEEEEEeCCC---CHH
Confidence 876 34556777 677889999999999998765 9999999874 899
Q ss_pred HHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC-CCCeeecceeeeEEE
Q psy7902 203 DILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-DSHIAFGDAVHKARL 281 (342)
Q Consensus 203 ~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~-~~~l~ls~v~q~~~i 281 (342)
+++++|+.+ .+.+|.+. |..+.|+|.||||++++++||+++|++||++++|+..|||++|+ +++++||+|+|+++|
T Consensus 266 ~le~~L~~~--~l~~~~~~-l~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~~Adfsgis~~~~l~vs~v~hka~i 342 (395)
T 3b9f_I 266 QVENGLSEK--TLRKWLKM-FKKRQLELYLPKFSIEGSYQLEKVLPSLGISNVFTSHADLSGISNHSNIQVSEMVHKAVV 342 (395)
T ss_dssp HHHHHCSHH--HHHHHHHH-CEEEEEEEEEECEEEEEEEEGGGTGGGGTCCGGGSTTCCCTTTBSCSSCCCSEEEEEEEE
T ss_pred HHHHHhCHH--HHHHHHHh-cceeEEEEEeeEEEEEEeecHHHHHHHcCCccccCCCCCcccCcCCCCeeeeccceEEEE
Confidence 999999987 99999998 68899999999999999999999999999999998789999999 688999999999999
Q ss_pred EecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCC
Q psy7902 282 DLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337 (342)
Q Consensus 282 ~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P 337 (342)
+|||+|++|+|+|++....++.+..+.+|++||||+|+|+| ++|||+|+|.+|
T Consensus 343 eVnE~GteAaAaT~~~~~~~~~~~~~~~f~~drPFlf~I~~---~~iLF~G~v~~P 395 (395)
T 3b9f_I 343 EVDESGTRAAAATGTIFTFRSARLNSQRLVFNRPFLMFIVD---NNILFLGKVNRP 395 (395)
T ss_dssp EECSCEEECCCSCSCSSBCCSCCCCCEEEECCSCEEEEEES---SSEEEEEEESCC
T ss_pred EEcCCCcccccccchhhhhccCCCCCCEEEEeCCEEEEEEc---CCEEEEEEeCCC
Confidence 99999999999998765544433356899999999999999 899999999998
|
| >3le2_A Serpin-ZX; apoplast, glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase; 2.20A {Arabidopsis thaliana} SCOP: e.1.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-72 Score=532.21 Aligned_cols=326 Identities=22% Similarity=0.388 Sum_probs=279.8
Q ss_pred ChHHHHHHHH-hhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhh---C
Q psy7902 1 EFTFDLLTVL-NNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRA---N 76 (342)
Q Consensus 1 ~Fa~~l~~~l-~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~---~ 76 (342)
+||++||+++ ....+++|++|||+||+.+|+|++.||+|+|++||.++||++ +..+++..|+ .++..+.. .
T Consensus 14 ~Fa~~L~~~l~~~~~~~~Ni~~SP~Si~~aLaml~~GA~G~T~~ql~~~L~~~---~~~~~~~~~~--~l~~~l~~~~~~ 88 (393)
T 3le2_A 14 QVSMNLAKHVITTVSQNSNVIFSPASINVVLSIIAAGSAGATKDQILSFLKFS---STDQLNSFSS--EIVSAVLADGSA 88 (393)
T ss_dssp HHHHHHHHHHHHTSCTTCCEEECHHHHHHHHHHHHHTCCTHHHHHHHHHHTCS---SHHHHHHHHH--HTHHHHHSCCGG
T ss_pred HHHHHHHHHHhcccCCCCCEEECHHHHHHHHHHHHhcCCCcHHHHHHHHhCCC---CHHHHHHHHH--HHHHHhhccccC
Confidence 4999999999 666678999999999999999999999999999999999998 3567777776 66666642 2
Q ss_pred CCCceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceE
Q psy7902 77 ADSGLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNL 151 (342)
Q Consensus 77 ~~~~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~l 151 (342)
..+ +.+.++|++|++++++++++|++ +|+++++.+||.++++.+++ ||+||+++|+|+|++++++++++++|.+
T Consensus 89 ~~~-~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~~T~gkI~~ll~~~~l~~~t~l 167 (393)
T 3le2_A 89 NGG-PKLSVANGAWIDKSLSFKPSFKQLLEDSYKAASNQADFQSKAVEVIAEVNSWAEKETNGLITEVLPEGSADSMTKL 167 (393)
T ss_dssp GTS-CEEEEEEEEEEETTSCBCHHHHHHHHHHSCCEEEEECHHHHHHHHHHHHHHHHHHHTTTSCCCSSCTTCSCTTCCE
T ss_pred CCC-cEEEeeeehhhcCCCCcChHHHHHHHHhhcceEEEecccccHHHHHHHHHHHHHHhhcCchhhhCCccCCCCCcEE
Confidence 234 88999999999999999999975 89999999999656777887 9999999999999999998899999999
Q ss_pred EE---------ecc---------------CCceEEec------ceeecCCCCeEEEEeecCC----CceEEEEEeCCCCC
Q psy7902 152 VL---------WLP---------------STQESIII------ITVLSSELNAHILEVPYKG----GNMSMFFLLPPFAS 197 (342)
Q Consensus 152 vl---------W~~---------------~~~~~~V~------~~~~~~~~~~~vvelP~~~----~~~sm~iilP~~~~ 197 (342)
+| |++ +++.+.|| .+.+....++++++|||++ .++||+||||+++
T Consensus 168 vLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~~~~~~~~~~~vleLPy~~~~~~~~~sm~iiLP~~~- 246 (393)
T 3le2_A 168 IFANALYFKGTWNEKFDESLTQEGEFHLLDGNKVTAPFMTSKKKQYVSAYDGFKVLGLPYLQGQDKRQFSMYFYLPDAN- 246 (393)
T ss_dssp EEEEEEEEECCBSSCCCGGGCEEEEEECTTSCEEEEEEEECCSCEEEEEETTEEEEEEEBCCTTCSCCEEEEEEEESST-
T ss_pred EEEEeeeEecccccCCChhhccccccEeCCCcEEEEccccccCeeeeeeccCcEEEEeecCCCCCCCcEEEEEEeCCCC-
Confidence 88 877 35566777 3334444589999999987 5799999999997
Q ss_pred CCcHHHHHHHhcCCchHHHHHhhhcCCCee---EEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC-C----CC
Q psy7902 198 QDGVGDILAALKKDPTSFKRFTEDSQNLKP---VEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-D----SH 269 (342)
Q Consensus 198 ~~~l~~l~~~L~~~~~~l~~~~~~~l~~~~---v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~-~----~~ 269 (342)
.+|.+++++|+.. . .++.+.+.... ++|.||||++++++||+++|++||++++|++.|||++|+ . ++
T Consensus 247 -~~l~~l~~~L~~~--~--~~l~~~~~~~~v~~~~l~lPKF~i~~~~~L~~~L~~lGi~~~F~~~Adfsgis~~~~~~~~ 321 (393)
T 3le2_A 247 -NGLSDLLDKIVST--P--GFLDNHIPRRQVKVREFKIPKFKFSFGFDASNVLKGLGLTSPFSGEEGLTEMVESPEMGKN 321 (393)
T ss_dssp -TCHHHHHHHHHHS--T--TTGGGCCCCSEEEEEEEEEECEEEEEEEETHHHHHHTTCCGGGSTTTCCTTTBSCHHHHTT
T ss_pred -CCHHHHHHHHhcC--H--HHHHHhhhhceeeecceECcEEeccCCcchHHHHHhCCchhhcCCcCCccccccccccCCC
Confidence 7999999999875 2 23323234433 378999999999999999999999999999889999999 5 68
Q ss_pred eeecceeeeEEEEecCCCccccccchhhhcccCCCC-CC-ceEEecCCeEEEEEeCCCCcEEEEEEEcCCC
Q psy7902 270 IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPL-EP-VRYEANHPFLYFLVDKEIQSILFAGVFNEPP 338 (342)
Q Consensus 270 l~ls~v~q~~~i~v~E~G~~a~a~t~~~~~~~~~~~-~~-~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~ 338 (342)
++||+|+|+++|+|||+|++|+|+|++.+..++.+. .+ +.|++||||+|+|+|+.|+.|||+|+|.+|.
T Consensus 322 l~vs~v~hka~ieV~E~GteAaAaT~~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~ 392 (393)
T 3le2_A 322 LCVSNIFHKACIEVNEEGTEAAAASAGVIKLRGLLMEEDEIDFVADHPFLLVVTENITGVVLFIGQVVDPL 392 (393)
T ss_dssp CCCCEEEEEEEEEECSCBCSCCCCCCCHHHHHTTTSCCCEEEEECCSCEEEEEEETTTCCEEEEEEESCTT
T ss_pred eeEeEEEEEEEEEEcCCCchhhcccceeeeeccCCCCCCCceEEecCCEEEEEEECCCCcEEEEEEecCCC
Confidence 999999999999999999999999987655444433 33 6899999999999999999999999999996
|
| >1sek_A Serpin K; serine protease inhibitor, protease; 2.10A {Manduca sexta} SCOP: e.1.1.1 PDB: 1k9o_I | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-72 Score=525.03 Aligned_cols=321 Identities=30% Similarity=0.472 Sum_probs=282.3
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCCc
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADSG 80 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 80 (342)
+||++||+++...++++|++|||+||+.+|+|++.||+|+|++||.++||++.. ......++ .+...+... .+
T Consensus 17 ~Fa~~l~~~l~~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~---~~~~~~~~--~l~~~l~~~-~~- 89 (378)
T 1sek_A 17 QFTAQMFSEVVKANPGQNVVLSAFSVLPPLGQLALASVGESHDELLRALALPND---NVTKDVFA--DLNRGVRAV-KG- 89 (378)
T ss_dssp HHHHHHHHHHHHTSTTSCEEECSTTTHHHHHHHHHHCCHHHHHHHHHHHTCCCH---HHHHHHHH--HHHHTCSCC-TT-
T ss_pred HHHHHHHHHHHhcCCCCCEEEcHHHHHHHHHHHHhhcCCcHHHHHHHHhCCCCC---chHHHHHH--HHHHHHhcc-CC-
Confidence 499999999998777899999999999999999999999999999999999842 11113343 444445432 34
Q ss_pred eEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE--
Q psy7902 81 LTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL-- 153 (342)
Q Consensus 81 ~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl-- 153 (342)
..+.++|++|++++++++++|.+ +|+++++.+|| .+++.+++ ||+||+++|+|+|++++++++++++|.++|
T Consensus 90 ~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF-~~~~~a~~~IN~WV~~~T~gkI~~ll~~~~l~~~t~lvLvN 168 (378)
T 1sek_A 90 VDLKMASKIYVAKGLELNDDFAAVSRDVFGSEVQNVDF-VKSVEAAGAINKWVEDQTNNRIKNLVDPDALDETTRSVLVN 168 (378)
T ss_dssp EEEEEEEEEEEETTSCBCHHHHHHHHHTTCCEEEEECG-GGHHHHHHHHHHHHHHHTTTSSCCCSCGGGCCTTCCEEEEE
T ss_pred CeEEeeeehhhhCCCCHhHHHHHHHHHHhCCeeEeeCC-cCHHHHHHHHHHHHHHHhCCcccccCCcccCCCCCeEEEEE
Confidence 78999999999999999999975 79999999999 57888888 999999999999999998889999999988
Q ss_pred -------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHHH
Q psy7902 154 -------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGD 203 (342)
Q Consensus 154 -------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~~ 203 (342)
|++ +++.+.|| +|++.++++|++++|||+++++||+|+||++. .+|.+
T Consensus 169 aiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~l~~~vleLPy~~~~~sm~iiLP~~~--~~l~~ 246 (378)
T 1sek_A 169 AIYFKGSWKDKFNKERTMDRDFHVSKDKTIKVPTMIGKKDVRYADVPELDAKMIEMSYEGDQASMIIILPNQV--DGITA 246 (378)
T ss_dssp EEEEEECBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEEGGGTEEEEEEEBGGGSEEEEEEEESST--TTHHH
T ss_pred eeEEeccccCCCCCCCcccceEEeCCCEEEEeeEEEeeceEeEEEeCCCCeEEEEEECCCCcEEEEEEEeCCC--CCHHH
Confidence 876 35566777 67888999999999999988999999999987 79999
Q ss_pred HHHHhc-CCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCC-CCCCCCCCCC-C-CCeeecceeeeE
Q psy7902 204 ILAALK-KDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLF-SPGADLSRLT-D-SHIAFGDAVHKA 279 (342)
Q Consensus 204 l~~~L~-~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F-~~~ad~s~i~-~-~~l~ls~v~q~~ 279 (342)
++++|+ .+ .+..|.+. +..+.|+|.||||++++++||+++|++||++++| +..|||++|+ + .+++|++|+|++
T Consensus 247 l~~~L~~~~--~l~~~~~~-~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfs~i~~~~~~l~vs~v~hka 323 (378)
T 1sek_A 247 LEQKLKDPK--ALSRAEER-LYNTEVEIYLPKFKIETTTDLKEVLSNMNIKKLFTPGAARLENLLKTKESLYVDAAIQKA 323 (378)
T ss_dssp HHHHTTSTT--HHHHHHTT-CEEEEEEEEEECEEEEEEEEHHHHHHHTTCCGGGSTTTCCCTTTBTTCCCCCCCEEEEEE
T ss_pred HHHHhcchh--HHHHHHHh-ccceEEEEEeeeEEeecccccHHHHHhcCCcccccCCcCCchhhcCCCCCeEEeeeeeEE
Confidence 999999 68 99999988 6889999999999999999999999999999999 4579999998 4 579999999999
Q ss_pred EEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCC
Q psy7902 280 RLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337 (342)
Q Consensus 280 ~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P 337 (342)
+|+|||+|++|+|+|++....++.+ .+..|++||||+|+|+| +++|||+|+|.+|
T Consensus 324 ~ieV~E~GteAaAaT~~~~~~~~~~-~~~~f~~drPFlf~I~~--~~~iLF~G~v~~P 378 (378)
T 1sek_A 324 FIEVNEEGAEAAAANAFKITTYSFH-FVPKVEINKPFFFSLKY--NRNSMFSGVCVQP 378 (378)
T ss_dssp EEEECSCBSSCTTSSTTCCCCSCCC-CCCEEECCSCEEEEEEE--TTEEEEEEEESCC
T ss_pred EEEeCCCCcccccccchhhccccCC-CCCeEEecCCEEEEEEe--CCEEEEEEEecCC
Confidence 9999999999999998765544433 34579999999999999 5899999999998
|
| >1qmn_A AACT, alpha-1-antichymotrypsin; serpin, serine proteinase inhibitor, partial loop insertion, loop-sheet polymerization, emphysema, disease mutation; 2.27A {Homo sapiens} SCOP: e.1.1.1 PDB: 3dlw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-73 Score=534.77 Aligned_cols=326 Identities=30% Similarity=0.472 Sum_probs=284.0
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCC-ChHHHHHHhhHHHHHHHhhhCCCC
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENL-DKLDTMNVYKMEKLIQGLRANADS 79 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~-~~~~~~~~~~~~~~l~~l~~~~~~ 79 (342)
+||++||+++...++++|++|||+||+.+|+|++.||+|+|++||.++||++... +..+++..|+ .++..+...+.+
T Consensus 33 ~Fa~~l~~~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~--~l~~~l~~~~~~ 110 (401)
T 1qmn_A 33 DFAFSLYKQLVLKAPDKNVIFSPPSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQ--HLLRTLNQSSDE 110 (401)
T ss_dssp HHHHHHHHHHHHHCSSSCEEECHHHHHHHHHHHGGGCCHHHHHHHHHHTTCCTTTCCHHHHHHHHH--HHHHHHCCCSSS
T ss_pred HHHHHHHHHHHhcCCCCCEEEecHHHHHHHHHHHhhccCHHHHHHHHHhCCCCCCCCHHHHHHHHH--HHHHHHhcCCCC
Confidence 4999999999877788999999999999999999999999999999999997532 3567888887 778877665555
Q ss_pred ceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE-
Q psy7902 80 GLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL- 153 (342)
Q Consensus 80 ~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl- 153 (342)
+.+.++|++|++++++++++|.+ +|+++++.+|| .+++.+++ ||+||+++|+|+|+++++ +++++|.++|
T Consensus 111 -~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF-~~~~~a~~~IN~WV~~~T~gkI~~ll~--~l~~~t~lvLv 186 (401)
T 1qmn_A 111 -LQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDF-QDSAAAKKLINDYVKNGTRGKITDLIK--DLDSQTMMVLV 186 (401)
T ss_dssp -CEEEEEEEEEEESSCCCCHHHHHHHHHHHCCEEEEECG-GGHHHHHHHHHHHCSSEEEEEEEECC------CCCCEEEE
T ss_pred -ceEEEEEEEEeeCCCchHHHHHHHHHHhcCCeEEecCc-cCHHHHHHHHHHHHHHHhcCchhhhcc--CCCCCceEEEE
Confidence 88999999999999999999975 89999999999 57888888 999999999999999994 5899999988
Q ss_pred --------ecc---------------CCceEEec---------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcH
Q psy7902 154 --------WLP---------------STQESIII---------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGV 201 (342)
Q Consensus 154 --------W~~---------------~~~~~~V~---------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l 201 (342)
|+. +++.+.|| +|++.++++|++++|||+++ .+|+||||+++ +|
T Consensus 187 NaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~y~~~~~l~~~vleLPY~~~-~sm~iiLP~~~---~L 262 (401)
T 1qmn_A 187 NYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVELKYTGN-ASALFILPDQD---KM 262 (401)
T ss_dssp EEEEEEEEBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSS-EEEEEEEECTT---CH
T ss_pred EeeeeeehhcCCCChhcCccceEEcCCCcEEEeeEEEEcCceEEEEEeCCCceEEEEEecCCC-eEEEEEEECCC---CH
Confidence 876 34556676 35667889999999999775 59999999875 89
Q ss_pred HHHHHHhcCCchHHHHHhhhcCCCeeE-EEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC-CCCeeecceeeeE
Q psy7902 202 GDILAALKKDPTSFKRFTEDSQNLKPV-EIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-DSHIAFGDAVHKA 279 (342)
Q Consensus 202 ~~l~~~L~~~~~~l~~~~~~~l~~~~v-~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~-~~~l~ls~v~q~~ 279 (342)
.+++++|+.+ .+..|.+. +..+.| +|.||||++++++||+++|++||++++|+..|||++|+ +++++|++|+|++
T Consensus 263 ~~le~~L~~~--~l~~~~~~-~~~~~v~~v~lPKFki~~~~dL~~~L~~lGi~~~F~~~Adfsgis~~~~l~vs~v~hka 339 (401)
T 1qmn_A 263 EEVEAMLLPE--TLKRWRDS-LEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADLSGITGARNLAVSQVVHKA 339 (401)
T ss_dssp HHHHTTCSHH--HHHHHHHS-CEEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGSTTCCCHHHHSSSCEEEEEEEEEE
T ss_pred HHHHHHhCHH--HHHHHHHh-CcceEcceEeeeeEEEeccccHHHHHHhcCccccccCcCCcccccCCCCeEEEeeeeEE
Confidence 9999999987 99999988 688999 99999999999999999999999999998789999999 6889999999999
Q ss_pred EEEecCCCccccccchhhhcccCCCC-CCceEEecCCeEEEEEeCCCCcEEEEEEEcCCCC
Q psy7902 280 RLDLDEQGTTAAAATAVFAFRSSRPL-EPVRYEANHPFLYFLVDKEIQSILFAGVFNEPPN 339 (342)
Q Consensus 280 ~i~v~E~G~~a~a~t~~~~~~~~~~~-~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~~ 339 (342)
+|+|||+|++|+|+|++.+..++.+. .+..|++||||+|+|+|+.|+.|||+|+|.+|..
T Consensus 340 ~ieVnE~GteAaAaT~~~~~~~s~~~~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 400 (401)
T 1qmn_A 340 VLDVFEEGTEASAATAVKITLLSALVETRTIVRFNRPFLMIIVPTDTQNIFFMSKVTNPKQ 400 (401)
T ss_dssp EEEECSSEEESSCCCC-----CCCCCCCSCEEECCSCEEEEEEETTSSCCSEEEEESCTTC
T ss_pred EEEeCCCccccccccchhhccccCCCCCCceEEecCCEEEEEEECCCCcEEEEEEcCCCCC
Confidence 99999999999999987655444332 2478999999999999999999999999999974
|
| >1jmo_A HC-II, heparin cofactor II, HLS2, serin; serpin, thrombin, protease, inhibition, inhibitor, blood CLO; HET: TYS NDG NAG; 2.20A {Homo sapiens} SCOP: e.1.1.1 PDB: 1jmj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-72 Score=535.23 Aligned_cols=323 Identities=24% Similarity=0.456 Sum_probs=290.1
Q ss_pred ChHHHHHHHHhhc-CCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCC----CC--ChHHHHHHhhHHHHHHHh
Q psy7902 1 EFTFDLLTVLNNA-NKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPE----NL--DKLDTMNVYKMEKLIQGL 73 (342)
Q Consensus 1 ~Fa~~l~~~l~~~-~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~----~~--~~~~~~~~~~~~~~l~~l 73 (342)
+||++||+++... .+++|++|||+||+.+|+|++.||+|+|++||.++||++. .. +..+++..|+ .++..+
T Consensus 113 ~Fa~~L~k~l~~~~~~~~NivfSP~SI~~aLaml~~GA~G~T~~eL~~~L~~~~~~~~~~~~~~~~i~~~f~--~ll~~l 190 (480)
T 1jmo_A 113 KFAFNLYRVLKDQVNTFDNIFIAPVGISTAMGMISLGLKGETHEQVHSILHFKDFVNASSKYEITTIHNLFR--KLTHRL 190 (480)
T ss_dssp HHHHHHHHHHHTTSCTTSCEEECHHHHHHHHHHHGGGCCHHHHHHHHHHTTHHHHHHHCTTCCHHHHHHHHH--HHHHHH
T ss_pred HHHHHHHHHHHhccCCCCCEEEcHHHHHHHHHHHHHhcCcHHHHHHHHHhCCCccccccccCCHHHHHHHHH--HHHHHh
Confidence 4999999999875 6789999999999999999999999999999999999974 11 2467888887 788888
Q ss_pred hhCCCCceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCC
Q psy7902 74 RANADSGLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSR 148 (342)
Q Consensus 74 ~~~~~~~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~ 148 (342)
...+.+ +.++++|++|++++++++++|.+ +|+++++.+||. ++.. ++ ||+||+++|+|+|++++ ++++++
T Consensus 191 ~~~~~~-~~L~~AN~lfv~~~~~l~~~F~~~~~~~y~a~~~~vDF~-~~~~-~~~IN~WV~~~T~gkI~~ll--~~l~~~ 265 (480)
T 1jmo_A 191 FRRNFG-YTLRSVNDLYIQKQFPILLDFKTKVREYYFAEAQIADFS-DPAF-ISKTNNHIMKLTKGLIKDAL--ENIDPA 265 (480)
T ss_dssp HSSCSS-SEEEEEEEEEEETTSCCCHHHHHHHHHHHSCCEEEECTT-CHHH-HHHHHHHHHHHTTTSSCCTT--CSCCTT
T ss_pred hcCCCC-ceEEEEEEEeecCCCcccHHHHHHHHHhhccceeeeccc-CHHH-HHHHHHHHHHhhCCChhhhh--cccCCC
Confidence 766556 89999999999999999999975 899999999995 5555 66 99999999999999999 789999
Q ss_pred ceEEE---------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCC
Q psy7902 149 TNLVL---------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFA 196 (342)
Q Consensus 149 t~lvl---------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~ 196 (342)
|.++| |++ +++.+.|| +|++.++++|++++|||+ +++||+|+||++.
T Consensus 266 T~lvLvNAiyFKg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~f~y~~~~~l~~~vleLPY~-~~~SM~IiLP~~~ 344 (480)
T 1jmo_A 266 TQMMILNCIYFKGSWVNKFPVEMTHNHNFRLNEREVVKVSMMQTKGNFLAANDQELDCDILQLEYV-GGISMLIVVPHKM 344 (480)
T ss_dssp CCEEEEEEEEEECCBSSCCCGGGCEEEEEECSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEET-TTEEEEEEEESSG
T ss_pred CeEEEEehHeeeccccCCCCCCCceeEEEEeCCCcEEEEEEEEEecceeeEEeCCCceEEEEEecC-CcEEEEEEecCCC
Confidence 99988 876 34556676 678889999999999998 8999999999887
Q ss_pred CCCcHHHHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCCCCCeeeccee
Q psy7902 197 SQDGVGDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLTDSHIAFGDAV 276 (342)
Q Consensus 197 ~~~~l~~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~~~~l~ls~v~ 276 (342)
.+|.+++++|+.+ .+..|.+. |..+.|+|.||||++++++||+++|++||++++|+..|||++|++++++|++|+
T Consensus 345 --~~L~~le~~L~~~--~l~~~~~~-l~~~~V~v~LPKFkie~~~dL~~~L~~LGi~~~F~~~ADfsgis~~~L~VS~v~ 419 (480)
T 1jmo_A 345 --SGMKTLEAQLTPR--VVERWQKS-MTNRTREVLLPKFKLEKNYNLVESLKLMGIRMLFDKNGNMAGISDQRIAIDLFK 419 (480)
T ss_dssp --GGHHHHHHHCCHH--HHHHHHHH-CEEEEEEEEEECEEEECCEECHHHHHHHTCCGGGSTTSCCTTTCSSCCCEEEEE
T ss_pred --CCHHHHHHhhCHH--HHHHHHhc-ccceEEEEEeccEEEEEeecHHHHHHhCCccccccCCCCcCcccCCCceecchh
Confidence 7999999999987 99999998 788999999999999999999999999999999977899999997779999999
Q ss_pred eeEEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCCCC
Q psy7902 277 HKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEPPN 339 (342)
Q Consensus 277 q~~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~~ 339 (342)
|+++|+|||+|++|+|+|++.+..++.+ ..|+|||||+|+|+|+.|+.|||+|+|.+|.+
T Consensus 420 HKa~IeVnEeGtEAAAaT~v~~~~~s~~---~~F~aDrPFlF~I~d~~t~~iLF~G~v~~P~~ 479 (480)
T 1jmo_A 420 HQGTITVNEEGTQATTVTTVGFMPLSTQ---VRFTVDRPFLFLIYEHRTSCLLFMGRVANPSR 479 (480)
T ss_dssp EEEEEEECSCBSCCCCCCCCSEEECSCC---CEEECCSCEEEEEEETTTTEEEEEEEESCTTC
T ss_pred eeEEEEccCCccccccccccccccccCC---CcEEecCCEEEEEEECCCCcEEEEEEeCCCCC
Confidence 9999999999999999998766554432 38999999999999999999999999999975
|
| >3ozq_A Serpin48; SPE, hydrolase I; 1.90A {Tenebrio molitor} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-72 Score=524.56 Aligned_cols=318 Identities=27% Similarity=0.469 Sum_probs=277.0
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCCc
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADSG 80 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 80 (342)
+||++||+++. ..+++|++|||+||+.+|+|++.||+|+|++||.++||++. +..+++..|+ .++..+. +.+
T Consensus 17 ~Fa~~l~~~l~-~~~~~Ni~~SP~Si~~aLaml~~GA~g~T~~ql~~~L~~~~--~~~~~~~~~~--~~l~~l~--~~~- 88 (376)
T 3ozq_A 17 SFTPSVYKEVL-KTEKANFLVSPFSAATLLALAQSGCRGDTAEEIRQVLHFVG--DREKAEGAVK--EVLSKLT--NEE- 88 (376)
T ss_dssp HHHHHHHHHHH-HHCCSCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHTTCCS--CHHHHHHHHH--HHHHHTB--CSS-
T ss_pred HHHHHHHHHHh-hCCCCCEEEcHHHHHHHHHHHHhHCchHHHHHHHHHHCCCC--cHHHHHHHHH--HHHHHhc--CCC-
Confidence 49999999998 45789999999999999999999999999999999999964 4566777776 6666654 234
Q ss_pred eEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE--
Q psy7902 81 LTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL-- 153 (342)
Q Consensus 81 ~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl-- 153 (342)
..+.++|++|++++++++++|++ +|+++++.+||. +++.+++ ||+||+++|+|+|++++++++++++|.++|
T Consensus 89 ~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~-~~~~a~~~IN~wV~~~T~gkI~~ll~~~~l~~~t~lvLvN 167 (376)
T 3ozq_A 89 YTLHTANKIYVKTNFSVREEFQKIAVEVYGAQSENVDFS-EKNDAAKLMNAWVEEQTQHKIQNLVDPEILNNLTRVVLIN 167 (376)
T ss_dssp CEEEEEEEEEEETTSCCCHHHHHHHHHTTSCEEEEECCS-SHHHHHHHHHHHHHHHTTTCSCCCSCGGGCCTTCCEEEEE
T ss_pred cEEeeehhHHHhCCCcchHHHHHHHHHhhCCeeEEecCC-ChHHHHHHHHHHHHhhhcCchhhccCcccCCCcceEEEEe
Confidence 78999999999999999999975 899999999995 5577777 999999999999999998889999999988
Q ss_pred -------ecc---------------CCceEEec---------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHH
Q psy7902 154 -------WLP---------------STQESIII---------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVG 202 (342)
Q Consensus 154 -------W~~---------------~~~~~~V~---------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~ 202 (342)
|++ +++.+.|| +|++.++++|++++|||+++ +||+||||+++ .+|.
T Consensus 168 aiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~y~~~~~~~~~vleLPy~~~-~sm~iiLP~~~--~~l~ 244 (376)
T 3ozq_A 168 ALYFNAKWLVPFPPFHTRKSDFHKSAKEVVQVDTMYLDEQYFNYYECHHLDAKLLELPFKGG-ASLTIVLSNQI--EGLV 244 (376)
T ss_dssp EEEEEEEBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBTTS-CEEEEEEESST--TCHH
T ss_pred hhhhhhhhccCCCcccceeeeeEecCCcEEEEeehhhccCceeEEEecCCCeEEEEEeCCCC-EEEEEEeCCCC--CCHH
Confidence 877 34455666 57778899999999999887 99999999987 7999
Q ss_pred HHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC-CC-CeeecceeeeEE
Q psy7902 203 DILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-DS-HIAFGDAVHKAR 280 (342)
Q Consensus 203 ~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~-~~-~l~ls~v~q~~~ 280 (342)
+++++|+.+ .+.+ . +..+.|+|.||||++++++||+++|++||++++|+..|||++|+ ++ +++|++|+|+++
T Consensus 245 ~l~~~L~~~--~l~~---~-~~~~~v~v~lPKF~i~~~~~L~~~L~~lGi~~~F~~~Adfs~is~~~~~l~vs~v~hka~ 318 (376)
T 3ozq_A 245 SLESKIKRS--FLPH---N-LTKQLVNVALPKFKIESTVDFKKVLKKLGVKKAFGDEADLSGIAGEKGDLVISNIVQKSF 318 (376)
T ss_dssp HHHHTHHHH--HSCC---C-CEEEEEEEEEECEEEEEEEEHHHHHHHHTCCGGGSTTCCCTTTSSSTTSCCEEEEEEEEE
T ss_pred HHHHHhCHH--HHHh---h-CCeeEEEEEcccEEeecccchHHHHHhcCchhhcCCCCCCccccCCCCCeEEeeeEeeEE
Confidence 999999876 5543 4 67889999999999999999999999999999999779999999 55 899999999999
Q ss_pred EEecCCCccccccchhhhc-ccCCC-CCCceEEecCCeEEEEEeCCCCcEEEEEEEcCCC
Q psy7902 281 LDLDEQGTTAAAATAVFAF-RSSRP-LEPVRYEANHPFLYFLVDKEIQSILFAGVFNEPP 338 (342)
Q Consensus 281 i~v~E~G~~a~a~t~~~~~-~~~~~-~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~ 338 (342)
|+|||+|++|+|+|++.+. .++.+ ..+..|++||||+|+|+|+ ++|||+|+|.+|.
T Consensus 319 ieV~E~GteAaAaT~~~~~~~~s~~~~~p~~f~~drPFlf~I~~~--~~iLF~G~v~~p~ 376 (376)
T 3ozq_A 319 IDVSEEGVEAAAATYIPVILPEMALPDSPKQFIVDHPFIFYIKVK--GMILFAGRVTTLN 376 (376)
T ss_dssp EEECSSEESCCCCCCCCC---------CCEEEECCSCEEEEEEET--TEEEEEEEECCCC
T ss_pred EEECCCCccccccceeeecccccccCCCCceEEeECCEEEEEEEC--CEEEEEEEecCCC
Confidence 9999999999999987654 33332 3457899999999999999 9999999999994
|
| >2v95_A Corticosteroid-binding globulin; transport protein, CBG, RCL, serpin, secreted, transport, glycoprotein, lipid-binding, glucocorticoids; HET: HCY; 1.93A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-72 Score=523.30 Aligned_cols=318 Identities=28% Similarity=0.423 Sum_probs=263.8
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCC-ChHHHHHHhhHHHHHHHhhhCCCC
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENL-DKLDTMNVYKMEKLIQGLRANADS 79 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~-~~~~~~~~~~~~~~l~~l~~~~~~ 79 (342)
+||++||+++...++++|++|||+||+.+|+|++.|| |++||.++||++... +..+++..|+ .++..+...+.+
T Consensus 15 ~Fa~~l~~~l~~~~~~~N~v~SP~Si~~aLaml~~GA---T~~el~~~L~~~~~~~~~~~~~~~~~--~l~~~l~~~~~~ 89 (371)
T 2v95_A 15 DFAFNLYQRLVALNPDKNTLISPVSISMALAMVSLGS---AQTQSLQSLGFNLTETSEAEIHQSFQ--YLNYLLKQSDTG 89 (371)
T ss_dssp HHHHHHHHHHHHHCTTSCEEECHHHHHHHHHHHTTTC-----CHHHHHHTCCTTTSCHHHHHHHHH--HHHHHHTTGGGS
T ss_pred HHHHHHHHHHhccCCCCcEEEchHHHHHHHHHHHHHH---HHHHHHHHhCCCCCCCCHHHHHHHHH--HHHHHHhCCCCC
Confidence 4999999999877788999999999999999999999 999999999998532 3567888887 777777655455
Q ss_pred ceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE-
Q psy7902 80 GLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL- 153 (342)
Q Consensus 80 ~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl- 153 (342)
+.++++|++|++++++++++|.+ +|+++++.+|| .+++.+++ ||+||+++|+|+|+++++ +++++|.++|
T Consensus 90 -~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF-~~~~~a~~~IN~WV~~~T~gkI~~l~~--~l~~~t~lvLv 165 (371)
T 2v95_A 90 -LEMNMGNAMFLLQKLKLKDSFLADVKQYYESEALAIDF-EDWTKASQQINQHVKDKTQGKIEHVFS--DLDSPASFILV 165 (371)
T ss_dssp -EEEEEEEEEEECTTCCBCHHHHHHHHHHSCCEEEECCC-SSHHHHHHHHHHHHHHHTTTCCCCSCC--C--CCCSEEEE
T ss_pred -cEEEEEEEEeEeCCCchhHHHHHHHHHHhCCceEEecC-ccHHHHHHHHHHHHHHHhcCchhhhcc--CCCCCceEEEE
Confidence 88999999999999999999975 89999999999 47888888 999999999999999994 5999999988
Q ss_pred --------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHH
Q psy7902 154 --------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVG 202 (342)
Q Consensus 154 --------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~ 202 (342)
|++ +++.+.|| +|++.++++|++++|||++ +.+|+||||+++ +|.
T Consensus 166 NaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~l~~~vleLPy~~-~~sm~iiLP~~~---~l~ 241 (371)
T 2v95_A 166 NYIFLRGIWELPFSPENTREEDFYVNETSTVKVPMMVQSGSIGYFRDSVFPCQLIQMDYVG-NGTAFFILPDQG---QMD 241 (371)
T ss_dssp EEEEEEECBSSCCCGGGCEEEEEECSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSS-SEEEEEEEECTT---CHH
T ss_pred EHHhhhhhhhCcCCCcccceeEEEECCCeEEEEEEEEeeeeEeeEEeCCCCEEEEEEecCC-CeEEEEEecCCC---CHH
Confidence 876 34556777 6788899999999999976 479999999875 799
Q ss_pred HHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC-CCCeeecceeeeEEE
Q psy7902 203 DILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-DSHIAFGDAVHKARL 281 (342)
Q Consensus 203 ~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~-~~~l~ls~v~q~~~i 281 (342)
+++++|+.+ .+..|.+. +..+.|+|.||||++++++||++.|++||++++|+..|||++|+ +++++|+ |+|+++|
T Consensus 242 ~le~~L~~~--~l~~~~~~-l~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~~Adfsgis~~~~l~vs-v~hka~i 317 (371)
T 2v95_A 242 TVIAALSRD--TIDRWGKL-MTPRQVNLYIPKFSMSDTYDLKDVLEDLNIKDLLTNQSDFSGNTKDVPLTLT-MVHKAML 317 (371)
T ss_dssp HHHHHCSHH--HHHHHHHH-CEEEEEEEEEECEEEEEEEEGGGTSCSCCHHHHBCC------------CCEE-EEEEEEE
T ss_pred HHHHHhCHH--HHHHHHHh-hhcccceEeeeEEEeecccchHHHHHhcCCccccCCCCCcCCCCCCCCeeEE-EEEEEEE
Confidence 999999987 99999998 78899999999999999999999999999999999779999999 6789999 9999999
Q ss_pred EecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCCC
Q psy7902 282 DLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEPP 338 (342)
Q Consensus 282 ~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~ 338 (342)
+|||+|++|+|+|++....++ .+..|++||||+|+|+|+.|+.|||+|+|.+|.
T Consensus 318 eVnE~GteAaAaT~~~~~~~~---~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~ 371 (371)
T 2v95_A 318 QLDEGNVLPNSTNGAPLHLRS---EPLDIKFNKPFILLLFDKFTWSSLMMSQVVNPA 371 (371)
T ss_dssp EESCCCCC----------CCC---CCEEEECCSCEEEEEEETTTCCEEEEEEESCCC
T ss_pred EecCCcccccccccccccccC---CCcEEEeeCCEEEEEEECCCCcEEEEEEecCCC
Confidence 999999999999987655443 358899999999999999999999999999995
|
| >2wxy_C Angiotensinogen, serpin A8; glycoprotein, hypertension, vasoconstrictor, renin, serpins, vasoactive, hormone; 2.10A {Mus musculus} PDB: 2wxx_A 2wy0_C 2wxz_A 2wxz_C 2wy1_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-71 Score=527.57 Aligned_cols=324 Identities=16% Similarity=0.275 Sum_probs=278.0
Q ss_pred ChHHHHHHHHhhcCCCCcE-EEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCC-------hHHHHHHhhHHHHHHH
Q psy7902 1 EFTFDLLTVLNNANKGKNV-FVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLD-------KLDTMNVYKMEKLIQG 72 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~-v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~-------~~~~~~~~~~~~~l~~ 72 (342)
+||++||+++....+++|+ +|||+||+.+|+|++.||+|+|++||.++||++.... ..+++..|+ .++..
T Consensus 79 ~Fa~~L~~~l~~~~~~~Ni~v~SP~SI~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~--~l~~~ 156 (453)
T 2wxy_C 79 FVGFRMYKMLNEAGSGASGAILSPPALFGTLVSFYLGSLDPTASQLQTLLDVPVKEGDCTSRLDGHKVLAALR--AVQGL 156 (453)
T ss_dssp HHHHHHHHHHHHHCCCSSEEEECHHHHHHHHHHHHHTCCTTHHHHHHHHTTCCCCTTCGGGSBCHHHHHHHHH--HHHHH
T ss_pred HHHHHHHHHHhhcCCCCcEEEECHHHHHHHHHHHHhhcccHHHHHHHHHhCCCcccccccccccHHHHHHHHH--HHHHH
Confidence 4999999999887788999 9999999999999999999999999999999986421 145677776 66666
Q ss_pred hhhC-----CCCceEEEEEeeeeccCCCCchhhHhh----hcCCc-eEEecCCCCHHHHHH-HHHHHHHhcccccccCcc
Q psy7902 73 LRAN-----ADSGLTFTSTNKIFVNDKIPVKECMTA----IFPSE-IQSMDFGNEVEAARA-INSWVAQETKNNIKDLIA 141 (342)
Q Consensus 73 l~~~-----~~~~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~-~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~ 141 (342)
+... +.. +.+.++|++|++++++++++|.+ +|+++ ++.+||..+++.+++ ||+||+++|+|+|++++
T Consensus 157 l~~~~~~~~~~~-~~l~~an~l~~~~~~~l~~~F~~~~~~~y~a~~~~~vdF~~~~~~a~~~IN~WV~~~T~gkI~~ll- 234 (453)
T 2wxy_C 157 LVTQGGSSSQTP-LLQSIVVGLFTAPGFRLKHSFVQSLALFTPALFPRSLDLSTDPVLATEKINRFIKAVTGWKMNLPL- 234 (453)
T ss_dssp HHC--------C-EEEEEEEEEEECTTCCEEHHHHHHHHTTCSCEEEEECCCSSCHHHHHHHHHHHHHHHHCCCCCCCC-
T ss_pred HhhccccCCCCc-cEEEEEEeEeEeCCCCccHHHHHHHHHHcCCCceeeecccCCHHHHHHHHHHHHHHhcCCchhhhh-
Confidence 6531 234 77999999999999999999975 78885 999999667888888 99999999999999999
Q ss_pred CCCCCCCceEEE---------ecc-------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEE
Q psy7902 142 TGQVNSRTNLVL---------WLP-------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFL 191 (342)
Q Consensus 142 ~~~i~~~t~lvl---------W~~-------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~ii 191 (342)
.+++++|.++| |+. +++.+.|| +|+++++++|++++|||+ +++||+||
T Consensus 235 -~~l~~~t~lvLvNaiyFKg~W~~~F~~~~~~~F~~~~~~~v~V~mM~~~~~f~y~~~~~l~~~vleLPY~-~~~sm~ii 312 (453)
T 2wxy_C 235 -EGVSTDSTLLFNTYVHFQGTMRGFSQLPGVHEFWVDNSISVSVPMISGTGNFQHWSDAQNNFSVTCVPLG-ERATLLLI 312 (453)
T ss_dssp -CCCCTTCCEEEEEEEEEEEEEEEEEECSSCEEEEEETTEEEEECEEEEEEEEEEEEETTTTEEEEEEESS-SSEEEEEE
T ss_pred -cccCCCCeEEEEehheeeccCCCCCCCccCCCcEeCCCeEEEEEEEEEeCCCCEEEecCCCcEEEEEECC-CCEEEEEE
Confidence 46999999988 976 35566777 677788999999999996 48999999
Q ss_pred eCCCCCCCcHHHHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCCCCCee
Q psy7902 192 LPPFASQDGVGDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLTDSHIA 271 (342)
Q Consensus 192 lP~~~~~~~l~~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~~~~l~ 271 (342)
||+++ .+|.+++++|+.+ .+..|.++ |..+.|+|.||||+|++++||+++|++||++++|+..|||++|++.+++
T Consensus 313 LP~~~--~~L~~le~~L~~~--~l~~~~~~-l~~~~V~v~LPKFkie~~~dL~~~L~~lGi~~~F~~~Adfsgis~~~l~ 387 (453)
T 2wxy_C 313 QPHCI--SDLDRVEALIFQN--DLLTWIEN-PPPRAIRLTLPQLEIRGSYNLQDLLAEDKLPTLLGAEANLNNIGDTNPR 387 (453)
T ss_dssp EESSG--GGHHHHHHHHTC---CCCTTCCC-CCCEEEEEEEECEEEEEEEEHHHHHHHTTCTTTTSTTCCCTTTBSSCCC
T ss_pred ecCCC--CCHHHHHHHhCHH--HHHHHHHh-ccccccEEecceEEEeccccHHHHHHhcChhhhhcccCCcccccCCCce
Confidence 99987 7999999999998 89999988 7899999999999999999999999999999999878999999954599
Q ss_pred ecceeeeEEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCCCC
Q psy7902 272 FGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEPPN 339 (342)
Q Consensus 272 ls~v~q~~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~~ 339 (342)
||+|+|+++|+|||+|++|+|+|++... ...+..|++||||+|+|+|+.|+.|||+|+|.+|..
T Consensus 388 Vs~v~hka~ieVnEeGteAaAaT~~~~~----~~~~~~f~~drPFlF~I~d~~t~~iLF~G~v~~P~~ 451 (453)
T 2wxy_C 388 VGEVLNSILLELKAGEEEQPTTSVQQPG----SPEALDVTLSSPFLFAIYEQDSGTLHFLGRVNNPQS 451 (453)
T ss_dssp BCCCEEEEEEEEEEEECCCC--------------CCEEEECCSCEEEEEEETTTCCEEEEEEESCCC-
T ss_pred eeEEEEEEEEEecCCCcccccccccccc----CCCCceEEeeCCEEEEEEECCCCcEEEEEEeCCCCC
Confidence 9999999999999999999999875321 224689999999999999999999999999999975
|
| >2pef_A Serine protease inhibitor; serpin; 1.60A {Thermoanaerobacter tengcongensis} PDB: 2vh4_A 2pee_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-71 Score=521.78 Aligned_cols=319 Identities=22% Similarity=0.349 Sum_probs=280.7
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCCc
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADSG 80 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 80 (342)
+||++||+++. .+++|++|||+||+.+|+|++.||+|+|++||.++||++. +..+++..|+ .++..+.. ..+
T Consensus 15 ~Fa~~L~~~l~--~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~--~~~~~~~~~~--~l~~~l~~-~~~- 86 (373)
T 2pef_A 15 DFSIELFKNSI--DDKENSLISPLSAMLALAMTANGADNETLAQMEKALGKDI--SIEDLNKYLY--TYMKKLPN-EEK- 86 (373)
T ss_dssp HHHHHHHHTSC--CSSSCCEECHHHHHHHHHHHHTTCCHHHHHHHHHHHHTTC--CHHHHHHHHH--HHHHHSCC-BTT-
T ss_pred HHHHHHHHHhh--CCCCCEEEccHHHHHHHHHHHhhccChHHHHHHHHhCCCC--CHHHHHHHHH--HHHHHhhc-CCC-
Confidence 49999999985 3679999999999999999999999999999999999864 4567888887 77777754 345
Q ss_pred eEEEEEeeeecc-CCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE-
Q psy7902 81 LTFTSTNKIFVN-DKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL- 153 (342)
Q Consensus 81 ~~l~~~n~l~~~-~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl- 153 (342)
+.++++|++|++ ++++++++|.+ +|+++++.+||. +.+++ ||+||+++|+|+|+++++ +++++|.++|
T Consensus 87 ~~l~~an~l~~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~---~~a~~~IN~WV~~~T~gkI~~ll~--~l~~~t~lvLv 161 (373)
T 2pef_A 87 SKLTIANSIWFKENDFMPSKDFLQIIADYYKADIFKAAFD---SSTVSDINNWVKSKTNGMIDKILN--KIDPEDVMYLI 161 (373)
T ss_dssp EEEEEEEEEEEETTTEEECHHHHHHHHHHHCCEEEEECCS---HHHHHHHHHHHHHHTTTSCCCSCS--CCCTTCCEEEE
T ss_pred cEEEEEEEEEEecCCCchhHHHHHHHHHHhCCeeEecCch---HHHHHHHHHHHHHhccCchhhhhc--cCCCCceEEEE
Confidence 889999999999 79999999975 899999999994 35666 999999999999999994 7899999988
Q ss_pred --------ecc---------------CCceEEec------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHHHH
Q psy7902 154 --------WLP---------------STQESIII------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDI 204 (342)
Q Consensus 154 --------W~~---------------~~~~~~V~------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~~l 204 (342)
|++ +++.+.|| .| |.++++|++++|||+++++||+|+||+++ .+|.++
T Consensus 162 NaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~-y~~~~~~~vleLPy~~~~~sm~iiLP~~~--~~L~~l 238 (373)
T 2pef_A 162 NAVAFDAEWETVYEKASVHEDIFTDVYGNRQKVEFMNSEENL-YIEEENAVGFVKPYAKNHYSFVAILPDEN--ISVNEY 238 (373)
T ss_dssp EEEEEEEEBSSCCCGGGEEEEEEECTTSCEEEEEEEEEEEEE-EEEETTEEEEEEEBGGGSEEEEEEEECTT--SCHHHH
T ss_pred EeeeeeccccccCChhhccccceecCCCeEEEechhhccCeE-EeecCCeEEEEEecCCCcEEEEEEECCCC--CCHHHH
Confidence 876 35566777 45 77889999999999988999999999987 799999
Q ss_pred HHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCC-CCCCCCCC-C--CCeeecceeeeEE
Q psy7902 205 LAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSP-GADLSRLT-D--SHIAFGDAVHKAR 280 (342)
Q Consensus 205 ~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~-~ad~s~i~-~--~~l~ls~v~q~~~ 280 (342)
+++|+.+ .+..|+++ +..+.|+|.||||++++++||+++|++||++++|++ .|||++|+ . .+++||+|+|++.
T Consensus 239 ~~~L~~~--~l~~~~~~-~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfs~is~~~~~~l~vs~v~hka~ 315 (373)
T 2pef_A 239 IKTLTGQ--KFIDLIKN-AKITLVRASLPKFKYEYTIKMNETLESLGMTDAFLPDKADFSKLGKSDIGNLYISEVLHKTF 315 (373)
T ss_dssp HHHCCHH--HHHHHHHT-CEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGCTTTCCCTTTEEETTSCCCCCCEEEEEE
T ss_pred Hhhhhhh--HHHHHHhh-ceeeEEEEECceEEeecccchHHHHHhcCCccccCCCcCchhhcccCCCCCeEEcchhheeE
Confidence 9999987 99999998 688999999999999999999999999999999994 79999999 4 3799999999999
Q ss_pred EEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCCC
Q psy7902 281 LDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEPP 338 (342)
Q Consensus 281 i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~ 338 (342)
|+|||+|++|+|+|++.+..++.+..+.+|++||||+|+|+|+.|+.|||+|+|.+|.
T Consensus 316 ieVnE~GteAaAaT~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~p~ 373 (373)
T 2pef_A 316 ISVDELGTKAGAVTSVDITAAGIPVNFKTVKLNRPFIFAIIDNSTNLPIFIGTVLSLK 373 (373)
T ss_dssp EEECSSEEEEEEEEEESCC-------CCSEEEEEEEEEEEEETTTTEEEEEEEEEEEC
T ss_pred EEECCCccccccccchhhccccCCCCCCeEEecCCEEEEEEECCCCcEEEEEEecCCC
Confidence 9999999999999987655544444567899999999999999999999999999984
|
| >1imv_A PEDF, pigment epithelium-derived factor; serpin, angiogenesis, signaling protein; HET: NAG; 2.85A {Homo sapiens} SCOP: e.1.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-71 Score=519.59 Aligned_cols=318 Identities=22% Similarity=0.422 Sum_probs=276.0
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCCc
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADSG 80 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 80 (342)
+||++||+++....+++|++|||+||+.+|+|++.||+|+|++||.++||++.. +..+++..|+ .++..+...+
T Consensus 40 ~Fa~~l~~~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~-~~~~~~~~~~--~l~~~l~~~~--- 113 (398)
T 1imv_A 40 NFGYDLYRVRSSMSPTTNVLLSPLSVATALSALSLGADERTESIIHRALYYDLI-SSPDIHGTYK--ELLDTVTAPQ--- 113 (398)
T ss_dssp HHHHHHHHHHHHHCTTSCEEECHHHHHHHHHHHGGGCCHHHHHHHHHHTTGGGC-CCSCHHHHHH--HHHHHHTSTT---
T ss_pred HHHHHHHHHHHccCCCCCEEEChHHHHHHHHHHHHhcccHHHHHHHHHhCCCCC-CcHHHHHHHH--HHHHHhhCCC---
Confidence 499999999988778899999999999999999999999999999999999854 2236788887 7777775543
Q ss_pred eEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE--
Q psy7902 81 LTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL-- 153 (342)
Q Consensus 81 ~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl-- 153 (342)
..+.++|++|++++++++++|.+ +|+++++.+| . +++.+++ ||+||+++|+|+|++++ .+++++|.++|
T Consensus 114 ~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vd-~-~~~~a~~~IN~WV~~~T~gkI~~ll--~~l~~~t~lvLvN 189 (398)
T 1imv_A 114 KNLKSASRIVFEKKLRIKSSFVAPLEKSYGTRPRVLT-G-NPRLDLQEINNWVQAQMKGKLARST--KEIPDEISILLLG 189 (398)
T ss_dssp SCEEEEEEEEECTTCCCCHHHHHHHHHHHCCCCEECC-S-CHHHHHHHHHHHHHHHTTTCSCCCC--SCCCSSCSEEEEE
T ss_pred CCeEEEEEEeecCCCcHHHHHHHHHHHHhCCcceecC-C-CHHHHHHHHHHHHHHhhcCchhhhh--hccCCCceEEEEE
Confidence 34779999999999999999975 8999999999 4 7888887 99999999999999999 47999999988
Q ss_pred -------ecc---------------CCceEEec---------ceeecCCCCeEEEEeecCCCceEEEEEeC--CCCCCCc
Q psy7902 154 -------WLP---------------STQESIII---------ITVLSSELNAHILEVPYKGGNMSMFFLLP--PFASQDG 200 (342)
Q Consensus 154 -------W~~---------------~~~~~~V~---------~~~~~~~~~~~vvelP~~~~~~sm~iilP--~~~~~~~ 200 (342)
|+. +++.+.|| +|++.++++|++++|||++ +++|+|||| ++ .+
T Consensus 190 aiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~~f~~~~~~~l~~~vleLPY~~-~~sm~iiLP~~~~---~~ 265 (398)
T 1imv_A 190 VAHFKGQWVTKFDSRKTSLEDFYLDEERTVRVPMMSDPKAVLRYGLDSDLSCKIAQLPLTG-SMSIIFFLPLKVT---QN 265 (398)
T ss_dssp EEEEECCEEECCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEEETTTTEEEEEEEETT-TEEEEEEEESSCC---SC
T ss_pred hhhhhhhhcCcCChhhCeeeEEEeCCCEEEEEEEEEEecceeEEEEecCCCeEEEEEccCC-CeEEEEEEeCCCC---CC
Confidence 876 34556666 4677899999999999976 599999999 55 38
Q ss_pred HHHHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCCCCCeeecceeeeEE
Q psy7902 201 VGDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLTDSHIAFGDAVHKAR 280 (342)
Q Consensus 201 l~~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~~~~l~ls~v~q~~~ 280 (342)
|.+++++|+.+ .+..|.+. +..+.|+|.||||++++++||+++|++||++++| ..|||++|++++++||+|+|+++
T Consensus 266 L~~le~~L~~~--~l~~~~~~-~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F-~~Adfsgis~~~l~vs~v~hka~ 341 (398)
T 1imv_A 266 LTLIEESLTSE--FIHDIDRE-LKTVQAVLTVPKLKLSYEGEVTKSLQEMKLQSLF-DSPDFSKITGKPIKLTQVEHRAG 341 (398)
T ss_dssp CHHHHTTCCHH--HHHHHHHH-CEEEEEEEEEECEEEEEEEECHHHHHTTTTTHHH-HSCCCTTTCSSCCCEEEEEEEEE
T ss_pred HHHHHHHhCHH--HHHHHHHh-cceeEEEEEeeeEEEEeEEchhHhhhhcChhhcc-cccCCCCCcCCCEEEEEEEEEEE
Confidence 99999999987 99999988 6889999999999999999999999999999999 77999999977799999999999
Q ss_pred EEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCCCC
Q psy7902 281 LDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEPPN 339 (342)
Q Consensus 281 i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~~ 339 (342)
|+|||+|++|+|+|++.+... ..+..|++||||+|+|+|+.|+.|||+|+|.+|..
T Consensus 342 ieVnE~GteAaAaT~~~~~~~---~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 397 (398)
T 1imv_A 342 FEWNEDGAGTTPSPGLQPAHL---TFPLDYHLNQPFIFVLRDTDTGALLFIGKILDPRG 397 (398)
T ss_dssp EEECSCEEECC--------CC---CCCCEEECCSCEEEEEEETTTCCEEEEEEESCTTC
T ss_pred EEecCCccccccccccccccC---CCCceEEccCCEEEEEEECCCCeEEEEEEeCCCCC
Confidence 999999999999998655432 24578999999999999999999999999999964
|
| >2wxw_A Angiotensinogen, serpin A8; glycoprotein, hypertension, vasoconstrictor, renin, serpins, vasoactive, hormone; 3.30A {Homo sapiens} PDB: 2x0b_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-70 Score=523.73 Aligned_cols=322 Identities=15% Similarity=0.259 Sum_probs=274.6
Q ss_pred ChHHHHHHHHhhcCCCCcE--EEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCC-------hHHHHHHhhHHHHHH
Q psy7902 1 EFTFDLLTVLNNANKGKNV--FVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLD-------KLDTMNVYKMEKLIQ 71 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~--v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~-------~~~~~~~~~~~~~l~ 71 (342)
+||++||+++....+++|+ +|||+||+.+|+|++.||+|+|++||.++||++.... ..+++..|+ .++.
T Consensus 80 ~Fa~~L~k~l~~~~~~~Nin~v~SP~SI~~aLaml~~GA~G~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~--~l~~ 157 (453)
T 2wxw_A 80 FLGFRIYGMHSELWGVVHGATVLSPTAVFGTLASLYLGALDHTADRLQAILGVPWKDKNCTSRLDAHKVLSALQ--AVQG 157 (453)
T ss_dssp HHHHHHGGGCSCTTTSCSBSSEECHHHHHHHHHHHHHSCCTTHHHHHHHHHTCCCCTTCTTTSBCHHHHHHHHH--HHHH
T ss_pred HHHHHHHHHHhhcCCCCCcCEEECHHHHHHHHHHHHhhcccHHHHHHHHHhCCCCccccccccccHHHHHHHHH--HHHH
Confidence 4999999999876678899 9999999999999999999999999999999986421 246777776 6666
Q ss_pred Hhhh-----CCCCceEEEEEeeeeccCCCCchhhHhh----hcCC-ceEEecCCCCHHHHHH-HHHHHHHhcccccccCc
Q psy7902 72 GLRA-----NADSGLTFTSTNKIFVNDKIPVKECMTA----IFPS-EIQSMDFGNEVEAARA-INSWVAQETKNNIKDLI 140 (342)
Q Consensus 72 ~l~~-----~~~~~~~l~~~n~l~~~~~~~l~~~f~~----~~~~-~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~ 140 (342)
.+.. .+.. +.++++|++|++++++++++|.+ +|++ +++.+|| .+++.+++ ||+||+++|+|+|++++
T Consensus 158 ~l~~~~~~~~~~~-~~l~~an~lf~~~~~~l~~~F~~~~~~~y~a~~~~~vdF-~~~~~a~~~IN~WV~~~T~gkI~~ll 235 (453)
T 2wxw_A 158 LLVAQGRADSQAQ-LLLSTVVGVFTAPGLHLKQPFVQGLALYTPVVLPRSLDF-TELDVAAEKIDRFMQAVTGWKTGCSL 235 (453)
T ss_dssp HHSCCTTTCSCCC-EEEEEEEEEECCTTCCEEHHHHHHHHHHCSCEEECBCCT-TSHHHHHHHHHHHHHHHHCSCCSCSS
T ss_pred HHhhcccccCCCc-cEEEEEEeEeEECCCccCHHHHHHHHHHhCccceeeeCC-CCHHHHHHHHHHHHHHHhcCchhhhh
Confidence 6653 2234 78999999999999999999975 7888 4999999 68888888 99999999999999999
Q ss_pred cCCCCCCCceEEE---------ecc-------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEE
Q psy7902 141 ATGQVNSRTNLVL---------WLP-------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFF 190 (342)
Q Consensus 141 ~~~~i~~~t~lvl---------W~~-------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~i 190 (342)
.+++++|.++| |+. +++.+.|| +|+++++++|++++|||++ ++||+|
T Consensus 236 --~~l~~~t~lvLvNaiyFKg~W~~~F~~~~~~~F~~~~~~~v~V~mM~~~~~f~y~~~~~l~~~vleLPY~~-~~sm~i 312 (453)
T 2wxw_A 236 --MGASVDSTLAFNTYVHFQGKMKGFSLLAEPQEFWVDNSTSVSVPMLSGMGTFQHWSDIQDNFSVTQVPFTE-SACLLL 312 (453)
T ss_dssp --TTCCSSCCCEEEEEEEEEEEETTEEECSSCCCBCSSSSCCBCCCCEEEEEEEEEECCTTTTEEEEECCBTT-TEEEEE
T ss_pred --cCcCCCCeEEEEehhEEeccCCCCCCcccCCCcEeCCCEEEEEEEEEEecccceEEecCCCeEEEEEecCC-cEEEEE
Confidence 46999999988 976 34456666 6777889999999999964 799999
Q ss_pred EeCCCCCCCcHHHHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCCCCCe
Q psy7902 191 LLPPFASQDGVGDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLTDSHI 270 (342)
Q Consensus 191 ilP~~~~~~~l~~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~~~~l 270 (342)
|||+++ .+|.+++++|+.+ .+..|.++ |..+.|+|.||||+|++++||+++|++||++++|+..|||++|++.++
T Consensus 313 iLP~~~--~~L~~le~~L~~~--~l~~~~~~-l~~~~V~v~LPKFkie~~~dL~~~L~~lGi~~~F~~~Adfsgis~~~l 387 (453)
T 2wxw_A 313 IQPHYA--SDLDKVEGLTFQQ--NSLNWMKK-LSPRTIHLTMPQLVLQGSYDLQDLLAQAELPAILHTELNLQKLSNDRI 387 (453)
T ss_dssp EEESSC--SCHHHHHHTTSCT--THHHHCCC-CCEEEEEEEECCCEEEEEEEHHHHSCTTSCHHHHHSSSCCCSSCSSCC
T ss_pred EeCCCC--CCHHHHHHHhCHH--HHHHHHHh-cccccceEecceEEecccccHHHHHHhcCchhhcCCCCCCCcccCCCc
Confidence 999987 7999999999998 99999988 789999999999999999999999999999999987799999995459
Q ss_pred eecceeeeEEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCCCC
Q psy7902 271 AFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEPPN 339 (342)
Q Consensus 271 ~ls~v~q~~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~~ 339 (342)
+||+|+|+++|+|||+|++|+|+|.... ...+.+|++||||+|+|+|+.|+.|||+|+|.+|..
T Consensus 388 ~Vs~v~hka~ieVnEeGteAaAat~~~~-----~~~~~~f~~drPFlF~I~~~~t~~iLF~G~v~~P~~ 451 (453)
T 2wxw_A 388 RVGEVLNSIFFELEADEREPTESTQQLN-----KPEVLEVTLNRPFLFAVYDQSATALHFLGRVANPLS 451 (453)
T ss_dssp CCSCCEEEEEEEEEECC-----------------CCCEEEECCSCEEEEEEETTTTEECCEEEESCCC-
T ss_pred eEeEEEEEEEEEecCCCccccccccccc-----CCCCCeEEEeCCEEEEEEECCCCcEEEEEEeCCCCC
Confidence 9999999999999999999998885421 124679999999999999999999999999999975
|
| >1sng_A COG4826: serine protease inhibitor; serine protease inhibitor (serpin), native state., hydrolase inhibitor; 1.76A {Thermobifida fusca} SCOP: e.1.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-69 Score=504.67 Aligned_cols=312 Identities=26% Similarity=0.419 Sum_probs=264.0
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCCc
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADSG 80 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 80 (342)
+||++||+++...++++|++|||+||+.+|+|++.||+|+|++||.++|| . +++..|+ .+ ..+. +.+
T Consensus 16 ~Fa~~l~~~l~~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~-~------~~~~~~~--~l-~~l~--~~~- 82 (370)
T 1sng_A 16 EFALHLHRRLAEAVPDGEVIWSPYSVAXALGVLAAGARATTRTELTTLLG-T------DPAPLLA--AL-DRAV--TDS- 82 (370)
T ss_dssp HHHHHHHHHHHHTSTTCCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHHT-S------CHHHHHH--HH-HHTT--TTC-
T ss_pred HHHHHHHHHHHhcCCCCCEEEccHHHHHHHHHHHhhccchHHHHHHHHHH-H------HHHHHHH--HH-HHHh--CCC-
Confidence 49999999999877889999999999999999999999999999999999 2 3567775 55 5565 334
Q ss_pred eEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE--
Q psy7902 81 LTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL-- 153 (342)
Q Consensus 81 ~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl-- 153 (342)
+.++++|++|++++++++++|.+ +|+++++.+||.++++.+++ ||+||+++|+|+|++++++++++++|.++|
T Consensus 83 ~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~~T~g~I~~l~~~~~l~~~t~lvLvN 162 (370)
T 1sng_A 83 PDLASRTVLWVSADVPVRSSFRATMHDRPDSDVRTADFRTNPEGVRATVNADIADATRGMIRELLPQGAVTPDLRAILTN 162 (370)
T ss_dssp TTEEEEEEEEEETTSCCCHHHHHHHHTSTTEEEEEECTTTCHHHHHHHHHHHHHHHTTTSSCCSSCTTSCCTTCCEEEEE
T ss_pred ceEEEeeeeeeeCCCcccHHHHHHHHhhhCCeEEEecCcCCHHHHHHHHHHHHHHHhcCchhhccCccccCCcccEEEEE
Confidence 67999999999999999999976 79999999999768888888 999999999999999999889999999988
Q ss_pred -------ecc--------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHHHH
Q psy7902 154 -------WLP--------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDI 204 (342)
Q Consensus 154 -------W~~--------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~~l 204 (342)
|++ +++.+.|| +|++.++++|++++| ++++||+|+||+ . +|.++
T Consensus 163 aiyFkg~W~~~F~~~~T~~~~F~~~~~~~~V~mM~~~~~~~y~~~~~~~~~vleL---~~~~sm~iiLP~-~---~L~~l 235 (370)
T 1sng_A 163 ALWAKARWTTPFEAHLTRAGTFRTPRGPKRVPFMHRTKTMPYATARGWRMVTLHA---HDELAVDVLLPP-G---TNAAA 235 (370)
T ss_dssp EEEEECCBSSCCCGGGCEEEEEEETTEEEEEEEEEEEEEEEEEEETTEEEEEEEB---STTCEEEEEECC-G---GGTTC
T ss_pred EEEEccccccCCCcccCeeeeEecCCeEEEeEEEEEeeeeeeEEeCCCCEEEEEE---CCCEEEEEEecC-C---CHHHH
Confidence 876 23456666 678889999999999 778999999998 5 78877
Q ss_pred HHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC-CCCeeecceeeeEEEEe
Q psy7902 205 LAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-DSHIAFGDAVHKARLDL 283 (342)
Q Consensus 205 ~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~-~~~l~ls~v~q~~~i~v 283 (342)
++ +.+ .+.+|.++ +..+.|+|.||||++++++||++.|++||++++|+..|||++|+ ++ ++|++|+|+++|+|
T Consensus 236 ~~--~~~--~l~~~~~~-~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~Adfsgis~~~-l~vs~v~hka~ieV 309 (370)
T 1sng_A 236 VP--TAP--LLTALHRR-SASTSVELALPRFELTQPHQLVEVLAEAGVRTLFTASADLSGISTVP-LYVDTVIHQARLRV 309 (370)
T ss_dssp CC--CHH--HHHHHHHT-CEEEEEEEEEECEEEEEEEECHHHHHHHTCCGGGSTTCCCTTTCSSC-CCCCEEEEEEEEEE
T ss_pred hh--CHH--HHHHHHHh-CcceeEEEEcceEEEecccchHHHHHhcCcchhcCCccCcccCCCCC-eEEEEEEEEEEEEE
Confidence 77 554 89999998 68899999999999999999999999999999999779999999 55 99999999999999
Q ss_pred cCCCccccccchhhhcccCCC--CCCceEEecCCeEEEEEeCCCCcEEEEEEEcCCCCC
Q psy7902 284 DEQGTTAAAATAVFAFRSSRP--LEPVRYEANHPFLYFLVDKEIQSILFAGVFNEPPNK 340 (342)
Q Consensus 284 ~E~G~~a~a~t~~~~~~~~~~--~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~~~ 340 (342)
||+|++|+|+|++.+..++.+ ..+.+|++||||+|+|+|+ ++|||+|+|.+|...
T Consensus 310 ~E~GteAaAaT~~~~~~~~~~~~~~~~~f~~drPFlf~I~~~--~~iLF~G~v~~P~~~ 366 (370)
T 1sng_A 310 DERGAEGAAATAAMMLLAGAMPPRRTIRFSVDRPFHIVVRRR--GAILFLGSIADPHDP 366 (370)
T ss_dssp CSCC--------------------CCEEEECCSCEEEEEEET--TEEEEEEEESSCCCC
T ss_pred cCCCcccccccchhhccccccCCCCCCEEEeeCCEEEEEEEC--CEEEEEEEcCCCCCC
Confidence 999999999998765544432 2468999999999999999 999999999999765
|
| >2r9y_A Alpha-2-antiplasmin; inhibitory serpin, plasmin inhibitor, AC phase, glycoprotein, protease inhibitor, secreted, serine P inhibitor, sulfation; 2.65A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-68 Score=502.59 Aligned_cols=314 Identities=26% Similarity=0.458 Sum_probs=263.1
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCCc
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADSG 80 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 80 (342)
+||++||+++....+++|++|||+||+.+|+|++.||+|+|++||.++||++.. .+++..++ .+... ...
T Consensus 27 ~Fa~~L~k~l~~~~~~~Niv~SP~SI~~aLaml~~GA~G~T~~eL~~~L~~~~~---~~~~~~~~--~l~~~----~~~- 96 (430)
T 2r9y_A 27 AFTTDLFSLVAQTSTSSNLVLSPLSVALALSHLALGAQNQTLHSLHRVLHMNTG---SCLPHLLS--HFYQN----LGP- 96 (430)
T ss_dssp HHHHHHHHHHHHHCCSSSEEECHHHHHHHHHHHHHHCCHHHHHHHHHHTTCCTT---SCHHHHHH--HHHHT----SCS-
T ss_pred HHHHHHHHHHHhcCCCCCEEECHHHHHHHHHHHHhhcCcHHHHHHHHHhCCCcH---HHHHHHHH--HHHhh----ccC-
Confidence 499999999987778899999999999999999999999999999999999843 23444443 33322 233
Q ss_pred eEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE--
Q psy7902 81 LTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL-- 153 (342)
Q Consensus 81 ~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl-- 153 (342)
..++++|++|++++++++++|.+ +|++++..+|| +++.+++ ||+||+++|+|+|++++ .+++++|.++|
T Consensus 97 ~~L~~An~l~~~~~~~l~~~F~~~~~~~y~a~~~~~d~--~~~~a~~~IN~WV~~~T~gkI~~ll--~~l~~~T~lvLvN 172 (430)
T 2r9y_A 97 GTIRLAARIYLQKGFPIKDDFLEQSERLFGAKPVKLTG--KQEEDLANINQWVKEATEGKIEDFL--SELPDSTVLLLLN 172 (430)
T ss_dssp SSEEEEEEEEECTTCCCCHHHHHHHHHHHSSCCEECCS--CHHHHHHHHHHHHHHHTTTSCCCCC--CCCCSSCSEEEEE
T ss_pred ceEEeeehhhhhCCCcccHHHHHHHHHHhCCceeecCC--CcHHHHHHHHHHHHHhcCCCccchh--hccCcccceeEee
Confidence 66999999999999999999976 79999998886 4666677 99999999999999999 47999999988
Q ss_pred -------ecc---------------CCceEEec---------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHH
Q psy7902 154 -------WLP---------------STQESIII---------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVG 202 (342)
Q Consensus 154 -------W~~---------------~~~~~~V~---------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~ 202 (342)
|+. +++.+.|| .|.+.++++|++++|||++ ++||+|+||+++ ..+|.
T Consensus 173 AiyFKg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~~~~~~~~~~l~~~vleLPY~~-~~SM~iiLP~~~-~~~L~ 250 (430)
T 2r9y_A 173 AIHFHGFWRTKFDPSLTQKDFFHLDERFTVSVDMMHAVSYPLRWFLLEQPEIQVAHFPFKN-NMSFVVVMPTYF-EWNVS 250 (430)
T ss_dssp EEEEECCEEECCCGGGCEEEEEESSSSEEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSS-SEEEEEEEESSS-CCCHH
T ss_pred eeEEecccCCCCCCCCcccceEEecCCeEEEEEeeeecccceeEEEecCCcEEEEEeecCC-CEEEEEEecCCC-CCCHH
Confidence 876 34556666 3456789999999999975 699999999875 24899
Q ss_pred HHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCCCCCeeecceeeeEEEE
Q psy7902 203 DILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLTDSHIAFGDAVHKARLD 282 (342)
Q Consensus 203 ~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~~~~l~ls~v~q~~~i~ 282 (342)
+++++|+.+ .+..+ . +..+.|+|.||||+|++++||+++|++||++++|+. |||++|++++++||+|+|+++|+
T Consensus 251 ~le~~L~~~--~l~~~--~-~~~~~v~v~LPKFkie~~~dL~~~L~~lGi~~~F~~-Adfsgis~~~l~Vs~v~Hka~ie 324 (430)
T 2r9y_A 251 EVLANLTWD--TLYHP--S-LQERPTKVWLPKLHLQQQLDLVATLSQLGLQELFQG-PDLRGISEQNLVVSSVQHQSTME 324 (430)
T ss_dssp HHHTTCCHH--HHSCC--C-SCCEEEEEEEECEEEEEEEECHHHHHHHTTGGGGTC-CCCTTTCSSCCCEEEEEEEEEEE
T ss_pred HHHHhcCHH--HHHHh--c-ccCceEEEEeccEEEEeeecHHHHHHhcCccccccc-ccccccCCCCeEeeccceEEEEE
Confidence 999999876 66542 2 577899999999999999999999999999999985 99999996689999999999999
Q ss_pred ecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCCCCC
Q psy7902 283 LDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEPPNK 340 (342)
Q Consensus 283 v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~~~ 340 (342)
|||+|++|+|+|++.+...+ ...|+|||||+|+|+|+.|++|||+|+|.+|...
T Consensus 325 VnEeGteAAAaT~~~~~~~s----~~~f~adrPFlF~I~d~~t~~iLF~G~v~~P~~~ 378 (430)
T 2r9y_A 325 LSEAGVEAAAATSVAMNRMS----LSSFTVNRPFLFFIMEDTIGVPLFVGSVRNPNPS 378 (430)
T ss_dssp ECSCEEECC---------CC----CEEEECCSCEEEEEEETTTCCEEEEEEESCSCTT
T ss_pred ecCCCccccccccccccccC----CceEEecCCEEEEEEECCCCcEEEEEEecCCCcc
Confidence 99999999999987554322 3479999999999999999999999999999764
|
| >2oay_A C1-inhibitor, plasma protease C1 inhibitor, C1 INH, C1INH; latent serpin, RCL insertion, immune system,hydrolase inhibi; HET: NAG; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-67 Score=491.93 Aligned_cols=310 Identities=26% Similarity=0.447 Sum_probs=263.1
Q ss_pred ChHHHHHHHHhh-cCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCC
Q psy7902 1 EFTFDLLTVLNN-ANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADS 79 (342)
Q Consensus 1 ~Fa~~l~~~l~~-~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~ 79 (342)
+||++||+++.. ..+++|++|||+||+.+|+|++.||+|+|++||.++||++.. ..++++.|+ . +. .
T Consensus 38 ~Fa~~L~~~l~~~~~~~~Niv~SP~SI~~aLaml~~GA~g~T~~el~~~L~~~~~--~~~i~~~~~--~----l~----~ 105 (390)
T 2oay_A 38 DFSLKLYHAFSAMKKVETNMAFSPFSIASLLTQVLLGAGENTKTNLESILSYPKD--FTCVHQALK--G----FT----T 105 (390)
T ss_dssp HHHHHHHHHHCC----CCCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHHTCCTT--CTTHHHHHH--T----TC----C
T ss_pred HHHHHHHHHHHhccCCCCCEEECHHHHHHHHHHHHhhcccHHHHHHHHHhCCCCc--HHHHHHHHH--H----Hh----h
Confidence 499999999975 357899999999999999999999999999999999999853 335565553 1 21 1
Q ss_pred ceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE-
Q psy7902 80 GLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL- 153 (342)
Q Consensus 80 ~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl- 153 (342)
..+.++|++|++++++++++|.+ +|+++++.+|+ +++.+++ ||+||+++|+|+|++++ ++++++|.++|
T Consensus 106 -~~l~~an~l~~~~~~~l~~~F~~~~~~~y~a~~~~~~~--~~~~a~~~IN~WV~~~T~gkI~~ll--~~l~~~t~lvLv 180 (390)
T 2oay_A 106 -KGVTSVSQIFHSPDLAIRDTFVNASRTLYSSSPRVLSN--NSDANLELINTWVAKNTNNKISRLL--DSLPSDTRLVLL 180 (390)
T ss_dssp -SSEEEEEEEEECTTSCCCHHHHHHHHHHHSCCCEECCS--CHHHHHHHHHHHHHHTTTTSCSCSC--SCCCTTCCEEEE
T ss_pred -CchhhhhhHhHhcCCcccHHHHHHHHHHhCceeeeccC--ChHHHHHHHHHHHHHhhCCcccccc--cccCcccceEEE
Confidence 23889999999999999999975 89999999986 5677777 99999999999999999 47999999988
Q ss_pred --------ecc--------------CCceEEec-------cee--ecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHH
Q psy7902 154 --------WLP--------------STQESIII-------ITV--LSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVG 202 (342)
Q Consensus 154 --------W~~--------------~~~~~~V~-------~~~--~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~ 202 (342)
|+. +++.+.|| +|. +.+++++++++|||+ +++||+|+||++. ..+|.
T Consensus 181 NaiyFkg~W~~~F~~~~T~~~~F~~~~~~v~V~mM~~~~~~~~~~~~~~l~~~vleLpy~-~~~sm~iiLP~~~-~~~L~ 258 (390)
T 2oay_A 181 NAIYLSAKWKTTFDPKKTRMEPFHFKNSVIKVPMMNSKKYPVAHFIDQTLKAKVGQLQLS-HNLSLVILVPQNL-KHRLE 258 (390)
T ss_dssp EEEEEEEEBSSCCCTTSCEEEEECC--CCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBS-TTEEEEEEEESST-TSCHH
T ss_pred eeEEEecccCCCCCccccEEeeeEECCceEEEEEEEeCceeEEEEecccCceEEEEEecC-CcEEEEEEeCCcc-CCCHH
Confidence 877 23345666 233 346789999999995 5899999999874 24899
Q ss_pred HHHHHhcCCchHHHHHhhhcCCC---eeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC-CCCeeecceeee
Q psy7902 203 DILAALKKDPTSFKRFTEDSQNL---KPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-DSHIAFGDAVHK 278 (342)
Q Consensus 203 ~l~~~L~~~~~~l~~~~~~~l~~---~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~-~~~l~ls~v~q~ 278 (342)
+++++|+.+ .+..|.++ +.. ..|+|.||||+|++++||+++|++||+.+ |+..|||++|+ +++++||+|+|+
T Consensus 259 ~le~~L~~~--~l~~~~~~-l~~~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~-f~~~Adfsgis~~~~l~vs~v~hk 334 (390)
T 2oay_A 259 DMEQALSPS--VFKAIMEK-LEMSKFQPTLLTLPRIKVTTSQDMLSIMEKLEFFD-FSYDLNLCGLTEDPDLQVSAMQHQ 334 (390)
T ss_dssp HHHHHCCHH--HHHHHHHH-HHTCCEEEEEEEEECCEEEEEEEHHHHHGGGSSSC-GGGGCCCTTTCSCCCCCCCCEEEE
T ss_pred HHHHHhCHH--HHHHHHHh-CcccccceeEEecceEEEeccccHHHHHhhcCccc-ccccCCccccCCCCCeEEcchhhc
Confidence 999999987 89999887 443 46899999999999999999999999999 87679999999 678999999999
Q ss_pred EEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCCC
Q psy7902 279 ARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEPP 338 (342)
Q Consensus 279 ~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~ 338 (342)
++|+|||+|++|+|+|++...+ .+..|++||||+|+|+|+.|+.|||+|+|.+|.
T Consensus 335 a~ieVnE~GteAaAaT~~~~~~-----~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~ 389 (390)
T 2oay_A 335 TVLELTETGVEAAAASAISVAR-----TLLVFEVQQPFLFMLWDQQHKFPVFMGRVYDPR 389 (390)
T ss_dssp EEEEECSSEEEEEEEEEESCCC-----CEEECCCCSCEEEEEEETTTTEEEEEEEECCC-
T ss_pred ceEEECCCCccccccccccccC-----CCCeEEecCCEEEEEEECCCCCEEEEEEecCCC
Confidence 9999999999999999865432 236799999999999999999999999999996
|
| >3f02_A Neuroserpin; cleaved form, fenib, human, disease MUT glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase inhibitor; 1.80A {Homo sapiens} PDB: 3fgq_A 1jjo_C 1jjo_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-64 Score=466.54 Aligned_cols=288 Identities=24% Similarity=0.433 Sum_probs=252.3
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCCc
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADSG 80 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 80 (342)
+||++||+++....+++|++|||+||+.+|+|++.||+|+|++||.++||++.. +..+++..|+ .++..+...+.+
T Consensus 25 ~Fa~~L~~~l~~~~~~~Niv~SP~Si~~aLaml~~GA~G~T~~ql~~~L~~~~~-~~~~~~~~~~--~l~~~l~~~~~~- 100 (359)
T 3f02_A 25 DLSVNMYNRLRATGEDENILFSPLSIALAMGMMELGAQGSTQKEIRHSMGYDSL-KNGEEFSFLK--EFSNMVTAKESQ- 100 (359)
T ss_dssp HHHHHHHHHHHHHSTTCCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHHTCCC-----CHHHHHH--CC-----------
T ss_pred HHHHHHHHHHhhcCCCCCEEEcHHHHHHHHHHHHhhcCChHHHHHHHHhCCCCC-CHHHHHHHHH--HHHHHHhcCCCC-
Confidence 499999999998778899999999999999999999999999999999999864 3346777776 666666554455
Q ss_pred eEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE--
Q psy7902 81 LTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL-- 153 (342)
Q Consensus 81 ~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl-- 153 (342)
+.+.++|++|++++++++++|++ +|+++++.+||. +++.+++ ||+||+++|+|+|++++++++++++|.++|
T Consensus 101 ~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~-~~~~a~~~IN~WV~~~T~gkI~~ll~~~~l~~~t~lvLvN 179 (359)
T 3f02_A 101 YVMKIANSLFVQNGFHVNEEFLQMMKKYFNAAVNHVDFS-QNVAVANYINKWVENNTNNLVKDLVSPRDFDAATYLALIN 179 (359)
T ss_dssp CEEEEEEEEEEETTCCCCHHHHHHHHHHHCCEEEEECTT-SHHHHHHHHHHHHHHTTTTCSCCSSCGGGCSTTEEEEEEE
T ss_pred cEEEEEEEEEEeCCCccchHHHHHHHHHhcCceEEcCCC-CHHHHHHHHHHHHHhhhCCcccccCCcccCCCCceEEEEe
Confidence 88999999999999999999975 899999999996 8888888 999999999999999998889999999988
Q ss_pred -------ecc---------------CCceEEec--------ceeecCCCCe------EEEEeecCCCceEEEEEeCCCCC
Q psy7902 154 -------WLP---------------STQESIII--------ITVLSSELNA------HILEVPYKGGNMSMFFLLPPFAS 197 (342)
Q Consensus 154 -------W~~---------------~~~~~~V~--------~~~~~~~~~~------~vvelP~~~~~~sm~iilP~~~~ 197 (342)
|++ +++.+.|| +|+++++++| ++++|||+++++||+||||+++
T Consensus 180 aiyFkg~W~~~F~~~~T~~~~F~~~~g~~v~V~mM~~~~~~~y~~~~~l~a~~~~~~~vleLPY~~~~~sm~iiLP~~~- 258 (359)
T 3f02_A 180 AVYFKGNWKSQFRPENTRTFSFTKDDESEVQIPMMYQQGEFYYGEFSDGSNEAGGIYQVLEIPYEGDEISMMLVLSRQE- 258 (359)
T ss_dssp EEEEEEEBSSCCCGGGCEEEEEECTTSCEEEEEEEEEEEEEEEEEEECCC---CCEEEEEEEEBTTSSEEEEEEECCTT-
T ss_pred HHHHhHHhhccCCcccceeeeeEecCCcEEEccceEeeceEeEEEccCcCcccccccEEEEeEcCCCcEEEEEEEcCCC-
Confidence 877 35566777 6777788887 9999999988999999999997
Q ss_pred CCcHHHHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC-CCCeeeccee
Q psy7902 198 QDGVGDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-DSHIAFGDAV 276 (342)
Q Consensus 198 ~~~l~~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~-~~~l~ls~v~ 276 (342)
.+|.+++++|+.+ .+.+|.+. +..+.|+|.||||++++++||+++|++||++++|+..|||++|+ +++++||+|+
T Consensus 259 -~~L~~l~~~L~~~--~l~~~~~~-~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~~Adfsgis~~~~l~vs~v~ 334 (359)
T 3f02_A 259 -VPLATLEPLVKAQ--LVEEWANS-VKKQKVEVYLPRFTVEQEIDLKDVLKALGITEIFIKDANLTGLSDNKEIFLSKAI 334 (359)
T ss_dssp -SCHHHHGGGCCHH--HHHHHHHH-CEEEEEEEEEECEEEEEEEEHHHHHHHHTCCGGGSTTCCCTTTCSCTTEEEEEEE
T ss_pred -CCHHHHHHHhCHH--HHHHHHHh-CcceEEEEEeeeeEeEeeechHHHHHHcCchhhcCCCCCccccCCCCCeeEEEEE
Confidence 7999999999987 99999988 68999999999999999999999999999999999889999999 7889999999
Q ss_pred eeEEEEecCCCccccccchhhh
Q psy7902 277 HKARLDLDEQGTTAAAATAVFA 298 (342)
Q Consensus 277 q~~~i~v~E~G~~a~a~t~~~~ 298 (342)
|+++|+|||+|++|+|+|++.+
T Consensus 335 hka~ieVnE~GteAaAaT~~~~ 356 (359)
T 3f02_A 335 HKSFLEVNEEGSEAAAVSGMIA 356 (359)
T ss_dssp EEEEEEECSSEEEEEEEEEEEE
T ss_pred EEEEEEECCCCchhhhhheeeh
Confidence 9999999999999999998643
|
| >3dy0_A N-terminus plasma serine protease inhibitor; serpin, blood clotting, hydrolase inhibitor; HET: IDS SGN; 1.55A {Homo sapiens} PDB: 1lq8_A* 2hi9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-63 Score=455.81 Aligned_cols=284 Identities=27% Similarity=0.482 Sum_probs=257.0
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCC-ChHHHHHHhhHHHHHHHhhhCCCC
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENL-DKLDTMNVYKMEKLIQGLRANADS 79 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~-~~~~~~~~~~~~~~l~~l~~~~~~ 79 (342)
+||++||+++...++++|++|||+||+.+|+|++.||+|+|++||.++||++... +..+++..|+ .++..+...+.+
T Consensus 11 ~Fa~~l~~~l~~~~~~~Ni~~SP~Si~~aLaml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~~~--~l~~~l~~~~~~ 88 (336)
T 3dy0_A 11 DFTFDLYRALASAAPSQNIFFSPVSISMSLAMLSLGAGSSTKMQILEGLGLNLQKSSEKELHRGFQ--QLLQELNQPRDG 88 (336)
T ss_dssp CHHHHHHHHHHHHSTTSCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHTTCCSCHHHHHHHHHHHH--HHHHHTTSCCSS
T ss_pred HHHHHHHHHHhhhCCCCCEEEchHHHHHHHHHHHhHCcHHHHHHHHHHhCCCCCcCCHHHHHHHHH--HHHHHHhCCCCC
Confidence 6999999999987788999999999999999999999999999999999998531 2346788887 778877665555
Q ss_pred ceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE-
Q psy7902 80 GLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL- 153 (342)
Q Consensus 80 ~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl- 153 (342)
+.+.++|++|++++++++++|.+ +|+++++.+||. +++.+++ ||+||+++|+|+|+++++ +++++|.++|
T Consensus 89 -~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~-~~~~a~~~IN~wV~~~T~g~I~~l~~--~l~~~t~lvLv 164 (336)
T 3dy0_A 89 -FQLSLGNALFTDLVVDLQDTFVSAMKTLYLADTFPTNFR-DSAGAMKQINDYVAKQTKGKIVDLLK--NLDSNAVVIMV 164 (336)
T ss_dssp -SEEEEEEEEEECTTCCBCHHHHHHHHHHHCCEEEECCTT-SHHHHHHHHHHHHHHHTTTSSCCCCC--SCCSCEEEEEE
T ss_pred -cEEEEeehhhhCCCCCccHHHHHHHHHHhCCeeEEECCC-ChHHHHHHHHHHHHHhhcCcHhHhhc--CCCCCCeEEeE
Confidence 89999999999999999999975 899999999995 7888888 999999999999999995 7999999988
Q ss_pred --------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHH
Q psy7902 154 --------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVG 202 (342)
Q Consensus 154 --------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~ 202 (342)
|++ +++.+.|| +|+++++++|++++|||++ +++|+||||+++ +|.
T Consensus 165 NaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~f~~~~~~~l~~~vleLPy~~-~~sm~iiLP~~~---~l~ 240 (336)
T 3dy0_A 165 NYIFFKAKWETSFNHKGTQEQDFYVTSETVVRVPMMSREDQYHYLLDRNLSCRVVGVPYQG-NATALFILPSEG---KMQ 240 (336)
T ss_dssp EEEEEEEEBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSS-SCEEEEEEECTT---CHH
T ss_pred ehheeeeeccCCCCcccccccceeccCCcEEEEeeEEEEeEEEEEEecCCCeEEEEeecCC-CeEEEEEecCCC---CHH
Confidence 877 35556777 6777899999999999975 599999999874 899
Q ss_pred HHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC-CCCeeecceeeeEEE
Q psy7902 203 DILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-DSHIAFGDAVHKARL 281 (342)
Q Consensus 203 ~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~-~~~l~ls~v~q~~~i 281 (342)
+++++|+.+ .+.+|.+. +..+.|+|.||||++++++||+++|++||++++|++.|||++|+ +++++|++|+|+++|
T Consensus 241 ~le~~L~~~--~l~~~~~~-l~~~~v~v~lPKF~i~~~~~L~~~L~~lGi~~~F~~~Adfsgis~~~~l~vs~v~hka~i 317 (336)
T 3dy0_A 241 QVENGLSEK--TLRKWLKM-FKKRQLELYLPKFSIEGSYQLEKVLPSLGISNVFTSHADLSGISNHSNIQVSEMVHKAVV 317 (336)
T ss_dssp HHHHHCCHH--HHHHHHHH-CEEEEEEEEEECEEEEEEEEGGGTGGGGTCCGGGSTTCCCTTTBCSTTCEEEEEEEEEEE
T ss_pred HHHHHhCHH--HHHHHHHh-CCcceEEEEcCcEEEEeccchHHHHHhCChhhhhCCCCCcccccCCCCceeeeeEEEEEE
Confidence 999999988 99999988 78999999999999999999999999999999999889999999 688999999999999
Q ss_pred EecCCCccccccchhh
Q psy7902 282 DLDEQGTTAAAATAVF 297 (342)
Q Consensus 282 ~v~E~G~~a~a~t~~~ 297 (342)
+|||+|++|+|+|++.
T Consensus 318 eV~E~GteAaAaT~~~ 333 (336)
T 3dy0_A 318 EVDESGTRAAAATGTI 333 (336)
T ss_dssp EECSSEEEEEEEEEEE
T ss_pred EECCCcchhhhheeee
Confidence 9999999999999753
|
| >3ndd_A Alpha-1-antitrypsin; serpin, hydrolase inhibitor; 1.50A {Homo sapiens} PDB: 3ndf_A 7api_A* 8api_A* 9api_A* 1d5s_A 1ezx_A 3t1p_A 2d26_A 1qmb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-62 Score=454.87 Aligned_cols=285 Identities=27% Similarity=0.462 Sum_probs=258.8
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCC-ChHHHHHHhhHHHHHHHhhhCCCC
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENL-DKLDTMNVYKMEKLIQGLRANADS 79 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~-~~~~~~~~~~~~~~l~~l~~~~~~ 79 (342)
+||++||+++...++++|++|||+||+.+|+|++.||+|+|++||.++||++... +..+++..|+ .++..+...+.+
T Consensus 17 ~Fa~~l~~~l~~~~~~~Ni~~SP~Si~~aLaml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~~~--~l~~~l~~~~~~ 94 (343)
T 3ndd_A 17 EFAFSLYRQLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGFQ--ELLRTLNQPDSQ 94 (343)
T ss_dssp HHHHHHHHHHHHHCTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHH--HHHHHHTSCCTT
T ss_pred HHHHHHHHHHhhcCCCCCEEEChHHHHHHHHHHHhhccchHHHHHHHHhCCCCCCCCHHHHHHHHH--HHHHHHhCCCCC
Confidence 4999999999987788999999999999999999999999999999999998532 4567888887 788888765556
Q ss_pred ceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE-
Q psy7902 80 GLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL- 153 (342)
Q Consensus 80 ~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl- 153 (342)
+.+.++|++|++++++++++|.+ +|+++++.+||. +++.+++ ||+||+++|+|+|+++++ +++++|.++|
T Consensus 95 -~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~-~~~~a~~~IN~wV~~~T~g~I~~ll~--~l~~~t~lvLv 170 (343)
T 3ndd_A 95 -LQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFG-DTEEAKKQINDYVEKGTQGKIVDLVK--ELDRDTVFALV 170 (343)
T ss_dssp -CEEEEEEEEEEETTCCCCHHHHHHHHHHHCEEEEEECTT-SHHHHHHHHHHHHHHHTTTSSCSCCS--CCCTTCCEEEE
T ss_pred -ceEEeehhhHhhCCCChhHHHHHHHHHHhccccEeecCC-CHHHHHHHHHHHHHHhhcCchhhhhh--cCCCCceEEEE
Confidence 89999999999999999999975 899999999995 7888888 999999999999999995 7999999988
Q ss_pred --------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHH
Q psy7902 154 --------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVG 202 (342)
Q Consensus 154 --------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~ 202 (342)
|++ +++.+.|| +|+++++++|++++|||++ +++|+||||+++ +|.
T Consensus 171 NaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~~~~~~~~~l~~~vleLPY~~-~~sm~iiLP~~~---~l~ 246 (343)
T 3ndd_A 171 NYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHAKKLSSWVLLMKYLG-NATAIFFLPDEG---KLQ 246 (343)
T ss_dssp EEEEEEEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEEGGGTEEEEEEEBSS-SEEEEEEEECTT---CHH
T ss_pred eHHHHhHHHhcccCCccccCcceecCCCcEEEEEEEEEEeeEEEEEeccCCeEEEEEecCC-CeEEEEEEeCcc---CHH
Confidence 887 35556777 6777899999999999975 689999999874 899
Q ss_pred HHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC-CCCeeecceeeeEEE
Q psy7902 203 DILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-DSHIAFGDAVHKARL 281 (342)
Q Consensus 203 ~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~-~~~l~ls~v~q~~~i 281 (342)
++++.|+.+ .+.+|.+. +..+.|+|.||||++++++||+++|++||++++|++.|||++|+ +++++|++|+|+++|
T Consensus 247 ~le~~L~~~--~l~~~~~~-~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~Adfsgis~~~~l~vs~v~hka~i 323 (343)
T 3ndd_A 247 HLENELTHD--IITKFLEN-EDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSNGADLSGVTEEAPLKLSKAVHKAVL 323 (343)
T ss_dssp HHHHHCCHH--HHHHHHHC-CCCEEEEEEEECEEEEEEEECHHHHHHTTCCGGGSTTCCCTTTCSSSCEEEEEEEEEEEE
T ss_pred HHHHHhCHH--HHHHHHHh-CCcceEEEecccEEEeeccchHHHHHhCCcHhhcCCCCCCcccCCCCCeeEEEEEEEEEE
Confidence 999999987 99999988 79999999999999999999999999999999999889999999 688999999999999
Q ss_pred EecCCCccccccchhhh
Q psy7902 282 DLDEQGTTAAAATAVFA 298 (342)
Q Consensus 282 ~v~E~G~~a~a~t~~~~ 298 (342)
+|||+|++|+|+|++.+
T Consensus 324 eV~E~GteAaAaT~~~~ 340 (343)
T 3ndd_A 324 TIDEKGTEAAPDDDDEA 340 (343)
T ss_dssp EECSSEEEEEEEEEEEE
T ss_pred EECCCCcceecccceee
Confidence 99999999999998654
|
| >2h4p_A MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 1.70A {Gallus gallus} PDB: 2h4q_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-62 Score=460.38 Aligned_cols=291 Identities=29% Similarity=0.538 Sum_probs=259.1
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCC----h-------------------
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLD----K------------------- 57 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~----~------------------- 57 (342)
+||++||+++...++++|+||||+||+.+|+|++.||+|+|++||.++||++.... .
T Consensus 35 ~Fa~~L~k~l~~~~~~~Niv~SP~SI~~aLaml~~GA~G~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 114 (394)
T 2h4p_A 35 NFTVDLFNKLNETNRDKNIFFSPWSISSALALTYLAAKGSTAREMAEVLHFTEAVRAESSSVARPSRGRPKRRRMDPEHE 114 (394)
T ss_dssp HHHHHHHHHHHHHCTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTSSCC------------------------CC
T ss_pred HHHHHHHHHHhccCCCCCEEEChHHHHHHHHHHHHhccChHHHHHHHHhCCCcccccccccccccccccccccccccccc
Confidence 49999999998877789999999999999999999999999999999999985310 1
Q ss_pred --HHHHHHhhHHHHHHHhhhCCCCceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHH
Q psy7902 58 --LDTMNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQ 130 (342)
Q Consensus 58 --~~~~~~~~~~~~l~~l~~~~~~~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~ 130 (342)
.+++..|+ .++..+...+.+ +.++++|++|++++++++++|.+ +|+++++.+||.++++.+++ ||+||++
T Consensus 115 ~~~~i~~~~~--~l~~~l~~~~~~-~~l~~an~l~~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~ 191 (394)
T 2h4p_A 115 QAENIHSGFK--ELLTAFNKPRNN-YSLRSANRIYVEKTYALLPTYLQLSKKYYKAEPQKVNFKTAPEQSRKEINTWVEK 191 (394)
T ss_dssp CCHHHHHHHH--HHHHHHTCCCSS-SEEEEEEEEEEETTSCCCHHHHHHHHHHHCCEEEEECTTTCHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHH--HHHHHhhcCCCC-cEEEEEEEEEEeCCCCccHHHHHHHHHHhCCeeEEecCcCCHHHHHHHHHHHHHH
Confidence 56788887 777777665555 89999999999999999999975 89999999999778888888 9999999
Q ss_pred hcccccccCccCCCCCCCceEEE---------ecc---------------CCceEEec--------ceeecCCCCeEEEE
Q psy7902 131 ETKNNIKDLIATGQVNSRTNLVL---------WLP---------------STQESIII--------ITVLSSELNAHILE 178 (342)
Q Consensus 131 ~T~g~i~~~~~~~~i~~~t~lvl---------W~~---------------~~~~~~V~--------~~~~~~~~~~~vve 178 (342)
+|+|+|++++++++++++|.++| |+. +++.+.|| +|++.++++|++|+
T Consensus 192 ~T~gkI~~ll~~~~l~~~T~lvLvNAiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~f~~~~~~~l~~~vle 271 (394)
T 2h4p_A 192 QTESKIKNLLSSDDVKATTRLILVNAIYFKAEWEVKFQAEKTSIQPFRLSKNKSKPVKMMYMRDTFPVLIMEKMNFKMIE 271 (394)
T ss_dssp HTTTCC-CCSCTTTSCTTCCEEEEEEEEEEEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEETTTTEEEEE
T ss_pred hhCCchhhccCccccCCccceeeeeeeeEEceeCCCCCcccccceEEEecCCeEEECceEeccCceeeEEeCCCCEEEEE
Confidence 99999999999888999999988 876 35556677 67889999999999
Q ss_pred eecCCCceEEEEEeCCCCC--CCcHHHHHHHhcCCchHHHHHhhh-cCCCeeEEEEeeeeEEeeccchHHHHhhCCCccC
Q psy7902 179 VPYKGGNMSMFFLLPPFAS--QDGVGDILAALKKDPTSFKRFTED-SQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDL 255 (342)
Q Consensus 179 lP~~~~~~sm~iilP~~~~--~~~l~~l~~~L~~~~~~l~~~~~~-~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~ 255 (342)
|||+++++||+||||++++ ..+|.+++++|+.+ .+..|.+. .+..+.|+|.||||+|++++||+++|++||++++
T Consensus 272 LPY~~~~~sM~iiLP~~~~~~~~~L~~le~~L~~~--~l~~~~~~~~~~~~~v~v~lPKFkie~~~dL~~~L~~lGi~~~ 349 (394)
T 2h4p_A 272 LPYVKRELSMFILLPDDIKDGTTGLEQLERELTYE--RLSEWADSKMMTETLVDLHLPKFSLEDRIDLRDTLRNMGMTTA 349 (394)
T ss_dssp EEBGGGSEEEEEEEESSCCSSSSSCHHHHHSCCHH--HHHHHHTCTTCEEEEEEEEEECEEEEEEEECHHHHHHHTCCGG
T ss_pred eecCCCcEEEEEEecCCCcccCccHHHHHHHhCHH--HHHHHhhhhccccceEEEecceEEEeeeechHHHHHhcCCccc
Confidence 9999889999999998730 14899999999988 99999983 1578899999999999999999999999999999
Q ss_pred CCCCCCCCCCC-CCCeeecceeeeEEEEecCCCccccccchh
Q psy7902 256 FSPGADLSRLT-DSHIAFGDAVHKARLDLDEQGTTAAAATAV 296 (342)
Q Consensus 256 F~~~ad~s~i~-~~~l~ls~v~q~~~i~v~E~G~~a~a~t~~ 296 (342)
|+..|||++|+ +++++|++|+|+++|+|||+|++|+|+|++
T Consensus 350 F~~~Adfsgis~~~~l~vs~v~hka~ieVnE~GteAaAaT~~ 391 (394)
T 2h4p_A 350 FTTNADFRGMTDKKDLAISKVIHQSFVAVDEKGTEAAAATAV 391 (394)
T ss_dssp GSTTCCCTTSCSSSCCCEEEEEEEEEEEECSSEEEEEEEEEE
T ss_pred cCCccCcccccCCCCeEEeeeEEEEEEEECCCCchhhcceee
Confidence 99779999999 688999999999999999999999999975
|
| >2xn6_A Thyroxine-binding globulin; transport, cleaved protein; HET: F6Y T44; 1.29A {Homo sapiens} PDB: 2xn7_A* 2xn5_A* 2riv_A 2xn3_A* 2riw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-61 Score=450.42 Aligned_cols=289 Identities=28% Similarity=0.430 Sum_probs=258.1
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCC-ChHHHHHHhhHHHHHHHhhhCCCC
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENL-DKLDTMNVYKMEKLIQGLRANADS 79 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~-~~~~~~~~~~~~~~l~~l~~~~~~ 79 (342)
+||++||+++....+++|++|||+||+.+|+|++.||+|+|++||.++||++... +..+++..|+ .++..+...+.+
T Consensus 17 ~Fa~~l~~~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~--~l~~~l~~~~~~ 94 (350)
T 2xn6_A 17 DFAFNLYRRFTVETPDKNIFFSPVSISAALVMLSFGACCSTQTEIVETLGFNLTDTPMVEIQHGFQ--HLICSLNFPKKE 94 (350)
T ss_dssp HHHHHHHHHHHHHSTTSCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHH--HHHHHHHSCBTT
T ss_pred HHHHHHHHHHHhcCCCCCEEEchHHHHHHHHHHHhhccChHHHHHHHHhCCCccCCCHHHHHHHHH--HHHHHhhCCCCC
Confidence 4999999999877778999999999999999999999999999999999997532 3467888887 778888765556
Q ss_pred ceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE-
Q psy7902 80 GLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL- 153 (342)
Q Consensus 80 ~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl- 153 (342)
+.+.++|++|++++++++++|.+ +|+++++.+|| .+++.+++ ||+||+++|+|+|+++++ +++++|.++|
T Consensus 95 -~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF-~~~~~a~~~IN~WV~~~T~gkI~~ll~--~l~~~t~lvLv 170 (350)
T 2xn6_A 95 -LELQIGNALFIGKHLKPLAKFLNDVKTLYETEVFSTDF-SNISAAKQEINSHVEMQTKGKVVGLIQ--DLKPNTIMVLV 170 (350)
T ss_dssp -EEEEEEEEEEEETTCCBCHHHHHHHHHHSCEEEEEECT-TSHHHHHHHHHHHHHHHTTTCSCCCCS--CCCTTCCEEEE
T ss_pred -cEEEEEEeehhhCCCcHHHHHHHHHHHHhCCEEEeeCC-CCHHHHHHHHHHHHHHhhCCchhhhhc--ccCCCceeeee
Confidence 89999999999999999999975 89999999999 57888888 999999999999999994 5999999988
Q ss_pred --------ecc----------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcH
Q psy7902 154 --------WLP----------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGV 201 (342)
Q Consensus 154 --------W~~----------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l 201 (342)
|++ +++.+.|| +|++.++++|++++|||+++ .+|+||||+++ +|
T Consensus 171 NaiyFkg~W~~~F~~~~T~~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~l~~~vleLPy~~~-~sm~iiLP~~~---~l 246 (350)
T 2xn6_A 171 NYIHFKAQWANPFDPSKTEDSSSFLIDKTTTVQVPMMHQMDQYYHLVDMELNCTVLQMDYSKN-ALALFVLPKEG---QM 246 (350)
T ss_dssp EEEEEEEEBSSCCCGGGCEEEEEEEEETTEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSS-EEEEEEEECTT---CH
T ss_pred eHHHHhhHhhccCChhhCccCCceEeCCCcEEEEEEEEEeeeEeEEEeCCCCeEEEEeecCCC-eEEEEEecCCC---CH
Confidence 976 23445666 67788999999999999775 59999999875 89
Q ss_pred HHHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC-CCCeeecceeeeEE
Q psy7902 202 GDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-DSHIAFGDAVHKAR 280 (342)
Q Consensus 202 ~~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~-~~~l~ls~v~q~~~ 280 (342)
.+++++|+.+ .+..|.+. +..+.|+|.||||++++++||+++|++||++++|+..|||++|+ +++++|++|+|+++
T Consensus 247 ~~le~~L~~~--~l~~~~~~-~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~~Adfs~is~~~~l~vs~v~hka~ 323 (350)
T 2xn6_A 247 ESVEAAMSSK--TLKKWNRL-LQKGWVDLFVPKFSISATYDLGATLLKMGIQHAYSENADFSGLTEDNGLKLSNAAHKAV 323 (350)
T ss_dssp HHHHHHCSHH--HHHHHHHH-CEEEEEEEEEECEEEEEEEECHHHHHHHTCCGGGSTTCCCTTTBTTCCEEEEEEEEEEE
T ss_pred HHHHHHhCHH--HHHHHHHh-hhcccceeeeeEEEEEeeecHHHHHHhcCchhhccCcCCcccccCCCCceeeeeeEEEE
Confidence 9999999987 99999988 68899999999999999999999999999999998789999999 67899999999999
Q ss_pred EEecCCCccccccchhhhcccC
Q psy7902 281 LDLDEQGTTAAAATAVFAFRSS 302 (342)
Q Consensus 281 i~v~E~G~~a~a~t~~~~~~~~ 302 (342)
|+|||+|++|+|+|++.+..++
T Consensus 324 ieVnE~GteAaAaT~~~~~~~s 345 (350)
T 2xn6_A 324 LHIGEKGTEAAGAMFLEAIPRS 345 (350)
T ss_dssp EEECSSEEEEEEEEEEEEEEC-
T ss_pred EEECCCceeeccccceeecccC
Confidence 9999999999999987655443
|
| >1hle_A Horse leukocyte elastase inhibitor; hydrolase inhibitor(serine proteinase); 1.95A {Equus caballus} SCOP: e.1.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-62 Score=455.78 Aligned_cols=289 Identities=30% Similarity=0.510 Sum_probs=259.8
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCCc
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADSG 80 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 80 (342)
+||++||+++...++++|++|||+||+.+|+|++.||+|+|++||.++||++.. .+++..|+ .++..+...+.+
T Consensus 11 ~Fa~~l~~~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~---~~~~~~~~--~l~~~l~~~~~~- 84 (345)
T 1hle_A 11 HFAVDLFRALNESDPTGNIFISPLSISSALAMIFLGTRGNTAAQVSKALYFDTV---EDIHSRFQ--SLNADINKPGAP- 84 (345)
T ss_dssp HHHHHHHHHHHHHCSSSCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHHTGGGS---TTHHHHHH--HHHHHHTCSSCS-
T ss_pred HHHHHHHHHHhhcCCCCCEEEchHHHHHHHHHHHHhccChHHHHHHHHhCCCCH---HHHHHHHH--HHHHHHhCCCCC-
Confidence 499999999988777899999999999999999999999999999999999843 45788887 778888665555
Q ss_pred eEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE--
Q psy7902 81 LTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL-- 153 (342)
Q Consensus 81 ~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl-- 153 (342)
+.++++|++|++++++++++|.+ +|+++++.+||.++++.+++ ||+||+++|+|+|++++++++++++|.++|
T Consensus 85 ~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~~T~gkI~~ll~~~~l~~~t~lvLvN 164 (345)
T 1hle_A 85 YILKLANRLYGEKTYNFLADFLASTQKMYGAELASVDFQQAPEDARKEINEWVKGQTEGKIPELLVKGMVDNMTKLVLVN 164 (345)
T ss_dssp SEEEEEEEEEEETTCCCCHHHHHHHHHHHCCEEEEECTTTCHHHHHHHHHHHHHHHTTTSSSCSSCTTSSCTTEEEEEEE
T ss_pred cEEEEEEEeeecCCCchhHHHHHHHHHHhCCeEEEecCCCCHHHHHHHHHHHHHHHhcCchhhhcCCcCCCCcceEEEEE
Confidence 89999999999999999999975 89999999999778888888 999999999999999999888999999988
Q ss_pred -------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCC--CCcH
Q psy7902 154 -------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFAS--QDGV 201 (342)
Q Consensus 154 -------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~--~~~l 201 (342)
|+. +++.+.|| +|++.++++|++++|||+++++||+|+||++++ ..+|
T Consensus 165 aiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vleLPy~~~~~sm~iiLP~~~~~~~~~l 244 (345)
T 1hle_A 165 AIYFKGNWQQKFMKEATRDAPFRLNKKDTKTVKMMYQKKKFPYNYIEDLKCRVLELPYQGKELSMIILLPDDIEDESTGL 244 (345)
T ss_dssp EEEEEEEBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEEGGGTEEEEEEEBTTSSEEEEEEEESSCCSSSSSC
T ss_pred eeEecccccCCCCcccCcceeEEeCCCeEEEEEEEEeeceEeeEEeCCCCeEEEEecCCCCeEEEEEEecCCCcccCcCH
Confidence 876 34556677 678889999999999999989999999998730 0489
Q ss_pred HHHHHHhcCCchHHHHHhhh-cCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCC-CCCCCCCC-CCCeeecceeee
Q psy7902 202 GDILAALKKDPTSFKRFTED-SQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSP-GADLSRLT-DSHIAFGDAVHK 278 (342)
Q Consensus 202 ~~l~~~L~~~~~~l~~~~~~-~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~-~ad~s~i~-~~~l~ls~v~q~ 278 (342)
.+++++|+.+ .+..|.+. .+..+.|+|.||||++++++||+++|++||++++|++ .|||++|+ +++++|++|+|+
T Consensus 245 ~~l~~~L~~~--~l~~~~~~~~~~~~~v~v~lPKF~i~~~~~L~~~L~~lGi~~~F~~~~Adfs~is~~~~l~vs~v~hk 322 (345)
T 1hle_A 245 EKIEKQLTLD--KLREWTKPENLYLAEVNVHLPRFKLEESYDLTSHLARLGVQDLFNRGKADLSGMSGARDLFVSKIIHK 322 (345)
T ss_dssp HHHHHTCCHH--HHHHHHCGGGCEEEEEEEEEECEEEEEEEECHHHHHHHTCCGGGCTTTCCCHHHHSSSCEEEEEEEEE
T ss_pred HHHHHHhCHH--HHHHHhhhhccccceEEEEcceEeeecccchHHHHHhcChhhcCCCCCCCcccCCCCCCeEEeeEEEE
Confidence 9999999987 99999872 2678899999999999999999999999999999995 79999999 688999999999
Q ss_pred EEEEecCCCccccccchhh
Q psy7902 279 ARLDLDEQGTTAAAATAVF 297 (342)
Q Consensus 279 ~~i~v~E~G~~a~a~t~~~ 297 (342)
++|+|||+|++|+|+|++.
T Consensus 323 a~ieV~E~GteAaAaT~~~ 341 (345)
T 1hle_A 323 SFVDLNEEGTEAAAATAGT 341 (345)
T ss_dssp EEEEECSSEEEEEEEEEEE
T ss_pred EEEEECCCCeeecccccee
Confidence 9999999999999999753
|
| >1as4_A Antichymotrypsin, ACT; serpin, serine protease inhibitor; 2.10A {Homo sapiens} SCOP: e.1.1.1 PDB: 2ach_A* 4caa_A 3caa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-61 Score=447.76 Aligned_cols=284 Identities=30% Similarity=0.495 Sum_probs=254.7
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCC-ChHHHHHHhhHHHHHHHhhhCCCC
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENL-DKLDTMNVYKMEKLIQGLRANADS 79 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~-~~~~~~~~~~~~~~l~~l~~~~~~ 79 (342)
+||++||+++....+++|++|||+||+.+|+|++.||+|+|++||.++||++... +..+++..|+ .++..+...+.+
T Consensus 13 ~Fa~~l~~~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~--~l~~~l~~~~~~ 90 (341)
T 1as4_A 13 DFAFSLYKQLVLKAPDKNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQ--HLLRTLNQSSDE 90 (341)
T ss_dssp HHHHHHHHHHHHHCTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHH--HHHHHHCEECSS
T ss_pred HHHHHHHHHHhccCCCCcEEEchHHHHHHHHHHHhhccChHHHHHHHHhCCCCcCCCHHHHHHHHH--HHHHHHhccCCC
Confidence 4999999999877788999999999999999999999999999999999998532 3467888887 777887665555
Q ss_pred ceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE-
Q psy7902 80 GLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL- 153 (342)
Q Consensus 80 ~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl- 153 (342)
+.++++|++|++++++++++|.+ +|+++++.+|| .+++.+++ ||+||+++|+|+|+++++ +++++|.++|
T Consensus 91 -~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF-~~~~~a~~~IN~WV~~~T~gkI~~ll~--~l~~~t~lvLv 166 (341)
T 1as4_A 91 -LQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDF-QDSAAAKKLINDYVKNGTRGKITDLIK--DLDSQTMMVLV 166 (341)
T ss_dssp -CEEEEEEEEEEETTCCCCHHHHHHHHHHHCCEEEEECT-TSHHHHHHHHHHHHHHHTTTSCCCSCC--CCCTTEEEEEE
T ss_pred -cEEEeeehhHHhCCCchhHHHHHHHHHHhCCceEecCC-CCHHHHHHHHHHHHHHhhcCchhhHhh--ccCCCceEEEE
Confidence 88999999999999999999975 89999999999 57888888 999999999999999994 5999999988
Q ss_pred --------ecc---------------CCceEEec---------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcH
Q psy7902 154 --------WLP---------------STQESIII---------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGV 201 (342)
Q Consensus 154 --------W~~---------------~~~~~~V~---------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l 201 (342)
|+. +++.+.|| +|++.++++|++++|||+++ .+|+||||+++ +|
T Consensus 167 NaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~y~~~~~l~~~vleLPY~~~-~sm~iiLP~~~---~l 242 (341)
T 1as4_A 167 NYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVELKYTGN-ASALFILPDQD---KM 242 (341)
T ss_dssp EEEEEEEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSS-EEEEEEEECTT---CH
T ss_pred EhHhhcchhcCCCCccccccceeEeCCCeEEEEEEEEecCceEEEEEecCCCeEEEEecCCCC-cEEEEEeeCCC---CH
Confidence 876 35556676 35567889999999999765 59999999875 89
Q ss_pred HHHHHHhcCCchHHHHHhhhcCCCeeE-EEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC-CCCeeecceeeeE
Q psy7902 202 GDILAALKKDPTSFKRFTEDSQNLKPV-EIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-DSHIAFGDAVHKA 279 (342)
Q Consensus 202 ~~l~~~L~~~~~~l~~~~~~~l~~~~v-~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~-~~~l~ls~v~q~~ 279 (342)
.+++++|+.+ .+..|.+. +..+.| +|.||||++++++||+++|++||++++|+..|||++|+ +++++||+|+|++
T Consensus 243 ~~le~~L~~~--~l~~~~~~-~~~~~v~~v~lPKFki~~~~dL~~~L~~lGi~~~F~~~Adfs~is~~~~l~vs~v~hka 319 (341)
T 1as4_A 243 EEVEAMLLPE--TLKRWRDS-LEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADLSGITGARNLAVSQVVHKA 319 (341)
T ss_dssp HHHHHTCCHH--HHHHHHHH-CEEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGSTTCCCHHHHSSSCEEEEEEEEEE
T ss_pred HHHHHHhCHH--HHHHHHHh-ccccccceEeeeEEEEeeecchHHHHHHcCchhhccCCCCcccccCCCCEEEeeEEEEE
Confidence 9999999987 99999998 688999 99999999999999999999999999998779999999 6789999999999
Q ss_pred EEEecCCCccccccchhh
Q psy7902 280 RLDLDEQGTTAAAATAVF 297 (342)
Q Consensus 280 ~i~v~E~G~~a~a~t~~~ 297 (342)
+|+|||+|++|+|+|++.
T Consensus 320 ~ieVnE~GteAaAaT~~~ 337 (341)
T 1as4_A 320 VLDVFEEGTEASRATAVK 337 (341)
T ss_dssp EEEECSSEEEEEEEEEEE
T ss_pred EEEECCCcccccccccee
Confidence 999999999999999754
|
| >4afx_A Protein Z dependent protease inhibitor; hydrolase inhibitor, serpin, protein Z dependent inhibitor, coagulation; 2.09A {Homo sapiens} PDB: 4aju_A 3h5c_A* 3f1s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-61 Score=454.37 Aligned_cols=285 Identities=25% Similarity=0.433 Sum_probs=255.9
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCC-C-CChHHHHHHhhHHHHHHHhhhCCC
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPE-N-LDKLDTMNVYKMEKLIQGLRANAD 78 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~-~-~~~~~~~~~~~~~~~l~~l~~~~~ 78 (342)
+||++||+++....++ |++|||+||+.+|+|++.||+|+|++||.++||++. . .+..+++..|+ .++..+. ...
T Consensus 60 ~Fa~~L~~~l~~~~~~-Niv~SP~SI~~aLaml~~GA~G~T~~ql~~~L~~~~~~~~~~~~~~~~~~--~l~~~l~-~~~ 135 (387)
T 4afx_A 60 NFGFSLLRKISMRHDG-NMVFSPFGMSLAMTGLMLGATGPTETQIKRGLHLQALKPTKPGLLPSLFK--GLRETLS-RNL 135 (387)
T ss_dssp HHHHHHHHHHHHHCCS-CEEECHHHHHHHHHHHHTTCCTHHHHHHHHHTTCTTCSCCCTTHHHHHHH--HHHHHHH-HCG
T ss_pred HHHHHHHHHHhhcCCC-CEEEChHHHHHHHHHHHhhccchHHHHHHHHhCCCccccCCHHHHHHHHH--HHHHHhc-cCC
Confidence 4999999999987666 999999999999999999999999999999999985 1 13467888887 7777776 333
Q ss_pred CceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE
Q psy7902 79 SGLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL 153 (342)
Q Consensus 79 ~~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl 153 (342)
+ +.+.++|++|++++++++++|.+ +|+++++.+|| .++..+++ ||.||+++|+|+|++++ ++++++|.++|
T Consensus 136 ~-~~l~~an~lf~~~~~~l~~~F~~~~~~~y~a~~~~vdF-~~~~~a~~~IN~WV~~~T~gkI~~ll--~~l~~~t~lvL 211 (387)
T 4afx_A 136 E-LGLTQGSFAFIHKDFDVKETFFNLSKRYFDTECVPMNF-RNASQAKRLMNHYINKETRGKIPKLF--DEINPETKLIL 211 (387)
T ss_dssp G-GCEEEEEEEEEETTCCBCHHHHHHHHHHHCCEEEEECT-TSHHHHHHHHHHHHHHHTTTSSSCSC--CCCCTTEEEEE
T ss_pred C-ceEEEEEEEeecCCCchhHHHHHHHHHHhccceEecCC-CChHHHHHHHHHHHHHhcCCCccccc--cCCCCCceEEE
Confidence 4 78999999999999999999975 89999999999 56777777 99999999999999999 78999999988
Q ss_pred ---------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcH
Q psy7902 154 ---------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGV 201 (342)
Q Consensus 154 ---------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l 201 (342)
|++ +++.+.|| .|+++++++|++++|||++ ++||+||||++. .+|
T Consensus 212 vNAiyFKg~W~~~F~~~~T~~~~F~~~~g~~v~V~mM~~~~~f~y~~~~~l~~~vleLPY~~-~~sM~iiLP~~~--~~L 288 (387)
T 4afx_A 212 VDYILFKGKWLTPFDPVFTEVDTFHLDKYKTIKVPMMYGAGKFASTFDKNFRCHVLKLPYQG-NATMLVVLMEKM--GDH 288 (387)
T ss_dssp EEEEEEEEEBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBTT-SEEEEEEEESCC--SSC
T ss_pred EeeeEEEeecccCCCcccceeeeeecCCCcEEEEEEEEeeeeEeEEEecCCceEEEEEEcCC-cEEEEEEecCCC--CCH
Confidence 877 35556777 6778899999999999988 999999999997 789
Q ss_pred HHHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCCC--CCeeecceeeeE
Q psy7902 202 GDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLTD--SHIAFGDAVHKA 279 (342)
Q Consensus 202 ~~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~~--~~l~ls~v~q~~ 279 (342)
.+++++|+.+ .+..|.+. +..+.|+|.||||+|++++||+++|++||++++|++.|||++|+. ++++|++|+|++
T Consensus 289 ~~le~~L~~~--~l~~~~~~-l~~~~v~v~LPKFki~~~~dL~~~L~~lGi~~~F~~~ADfsgis~~~~~l~Vs~v~Hka 365 (387)
T 4afx_A 289 LALEDYLTTD--LVETWLRN-MKTRNMEVFFPKFKLDQKYEMHELLRQMGIRRIFSPFADLSELSATGRNLQVSRVLQRT 365 (387)
T ss_dssp CCGGGTCCHH--HHHHHHHT-CEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGSTTCCCTTTBSSCCCCEEEEEEEEE
T ss_pred HHHHHHhCHH--HHHHHHHh-CceeEEEEecCcEEEEeeccHHHHHHhcChhhhhCCCCCcccccCCCCCceeeeEEEEE
Confidence 9999999988 99999888 689999999999999999999999999999999998899999994 789999999999
Q ss_pred EEEecCCCccccccchhhhc
Q psy7902 280 RLDLDEQGTTAAAATAVFAF 299 (342)
Q Consensus 280 ~i~v~E~G~~a~a~t~~~~~ 299 (342)
+|+|||+|++|+|+|++.+.
T Consensus 366 ~ieVnEeGteAAAaT~~~~~ 385 (387)
T 4afx_A 366 VIEVDERGTEAVAGILSEIT 385 (387)
T ss_dssp EEEECSSEEEEEEEEEEEEE
T ss_pred EEEECCCcccccccceeeec
Confidence 99999999999999986543
|
| >1mtp_A Serine proteinase inhibitor (serpin), chain A; structural genomics, protease inhibitor; 1.50A {Thermobifida fusca} SCOP: e.1.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-58 Score=424.86 Aligned_cols=271 Identities=27% Similarity=0.409 Sum_probs=242.4
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCCc
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADSG 80 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 80 (342)
+||++||+++...++++|++|||+||+.+|+|++.||+|+|++||.++|| . +++..|+ .+ ..+. ..+
T Consensus 12 ~Fa~~l~~~l~~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~-~------~~~~~~~--~l-~~l~--~~~- 78 (323)
T 1mtp_A 12 EFALHLHRRLAEAVPDGEVIWSPYSVACALGVLAAGARATTRTELTTLLG-T------DPAPLLA--AL-DRAV--TDS- 78 (323)
T ss_dssp HHHHHHHHHHHHHSTTCCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHHT-S------CHHHHHH--HH-HHHT--CSC-
T ss_pred HHHHHHHHHHhccCCCCCEEEchHHHHHHHHHHHhhcCchHHHHHHHHHH-H------HHHHHHH--HH-HHHh--CCC-
Confidence 49999999998877889999999999999999999999999999999999 2 3567775 55 6565 334
Q ss_pred eEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE--
Q psy7902 81 LTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL-- 153 (342)
Q Consensus 81 ~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl-- 153 (342)
+.+.++|++|++++++++++|.+ +|+++++.+||.++++.+++ ||+||+++|+|+|++++++++++++|.++|
T Consensus 79 ~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~~T~g~I~~l~~~~~l~~~t~lvLvN 158 (323)
T 1mtp_A 79 PDLASRTVLWVSADVPVRSSFRATMHDRPDSDVRTADFRTNPEGVRATVNADIADATRGMIRELLPQGAVTPDLRAILTN 158 (323)
T ss_dssp TTEEEEEEEEECTTSCBCHHHHHHHHHSTTCEEEECCTTTCHHHHHHHHHHHHHHHTTTSCSCSSCTTCSCTTEEEEEEE
T ss_pred cEEeeeeeeeeECCcEecHHHHHHHHHHhCCEEEEEcCCCCHHHHHHHHHHHHHHHhcCcccccCCcCCCCcccceeeee
Confidence 67999999999999999999976 79999999999768888888 999999999999999999889999999988
Q ss_pred -------ecc--------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHHHH
Q psy7902 154 -------WLP--------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDI 204 (342)
Q Consensus 154 -------W~~--------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~~l 204 (342)
|+. +++.+.|| +|++.+++++++++| ++++||+|+||+ . +|.++
T Consensus 159 aiyFkg~W~~~F~~~~T~~~~F~~~~~~~~V~mM~~~~~~~y~~~~~~~~~vleL---~~~~sm~iiLP~-~---~l~~l 231 (323)
T 1mtp_A 159 ALWAKARWTTPFEAHLTREGTFRTPRGPKRVPFMHRTKTMPYATARGWRMVTLHA---HDELAVDVLLPP-G---TNAAA 231 (323)
T ss_dssp EEEEEEEBSSCCCGGGCEEEEEEETTEEEEEEEEEEEEEEEEEEETTEEEEEEEB---STTEEEEEEECC-G---GGTTC
T ss_pred eeeeeccccCCCCcccCeeeeeecCCeEEEeeEEEeeeeEeeEEeCCCCEEEEEE---CCcEEEEEEecC-C---CHHHH
Confidence 876 34456677 678889999999999 778999999998 5 78877
Q ss_pred HHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC-CCCeeecceeeeEEEEe
Q psy7902 205 LAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-DSHIAFGDAVHKARLDL 283 (342)
Q Consensus 205 ~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~-~~~l~ls~v~q~~~i~v 283 (342)
++ +.+ .+..|.+. +..+.|+|.||||++++++||+++|++||++++|+..|||++|+ .+ ++|++|+|+++|+|
T Consensus 232 ~~--~~~--~l~~~~~~-~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~Adfs~is~~~-l~vs~v~hka~ieV 305 (323)
T 1mtp_A 232 VP--TAP--LLTALHRR-SASTSVELALPRFELTQPHQLVEVLAEAGVRTLFTASADLSGISTVP-LYVDTVIHQARLRV 305 (323)
T ss_dssp CC--CHH--HHHHHHHH-CEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGSTTCCCTTTBSSC-CEEEEEEEEEEEEE
T ss_pred Hh--CHH--HHHHHHHh-CcceeEEEEeeEEEEecccchHHHHHhCChhhhcCCCCCcccCCCCC-ceeeeeEEEEEEEE
Confidence 77 544 89999998 68899999999999999999999999999999999779999999 56 99999999999999
Q ss_pred cCCCccccccchhh
Q psy7902 284 DEQGTTAAAATAVF 297 (342)
Q Consensus 284 ~E~G~~a~a~t~~~ 297 (342)
||+|++|+|+|++.
T Consensus 306 ~E~GteAaAaT~~~ 319 (323)
T 1mtp_A 306 DERGAEGAAATAAM 319 (323)
T ss_dssp ETTEEEEEEEEEEE
T ss_pred CCCcccccccccee
Confidence 99999999999754
|
| >1f0c_A ICE inhibitor; apoptosis, caspase inhibitor, protease inhibitor, serpin, viral protein; 2.26A {Cowpox virus} SCOP: e.1.1.1 PDB: 1c8o_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=409.21 Aligned_cols=262 Identities=29% Similarity=0.477 Sum_probs=225.3
Q ss_pred HHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCCceEE
Q psy7902 4 FDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADSGLTF 83 (342)
Q Consensus 4 ~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~l 83 (342)
++||+++....+++|++|||+||+.+|+|++.||+|+|++||.++||++.. .++ .. ..+
T Consensus 1 ~~l~~~l~~~~~~~N~~~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~---~~~-----------------~~-l~l 59 (305)
T 1f0c_A 1 MDIFREIASSMKGENVFISPPSISSVLTILYYGANGSTAEQLSKYVEKEAD---KNK-----------------DD-ISF 59 (305)
T ss_dssp CHHHHHHHHTTTTSCEEECHHHHHHHHHHHHHHCCTHHHHHHHTTC-----------------------------C-CSE
T ss_pred ChHHHHHhccCCCCCEEEchHHHHHHHHHHHHhcCChHHHHHHHHhCCCCc---ccc-----------------ch-hhh
Confidence 479999988778899999999999999999999999999999999999742 011 12 447
Q ss_pred EEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE-----
Q psy7902 84 TSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL----- 153 (342)
Q Consensus 84 ~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl----- 153 (342)
.++|++|++++++++++|.+ +| +.+||. ++ .+++ ||+||+++|+|+|+++++ ..++.+|.++|
T Consensus 60 ~~an~l~~~~~~~l~~~f~~~~~~~y----~~vdF~-~~-~a~~~IN~WV~~~T~g~I~~l~~-~~~~~~t~lvLvNaiy 132 (305)
T 1f0c_A 60 KSMNKVYGRYSAVFKDSFLRKIGDNF----QTVDFT-DC-RTVDAINKCVDIFTEGKINPLLD-EPLSPDTCLLAISAVY 132 (305)
T ss_dssp EEEEEEEEETTSCBCHHHHHHHGGGE----EEECSS-ST-HHHHHHHHHHHHHTTTSSCCSCC-SCCCTTEEEEEEEEEE
T ss_pred hheeeEEEeCCCcHHHHHHHHHHHHh----hccCCC-CH-HHHHHHHHHHHHHhCCCcccccc-CCCCCCceeeeeehHh
Confidence 99999999999999999976 56 899996 56 6666 999999999999999993 22455688887
Q ss_pred ----ecc---------------CCceEEec---------ceeecCCC--CeEEEEeecCCCceEEEEEeCCCCCCCcHHH
Q psy7902 154 ----WLP---------------STQESIII---------ITVLSSEL--NAHILEVPYKGGNMSMFFLLPPFASQDGVGD 203 (342)
Q Consensus 154 ----W~~---------------~~~~~~V~---------~~~~~~~~--~~~vvelP~~~~~~sm~iilP~~~~~~~l~~ 203 (342)
|+. +++.+.|| .|++.+++ +|++++|||+++ +||+|+||+++ .+|.+
T Consensus 133 Fkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~y~~~~~~~~~~~vleLPy~~~-~sm~iiLP~~~--~~l~~ 209 (305)
T 1f0c_A 133 FKAKWLMPFEKEFTSDYPFYVSPTEMVDVSMMSMYGEAFNHASVKESFGNFSIIELPYVGD-TSMVVILPDNI--DGLES 209 (305)
T ss_dssp EEEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEEECCTTCCEEEEEEEBSSS-EEEEEEEESST--TCHHH
T ss_pred hhhhhhccCCcccCeecEEEECCCEEEEEEEEEecCcceeeEEcccccCCCEEEEEeCCCC-EEEEEEeCCCC--CCHHH
Confidence 876 35556666 34457888 999999999887 99999999987 79999
Q ss_pred HHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCCCCCeeecceeeeEEEEe
Q psy7902 204 ILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLTDSHIAFGDAVHKARLDL 283 (342)
Q Consensus 204 l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~~~~l~ls~v~q~~~i~v 283 (342)
++++|+.+ .+..|.+. +..+.|+|.||||++++++||+++|++||++++|++.|||++|++++++|++|+|+++|+|
T Consensus 210 l~~~L~~~--~l~~~~~~-~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~Adfs~is~~~l~vs~v~hka~ieV 286 (305)
T 1f0c_A 210 IEQNLTDT--NFKKWCDS-MDAMFIDVHIPKFKVTGSYNLVDALVKLGLTEVFGSTGDYSNMCNSDVSVDAMIHKTYIDV 286 (305)
T ss_dssp HHTTCCHH--HHHHHHHT-CEEEEEEEEEECEEEEEEEECHHHHHHTTCCSSSSTTCCCTTTBSSCCEEEEEEEEEEEEE
T ss_pred HHHHhCHH--HHHHHHhh-CceeEEEEecceEEEEeeechHHHHHhcCCCcCCCCccccccCCCCCcEeeeEEEEEEEEE
Confidence 99999987 89999998 6889999999999999999999999999999999988999999977799999999999999
Q ss_pred cCCCccccccchhhhc
Q psy7902 284 DEQGTTAAAATAVFAF 299 (342)
Q Consensus 284 ~E~G~~a~a~t~~~~~ 299 (342)
||+|++|+|+|++.+.
T Consensus 287 ~E~GteAaAaT~~~~~ 302 (305)
T 1f0c_A 287 NEEYTEAAAATCALVA 302 (305)
T ss_dssp CSSEEEEEEEEEEEEE
T ss_pred CCCceeccccceeeee
Confidence 9999999999986443
|
| >1m93_B Serine proteinase inhibitor 2; serpin, CRMA, apoptosis, ICE inhibitor, viral protein; 1.65A {Cowpox virus} SCOP: e.1.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=325.61 Aligned_cols=207 Identities=29% Similarity=0.476 Sum_probs=185.5
Q ss_pred eEEEEEeeeeccCCCCchhhHhhhcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE------
Q psy7902 81 LTFTSTNKIFVNDKIPVKECMTAIFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL------ 153 (342)
Q Consensus 81 ~~l~~~n~l~~~~~~~l~~~f~~~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl------ 153 (342)
..++++|++|++++++++++|.+........+||. + +.+++ ||+||+++|+|+|+++++++ ++++|.++|
T Consensus 2 ~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~vdF~-~-~~a~~~IN~WV~~~T~gkI~~ll~~~-l~~~t~lvLvNaiyF 78 (245)
T 1m93_B 2 ISFKSMNKVYGRYSAVFKDSFLRKIGDNFQTVDFT-D-SRTVDAINKSVDIFTEGKINPLLDEP-LSPDTSLLAISAVYF 78 (245)
T ss_dssp CSEEEEEEEEEETTSCBCHHHHHHHCSCEEEECTT-S-THHHHHHHHHHHHHTTTSSCCSCCSC-CCTTCCEEEEEEEEE
T ss_pred cEEEeEeeeeeeCCCCcCHHHHHHHHHHHHhcCCC-C-HHHHHHHHHHHHHHhcCchhhhcCCC-CCCCceEEEEEeeee
Confidence 45899999999999999999998655566789996 5 66666 99999999999999999765 999999988
Q ss_pred ---ecc---------------CCceEEec---------ceeecCCC--CeEEEEeecCCCceEEEEEeCCCCCCCcHHHH
Q psy7902 154 ---WLP---------------STQESIII---------ITVLSSEL--NAHILEVPYKGGNMSMFFLLPPFASQDGVGDI 204 (342)
Q Consensus 154 ---W~~---------------~~~~~~V~---------~~~~~~~~--~~~vvelP~~~~~~sm~iilP~~~~~~~l~~l 204 (342)
|+. +++.+.|| +|++.+++ +|++++|||+++ +||+|+||+++ .+|.++
T Consensus 79 kg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~l~~~~~vleLPy~~~-~sm~iiLP~~~--~~l~~l 155 (245)
T 1m93_B 79 KAKWLMPFEKEFTSDYPFYVSPTEMVDVSMMSMYGEAFNHASVKESFGNFSIIELPYVGD-TSMVVILPDNI--DGLESI 155 (245)
T ss_dssp EEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEECSCEEEEEEECCTTCCEEEEEEEBSSS-EEEEEEEESST--TCHHHH
T ss_pred echhcCCCCcccCceeeEEecCCcEEEEeeeeeccCceeEEEecccccCCEEEEEecCCC-eEEEEEecCCC--CCHHHH
Confidence 876 34555665 46778888 999999999877 99999999987 799999
Q ss_pred HHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCCCCCeeecceeeeEEEEec
Q psy7902 205 LAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLTDSHIAFGDAVHKARLDLD 284 (342)
Q Consensus 205 ~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~~~~l~ls~v~q~~~i~v~ 284 (342)
+++|+.+ .+..|.+. +..+.|+|.||||++++++||+++|++||++++|++.|||++|++.+++||+|+|+++|+||
T Consensus 156 ~~~L~~~--~l~~~~~~-~~~~~v~v~lPKF~i~~~~~L~~~L~~lGi~~~F~~~Adfs~is~~~l~vs~v~hka~ieV~ 232 (245)
T 1m93_B 156 EQNLTDT--NFKKWSDS-MDAMFIDVHIPKFKVTGSYNLVDALVKLGLTEVFGSTGDYSNMSNSDVSVDAMIHKTYIDVN 232 (245)
T ss_dssp HTTCCHH--HHHHHHHT-CEEEECEEEEECEEEEEEEEHHHHHHHTTCTTSSSTTCCCTTTBSSCCCCCCEEEEEEEEEC
T ss_pred HHHhCHH--HHHHHHHh-CccceEEEECCeEEEeeeeccHHHHHhcCccccCCCccCcccccCCCceEeeEEEEeEEEEC
Confidence 9999987 89999988 68899999999999999999999999999999999889999999448999999999999999
Q ss_pred CCCccccccchh
Q psy7902 285 EQGTTAAAATAV 296 (342)
Q Consensus 285 E~G~~a~a~t~~ 296 (342)
|+|++|+|+|++
T Consensus 233 E~GteAaAaT~~ 244 (245)
T 1m93_B 233 EEYTEAAAATSA 244 (245)
T ss_dssp SSEEEEEEEEEE
T ss_pred CCcccccccccc
Confidence 999999999863
|
| >1m93_A Serine proteinase inhibitor 2; serpin, CRMA, apoptosis, ICE inhibitor, viral protein; 1.65A {Cowpox virus} SCOP: e.1.1.1 | Back alignment and structure |
|---|
Probab=99.52 E-value=9.5e-15 Score=96.73 Aligned_cols=51 Identities=29% Similarity=0.483 Sum_probs=43.5
Q ss_pred HHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCC
Q psy7902 4 FDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPEN 54 (342)
Q Consensus 4 ~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~ 54 (342)
++||+++...++++|++|||+||+.+|+|++.||+|+|++||.++|+++..
T Consensus 1 ~~L~~~l~~~~~~~Ni~~SP~Si~~aLaml~~GA~g~T~~ql~~~L~~~~~ 51 (55)
T 1m93_A 1 MDIFREIASSMKGENVFISPPSISSVLTILYYGANGSTAEQLSKYVEKEAD 51 (55)
T ss_dssp CHHHHHHHHHTTTSCEEECHHHHHHHHHHHHHHCCHHHHHHHHTTC-----
T ss_pred ChHHHHHHhcCCCCCEEECHHHHHHHHHHHHhhccchHHHHHHHHhCCCcc
Confidence 479999987777899999999999999999999999999999999999864
|
| >2riv_B Thyroxine-binding globulin; TBG, serpin, cleaved, mutation, glycoprotein, secreted, signaling protein; 1.50A {Homo sapiens} PDB: 2riw_B* 2xn3_B* | Back alignment and structure |
|---|
Probab=99.46 E-value=8.1e-14 Score=85.52 Aligned_cols=36 Identities=19% Similarity=0.451 Sum_probs=31.4
Q ss_pred CCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCCCC
Q psy7902 304 PLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEPPN 339 (342)
Q Consensus 304 ~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~~ 339 (342)
+..+..|.+||||+|+|+|+.|+.|||+|+|.+|.+
T Consensus 4 ~~~p~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 39 (40)
T 2riv_B 4 TFLHPIIQIDRSFMLLILERSTRSILFLGKVVNPTE 39 (40)
T ss_dssp ---CCEEECCBCEEEEEEETTTTEEEEEEEESCTTC
T ss_pred CCCCCEEEecCCEEEEEEeCCCCcEEEEEEecCCCC
Confidence 345678999999999999999999999999999975
|
| >3ndd_B Alpha-1-antitrypsin; serpin, hydrolase inhibitor; 1.50A {Homo sapiens} PDB: 1ezx_B 3ndf_B 7api_B* 8api_B* 9api_B* 2d26_B | Back alignment and structure |
|---|
Probab=99.45 E-value=1.7e-13 Score=82.07 Aligned_cols=34 Identities=29% Similarity=0.677 Sum_probs=31.2
Q ss_pred CceEEecCCeEEEEEeCCCCcEEEEEEEcCCCCC
Q psy7902 307 PVRYEANHPFLYFLVDKEIQSILFAGVFNEPPNK 340 (342)
Q Consensus 307 ~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~~~ 340 (342)
+..|.+||||+|+|+|+.|+++||+|+|.+|.++
T Consensus 3 p~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~~ 36 (36)
T 3ndd_B 3 PPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQK 36 (36)
T ss_dssp CCEEECCSCEEEEEEETTTCCEEEEEEESSCCC-
T ss_pred CCEEEeeCCEEEEEEECCCCcEEEEEEecCCCCC
Confidence 5689999999999999999999999999999864
|
| >2xn6_B Thyroxine-binding globulin; transport, cleaved protein; HET: F6Y T44; 1.29A {Homo sapiens} PDB: 2xn5_B* 2xn7_B* | Back alignment and structure |
|---|
Probab=99.42 E-value=2.5e-13 Score=80.85 Aligned_cols=32 Identities=22% Similarity=0.526 Sum_probs=30.3
Q ss_pred ceEEecCCeEEEEEeCCCCcEEEEEEEcCCCC
Q psy7902 308 VRYEANHPFLYFLVDKEIQSILFAGVFNEPPN 339 (342)
Q Consensus 308 ~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~~ 339 (342)
..|.+||||+|+|+|+.|+++||+|+|.+|.+
T Consensus 3 ~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 34 (35)
T 2xn6_B 3 PIIQIDRSFMLLILERSTRSILFLGKVVNPTE 34 (35)
T ss_dssp CEEECCBCEEEEEEETTTTEEEEEEEESCTTC
T ss_pred CEEEecCCEEEEEEECCCCcEEEEEEeCCcCC
Confidence 57999999999999999999999999999975
|
| >1hle_B Horse leukocyte elastase inhibitor; hydrolase inhibitor(serine proteinase); 1.95A {Equus caballus} SCOP: e.1.1.1 | Back alignment and structure |
|---|
Probab=99.40 E-value=3.7e-13 Score=77.91 Aligned_cols=30 Identities=37% Similarity=0.877 Sum_probs=28.6
Q ss_pred ceEEecCCeEEEEEeCCCCcEEEEEEEcCC
Q psy7902 308 VRYEANHPFLYFLVDKEIQSILFAGVFNEP 337 (342)
Q Consensus 308 ~~f~~drPFlf~I~~~~t~~ilf~G~v~~P 337 (342)
..|.+||||+|+|+|+.|+++||+|+|.+|
T Consensus 2 ~~f~~drPFlf~I~~~~t~~iLF~G~v~~P 31 (31)
T 1hle_B 2 ENFNADHPFIFFIRHNPSANILFLGRFSSP 31 (31)
T ss_dssp EEEECCSCEEEEEEETTTTEEEEEEEECCC
T ss_pred CEEEEeCCEEEEEEECCCCcEEEEEEecCC
Confidence 479999999999999999999999999998
|
| >1as4_B Antichymotrypsin, ACT; serpin, serine protease inhibitor; 2.10A {Homo sapiens} SCOP: e.1.1.1 PDB: 2ach_B* 3caa_B 4caa_B | Back alignment and structure |
|---|
Probab=99.40 E-value=2e-13 Score=82.25 Aligned_cols=34 Identities=26% Similarity=0.473 Sum_probs=31.1
Q ss_pred CCceEEecCCeEEEEEeCCCCcEEEEEEEcCCCC
Q psy7902 306 EPVRYEANHPFLYFLVDKEIQSILFAGVFNEPPN 339 (342)
Q Consensus 306 ~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~~ 339 (342)
.+..|.+||||+|+|+|+.|+++||+|+|.+|.+
T Consensus 3 ~p~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 36 (37)
T 1as4_B 3 TGTIVRFNRPFLMIIVPTDTQNIFFMSKVTNPKQ 36 (37)
T ss_dssp -CEEEECCSCEEEEEEETTSSCCSEEEEESCTTC
T ss_pred CCCEEEecCCEEEEEEeCCCCcEEEEEEeCCCCC
Confidence 3578999999999999999999999999999975
|
| >2h4p_B MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 1.70A {Gallus gallus} PDB: 2h4q_B | Back alignment and structure |
|---|
Probab=99.40 E-value=3.8e-13 Score=79.61 Aligned_cols=33 Identities=30% Similarity=0.734 Sum_probs=30.2
Q ss_pred CceEEecCCeEEEEEeCCCCcEEEEEEEcCCCC
Q psy7902 307 PVRYEANHPFLYFLVDKEIQSILFAGVFNEPPN 339 (342)
Q Consensus 307 ~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~~ 339 (342)
+..|.+||||+|+|+|+.|+++||+|+|.+|.+
T Consensus 2 ~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 34 (34)
T 2h4p_B 2 VLKFKVDHPFHFFIRHNKSKTILFFGRFCCPVE 34 (34)
T ss_dssp CEEEECCSCEEEEEEETTTTEEEEEEEECSCC-
T ss_pred CCEEEecCCEEEEEEECCCCeEEEEEEeCCCCC
Confidence 468999999999999999999999999999963
|
| >4afx_B Protein Z dependent protease inhibitor; hydrolase inhibitor, serpin, protein Z dependent inhibitor, coagulation; 2.09A {Homo sapiens} PDB: 4aju_B | Back alignment and structure |
|---|
Probab=99.40 E-value=4.2e-13 Score=80.28 Aligned_cols=33 Identities=21% Similarity=0.483 Sum_probs=30.9
Q ss_pred CceEEecCCeEEEEEeCCCCcEEEEEEEcCCCC
Q psy7902 307 PVRYEANHPFLYFLVDKEIQSILFAGVFNEPPN 339 (342)
Q Consensus 307 ~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~~ 339 (342)
+..|.+||||+|+|+|+.|+.+||+|+|.+|.+
T Consensus 3 p~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 35 (36)
T 4afx_B 3 PPVIKIDRPFHFMIYEETSGMLLFLGRVVNPTL 35 (36)
T ss_dssp CCEEECCSCEEEEEEETTTTEEEEEEEESCTTC
T ss_pred CCEEEeeCCEEEEEEECCCCcEEEEEEecCCCC
Confidence 468999999999999999999999999999975
|
| >3f02_C Neuroserpin; cleaved form, fenib, human, disease MUT glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase inhibitor; 1.80A {Homo sapiens} PDB: 1jjo_E | Back alignment and structure |
|---|
Probab=99.31 E-value=3.7e-12 Score=81.18 Aligned_cols=34 Identities=24% Similarity=0.532 Sum_probs=31.1
Q ss_pred CceEEecCCeEEEEEeCCCCcEEEEEEEcCCCCC
Q psy7902 307 PVRYEANHPFLYFLVDKEIQSILFAGVFNEPPNK 340 (342)
Q Consensus 307 ~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~~~ 340 (342)
+..|.+||||+|+|+|+.|+.+||+|+|.+|...
T Consensus 5 ~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~~ 38 (48)
T 3f02_C 5 YPQVIVDHPFFFLIRNRRTGTILFMGRVMHPETM 38 (48)
T ss_dssp CCEEECCSCEEEEEEETTTCCEEEEEEESCCCC-
T ss_pred CCEEEeeCCEEEEEEECCCCcEEEEEEeCCCCcc
Confidence 4689999999999999999999999999999754
|
| >1m93_C Serine proteinase inhibitor 2; serpin, CRMA, apoptosis, ICE inhibitor, viral protein; 1.65A {Cowpox virus} SCOP: e.1.1.1 PDB: 1c8o_B 1f0c_B | Back alignment and structure |
|---|
Probab=99.29 E-value=3.9e-12 Score=78.34 Aligned_cols=34 Identities=29% Similarity=0.724 Sum_probs=29.5
Q ss_pred CCceEEecCCeEEEEEeCCCCcEEEEEEEcCCCCC
Q psy7902 306 EPVRYEANHPFLYFLVDKEIQSILFAGVFNEPPNK 340 (342)
Q Consensus 306 ~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~~~ 340 (342)
.+..|.+||||+|+|+|+. +++||+|+|.+|.++
T Consensus 8 ~p~~f~~drPFlf~I~~~~-~~iLF~G~v~~P~~~ 41 (41)
T 1m93_C 8 VTNEFSADHPFIYVIRHVD-GKILFVGRYSSPTTN 41 (41)
T ss_dssp -CCEEECCSCEEEEEEETT-SCEEEEEEECSCC--
T ss_pred CCCEEEeeCCEEEEEEECC-CCEEEEEEeCCcCCC
Confidence 4578999999999999998 999999999999863
|
| >1mtp_B Serine proteinase inhibitor (serpin), chain B; structural genomics, protease inhibitor; 1.50A {Thermobifida fusca} SCOP: e.1.1.1 | Back alignment and structure |
|---|
Probab=99.23 E-value=1.4e-11 Score=76.45 Aligned_cols=33 Identities=24% Similarity=0.625 Sum_probs=29.6
Q ss_pred CCceEEecCCeEEEEEeCCCCcEEEEEEEcCCCCC
Q psy7902 306 EPVRYEANHPFLYFLVDKEIQSILFAGVFNEPPNK 340 (342)
Q Consensus 306 ~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~~~ 340 (342)
.+..|.+||||+|+|+|+ +++||+|+|.+|..+
T Consensus 7 ~p~~f~~drPFlf~I~~~--~~iLF~G~v~~P~~~ 39 (43)
T 1mtp_B 7 RTIRFSVDRPFHIVVRRR--GAILFLGSIADPHDP 39 (43)
T ss_dssp -CEEEECCSCEEEEEEET--TEEEEEEEESSCCCC
T ss_pred CCCEEEeeCCEEEEEEEC--CEEEEEEEeCCcccc
Confidence 457899999999999999 999999999999754
|
| >3dy0_B C-terminus plasma serine protease inhibitor; serpin, blood clotting, hydrolase inhibitor; HET: IDS SGN; 1.55A {Homo sapiens} PDB: 1lq8_B* | Back alignment and structure |
|---|
Probab=99.15 E-value=4.8e-11 Score=67.53 Aligned_cols=28 Identities=50% Similarity=0.861 Sum_probs=25.9
Q ss_pred CceEEecCCeEEEEEeCCCCcEEEEEEEcCC
Q psy7902 307 PVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337 (342)
Q Consensus 307 ~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P 337 (342)
+..|.+||||+|+|+|+ ++||+|+|.+|
T Consensus 2 ~~~f~~drPFlf~I~~~---~iLF~G~v~~P 29 (29)
T 3dy0_B 2 SQRLVFNRPFLMFIVDN---NILFLGKVNRP 29 (29)
T ss_dssp CEEEECCSCEEEEEESS---SEEEEEEESCC
T ss_pred CCEEEecCCEEEEEEcC---ceEEEEEecCC
Confidence 45799999999999998 79999999998
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 342 | ||||
| d1uhga_ | 385 | e.1.1.1 (A:) Ovalbumin {Hen (Gallus gallus) [TaxId | 3e-61 | |
| d2b5ti1 | 426 | e.1.1.1 (I:6-431) Antithrombin {Human (Homo sapien | 1e-60 | |
| d1qlpa_ | 372 | e.1.1.1 (A:) Antitrypsin, alpha-1 {Human (Homo sap | 3e-58 | |
| d1k9oi_ | 376 | e.1.1.1 (I:) Alaserpin (serpin 1) {Tobacco hornwor | 2e-57 | |
| d1jmja_ | 420 | e.1.1.1 (A:) Heparin cofactor II (Hc-II, leuserpin | 3e-57 | |
| d1lj5a_ | 379 | e.1.1.1 (A:) Plasminogen activator inhibitor-1 {Hu | 1e-56 | |
| d1by7a_ | 381 | e.1.1.1 (A:) Plasminogen activator inhibitor-2 {Hu | 4e-55 | |
| d1xqga_ | 378 | e.1.1.1 (A:) Maspin {Human (Homo sapiens) [TaxId: | 7e-55 | |
| g1lq8.1 | 358 | e.1.1.1 (A:,B:) Protein C inhibitor {Human (Homo s | 1e-53 | |
| g1hle.1 | 375 | e.1.1.1 (A:,B:) Elastase inhibitor {Horse (Equus c | 4e-52 | |
| g1as4.1 | 369 | e.1.1.1 (A:,B:) Antichymotrypsin, alpha-1 {Human ( | 7e-52 | |
| d1imva_ | 383 | e.1.1.1 (A:) Pigment epithelium-derived factor, PE | 3e-50 | |
| g1mtp.1 | 355 | e.1.1.1 (A:,B:) Thermopin {Thermobifida fusca [Tax | 4e-48 | |
| g1jjo.1 | 334 | e.1.1.1 (A:,C:,E:) Neuroserpin {Mouse (Mus musculu | 9e-48 | |
| g1m93.1 | 322 | e.1.1.1 (A:,B:,C:) Viral serpin crmA (cytokine res | 6e-45 |
| >d1uhga_ e.1.1.1 (A:) Ovalbumin {Hen (Gallus gallus) [TaxId: 9031]} Length = 385 | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Ovalbumin species: Hen (Gallus gallus) [TaxId: 9031]
Score = 198 bits (505), Expect = 3e-61
Identities = 77/383 (20%), Positives = 160/383 (41%), Gaps = 52/383 (13%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPE------- 53
EF FD+ L + +N+F P +I AL Y + +T + +V+R +
Sbjct: 9 EFCFDVFKELKVHHANENIFYCPIAIMSALAMVYLGAKDSTRTQINKVVRFDKLPGFGDS 68
Query: 54 -NLDKLDTMNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPV----KECMTAIFPSE 108
++NV+ + I + +F+ ++++ ++ P+ +C+ ++
Sbjct: 69 IEAQCGTSVNVHSSLRDILNQITKPNDVYSFSLASRLYAEERYPILPEYLQCVKELYRGG 128
Query: 109 IQSMDFGNEVEAAR-AINSWVAQETKNNIKDLIATGQVNSRTNLVLW------------- 154
++ ++F + AR INSWV +T I++++ V+S+T +VL
Sbjct: 129 LEPINFQTAADQARELINSWVESQTNGIIRNVLQPSSVDSQTAMVLVNAIVFKGLWEKAF 188
Query: 155 -------------------LPSTQESIIIITVLSSELNAHILEVPYKGGNMSMFFLLPPF 195
+ + + + ILE+P+ G MSM LLP
Sbjct: 189 KDEDTQAMPFRVTEQESKPVQMMYQIGLFRVASMASEKMKILELPFASGTMSMLVLLPD- 247
Query: 196 ASQDGVGDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDL 255
G+ + + + + + + + K +++ +P+ + ++ NL L +G+ D+
Sbjct: 248 -EVSGLEQLESIINFEKLTEWTSSNVMEERK-IKVYLPRMKMEEKYNLTSVLMAMGITDV 305
Query: 256 FSPGADLSRLTDSH-IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANH 314
FS A+LS ++ + + AVH A +++E G + +S E + A+H
Sbjct: 306 FSSSANLSGISSAESLKISQAVHAAHAEINEAGREVVGSAEAGVDAASVSEE---FRADH 362
Query: 315 PFLYFLVDKEIQSILFAGVFNEP 337
PFL+ + ++LF G P
Sbjct: 363 PFLFCIKHIATNAVLFFGRCVSP 385
|
| >d2b5ti1 e.1.1.1 (I:6-431) Antithrombin {Human (Homo sapiens) [TaxId: 9606]} Length = 426 | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Antithrombin species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 1e-60
Identities = 91/378 (24%), Positives = 155/378 (41%), Gaps = 46/378 (12%)
Query: 1 EFTFDLLTVLNNA-NKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLD 59
F L ++ N N+F+SP SI A + +T L +V + +K
Sbjct: 52 RFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTS 111
Query: 60 TMNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKECMTAIFP----SEIQSMDFG 115
+ KL L A+ S N++F + + E I +++Q +DF
Sbjct: 112 DQIHFFFAKLNCRLYRKANKASKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFK 171
Query: 116 NEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL--------------WLPSTQE 160
E +RA IN WV+ +T+ I D+I + +N T LVL +T++
Sbjct: 172 ENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRK 231
Query: 161 SIIIIT-----------------VLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGD 203
+ +LE+P+KG +++M +LP
Sbjct: 232 ELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPK----PEKSL 287
Query: 204 ILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPG-ADL 262
+ P + + D + + +P+F + +L L D+G+ DLFSP + L
Sbjct: 288 AKVEKELTPEVLQEWL-DELEEMMLCVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKL 346
Query: 263 SRLTDSH---IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYF 319
+ + DA HKA L+++E+G+ AAA+TAV S V ++AN PFL F
Sbjct: 347 PGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVCFKANRPFLVF 406
Query: 320 LVDKEIQSILFAGVFNEP 337
+ + + +I+F G P
Sbjct: 407 IREVPLNTIIFMGRVANP 424
|
| >d1qlpa_ e.1.1.1 (A:) Antitrypsin, alpha-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 372 | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Antitrypsin, alpha-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 3e-58
Identities = 88/375 (23%), Positives = 161/375 (42%), Gaps = 47/375 (12%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
EF F L L + + N+F SP SI A + +T + + L NL ++
Sbjct: 10 EFAFSLYRQLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNF--NLTEIPE 67
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKECMTAI----FPSEIQSMDFGN 116
+++ + + DS L T+ N +F+++ + + + + SE +++FG+
Sbjct: 68 AQIHEGFQELLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGD 127
Query: 117 EVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVLWL--------------------- 155
EA + IN +V + T+ I DL+ ++ LV ++
Sbjct: 128 TEEAKKQINDYVEKGTQGKIVDLVKELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFH 187
Query: 156 ---------PSTQESIIIITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDILA 206
P + + +L++ +L + Y G ++FFL Q ++
Sbjct: 188 VDQVTTVKVPMMKRLGMFNIQHCKKLSSWVLLMKYLGNATAIFFLPDEGKLQHLENELTH 247
Query: 207 ALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT 266
+ +++ + + +PK S+T +L L LG+ +FS GADLS +T
Sbjct: 248 DIITKFLE-------NEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSNGADLSGVT 300
Query: 267 -DSHIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEI 325
++ + AVHKA L +DE+GT AA A + A S P E + N PF++ ++++
Sbjct: 301 EEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPE---VKFNKPFVFLMIEQNT 357
Query: 326 QSILFAGVFNEPPNK 340
+S LF G P K
Sbjct: 358 KSPLFMGKVVNPTQK 372
|
| >d1k9oi_ e.1.1.1 (I:) Alaserpin (serpin 1) {Tobacco hornworm (Manduca sexta) [TaxId: 7130]} Length = 376 | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Alaserpin (serpin 1) species: Tobacco hornworm (Manduca sexta) [TaxId: 7130]
Score = 188 bits (478), Expect = 2e-57
Identities = 99/376 (26%), Positives = 154/376 (40%), Gaps = 53/376 (14%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
+FT + + + AN G+NV +S FS+ L S + L + L LP D
Sbjct: 15 QFTAQMFSEVVKANPGQNVVLSAFSVLPPLGQLALASVGESHDELLRALALPN-----DN 69
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKECMTAIFP----SEIQSMDFGN 116
+ L +G+RA G+ +KI+V + + + A+ SE+Q++DF
Sbjct: 70 VTKDVFADLNRGVRAV--KGVDLKMASKIYVAKGLELNDDFAAVSRDVFGSEVQNVDFVK 127
Query: 117 EVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVLW---------------------- 154
VEAA AIN WV +T N IK+L+ ++ T VL
Sbjct: 128 SVEAAGAINKWVEDQTNNRIKNLVDPDALDETTRSVLVNAIYFKGSWKDKFVKERTMDRD 187
Query: 155 ----------LPSTQESIIIITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDI 204
+P+ + EL+A ++E+ Y+G SM +LP G
Sbjct: 188 FHVSKDKTIKVPTMIGKKDVRYADVPELDAKMIEMSYEGDQASMIIILPN----QVDGIT 243
Query: 205 LAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPG-ADLS 263
K E+ VEI +PKF + +L LS++ +K LF+PG A L
Sbjct: 244 ALEQKLKDPKALSRAEERLYNTEVEITLPKFKIETTTDLKEVLSNMNIKKLFTPGAARLE 303
Query: 264 RLTDSH--IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLV 321
L + + A+ KA ++++E+G AAAA A S L P + PF + L
Sbjct: 304 NLLKTKESLTVDAAIQKAFIEVNEEGAEAAAANAFGIVPKSLILYP-EVHIDRPFYFELK 362
Query: 322 DKEIQSILFAGVFNEP 337
+F G EP
Sbjct: 363 ID--GIPMFNGKVIEP 376
|
| >d1jmja_ e.1.1.1 (A:) Heparin cofactor II (Hc-II, leuserpin 2) {Human (Homo sapiens) [TaxId: 9606]} Length = 420 | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Heparin cofactor II (Hc-II, leuserpin 2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 3e-57
Identities = 72/377 (19%), Positives = 144/377 (38%), Gaps = 52/377 (13%)
Query: 1 EFTFDLLTVL-NNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLD 59
+F F+L VL + N N+F++P I A+ T + +L + ++
Sbjct: 53 KFAFNLYRVLKDQVNTFDNIFIAPVGISTAMGMISLGLKGETHEQVHSILHFKDFVNASS 112
Query: 60 TMNVYKMEKLIQGLRA---NADSGLTFTSTNKIFVNDKIPV----KECMTAIFPSEIQSM 112
+ + L + L + G T S N +++ + P+ K + + +E Q
Sbjct: 113 KYEITTIHNLFRKLTHRLFRRNFGYTLRSVNDLYIQKQFPILLDFKTKVREYYFAEAQIA 172
Query: 113 DFGNEVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVLW------------------ 154
DF + ++ N+ + + TK IKD + ++ T +++
Sbjct: 173 DFSDPAFISK-TNNHIMKLTKGLIKDAL--ENIDPATQMMILNCIYFKGSWVNKFPVEMT 229
Query: 155 --------------LPSTQESIIIITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDG 200
+ Q + EL+ IL++ Y GG + +
Sbjct: 230 HNHNFRLNEREVVKVSMMQTKGNFLAANDQELDCDILQLEYVGGISMLIVVPHK------ 283
Query: 201 VGDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGA 260
+ + + + S + E+ +PKF L + NL+ +L +G++ LF
Sbjct: 284 MSGMKTLEAQLTPRVVERWQKSMTNRTREVLLPKFKLEKNYNLVESLKLMGIRMLFDKNG 343
Query: 261 DLSRLTDSHIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFL 320
+++ ++D IA H+ + ++E+GT A T V S VR+ + PFL+ +
Sbjct: 344 NMAGISDQRIAIDLFKHQGTITVNEEGTQATTVTTVGFMPLS---TQVRFTVDRPFLFLI 400
Query: 321 VDKEIQSILFAGVFNEP 337
+ +LF G P
Sbjct: 401 YEHRTSCLLFMGRVANP 417
|
| >d1lj5a_ e.1.1.1 (A:) Plasminogen activator inhibitor-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 379 | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Plasminogen activator inhibitor-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 1e-56
Identities = 83/378 (21%), Positives = 146/378 (38%), Gaps = 53/378 (14%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
+F + + A+K +NV SP+ + L + T+ ++ + +D
Sbjct: 14 DFGVRVFQQVAQASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFK-----IDD 68
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKECMTAI----FPSEIQSMDFGN 116
+ + + + ++T+ IFV + + + F S ++ +DF
Sbjct: 69 KGMAPALRHLYKELMGPWNKDEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSE 128
Query: 117 EVEAARAINSWVAQETKNNIKDLIATGQVNSRTNLVLW--------------LPSTQESI 162
A IN WV TK I +L+ G V+ T LVL ST +
Sbjct: 129 VERARFIINDWVKTHTKGMISNLLGKGAVDQLTRLVLVNALYFNGQWKTPFPDSSTHRRL 188
Query: 163 IIITVLSS---------------------ELNAHILEVPYKGGNMSMFFLLPPFASQDGV 201
+ S+ ILE+PY G +SMF P +
Sbjct: 189 FHKSDGSTVSVPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAAPY----EKE 244
Query: 202 GDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPG-A 260
+ A + + P + +PKFSL E++L L +LG+ D+F A
Sbjct: 245 VPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQFQA 304
Query: 261 DLSRLTDSH-IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYF 319
D + L+D + A+ K +++++E GT A+++TAV S + P + PFL+
Sbjct: 305 DFTSLSDQEPLHVAQALQKVKIEVNESGTVASSSTAVIV---SARMAPEEIIMDRPFLFV 361
Query: 320 LVDKEIQSILFAGVFNEP 337
+ ++LF G EP
Sbjct: 362 VRHNPTGTVLFMGQVMEP 379
|
| >d1by7a_ e.1.1.1 (A:) Plasminogen activator inhibitor-2 {Human (Homo sapiens) [TaxId: 9606]} Length = 381 | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Plasminogen activator inhibitor-2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 4e-55
Identities = 93/376 (24%), Positives = 158/376 (42%), Gaps = 42/376 (11%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
F +L L A+ +N+F+SP+SI + Y S +TE + +VL+ E D
Sbjct: 9 LFALNLFKHLAKASPTQNLFLSPWSISSTMAMVYMGSRGSTEDQMAKVLQFNEVGAAADK 68
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPV----KECMTAIFPSEIQSMDFGN 116
++ L + A+ S NK+F + SE Q++DF
Sbjct: 69 IHSS-FRSLSSAINAS-TGNYLLESVNKLFGEKSASFREEYIRLCQKYYSSEPQAVDFLE 126
Query: 117 EVEA-ARAINSWVAQETKNNIKDLIATGQVNSRTNLVL---------------------- 153
E + INSWV +TK I +L+ G V+ T +VL
Sbjct: 127 CAEEARKKINSWVKTQTKGKIPNLLPEGSVDGDTRMVLVNAVYFKGKWKTPFEKKLNGLY 186
Query: 154 -WLPSTQESIIIITVLS---------SELNAHILEVPYKGGNMSMFFLLPPFASQDGVGD 203
+ ++ + + + +L A ILE+PY G L A +
Sbjct: 187 PFRVNSAQRTPVQMMYLREKLNIGYIEDLKAQILELPYAGDVSMFLLLPDEIADVSTGLE 246
Query: 204 ILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPG-ADL 262
+L + K ++D VE+ IP+F L + L L +G++D F+ G A+
Sbjct: 247 LLESEITYDKLNKWTSKDKMAEDEVEVYIPQFKLEEHYELRSILRSMGMEDAFNKGRANF 306
Query: 263 SRLTDSH-IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLV 321
S +++ + + + H+A +D++E+GT AAA T + ++ A+HPFL+ ++
Sbjct: 307 SGMSERNDLFLSEVFHQAMVDVNEEGTEAAAGTGGVMTGRTGH-GGPQFVADHPFLFLIM 365
Query: 322 DKEIQSILFAGVFNEP 337
K ILF G F+ P
Sbjct: 366 HKITNCILFFGRFSSP 381
|
| >d1xqga_ e.1.1.1 (A:) Maspin {Human (Homo sapiens) [TaxId: 9606]} Length = 378 | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Maspin species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 7e-55
Identities = 74/377 (19%), Positives = 158/377 (41%), Gaps = 51/377 (13%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
F DL L+ NV SP ++ +L A + +T + QVL D
Sbjct: 13 AFAVDLFKQLSEKEPLGNVLFSPIALSTSLSLAQVGAKGDTANEIGQVLHFENVKDVP-- 70
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKECMTAIFP----SEIQSMDFGN 116
+ + + + S + +++V+ + + + E++++DF +
Sbjct: 71 ---FGFQTVTSDVNKL-SSFYSLKLIKRLYVDKSLNLSTEFISSTKRPYAKELETVDFKD 126
Query: 117 EVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL--------------WLPSTQES 161
++E + IN+ + T + ++++A VN +T +++ T+ES
Sbjct: 127 KLEETKGQINNSIKDLTDGHFENILADNSVNDQTKILVVNAAYFVGKWMKKFSESETKES 186
Query: 162 IIIIT------------------VLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGD 203
+ +N+ I+E+P++ ++SMF LLP + G
Sbjct: 187 PFRVNKTDTKPVQMMNMEATFSMGNIDSINSKIIELPFQNKHLSMFILLPKDVEDESTGL 246
Query: 204 ILAALKKDPTSFKRFTEDSQ-NLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPG-AD 261
+ + S ++T S V+++IPKF + + ++ +L +LG+K +FS +D
Sbjct: 247 EKIEKQLNSESLSQWTNPSTMANAKVKLSIPKFKVEKMIDPKASLENLGLKHIFSEDTSD 306
Query: 262 LSRLTDSH-IAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFL 320
S ++++ +A + +HK L++ E G + + A+HPF+Y +
Sbjct: 307 FSGMSETKGVALSNVIHKVSLEITEDGGDSIEVPGARILQH-----KDELNADHPFIYII 361
Query: 321 VDKEIQSILFAGVFNEP 337
+ ++I+F G F+ P
Sbjct: 362 RHNKTRNIIFFGKFSSP 378
|
| >d1imva_ e.1.1.1 (A:) Pigment epithelium-derived factor, PEDF {Human (Homo sapiens) [TaxId: 9606]} Length = 383 | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Pigment epithelium-derived factor, PEDF species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 3e-50
Identities = 71/371 (19%), Positives = 140/371 (37%), Gaps = 49/371 (13%)
Query: 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDT 60
F +DL V ++ + NV +SP S+ AL +++ TE+ + + L + D
Sbjct: 25 NFGYDLYRVRSSMSPTTNVLLSPLSVATALSALSLGADERTESIIHRALYYD-LISSPDI 83
Query: 61 MNVYKMEKLIQGLRANADSGLTFTSTNKIFVNDKIPVKECMTAIFPSEIQS---MDFGNE 117
YK + L S ++I K+ +K A + + GN
Sbjct: 84 HGTYK-----ELLDTVTAPQKNLKSASRIVFEKKLRIKSSFVAPLEKSYGTRPRVLTGNP 138
Query: 118 VEAARAINSWVAQETKNNIKDLI---------------------ATGQVNSRTNLVLWLP 156
+ IN+WV + K + T + +T+L +
Sbjct: 139 RLDLQEINNWVQAQMKGKLARSTKEIPDEISILLLGVAHFKGQWVTKFDSRKTSLEDFYL 198
Query: 157 STQESIIIITV----------LSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGDILA 206
+ ++ + + L S+L+ I ++P G +MS+ F LP ++
Sbjct: 199 DEERTVRVPMMSDPKAVLRYGLDSDLSCKIAQLPLTG-SMSIIFFLPL----KVTQNLTL 253
Query: 207 ALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT 266
+ + F + + +PK L+ E + +L ++ ++ LF D S++T
Sbjct: 254 IEESLTSEFIHDIDRELKTVQAVLTVPKLKLSYEGEVTKSLQEMKLQSLFD-SPDFSKIT 312
Query: 267 DSHIAFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQ 326
I H+A + +E G + + + + P+ Y N PF++ L D +
Sbjct: 313 GKPIKLTQVEHRAGFEWNEDGAGTTPSPGL---QPAHLTFPLDYHLNQPFIFVLRDTDTG 369
Query: 327 SILFAGVFNEP 337
++LF G +P
Sbjct: 370 ALLFIGKILDP 380
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 342 | |||
| d2b5ti1 | 426 | Antithrombin {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uhga_ | 385 | Ovalbumin {Hen (Gallus gallus) [TaxId: 9031]} | 100.0 | |
| d1jmja_ | 420 | Heparin cofactor II (Hc-II, leuserpin 2) {Human (H | 100.0 | |
| d1lj5a_ | 379 | Plasminogen activator inhibitor-1 {Human (Homo sap | 100.0 | |
| g1hle.1 | 375 | Elastase inhibitor {Horse (Equus caballus) [TaxId: | 100.0 | |
| d1qlpa_ | 372 | Antitrypsin, alpha-1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1by7a_ | 381 | Plasminogen activator inhibitor-2 {Human (Homo sap | 100.0 | |
| d1xqga_ | 378 | Maspin {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| g1lq8.1 | 358 | Protein C inhibitor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1imva_ | 383 | Pigment epithelium-derived factor, PEDF {Human (Ho | 100.0 | |
| d1k9oi_ | 376 | Alaserpin (serpin 1) {Tobacco hornworm (Manduca se | 100.0 | |
| g1as4.1 | 369 | Antichymotrypsin, alpha-1 {Human (Homo sapiens) [T | 100.0 | |
| g1jjo.1 | 334 | Neuroserpin {Mouse (Mus musculus) [TaxId: 10090]} | 100.0 | |
| g1mtp.1 | 355 | Thermopin {Thermobifida fusca [TaxId: 2021]} | 100.0 | |
| g1m93.1 | 322 | Viral serpin crmA (cytokine response modifier prot | 100.0 |
| >d2b5ti1 e.1.1.1 (I:6-431) Antithrombin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Antithrombin species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-71 Score=525.98 Aligned_cols=329 Identities=26% Similarity=0.471 Sum_probs=290.1
Q ss_pred ChHHHHHHHHhh-cCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCC--hHHHHHHhhHHHHHHHhhh-C
Q psy7902 1 EFTFDLLTVLNN-ANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLD--KLDTMNVYKMEKLIQGLRA-N 76 (342)
Q Consensus 1 ~Fa~~l~~~l~~-~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~--~~~~~~~~~~~~~l~~l~~-~ 76 (342)
+||++||++++. .++++|+||||+||+.+|+||+.||+|+|++||.++||++.... ..+++..|+ .+...+.. .
T Consensus 52 ~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aLa~l~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~--~l~~~l~~~~ 129 (426)
T d2b5ti1 52 RFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFA--KLNCRLYRKA 129 (426)
T ss_dssp HHHHHHHHHHHHTSCTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTGGGSCHHHHHTHHHHHH--HHHHHHTSCC
T ss_pred HHHHHHHHHHHhcCCCCCEEEECHHHHHHHHHHHHHhCchHHHHHHHHhcCCCCCCcchHHHHHHHHH--HHHHHHhccC
Confidence 599999999985 46789999999999999999999999999999999999985421 234666665 56665533 3
Q ss_pred CCCceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceE
Q psy7902 77 ADSGLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNL 151 (342)
Q Consensus 77 ~~~~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~l 151 (342)
... ..+.++|++|++++++++++|++ +|+++++.+||.++++.+++ ||+|++++|+|+|.+++++++++++|.+
T Consensus 130 ~~~-~~l~~an~l~v~~~~~~~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~wv~~~T~g~I~~~~~~~~l~~~t~l 208 (426)
T d2b5ti1 130 NKA-SKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVL 208 (426)
T ss_dssp CSS-EEEEEEEEEEEETTSCCCHHHHHHHHHHHSSCCEEECTTTCHHHHHHHHHHHHHHHTTTSCSCSSCTTCSCTTCCE
T ss_pred CCC-cEEeeeehhhhcccccchHHHHHHHHHhcCCeEEEecccccHHHHHHHHHHHHHHhcCCCccCCCCccCCCchhHH
Confidence 334 88999999999999999999975 89999999999888888888 9999999999999999998999999998
Q ss_pred EE---------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCC
Q psy7902 152 VL---------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQD 199 (342)
Q Consensus 152 vl---------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~ 199 (342)
+| |++ +++.+.|+ .|++.+ .++++++|||++++++|+|+||++. .
T Consensus 209 ~Lvna~yFkg~W~~~F~~~~T~~~~F~~~~~~~v~v~mM~~~~~~~~~~~~-~~~~vveLPy~~~~~sm~iiLP~~~--~ 285 (426)
T d2b5ti1 209 VLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVA-EGTQVLELPFKGDDITMVLILPKPE--K 285 (426)
T ss_dssp EEEEEEEEEEEBSSCCCGGGCEEEEECCSSSCCEEEEEEEEEEEEEEEECG-GGCEEEEEEBTTSSEEEEEEECCSS--S
T ss_pred HHHhhhhhccccccCccccccccceeecCCCeEEEeecceeecceeeEEcc-CCeEEEEeecCCCceEEEEEecCCC--C
Confidence 87 876 34556666 344444 4899999999999999999999987 8
Q ss_pred cHHHHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCC-CCCCCCCC-C--CCeeecce
Q psy7902 200 GVGDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSP-GADLSRLT-D--SHIAFGDA 275 (342)
Q Consensus 200 ~l~~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~-~ad~s~i~-~--~~l~ls~v 275 (342)
++.++++.|+.+ .+..|... ++.+.++|.||||++++++||+++|++||++++|++ .|||++|+ + ++++|++|
T Consensus 286 ~l~~le~~L~~~--~l~~~~~~-l~~~~v~l~lPkF~i~~~~dL~~~L~~lGi~~~F~~~~Adfs~i~~~~~~~l~vs~v 362 (426)
T d2b5ti1 286 SLAKVEKELTPE--VLQEWLDE-LEEMMLCVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDA 362 (426)
T ss_dssp CHHHHHHHCCHH--HHHHHHHH-CEEEEEEEEEECEEEECCSCHHHHHHTTTCCGGGCTTTCCCTTTSCSSSSCCCCCEE
T ss_pred CHHHHHHhhhHH--HHHHHHHh-hhhccceEeeeeEEEEEeecHHHHHHHcCChhhcCCccccCccccccCCCCcEEEeE
Confidence 999999999987 99999998 799999999999999999999999999999999986 69999997 3 58999999
Q ss_pred eeeEEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCCC
Q psy7902 276 VHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEPP 338 (342)
Q Consensus 276 ~q~~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~ 338 (342)
+|++.|+|||+|++|+|+|.+....++.+..++.|++||||+|+|+|+.||.|||+|+|.||+
T Consensus 363 ~hka~ieVdE~GteAaa~T~~~~~~~s~~~~~~~f~~drPFlF~I~d~~t~~iLF~G~v~~Pt 425 (426)
T d2b5ti1 363 FHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVCFKANRPFLVFIREVPLNTIIFMGRVANPC 425 (426)
T ss_dssp EEEEEEEECSSEESCCCCCCCCCSCCCCCTTCCCEECCSCEEEEEEETTTCCEEEEEEESCCC
T ss_pred EEEEEEEECCCceeccccceeeeccccCCCCCcEEEecCCEEEEEEECCCCCEEEEEEecCCC
Confidence 999999999999999999987766555555678999999999999999999999999999996
|
| >d1uhga_ e.1.1.1 (A:) Ovalbumin {Hen (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Ovalbumin species: Hen (Gallus gallus) [TaxId: 9031]
Probab=100.00 E-value=1.4e-69 Score=509.44 Aligned_cols=327 Identities=23% Similarity=0.487 Sum_probs=291.3
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCC-----------ChHHHHHHhhHHHH
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENL-----------DKLDTMNVYKMEKL 69 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~-----------~~~~~~~~~~~~~~ 69 (342)
+||++||+++...++++|+|+||+||+.+|+||++||+|+|++||.++||++... ...++++.++ .+
T Consensus 9 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~Laml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 86 (385)
T d1uhga_ 9 EFCFDVFKELKVHHANENIFYCPIAIMSALAMVYLGAKDSTRTQINKVVRFDKLPGFGDSIEAQCGTSVNVHSSLR--DI 86 (385)
T ss_dssp HHHHHHHHHHHHHCTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHHTCTTCTTCSHHHHTTTTSCTTTTHHHH--HH
T ss_pred HHHHHHHHHHhccCcCCcEEECHHHHHHHHHHHHHhCChHHHHHHHHHhCCCCCccccchhhhhcccHHHHHHHHH--HH
Confidence 5999999999888889999999999999999999999999999999999997521 2234567776 67
Q ss_pred HHHhhhCCCCceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCC
Q psy7902 70 IQGLRANADSGLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQ 144 (342)
Q Consensus 70 l~~l~~~~~~~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~ 144 (342)
+..+...++. ..+.++|++|++++++++++|.+ +|+++++.+||..+++.+++ ||+|++++|+|+|.+++++.+
T Consensus 87 ~~~~~~~~~~-~~l~~~~~l~v~~~~~~~~~f~~~~~~~y~~~~~~~df~~~~~~a~~~IN~wv~~~T~g~i~~~v~~~~ 165 (385)
T d1uhga_ 87 LNQITKPNDV-YSFSLASRLYAEERYPILPEYLQCVKELYRGGLEPINFQTAADQARELINSWVESQTNGIIRNVLQPSS 165 (385)
T ss_dssp HHHHTSCCSS-EEEEEEEEEEEETTSCBCHHHHHHHHHHCSSCEEEECCTTTHHHHHHHHHHHHHHHTTTCSCCCSCTTS
T ss_pred HHHhhCCCCC-ceEEEEEEEEEecCccccHHHHHHHHHHhCCcccccccccHHHHHHHHHHHHHHHHccCCccccCCccC
Confidence 7777666566 88999999999999999999976 89999999999878888887 999999999999999999889
Q ss_pred CCCCceEEE---------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEe
Q psy7902 145 VNSRTNLVL---------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLL 192 (342)
Q Consensus 145 i~~~t~lvl---------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iil 192 (342)
+++++.+++ |+. +++.+.|+ +|++++++++++++|||++++++|+|+|
T Consensus 166 l~~~t~l~lina~~f~~~W~~~F~~~~t~~~~F~~~~~~~~~v~~m~~~~~~~~~~~~~~~~~~v~Lpy~~~~~sm~iil 245 (385)
T d1uhga_ 166 VDSQTAMVLVNAIVFKGLWEKAFKDEDTQAMPFRVTEQESKPVQMMYQIGLFRVASMASEKMKILELPFASGTMSMLVLL 245 (385)
T ss_dssp SCTTCCEEEEEEEEEEECEEECCCGGGCEEEEECCCC--CEEEEEEEEEEEEEEEEEGGGTEEEEEEEBTTSSEEEEEEE
T ss_pred CCcccceeeeeeEEEecccccccccccccccccccCCCceeeehhheeccccccccccccCcEEEEccccCCCeEEEEEE
Confidence 999999887 876 34445555 7888999999999999999999999999
Q ss_pred CCCCCCCcHHHHHHHhcCCchHHHHHhhh-cCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC-CCCe
Q psy7902 193 PPFASQDGVGDILAALKKDPTSFKRFTED-SQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-DSHI 270 (342)
Q Consensus 193 P~~~~~~~l~~l~~~L~~~~~~l~~~~~~-~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~-~~~l 270 (342)
|++. .++.++++.|... .+..|... .++.+.|+|.||||++++++||+++|++||++++|++.|||++|+ ++++
T Consensus 246 P~~~--~~l~~~~~~l~~~--~l~~~~~~~~~~~~~v~l~lPkF~i~~~~dl~~~L~~lGl~~~F~~~adfs~is~~~~l 321 (385)
T d1uhga_ 246 PDEV--SGLEQLESIINFE--KLTEWTSSNVMEERKIKVYLPRMKMEEKYNLTSVLMAMGITDVFSSSANLSGISSAESL 321 (385)
T ss_dssp ESST--TCHHHHHHHCCHH--HHHHHTSTTTCEEEEEEEEEECEEEEEEEEHHHHHHHHTCCGGGSTTCCCTTTBCSTTC
T ss_pred CCcc--Cchhhhhhhcchh--hHHHHhhhhcccceEEEEEeeeEEeecceeHHHHHHhcCCchhhcCCCCcccCCCCCCc
Confidence 9988 8999999999987 88888753 256789999999999999999999999999999999889999999 7889
Q ss_pred eecceeeeEEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCC
Q psy7902 271 AFGDAVHKARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337 (342)
Q Consensus 271 ~ls~v~q~~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P 337 (342)
+|++++|++.|+|||+|++|+++|.......+ .+.+|++||||+|+|+|+.|+.|||+|+|.||
T Consensus 322 ~vs~i~q~~~i~v~E~Gt~a~a~t~~~~~~~~---~~~~f~~drPF~f~I~~~~t~~~lf~G~v~~P 385 (385)
T d1uhga_ 322 KISQAVHAAHAEINEAGREVVGSAEAGVDAAS---VSEEFRADHPFLFCIKHIATNAVLFFGRCVSP 385 (385)
T ss_dssp CEEEEEEEEEEEECSCEEECCCHHHHHHHHTT---CCCEEECCSCEEEEEEETTTCCEEEEEEESCC
T ss_pred eeeeEEEEEEEEECCCCcccccccccccccCC---CCCEEEecCCEEEEEEECCCCcEEEEEEecCC
Confidence 99999999999999999999999886655433 45789999999999999999999999999999
|
| >d1jmja_ e.1.1.1 (A:) Heparin cofactor II (Hc-II, leuserpin 2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Heparin cofactor II (Hc-II, leuserpin 2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-69 Score=511.67 Aligned_cols=325 Identities=24% Similarity=0.455 Sum_probs=289.5
Q ss_pred ChHHHHHHHHhhc-CCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCC------CCChHHHHHHhhHHHHHHHh
Q psy7902 1 EFTFDLLTVLNNA-NKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPE------NLDKLDTMNVYKMEKLIQGL 73 (342)
Q Consensus 1 ~Fa~~l~~~l~~~-~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~------~~~~~~~~~~~~~~~~l~~l 73 (342)
+||++||+.+... ++++|+++||+||+.+|+||+.||+|+|++||.++||++. ..+..+++..|+ .++..+
T Consensus 53 ~F~~~ly~~l~~~~~~~~Niv~SP~si~~aLaml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~~i~~~~~--~l~~~l 130 (420)
T d1jmja_ 53 KFAFNLYRVLKDQVNTFDNIFIAPVGISTAMGMISLGLKGETHEQVHSILHFKDFVNASSKYEITTIHNLFR--KLTHRL 130 (420)
T ss_dssp HHHHHHHHHHHTTSCTTSCEEECHHHHHHHHHHHGGGCCHHHHHHHHHHTTHHHHHHHCTTCCHHHHHHHHH--HHHHHH
T ss_pred HHHHHHHHHHHhhcCCCCcEEECHHHHHHHHHHHHhhcchhHHHHHHHHcCCCCcCCcccchhHHHHHHHHH--HHHHHH
Confidence 5999999999864 5679999999999999999999999999999999999863 113456777786 777777
Q ss_pred hhCCCCceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHHHHHHHHHhcccccccCccCCCCCCCc
Q psy7902 74 RANADSGLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARAINSWVAQETKNNIKDLIATGQVNSRT 149 (342)
Q Consensus 74 ~~~~~~~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~iN~wv~~~T~g~i~~~~~~~~i~~~t 149 (342)
...+.+ +.++++|++|++++++++++|++ +|+++++.+|| .++..+.+||+||+++|+|+|.+++ .+++++|
T Consensus 131 ~~~~~~-~~l~~an~l~v~~~~~~~~~f~~~~~~~y~a~~~~~df-~~~~~~~~IN~wv~~~T~g~I~~~l--~~i~~~t 206 (420)
T d1jmja_ 131 FRRNFG-YTLRSVNDLYIQKQFPILLDFKTKVREYYFAEAQIADF-SDPAFISKTNNHIMKLTKGLIKDAL--ENIDPAT 206 (420)
T ss_dssp HSCCSS-EEEEEEEEEEEETTSCCCHHHHHHHHHHSSCCEEEECT-TCHHHHHHHHHHHHHHTTTSCCCTT--SSCCTTC
T ss_pred hcCCCC-cEehhhHHHHhhCCccccHHHHHHHHHhhCceeecccc-chHHHHHHHhHhHHhccCCcccchh--cccCCcc
Confidence 766666 89999999999999999999975 89999999999 4666665699999999999999999 4688999
Q ss_pred eEEE---------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCC
Q psy7902 150 NLVL---------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFAS 197 (342)
Q Consensus 150 ~lvl---------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~ 197 (342)
.++| |++ +++.+.|+ +|++.++++|++++|||++ +++|+|+||++.
T Consensus 207 ~lvLvNa~yFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~l~~~vl~Lpy~~-~~sm~iiLP~~~- 284 (420)
T d1jmja_ 207 QMMILNCIYFKGSWVNKFPVEMTHNHNFRLNEREVVKVSMMQTKGNFLAANDQELDCDILQLEYVG-GISMLIVVPHKM- 284 (420)
T ss_dssp CEEEEEEEEEEEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEETTTTEEEEEEEETT-TEEEEEEEESST-
T ss_pred HHHHHHHHHHHhhhhccCCcccccccceecCCCceeeeeeeeeeccEEEeeccCCCEEEEEEeecC-CeeEEEEecCCC-
Confidence 9988 876 45556666 6788999999999999965 799999999987
Q ss_pred CCcHHHHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCCCCCeeecceee
Q psy7902 198 QDGVGDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLTDSHIAFGDAVH 277 (342)
Q Consensus 198 ~~~l~~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~~~~l~ls~v~q 277 (342)
.+|.++++.|+.+ .+..|.++ +..+.++|.||||++++++||+++|++||++++|++.|||++|++++++|++++|
T Consensus 285 -~~l~~l~~~l~~~--~l~~~~~~-~~~~~v~v~lPkF~i~~~~dL~~~L~~lGi~~~F~~~ad~s~is~~~l~vs~v~h 360 (420)
T d1jmja_ 285 -SGMKTLEAQLTPR--VVERWQKS-MTNRTREVLLPKFKLEKNYNLVESLKLMGIRMLFDKNGNMAGISDQRIAIDLFKH 360 (420)
T ss_dssp -THHHHHHHHCCHH--HHHHHHHT-CEEEEEEEEEECEEEEEEEECHHHHHHHTCCGGGSTTSCCTTTCSSCCCCSEEEE
T ss_pred -CchhHHHHhhCHH--HHHHHHhh-CccceEEEEEEEEEEEeEechHHHHHHcCchhhcCCCCcccccCCCCceeeeEEE
Confidence 7999999999988 99999998 6999999999999999999999999999999999988999999977899999999
Q ss_pred eEEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCCCCC
Q psy7902 278 KARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEPPNK 340 (342)
Q Consensus 278 ~~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~~~ 340 (342)
++.|+|||+|++|+|+|.+...+.+ .+..|++||||+|+|+|+.|+.|||+|+|.+|+++
T Consensus 361 ka~ieVdE~GteAaa~T~~~~~~~~---~~~~f~~drPFlF~I~d~~t~~iLF~G~v~~Ptk~ 420 (420)
T d1jmja_ 361 QGTITVNEEGTQATTVTTVGFMPLS---TQVRFTVDRPFLFLIYEHRTSCLLFMGRVANPSRS 420 (420)
T ss_dssp EEEEEECSSEESCCCCCCSCCCCSC---CSEEEECCSCEEEEEEETTTTEEEEEEEESCTTCC
T ss_pred EEEEEEcCCceeecccceeeeccCC---CCcEEEecCCEEEEEEECCCCcEEEEEEeCCCCCC
Confidence 9999999999999999987654332 46899999999999999999999999999999874
|
| >d1lj5a_ e.1.1.1 (A:) Plasminogen activator inhibitor-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Plasminogen activator inhibitor-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-68 Score=499.84 Aligned_cols=324 Identities=26% Similarity=0.456 Sum_probs=285.3
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCCc
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADSG 80 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 80 (342)
+||++||+.+..+.+++|+|+||+||+.+|+||+.||+|+|++||.++||++.. ..+++..++ .+...+.....+
T Consensus 14 ~F~~~l~~~l~~~~~~~N~v~SP~si~~~La~l~~Ga~g~T~~el~~~L~~~~~--~~~~~~~~~--~~~~~l~~~~~~- 88 (379)
T d1lj5a_ 14 DFGVRVFQQVAQASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFKID--DKGMAPALR--HLYKELMGPWNK- 88 (379)
T ss_dssp HHHHHHHHHHHHHSTTBCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHHTSCTT--STTHHHHHH--HHHHHHHCGGGS-
T ss_pred HHHHHHHHHHHhhCcCCcEEECHHHHHHHHHHHHHhCCcHHHHHHHHHhCCCCC--hHHHHHHHH--HHHHHhhCcccc-
Confidence 599999999998888999999999999999999999999999999999999854 345566665 666666554445
Q ss_pred eEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE--
Q psy7902 81 LTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL-- 153 (342)
Q Consensus 81 ~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl-- 153 (342)
..++++|++|++++++++++|++ .|+++++.+|| .+++.+++ ||+|++++|+|+|.+++++.++++++.+++
T Consensus 89 ~~l~~an~l~v~~~~~~~~~f~~~~~~~y~~~~~~vdF-~~~~~a~~~IN~wv~~~T~g~I~~~~~~~~l~~~t~~~lvn 167 (379)
T d1lj5a_ 89 DEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDF-SEVERARFIINDWVKTHTKGMISNLLGKGAVDQLTRLVLVN 167 (379)
T ss_dssp SEEEEEEEEEEETTSCCCTTHHHHHHHHHSCCCEEECT-TSHHHHHHHHHHHHHHTTTTSCCCSSCTTSSCTTCCEEEEE
T ss_pred cchhhhhHHHHhccCcccHHHHHHHHHhhcceeccccc-cchHHHHHHHHHHHHhhcCCccccccCccCCCccceeeeEe
Confidence 78999999999999999999975 79999999999 57888887 999999999999999999889999999887
Q ss_pred -------ecc---------------CCceEEec--------ceeecC---CCCeEEEEeecCCCceEEEEEeCCCCCCCc
Q psy7902 154 -------WLP---------------STQESIII--------ITVLSS---ELNAHILEVPYKGGNMSMFFLLPPFASQDG 200 (342)
Q Consensus 154 -------W~~---------------~~~~~~V~--------~~~~~~---~~~~~vvelP~~~~~~sm~iilP~~~~~~~ 200 (342)
|+. +++++.|+ +|++.+ ..++++|+|||+++++||+||||++. ..+
T Consensus 168 a~~f~~~W~~~F~~~~t~~~~F~~~~~~~~~V~~M~~~~~~~~~~~~~~~~~~~~vv~Lp~~~~~~sm~iilP~~~-~~~ 246 (379)
T d1lj5a_ 168 ALYFNGQWKTPFPDSSTHRRLFHKSDGSTVSVPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAAPYEK-EVP 246 (379)
T ss_dssp EEEEEEEBSSCCCCCTTCEEEEECTTSCEEEEEEEEEEEEEEEEEEECTTSCEEEEEEEEBTTSSEEEEEEEESST-TSC
T ss_pred eEEEeeeecCcCCccccccccccccCCceEeecceeeccceeeEEeeccccceeEEEEeecCCCcEEEEEecCCcc-ccc
Confidence 876 34556666 444444 45689999999999999999999765 348
Q ss_pred HHHHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCC-CCCCCCCC-CCCeeecceeee
Q psy7902 201 VGDILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSP-GADLSRLT-DSHIAFGDAVHK 278 (342)
Q Consensus 201 l~~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~-~ad~s~i~-~~~l~ls~v~q~ 278 (342)
+..+++.|+.. .+..+..+ +....++|.||||++++++||+++|++||++++|++ .|||++|+ +++++|++++|+
T Consensus 247 l~~l~~~l~~~--~~~~~~~~-~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~v~hk 323 (379)
T d1lj5a_ 247 LSALTNILSAQ--LISHWKGN-MTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQFQADFTSLSDQEPLHVAQALQK 323 (379)
T ss_dssp THHHHTTCCHH--HHHHHHHH-CEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGCTTTCCCTTTCSSSCCCEEEEEEE
T ss_pred hHHHhhhccHH--HHHHHHhh-ccccccEEEEEEEEEeeeecHHHHHHhCCChhhcCcccccccccCCCCCcEEeeeEEE
Confidence 99999999877 88888888 689999999999999999999999999999999997 79999999 788999999999
Q ss_pred EEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCC
Q psy7902 279 ARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337 (342)
Q Consensus 279 ~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P 337 (342)
+.|+|||+|++|+|+|.+....++ .+.+|++||||+|+|+|+.||.|||+|+|.+|
T Consensus 324 ~~iev~E~G~~a~a~t~~~~~~~~---~~~~f~~drPF~f~I~~~~t~~~lf~G~v~~P 379 (379)
T d1lj5a_ 324 VKIEVNESGTVASSSTAVIVSARM---APEEIIMDRPFLFVVRHNPTGTVLFMGQVMEP 379 (379)
T ss_dssp EEEEECSSEEEEEEEEEEEESSCC---CCCCCCBCCEEEEEEEETTTTEEEEEEEEECC
T ss_pred EEEEECCCceeecccceeeeccCC---CCCEEEeeCCEEEEEEECCCCcEEEEEEecCC
Confidence 999999999999999986544332 35689999999999999999999999999999
|
| >d1qlpa_ e.1.1.1 (A:) Antitrypsin, alpha-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Antitrypsin, alpha-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-67 Score=488.52 Aligned_cols=324 Identities=27% Similarity=0.466 Sum_probs=286.1
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCC-ChHHHHHHhhHHHHHHHhhhCCCC
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENL-DKLDTMNVYKMEKLIQGLRANADS 79 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~-~~~~~~~~~~~~~~l~~l~~~~~~ 79 (342)
+||++||+.++...+++|+|+||+||+.+|+||+.||+|+|++||.++||++... ...+++..++ .++..+.....+
T Consensus 10 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~La~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 87 (372)
T d1qlpa_ 10 EFAFSLYRQLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGFQ--ELLRTLNQPDSQ 87 (372)
T ss_dssp HHHHHHHHHHHHHCSSSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHH--HHHHHHSCSSCC
T ss_pred HHHHHHHHHHhhhCCCCcEEECHHHHHHHHHHHHHhccHHHHHHHHHHhCCCCCCCcHHHHHHHHH--HHHHHhhccCcc
Confidence 5999999999887889999999999999999999999999999999999998653 4556777776 667777655555
Q ss_pred ceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE-
Q psy7902 80 GLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL- 153 (342)
Q Consensus 80 ~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl- 153 (342)
..+.++|++|+++++++.++|.+ +|+++++.+|| .+++.+++ ||+|++++|+|+|.++++ ++++++.+++
T Consensus 88 -~~l~~~n~i~~~~~~~l~~~f~~~~~~~f~~~~~~~df-~~~~~~~~~iN~wv~~~T~g~i~~~~~--~~~~~t~l~li 163 (372)
T d1qlpa_ 88 -LQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNF-GDTEEAKKQINDYVEKGTQGKIVDLVK--ELDRDTVFALV 163 (372)
T ss_dssp -CCEEEEEEEEEETTCCBCHHHHHHHHHTSCCEEEEECT-TSHHHHHHHHHHHHHHHTTTSSCSCCC--CCCTTCCEEEE
T ss_pred -hhhhhheeeeeccCCccCHHHHHHHHHHhCceeecccc-cchHHHHHHHHHHHHHHhCCCCccccc--CCCCcchhhhh
Confidence 78999999999999999999976 89999999999 57777777 999999999999999994 6889998887
Q ss_pred --------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHH
Q psy7902 154 --------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVG 202 (342)
Q Consensus 154 --------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~ 202 (342)
|.. +++.+.|+ +|++.+++++++++|||+++.++|+++.| . .+|.
T Consensus 164 na~~f~~~W~~~F~~~~t~~~~F~~~~~~~~~V~mm~~~~~f~~~~~~~l~~~~~~lp~~~~~~~~il~~~-~---~~l~ 239 (372)
T d1qlpa_ 164 NYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHCKKLSSWVLLMKYLGNATAIFFLPD-E---GKLQ 239 (372)
T ss_dssp EEEEECCCBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEETTTEEEEEEEEC-T---TCHH
T ss_pred hhheeecccccccchhccccccccccCCceEEEeeeecccceeeeccccCCeEEEecccCCCceEEEEECC-c---CCHH
Confidence 876 33445566 78899999999999999887766655554 3 4899
Q ss_pred HHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCC-CCCeeecceeeeEEE
Q psy7902 203 DILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLT-DSHIAFGDAVHKARL 281 (342)
Q Consensus 203 ~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~-~~~l~ls~v~q~~~i 281 (342)
++++.|+.+ .+.+|..+ ++.+.++|.||||++++++||+++|++||++++|++.+||++|+ +.+++|++++|++.|
T Consensus 240 ~l~~~L~~~--~l~~~~~~-~~~~~v~v~lPkF~i~~~~dl~~~L~~lGl~~~F~~~ad~~~i~~~~~l~vs~v~q~~~i 316 (372)
T d1qlpa_ 240 HLENELTHD--IITKFLEN-EDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSNGADLSGVTEEAPLKLSKAVHKAVL 316 (372)
T ss_dssp HHHHHCCHH--HHHHHHHC-CCCEEEEEEEECEEEEEEEEHHHHTGGGTCCGGGSTTCCCTTTBSSSCCCCCEEEEEEEE
T ss_pred HHHHhhhHH--HHHHHHHh-ccceEEEEEEEEEEEeeeccHHHHHHhcCchhhhcchhhhcCcCCCCCceeeeEEEEEEE
Confidence 999999987 99999998 79999999999999999999999999999999999889999999 788999999999999
Q ss_pred EecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCCCCC
Q psy7902 282 DLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEPPNK 340 (342)
Q Consensus 282 ~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~~~ 340 (342)
+|||+|++|+++|.+....++ .+.+|+|||||+|+|+|+.||.|||+|+|.||+++
T Consensus 317 ~v~E~Gteaaa~t~~~~~~~s---~~~~f~~drPFlf~I~~~~t~~iLf~G~v~~Pt~~ 372 (372)
T d1qlpa_ 317 TIDEKGTEAAGAMFLEAIPMS---IPPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQK 372 (372)
T ss_dssp EECSCSSSSCCCCCCCCCCSS---CCCEEECCSCEEEEEEETTTCCEEEEEEESCTTCC
T ss_pred EECCCccchhhhheeecccCC---CCCeEEecCCEEEEEEECCCCcEEEEEEeCCCCCC
Confidence 999999999988876544433 35799999999999999999999999999999975
|
| >d1by7a_ e.1.1.1 (A:) Plasminogen activator inhibitor-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Plasminogen activator inhibitor-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-67 Score=494.72 Aligned_cols=330 Identities=31% Similarity=0.517 Sum_probs=272.1
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCC-ChHHHHHHhhHHHHHHHhhhCCCC
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENL-DKLDTMNVYKMEKLIQGLRANADS 79 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~-~~~~~~~~~~~~~~l~~l~~~~~~ 79 (342)
+||++||++++..++++|+|+||+||+.+|+||+.||+|+|++||.++||++... ...+++..++ .+...+.....+
T Consensus 9 ~Fa~~L~~~l~~~~~~~N~v~SP~si~~~L~~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~--~l~~~l~~~~~~ 86 (381)
T d1by7a_ 9 LFALNLFKHLAKASPTQNLFLSPWSISSTMAMVYMGSRGSTEDQMAKVLQFNEVGAAADKIHSSFR--SLSSAINASTGN 86 (381)
T ss_dssp HHHHHHHHHHHHHSSSSCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHTTTTTTCCG-GGHHHHHH--HHHHHHC-----
T ss_pred HHHHHHHHHHHhcCCCCcEEECHHHHHHHHHHHHHhcchHHHHHHHHHhCCCCCCCCHHHHHHHHH--HHHHHHhcCCCC
Confidence 4999999999988889999999999999999999999999999999999998543 3456788886 677777655555
Q ss_pred ceEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE-
Q psy7902 80 GLTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL- 153 (342)
Q Consensus 80 ~~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl- 153 (342)
..+.++|++|++++++++++|++ .|+++++.+||.++++.+++ ||+|++++|+|+|.+++++.+++++|.+++
T Consensus 87 -~~~~~~~~l~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~IN~wv~~~T~g~I~~~~~~~~l~~~t~~~lv 165 (381)
T d1by7a_ 87 -YLLESVNKLFGEKSASFREEYIRLCQKYYSSEPQAVDFLECAEEARKKINSWVKTQTKGKIPNLLPEGSVDGDTRMVLV 165 (381)
T ss_dssp --CEEEEEEEEEETTSCBCHHHHHHHHHHHCCCCEEECHHHHHHHHHHHHHHHHHHHTTTSCTTSSCTTSCCTTCCEEEE
T ss_pred -cEEeeccchhcccCCccCHHHHHHHHHhhCCceeccccccchHHHHHHHHHHHHHhhcCCccccCCcccCCCccHhhhh
Confidence 77999999999999999999975 89999999999665667777 999999999999999999889999999988
Q ss_pred --------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCC--CCc
Q psy7902 154 --------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFAS--QDG 200 (342)
Q Consensus 154 --------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~--~~~ 200 (342)
|++ +++++.|+ .|++.++++|++|+|||++ +.+|+++||+... ...
T Consensus 166 na~~fk~~W~~~F~~~~t~~~~F~~~~~~~~~V~mm~~~~~~~~~~~~~~~~~~v~lp~~~-~~~m~iilp~~~~~~~~~ 244 (381)
T d1by7a_ 166 NAVYFKGKWKTPFEKKLNGLYPFRVNSAQRTPVQMMYLREKLNIGYIEDLKAQILELPYAG-DVSMFLLLPDEIADVSTG 244 (381)
T ss_dssp EEEEECCCBSSCCEECC---EEEEEETTEEEEECEEEEEEEEEEEEETTTTEEEEEEEETT-TEEEEEEEESSCCSSSSS
T ss_pred heeEEeecccCCCccccccccccccCCCeeEEEeeeeeccccccccccCcCeEEEEeccCC-CeEEEEEecCCccchhhh
Confidence 877 34555566 7888999999999999954 6899999997651 134
Q ss_pred HHHHHHHhcCCchHHHHHhhh-cCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCC-CCCCCCCC-CCCeeecceee
Q psy7902 201 VGDILAALKKDPTSFKRFTED-SQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSP-GADLSRLT-DSHIAFGDAVH 277 (342)
Q Consensus 201 l~~l~~~L~~~~~~l~~~~~~-~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~-~ad~s~i~-~~~l~ls~v~q 277 (342)
+..+++.++.+ .+..|... .|..+.|+|.||||+|++++||+++|++||++++|++ .|||++|+ +.+++|++++|
T Consensus 245 l~~~~~~~~~~--~~~~~~~~~~~~~~~v~v~lPkF~i~~~~dl~~~L~~lGi~~~F~~~~Adfs~is~~~~l~vs~i~q 322 (381)
T d1by7a_ 245 LELLESEITYD--KLNKWTSKDKMAEDEVEVYIPQFKLEEHYELRSILRSMGMEDAFNKGRANFSGMSERNDLFLSEVFH 322 (381)
T ss_dssp CHHHHHHCCHH--HHHHHTSTTTEEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGCTTTCCCTTTBSCSCCCCCEEEE
T ss_pred hHHhhhhccHH--HHHHHhhhhcccceeEEEecccEEEEeeechHHHHHhcCchhhhccccccccccCCCCCceEeeEEE
Confidence 77888888877 88888643 2467899999999999999999999999999999997 69999999 78899999999
Q ss_pred eEEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCC
Q psy7902 278 KARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337 (342)
Q Consensus 278 ~~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P 337 (342)
++.|+|||+|++|+|+|......++. ..+.+|++||||+|+|+|+.|+.|||+|+|.+|
T Consensus 323 ~~~ieVdE~Gt~aaa~t~~~~~~~~~-~~~~~f~~nrPF~f~I~d~~t~~iLF~G~v~~P 381 (381)
T d1by7a_ 323 QAMVDVNEEGTEAAAGTGGVMTGRTG-HGGPQFVADHPFLFLIMHKITNCILFFGRFSSP 381 (381)
T ss_dssp EEEEEECSCBC------------------CCEEECCSCEEEEEEETTTTEEEEEEEECCC
T ss_pred EEEEEECCCccccccccceeeecccC-CCCCEEEecCCEEEEEEECCCCCEEEEEEecCC
Confidence 99999999999999999876555443 346799999999999999999999999999999
|
| >d1xqga_ e.1.1.1 (A:) Maspin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Maspin species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-68 Score=496.38 Aligned_cols=324 Identities=23% Similarity=0.457 Sum_probs=285.3
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCCc
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADSG 80 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 80 (342)
+||++||+++...++++|+|+||+||+.+|+||+.||+|+|+.||.++||++.. .+++..|+ .+...+......
T Consensus 13 ~Fa~~L~~~l~~~~~~~N~v~SP~si~~~L~~l~~Ga~g~T~~el~~~L~~~~~---~~~~~~~~--~~~~~~~~~~~~- 86 (378)
T d1xqga_ 13 AFAVDLFKQLSEKEPLGNVLFSPIALSTSLSLAQVGAKGDTANEIGQVLHFENV---KDVPFGFQ--TVTSDVNKLSSF- 86 (378)
T ss_dssp HHHHHHHHHHHHHSTTSCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHTTGGGC---SSHHHHHH--HHHHHHHHHTTT-
T ss_pred HHHHHHHHHHHhhCCCCcEEECHHHHHHHHHHHHHhCChHHHHHHHHHhCCCCh---HHHHHHHH--HHHHHHhcccCC-
Confidence 599999999998788999999999999999999999999999999999999743 35666665 556666554445
Q ss_pred eEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE--
Q psy7902 81 LTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL-- 153 (342)
Q Consensus 81 ~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl-- 153 (342)
..++++|++|++++++++++|++ +|+++++.+||.++++.++. ||+|++++|+|+|++++++.++++++.+++
T Consensus 87 ~~l~~~~~l~~~~~~~~~~~f~~~~~~~y~~~v~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~~~~~~~~~~t~~~l~n 166 (378)
T d1xqga_ 87 YSLKLIKRLYVDKSLNLSTEFISSTKRPYAKELETVDFKDKLEETKGQINNSIKDLTDGHFENILADNSVNDQTKILVVN 166 (378)
T ss_dssp SSEEEEEEEEEETTSCCCHHHHHHTTTTTTTCEEEECHHHHHHHHHHHHHHHHHHHTTTSCSCCSCTTSCCTTCCEEEEE
T ss_pred ceEEEeechhhcccccccHHHHHHhhhhccceeEeccccchhhHHHHHHHHHHHHhccCCcccccCCCCCCCCceEEEEE
Confidence 77999999999999999999976 78999999999766777887 999999999999999999889999999877
Q ss_pred -------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCC--CCcH
Q psy7902 154 -------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFAS--QDGV 201 (342)
Q Consensus 154 -------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~--~~~l 201 (342)
|+. +++.+.|+ +|++.+++++++|+|||++++++|+||||++.+ ..+|
T Consensus 167 a~~f~~~W~~~F~~~~T~~~~F~~~~~~~~~v~mm~~~~~~~~~~~~~l~~~vv~Lp~~~~~~sm~iilP~~~~~~~~~L 246 (378)
T d1xqga_ 167 AAYFVGKWMKKFSESETKESPFRVNKTDTKPVQMMNMEATFSMGNIDSINSKIIELPFQNKHLSMFILLPKDVEDESTGL 246 (378)
T ss_dssp EEEEECCBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEEGGGTEEEEEEEBGGGSSEEEEEEESSCCSSSSSC
T ss_pred EeEEeeeecCCCccccceecceecCCCceEecccccccceeeeeeccCCCeEEEEeecCCCcEEEEEEecCccccccchH
Confidence 877 34445566 688999999999999999999999999998641 2479
Q ss_pred HHHHHHhcCCchHHHHHhhh-cCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCC-CCCCCCCC-CCCeeecceeee
Q psy7902 202 GDILAALKKDPTSFKRFTED-SQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSP-GADLSRLT-DSHIAFGDAVHK 278 (342)
Q Consensus 202 ~~l~~~L~~~~~~l~~~~~~-~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~-~ad~s~i~-~~~l~ls~v~q~ 278 (342)
.++++.|+.+ .+..|... .++...|+|.||||++++++||+++|++||++++|++ .|||++|+ +++++|++++|+
T Consensus 247 ~~l~~~l~~~--~l~~~~~~~~~~~~~v~l~lPkF~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~l~vs~i~qk 324 (378)
T d1xqga_ 247 EKIEKQLNSE--SLSQWTNPSTMANAKVKLSIPKFKVEKMIDPKASLENLGLKHIFSEDTSDFSGMSETKGVALSNVIHK 324 (378)
T ss_dssp HHHHHSCSHH--HHHHHTCGGGCEEEEEEEEEECEEEEEEECTHHHHHHHTCCGGGCTTTCCCTTTCSCSSCCEEEEEEE
T ss_pred HHHHHhcCHH--HHHHHhhhhhceeEEEEEEeeeEEEEEeechHHHHHhcCchhccCCCCCccccCCCCCCceEEEeEEE
Confidence 9999999987 89999853 2567789999999999999999999999999999998 69999999 788999999999
Q ss_pred EEEEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCC
Q psy7902 279 ARLDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337 (342)
Q Consensus 279 ~~i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P 337 (342)
+.|+|||+|++|+++|..... ..+.+|++||||+|+|+|+.|+.|||+|+|.+|
T Consensus 325 ~~i~vdE~G~~a~~~t~~~~~-----~~~~~f~~drPFlf~I~d~~t~~~Lf~G~v~~P 378 (378)
T d1xqga_ 325 VSLEITEDGGDSIEVPGARIL-----QHKDELNADHPFIYIIRHNKTRNIIFFGKFSSP 378 (378)
T ss_dssp EEEEECSCBCCCCCCTTTTTS-----SCCCCCBCCSCEEEEEEETTTTEEEEEEEECCC
T ss_pred EEEEEccCccccccccccccC-----CCCCEEEccCCEEEEEEECCCCCEEEEEEecCC
Confidence 999999999999888765332 235789999999999999999999999999999
|
| >d1imva_ e.1.1.1 (A:) Pigment epithelium-derived factor, PEDF {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Pigment epithelium-derived factor, PEDF species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-67 Score=491.85 Aligned_cols=320 Identities=22% Similarity=0.407 Sum_probs=276.6
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCCc
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADSG 80 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 80 (342)
+||++||++++..++++|+|+||+||+.+|+||+.||+|+|++||.++|+++.. +..+++..|+ +++..+....
T Consensus 25 ~F~~~L~~~l~~~~~~~Niv~SP~si~~~L~~l~~Ga~g~T~~el~~~L~~~~~-~~~~~~~~~~--~l~~~~~~~~--- 98 (383)
T d1imva_ 25 NFGYDLYRVRSSMSPTTNVLLSPLSVATALSALSLGADERTESIIHRALYYDLI-SSPDIHGTYK--ELLDTVTAPQ--- 98 (383)
T ss_dssp HHHHHHHHHHHHHCTTSCEEECHHHHHHHHHHHGGGCCHHHHHHHHHHTTGGGC-CCSCHHHHHH--HHHHHHTSTT---
T ss_pred HHHHHHHHHHhccCcCCcEEECHHHHHHHHHHHHHhcChHHHHHHHHHhCCCCC-ChHHHHHHHH--HHHHhhhcCC---
Confidence 499999999998888999999999999999999999999999999999998754 4456788887 7777765443
Q ss_pred eEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE--
Q psy7902 81 LTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL-- 153 (342)
Q Consensus 81 ~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl-- 153 (342)
..++++|++|++++++++++|.+ +|++.++.+|| +++.+.+ ||+|++++|+|+|.+++ .++++++.+++
T Consensus 99 ~~l~~~n~i~v~~~~~~~~~f~~~~~~~y~~~~~~~~~--~~~~~~~~IN~wv~~~T~g~I~~~~--~~~~~~t~~~lvn 174 (383)
T d1imva_ 99 KNLKSASRIVFEKKLRIKSSFVAPLEKSYGTRPRVLTG--NPRLDLQEINNWVQAQMKGKLARST--KEIPDEISILLLG 174 (383)
T ss_dssp SCEEEEEEEEECTTCCCCHHHHHHHHHHHCCCCEECCS--CHHHHHHHHHHHHHHHTTTCSCCCC--SCCCSSCSEEEEE
T ss_pred cchHHHHHHHhccCCccchHHHHHHHhhcCceeeeccc--cHHHHHHHHHHHHHhhCcccccccc--cccCccceeeeec
Confidence 45899999999999999999976 79999999998 3566666 99999999999999988 57888898887
Q ss_pred -------ecc---------------CCceEEec---------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHH
Q psy7902 154 -------WLP---------------STQESIII---------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVG 202 (342)
Q Consensus 154 -------W~~---------------~~~~~~V~---------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~ 202 (342)
|.+ +++.+.|+ .|++.+++++++++|||++ +++|++|||++. ..++.
T Consensus 175 a~~fk~~W~~~F~~~~t~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~~vv~lp~~~-~~sm~iiLP~~~-~~~l~ 252 (383)
T d1imva_ 175 VAHFKGQWVTKFDSRKTSLEDFYLDEERTVRVPMMSDPKAVLRYGLDSDLSCKIAQLPLTG-SMSIIFFLPLKV-TQNLT 252 (383)
T ss_dssp EEEEECCEEECCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEEETTTTEEEEEEEETT-TEEEEEEEESSC-CSCCH
T ss_pred ceeeecccccccccccccccccccCCCeEEEeecccccccceeeeeccccceEEEEeecCC-CeEEEEEEeccc-CCChH
Confidence 876 34555565 5778899999999999965 799999999875 35799
Q ss_pred HHHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCCCCCCCCCCCCCeeecceeeeEEEE
Q psy7902 203 DILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSPGADLSRLTDSHIAFGDAVHKARLD 282 (342)
Q Consensus 203 ~l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~~ad~s~i~~~~l~ls~v~q~~~i~ 282 (342)
.+++.++.+ .+..|... ++.+.++|.||||++++++||+++|++||++++|+. |||++|++++++|++++|++.|+
T Consensus 253 ~l~~~l~~~--~l~~~~~~-~~~~~v~v~lPkF~i~~~~dL~~~L~~lGl~~~F~~-adfs~is~~~l~vs~v~hka~ie 328 (383)
T d1imva_ 253 LIEESLTSE--FIHDIDRE-LKTVQAVLTVPKLKLSYEGEVTKSLQEMKLQSLFDS-PDFSKITGKPIKLTQVEHRAGFE 328 (383)
T ss_dssp HHHTTCCHH--HHHHHHHH-CEEEEEEEEEECEEEEEEEECHHHHHTTTTTHHHHS-CCCTTTCSSCCCEEEEEEEEEEE
T ss_pred HHhhhccHH--HHHHHHhh-ccceEEEEeeceEEEeeecchhHhhhhcchhhhccc-cCccccCCCCcEeeeEEEEEEEE
Confidence 999999887 89999988 799999999999999999999999999999999985 99999997779999999999999
Q ss_pred ecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCCCC
Q psy7902 283 LDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEPPN 339 (342)
Q Consensus 283 v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P~~ 339 (342)
|||+|++|+++|.+.... ...+.+|++||||+|+|+|+.||.|||+|+|.||..
T Consensus 329 VdE~G~~a~a~t~~~~~~---~~~~~~f~~drPF~f~I~~~~t~~iLF~G~v~~P~~ 382 (383)
T d1imva_ 329 WNEDGAGTTPSPGLQPAH---LTFPLDYHLNQPFIFVLRDTDTGALLFIGKILDPRG 382 (383)
T ss_dssp ECSCEEECC--------C---CCCCCEEECCSCEEEEEEETTTCCEEEEEEESCTTC
T ss_pred ECCCccccccccceeccc---CCCCcEEEecCCEEEEEEECCCCcEEEEEEecCCCC
Confidence 999999999888754332 234689999999999999999999999999999973
|
| >d1k9oi_ e.1.1.1 (I:) Alaserpin (serpin 1) {Tobacco hornworm (Manduca sexta) [TaxId: 7130]} | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Alaserpin (serpin 1) species: Tobacco hornworm (Manduca sexta) [TaxId: 7130]
Probab=100.00 E-value=8.1e-67 Score=489.06 Aligned_cols=322 Identities=30% Similarity=0.468 Sum_probs=278.8
Q ss_pred ChHHHHHHHHhhcCCCCcEEEChHHHHHHHHHHHhhcchhHHHHHHHhhCCCCCCChHHHHHHhhHHHHHHHhhhCCCCc
Q psy7902 1 EFTFDLLTVLNNANKGKNVFVSPFSIYQALLTAYFISNKNTEANLKQVLRLPENLDKLDTMNVYKMEKLIQGLRANADSG 80 (342)
Q Consensus 1 ~Fa~~l~~~l~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~ql~~~L~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 80 (342)
+||++||+++.+.++++|+|+||+||+.+|+||+.||+|+|++||.++||++.. ......++ .+...+. ...+
T Consensus 15 ~F~~~l~~~~~~~~~~~N~v~SP~si~~~La~l~~ga~g~T~~el~~~L~~~~~---~~~~~~~~--~l~~~~~-~~~~- 87 (376)
T d1k9oi_ 15 QFTAQMFSEVVKANPGQNVVLSAFSVLPPLGQLALASVGESHDELLRALALPND---NVTKDVFA--DLNRGVR-AVKG- 87 (376)
T ss_dssp HHHHHHHHHHHTTSTTSCEEECSGGGHHHHHHHTTTBCTHHHHHHHHHTTCSCT---THHHHHHH--HHTSSCS-CCSS-
T ss_pred HHHHHHHHHHHhhCCCCeEEECHHHHHHHHHHHHHhcChHHHHHHHHHcCCCCc---chHHHHHH--HHHHHHh-hcCC-
Confidence 599999999998888999999999999999999999999999999999999853 23344443 3322332 2234
Q ss_pred eEEEEEeeeeccCCCCchhhHhh----hcCCceEEecCCCCHHHHHH-HHHHHHHhcccccccCccCCCCCCCceEEE--
Q psy7902 81 LTFTSTNKIFVNDKIPVKECMTA----IFPSEIQSMDFGNEVEAARA-INSWVAQETKNNIKDLIATGQVNSRTNLVL-- 153 (342)
Q Consensus 81 ~~l~~~n~l~~~~~~~l~~~f~~----~~~~~~~~vdf~~~~~~~~~-iN~wv~~~T~g~i~~~~~~~~i~~~t~lvl-- 153 (342)
..++++|++|++++++++++|.+ +|+++++.+||. ++..+.+ ||+|++++|+|+|++++++.++++++.+++
T Consensus 88 ~~~~~~~~i~~~~~~~~~~~f~~~~~~~y~~~~~~vdf~-~~~~a~~~IN~wv~~~T~g~I~~~~~~~~l~~~~~~~lvn 166 (376)
T d1k9oi_ 88 VDLKMASKIYVAKGLELNDDFAAVSRDVFGSEVQNVDFV-KSVEAAGAINKWVEDQTNNRIKNLVDPDALDETTRSVLVN 166 (376)
T ss_dssp BCCEEEEEEEEESSCCBCSGGGSTTTSSSCCCEEEECTT-SHHHHHHHHHHHHHHHTTTSSCCCSCGGGCCTTCCEEEEE
T ss_pred CcEEEeeehhhhcCCCcchHHHHHHHhhcCceeeccccc-ccHHHHHHHHHHHHHhhCCceeeccCCCCCCcchhhhhhh
Confidence 67999999999999999999976 789999999996 5555666 999999999999999999889999998887
Q ss_pred -------ecc---------------CCceEEec--------ceeecCCCCeEEEEeecCCCceEEEEEeCCCCCCCcHHH
Q psy7902 154 -------WLP---------------STQESIII--------ITVLSSELNAHILEVPYKGGNMSMFFLLPPFASQDGVGD 203 (342)
Q Consensus 154 -------W~~---------------~~~~~~V~--------~~~~~~~~~~~vvelP~~~~~~sm~iilP~~~~~~~l~~ 203 (342)
|++ +++.+.|+ +|++.++++|++|||||++++++|++|||++. .++..
T Consensus 167 a~~f~~~W~~~F~~~~t~~~~F~~~~~~~~~v~~m~~~~~~~~~~~~~l~~~vveLP~~~~~~sm~iilP~~~--~~l~~ 244 (376)
T d1k9oi_ 167 AIYFKGSWKDKFVKERTMDRDFHVSKDKTIKVPTMIGKKDVRYADVPELDAKMIEMSYEGDQASMIIILPNQV--DGITA 244 (376)
T ss_dssp EEEEEBCBSSCCCGGGCEEEEECSSSSCCEEEEEEEEEEEEEEEEETTTTEEEEEEEBGGGSEEEEEEEESST--TTHHH
T ss_pred hhhhhhhhcCCCCccccccceeecCCCceEEEEeeeecccEEEEeeCCCCEEEEEeecCCCceEEEEEecCCC--cchhH
Confidence 876 34455565 78899999999999999999999999999987 89999
Q ss_pred HHHHhcCCchHHHHHhhhcCCCeeEEEEeeeeEEeeccchHHHHhhCCCccCCCC-CCCCCCCC--CCCeeecceeeeEE
Q psy7902 204 ILAALKKDPTSFKRFTEDSQNLKPVEIAIPKFSLTQEMNLIPTLSDLGVKDLFSP-GADLSRLT--DSHIAFGDAVHKAR 280 (342)
Q Consensus 204 l~~~L~~~~~~l~~~~~~~l~~~~v~l~lPkF~i~~~~dl~~~L~~lG~~~~F~~-~ad~s~i~--~~~l~ls~v~q~~~ 280 (342)
++++|.... .+..|... +..+.++|.||||++++++||+++|++||++++|++ .|||++|+ +++++|++++|++.
T Consensus 245 ~~~~l~~~~-~~~~~~~~-~~~~~v~v~lPkF~i~~~~~l~~~L~~lGl~~~F~~~~ad~s~~~~~~~~l~vs~v~q~~~ 322 (376)
T d1k9oi_ 245 LEQKLKDPK-ALSRAEER-LYNTEVEITLPKFKIETTTDLKEVLSNMNIKKLFTPGAARLENLLKTKESLTVDAAIQKAF 322 (376)
T ss_dssp HHHHTTSTT-TTTTTTTS-CEEEEEEEEEECEEEEEEEEHHHHHHTTTCCSTTSTTTSCBTTTBSSCCCCCCSEEEEEEE
T ss_pred HHhhhcchh-hHHHHHhh-ccceEEEEEeeeEEEeeeecHHHHhhhcCCccccCccccccccccCCCCCEEEEeeEEEEE
Confidence 999997641 56667766 578899999999999999999999999999999998 69999997 46899999999999
Q ss_pred EEecCCCccccccchhhhcccCCCCCCceEEecCCeEEEEEeCCCCcEEEEEEEcCC
Q psy7902 281 LDLDEQGTTAAAATAVFAFRSSRPLEPVRYEANHPFLYFLVDKEIQSILFAGVFNEP 337 (342)
Q Consensus 281 i~v~E~G~~a~a~t~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~ilf~G~v~~P 337 (342)
|+|||+|++|+|+|.+....++.+ ...+|++||||+|+|++. ++|||+|+|.+|
T Consensus 323 ievdE~G~~a~a~t~~~~~~~~~~-~~~~f~~drPF~f~I~~~--~~~lf~G~v~~P 376 (376)
T d1k9oi_ 323 IEVNEEGAEAAAANAFGIVPKSLI-LYPEVHIDRPFYFELKID--GIPMFNGKVIEP 376 (376)
T ss_dssp EEECSCBSSCSSSCCSSSEESCCC-CCCEEECCSCEEEEEEES--SSEEEEEEESCC
T ss_pred EEECCCceeeecccceeeeccCCC-CCCeEEeeCCEEEEEEEC--CeEEEEEEecCC
Confidence 999999999999998776655543 346899999999999985 899999999999
|